 
# GREAT version 3.0.0	Species assembly: hg19	Association rule: Basal+extension: 5000 bp upstream, 1000 bp downstream, 1000000 bp max extension, curated regulatory domains included
# Ontology summary statistics are provided in the footer.
#
# Ontology	ID	Desc	BinomRank	BinomP	BinomBonfP	BinomFdrQ	RegionFoldEnrich	ExpRegions	ObsRegions	GenomeFrac	SetCov	HyperRank	HyperP	HyperBonfP	HyperFdrQ	GeneFoldEnrich	ExpGenes	ObsGenes	TotalGenes	GeneSetCov	TermCov	Regions	Genes
GO Molecular Function	GO:0032181	dinucleotide repeat insertion binding	1	7.192132e-5	2.652458e-1	2.652458e-1	1.390408e+4	7.192132e-5	1	7.192132e-5	1.000000e+0	1	1.108586e-4	4.088465e-1	4.088465e-1	9.020500e+3	1.108586e-4	1	2	1.000000e+0	5.000000e-1	unnamed	MSH2
GO Molecular Function	GO:0000406	double-strand/single-strand DNA junction binding	1	7.192132e-5	2.652458e-1	2.652458e-1	1.390408e+4	7.192132e-5	1	7.192132e-5	1.000000e+0	1	1.108586e-4	4.088465e-1	4.088465e-1	9.020500e+3	1.108586e-4	1	2	1.000000e+0	5.000000e-1	unnamed	MSH2
GO Molecular Function	GO:0032139	dinucleotide insertion or deletion binding	3	7.665300e-5	2.826963e-1	9.423209e-2	1.304580e+4	7.665300e-5	1	7.665300e-5	1.000000e+0	5	1.662879e-4	6.132698e-1	1.226540e-1	6.013667e+3	1.662879e-4	1	3	1.000000e+0	3.333333e-1	unnamed	MSH2
GO Molecular Function	GO:0000404	loop DNA binding	4	1.487354e-4	5.485362e-1	1.371340e-1	6.723348e+3	1.487354e-4	1	1.487354e-4	1.000000e+0	5	1.662879e-4	6.132698e-1	1.226540e-1	6.013667e+3	1.662879e-4	1	3	1.000000e+0	3.333333e-1	unnamed	MSH2
GO Molecular Function	GO:0019237	centromeric DNA binding	5	1.500166e-4	5.532612e-1	1.106522e-1	6.665927e+3	1.500166e-4	1	1.500166e-4	1.000000e+0	13	3.325758e-4	1.000000e+0	9.434920e-2	3.006833e+3	3.325758e-4	1	6	1.000000e+0	1.666667e-1	unnamed	MSH2
GO Molecular Function	GO:0032357	oxidized purine DNA binding	6	1.847541e-4	6.813731e-1	1.135622e-1	5.412600e+3	1.847541e-4	1	1.847541e-4	1.000000e+0	1	1.108586e-4	4.088465e-1	4.088465e-1	9.020500e+3	1.108586e-4	1	2	1.000000e+0	5.000000e-1	unnamed	MSH2
GO Molecular Function	GO:0032143	single thymine insertion binding	6	1.847541e-4	6.813731e-1	1.135622e-1	5.412600e+3	1.847541e-4	1	1.847541e-4	1.000000e+0	1	1.108586e-4	4.088465e-1	4.088465e-1	9.020500e+3	1.108586e-4	1	2	1.000000e+0	5.000000e-1	unnamed	MSH2
GO Molecular Function	GO:0032142	single guanine insertion binding	8	1.868510e-4	6.891065e-1	8.613831e-2	5.351857e+3	1.868510e-4	1	1.868510e-4	1.000000e+0	5	1.662879e-4	6.132698e-1	1.226540e-1	6.013667e+3	1.662879e-4	1	3	1.000000e+0	3.333333e-1	unnamed	MSH2
GO Molecular Function	GO:0032138	single base insertion or deletion binding	9	2.268294e-4	8.365468e-1	9.294965e-2	4.408600e+3	2.268294e-4	1	2.268294e-4	1.000000e+0	9	2.217172e-4	8.176930e-1	9.085478e-2	4.510250e+3	2.217172e-4	1	4	1.000000e+0	2.500000e-1	unnamed	MSH2
GO Molecular Function	GO:0000400	four-way junction DNA binding	10	2.461580e-4	9.078307e-1	9.078307e-2	4.062431e+3	2.461580e-4	1	2.461580e-4	1.000000e+0	9	2.217172e-4	8.176930e-1	9.085478e-2	4.510250e+3	2.217172e-4	1	4	1.000000e+0	2.500000e-1	unnamed	MSH2
GO Molecular Function	GO:0032137	guanine/thymine mispair binding	11	2.501180e-4	9.224352e-1	8.385774e-2	3.998113e+3	2.501180e-4	1	2.501180e-4	1.000000e+0	5	1.662879e-4	6.132698e-1	1.226540e-1	6.013667e+3	1.662879e-4	1	3	1.000000e+0	3.333333e-1	unnamed	MSH2
GO Molecular Function	GO:0032405	MutLalpha complex binding	12	2.653420e-4	9.785813e-1	8.154844e-2	3.768722e+3	2.653420e-4	1	2.653420e-4	1.000000e+0	11	2.771465e-4	1.000000e+0	9.291966e-2	3.608200e+3	2.771465e-4	1	5	1.000000e+0	2.000000e-1	unnamed	MSH2
GO Molecular Function	GO:0032135	DNA insertion or deletion binding	13	3.083752e-4	1.000000e+0	8.748367e-2	3.242803e+3	3.083752e-4	1	3.083752e-4	1.000000e+0	13	3.325758e-4	1.000000e+0	9.434920e-2	3.006833e+3	3.325758e-4	1	6	1.000000e+0	1.666667e-1	unnamed	MSH2
GO Molecular Function	GO:0032404	mismatch repair complex binding	14	5.427240e-4	1.000000e+0	1.429690e-1	1.842557e+3	5.427240e-4	1	5.427240e-4	1.000000e+0	15	5.542930e-4	1.000000e+0	1.362822e-1	1.804100e+3	5.542930e-4	1	10	1.000000e+0	1.000000e-1	unnamed	MSH2
GO Molecular Function	GO:0030983	mismatched DNA binding	15	5.887873e-4	1.000000e+0	1.447632e-1	1.698406e+3	5.887873e-4	1	5.887873e-4	1.000000e+0	16	7.205809e-4	1.000000e+0	1.660939e-1	1.387769e+3	7.205809e-4	1	13	1.000000e+0	7.692308e-2	unnamed	MSH2
GO Molecular Function	GO:0000403	Y-form DNA binding	16	6.010731e-4	1.000000e+0	1.385473e-1	1.663691e+3	6.010731e-4	1	6.010731e-4	1.000000e+0	11	2.771465e-4	1.000000e+0	9.291966e-2	3.608200e+3	2.771465e-4	1	5	1.000000e+0	2.000000e-1	unnamed	MSH2
GO Molecular Function	GO:0000217	DNA secondary structure binding	17	1.746516e-3	1.000000e+0	3.788912e-1	5.725684e+2	1.746516e-3	1	1.746516e-3	1.000000e+0	16	7.205809e-4	1.000000e+0	1.660939e-1	1.387769e+3	7.205809e-4	1	13	1.000000e+0	7.692308e-2	unnamed	MSH2
GO Molecular Function	GO:0043531	ADP binding	18	3.353980e-3	1.000000e+0	6.871932e-1	2.981532e+2	3.353980e-3	1	3.353980e-3	1.000000e+0	18	1.385732e-3	1.000000e+0	2.839211e-1	7.216400e+2	1.385732e-3	1	25	1.000000e+0	4.000000e-2	unnamed	MSH2
GO Molecular Function	GO:0003684	damaged DNA binding	19	3.594888e-3	1.000000e+0	6.977867e-1	2.781728e+2	3.594888e-3	1	3.594888e-3	1.000000e+0	19	2.771465e-3	1.000000e+0	5.379559e-1	3.608200e+2	2.771465e-3	1	50	1.000000e+0	2.000000e-2	unnamed	MSH2
GO Molecular Function	GO:0003697	single-stranded DNA binding	20	4.825422e-3	1.000000e+0	8.898078e-1	2.072358e+2	4.825422e-3	1	4.825422e-3	1.000000e+0	20	3.602904e-3	1.000000e+0	6.643755e-1	2.775538e+2	3.602904e-3	1	65	1.000000e+0	1.538462e-2	unnamed	MSH2
GO Molecular Function	GO:0008094	DNA-dependent ATPase activity	21	6.777082e-3	1.000000e+0	1.000000e+0	1.475561e+2	6.777082e-3	1	6.777082e-3	1.000000e+0	21	3.990910e-3	1.000000e+0	7.008798e-1	2.505694e+2	3.990910e-3	1	72	1.000000e+0	1.388889e-2	unnamed	MSH2
GO Molecular Function	GO:0003690	double-stranded DNA binding	22	1.394514e-2	1.000000e+0	1.000000e+0	7.170956e+1	1.394514e-2	1	1.394514e-2	1.000000e+0	22	6.873233e-3	1.000000e+0	1.000000e+0	1.454919e+2	6.873233e-3	1	124	1.000000e+0	8.064516e-3	unnamed	MSH2
GO Molecular Function	GO:0008022	protein C-terminus binding	23	1.641438e-2	1.000000e+0	1.000000e+0	6.092218e+1	1.641438e-2	1	1.641438e-2	1.000000e+0	23	8.813259e-3	1.000000e+0	1.000000e+0	1.134654e+2	8.813259e-3	1	159	1.000000e+0	6.289308e-3	unnamed	MSH2
GO Molecular Function	GO:0000287	magnesium ion binding	24	1.834502e-2	1.000000e+0	1.000000e+0	5.451069e+1	1.834502e-2	1	1.834502e-2	1.000000e+0	24	1.036528e-2	1.000000e+0	1.000000e+0	9.647594e+1	1.036528e-2	1	187	1.000000e+0	5.347594e-3	unnamed	MSH2
GO Molecular Function	GO:0043566	structure-specific DNA binding	25	2.331952e-2	1.000000e+0	1.000000e+0	4.288253e+1	2.331952e-2	1	2.331952e-2	1.000000e+0	25	1.158472e-2	1.000000e+0	1.000000e+0	8.632057e+1	1.158472e-2	1	209	1.000000e+0	4.784689e-3	unnamed	MSH2
GO Molecular Function	GO:0042623	ATPase activity, coupled	26	2.500268e-2	1.000000e+0	1.000000e+0	3.999572e+1	2.500268e-2	1	2.500268e-2	1.000000e+0	26	1.585278e-2	1.000000e+0	1.000000e+0	6.308042e+1	1.585278e-2	1	286	1.000000e+0	3.496503e-3	unnamed	MSH2
GO Molecular Function	GO:0016887	ATPase activity	27	3.096702e-2	1.000000e+0	1.000000e+0	3.229242e+1	3.096702e-2	1	3.096702e-2	1.000000e+0	27	1.978826e-2	1.000000e+0	1.000000e+0	5.053501e+1	1.978826e-2	1	357	1.000000e+0	2.801120e-3	unnamed	MSH2
GO Molecular Function	GO:0019901	protein kinase binding	28	3.996582e-2	1.000000e+0	1.000000e+0	2.502138e+1	3.996582e-2	1	3.996582e-2	1.000000e+0	28	2.100770e-2	1.000000e+0	1.000000e+0	4.760158e+1	2.100770e-2	1	379	1.000000e+0	2.638522e-3	unnamed	MSH2
GO Molecular Function	GO:0019900	kinase binding	29	4.338612e-2	1.000000e+0	1.000000e+0	2.304885e+1	4.338612e-2	1	4.338612e-2	1.000000e+0	29	2.333574e-2	1.000000e+0	1.000000e+0	4.285273e+1	2.333574e-2	1	421	1.000000e+0	2.375297e-3	unnamed	MSH2
GO Molecular Function	GO:0032403	protein complex binding	30	5.694276e-2	1.000000e+0	1.000000e+0	1.756149e+1	5.694276e-2	1	5.694276e-2	1.000000e+0	30	3.187185e-2	1.000000e+0	1.000000e+0	3.137565e+1	3.187185e-2	1	575	1.000000e+0	1.739130e-3	unnamed	MSH2
GO Molecular Function	GO:0042803	protein homodimerization activity	31	6.175957e-2	1.000000e+0	1.000000e+0	1.619182e+1	6.175957e-2	1	6.175957e-2	1.000000e+0	31	3.198271e-2	1.000000e+0	1.000000e+0	3.126690e+1	3.198271e-2	1	577	1.000000e+0	1.733102e-3	unnamed	MSH2
GO Molecular Function	GO:0017111	nucleoside-triphosphatase activity	32	6.384690e-2	1.000000e+0	1.000000e+0	1.566247e+1	6.384690e-2	1	6.384690e-2	1.000000e+0	33	4.218170e-2	1.000000e+0	1.000000e+0	2.370696e+1	4.218170e-2	1	761	1.000000e+0	1.314060e-3	unnamed	MSH2
GO Molecular Function	GO:0016462	pyrophosphatase activity	33	6.707668e-2	1.000000e+0	1.000000e+0	1.490831e+1	6.707668e-2	1	6.707668e-2	1.000000e+0	34	4.428801e-2	1.000000e+0	1.000000e+0	2.257947e+1	4.428801e-2	1	799	1.000000e+0	1.251564e-3	unnamed	MSH2
GO Molecular Function	GO:0016818	hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides	34	6.729645e-2	1.000000e+0	1.000000e+0	1.485962e+1	6.729645e-2	1	6.729645e-2	1.000000e+0	35	4.445430e-2	1.000000e+0	1.000000e+0	2.249501e+1	4.445430e-2	1	802	1.000000e+0	1.246883e-3	unnamed	MSH2
GO Molecular Function	GO:0016817	hydrolase activity, acting on acid anhydrides	35	6.743909e-2	1.000000e+0	1.000000e+0	1.482820e+1	6.743909e-2	1	6.743909e-2	1.000000e+0	36	4.473145e-2	1.000000e+0	1.000000e+0	2.235564e+1	4.473145e-2	1	807	1.000000e+0	1.239157e-3	unnamed	MSH2
GO Molecular Function	GO:0043565	sequence-specific DNA binding	36	9.345854e-2	1.000000e+0	1.000000e+0	1.069993e+1	9.345854e-2	1	9.345854e-2	1.000000e+0	32	3.863422e-2	1.000000e+0	1.000000e+0	2.588379e+1	3.863422e-2	1	697	1.000000e+0	1.434720e-3	unnamed	MSH2
GO Molecular Function	GO:0042802	identical protein binding	37	9.800114e-2	1.000000e+0	1.000000e+0	1.020396e+1	9.800114e-2	1	9.800114e-2	1.000000e+0	37	5.360013e-2	1.000000e+0	1.000000e+0	1.865667e+1	5.360013e-2	1	967	1.000000e+0	1.034126e-3	unnamed	MSH2
GO Molecular Function	GO:0046983	protein dimerization activity	38	1.038803e-1	1.000000e+0	1.000000e+0	9.626466e+0	1.038803e-1	1	1.038803e-1	1.000000e+0	38	5.470872e-2	1.000000e+0	1.000000e+0	1.827862e+1	5.470872e-2	1	987	1.000000e+0	1.013171e-3	unnamed	MSH2
GO Molecular Function	GO:0019899	enzyme binding	39	1.157271e-1	1.000000e+0	1.000000e+0	8.641016e+0	1.157271e-1	1	1.157271e-1	1.000000e+0	39	6.485228e-2	1.000000e+0	1.000000e+0	1.541966e+1	6.485228e-2	1	1170	1.000000e+0	8.547009e-4	unnamed	MSH2
GO Molecular Function	GO:0005524	ATP binding	40	1.376192e-1	1.000000e+0	1.000000e+0	7.266427e+0	1.376192e-1	1	1.376192e-1	1.000000e+0	40	8.148107e-2	1.000000e+0	1.000000e+0	1.227279e+1	8.148107e-2	1	1470	1.000000e+0	6.802721e-4	unnamed	MSH2
GO Molecular Function	GO:0032559	adenyl ribonucleotide binding	41	1.426806e-1	1.000000e+0	1.000000e+0	7.008664e+0	1.426806e-1	1	1.426806e-1	1.000000e+0	41	8.325481e-2	1.000000e+0	1.000000e+0	1.201132e+1	8.325481e-2	1	1502	1.000000e+0	6.657790e-4	unnamed	MSH2
GO Molecular Function	GO:0030554	adenyl nucleotide binding	42	1.431520e-1	1.000000e+0	1.000000e+0	6.985581e+0	1.431520e-1	1	1.431520e-1	1.000000e+0	42	8.408625e-2	1.000000e+0	1.000000e+0	1.189255e+1	8.408625e-2	1	1517	1.000000e+0	6.591958e-4	unnamed	MSH2
GO Molecular Function	GO:0035639	purine ribonucleoside triphosphate binding	43	1.642264e-1	1.000000e+0	1.000000e+0	6.089156e+0	1.642264e-1	1	1.642264e-1	1.000000e+0	43	1.001607e-1	1.000000e+0	1.000000e+0	9.983951e+0	1.001607e-1	1	1807	1.000000e+0	5.534034e-4	unnamed	MSH2
GO Molecular Function	GO:0032550	purine ribonucleoside binding	44	1.650919e-1	1.000000e+0	1.000000e+0	6.057234e+0	1.650919e-1	1	1.650919e-1	1.000000e+0	44	1.006596e-1	1.000000e+0	1.000000e+0	9.934471e+0	1.006596e-1	1	1816	1.000000e+0	5.506608e-4	unnamed	MSH2
GO Molecular Function	GO:0001883	purine nucleoside binding	45	1.651911e-1	1.000000e+0	1.000000e+0	6.053594e+0	1.651911e-1	1	1.651911e-1	1.000000e+0	45	1.008259e-1	1.000000e+0	1.000000e+0	9.918087e+0	1.008259e-1	1	1819	1.000000e+0	5.497526e-4	unnamed	MSH2
GO Molecular Function	GO:0032549	ribonucleoside binding	46	1.652867e-1	1.000000e+0	1.000000e+0	6.050092e+0	1.652867e-1	1	1.652867e-1	1.000000e+0	46	1.008813e-1	1.000000e+0	1.000000e+0	9.912637e+0	1.008813e-1	1	1820	1.000000e+0	5.494505e-4	unnamed	MSH2
GO Molecular Function	GO:0001882	nucleoside binding	47	1.658155e-1	1.000000e+0	1.000000e+0	6.030800e+0	1.658155e-1	1	1.658155e-1	1.000000e+0	47	1.014356e-1	1.000000e+0	1.000000e+0	9.858470e+0	1.014356e-1	1	1830	1.000000e+0	5.464481e-4	unnamed	MSH2
GO Molecular Function	GO:0032555	purine ribonucleotide binding	48	1.693981e-1	1.000000e+0	1.000000e+0	5.903255e+0	1.693981e-1	1	1.693981e-1	1.000000e+0	48	1.022671e-1	1.000000e+0	1.000000e+0	9.778320e+0	1.022671e-1	1	1845	1.000000e+0	5.420054e-4	unnamed	MSH2
GO Molecular Function	GO:0017076	purine nucleotide binding	49	1.701196e-1	1.000000e+0	1.000000e+0	5.878217e+0	1.701196e-1	1	1.701196e-1	1.000000e+0	50	1.032094e-1	1.000000e+0	1.000000e+0	9.689044e+0	1.032094e-1	1	1862	1.000000e+0	5.370569e-4	unnamed	MSH2
GO Molecular Function	GO:0032553	ribonucleotide binding	50	1.708664e-1	1.000000e+0	1.000000e+0	5.852525e+0	1.708664e-1	1	1.708664e-1	1.000000e+0	49	1.030431e-1	1.000000e+0	1.000000e+0	9.704680e+0	1.030431e-1	1	1859	1.000000e+0	5.379236e-4	unnamed	MSH2
GO Molecular Function	GO:0016787	hydrolase activity	51	1.965374e-1	1.000000e+0	1.000000e+0	5.088091e+0	1.965374e-1	1	1.965374e-1	1.000000e+0	55	1.331966e-1	1.000000e+0	1.000000e+0	7.507699e+0	1.331966e-1	1	2403	1.000000e+0	4.161465e-4	unnamed	MSH2
GO Molecular Function	GO:0097367	carbohydrate derivative binding	52	1.996235e-1	1.000000e+0	1.000000e+0	5.009431e+0	1.996235e-1	1	1.996235e-1	1.000000e+0	51	1.185633e-1	1.000000e+0	1.000000e+0	8.434315e+0	1.185633e-1	1	2139	1.000000e+0	4.675082e-4	unnamed	MSH2
GO Molecular Function	GO:0000166	nucleotide binding	53	2.080686e-1	1.000000e+0	1.000000e+0	4.806107e+0	2.080686e-1	1	2.080686e-1	1.000000e+0	52	1.283188e-1	1.000000e+0	1.000000e+0	7.793089e+0	1.283188e-1	1	2315	1.000000e+0	4.319654e-4	unnamed	MSH2
GO Molecular Function	GO:1901265	nucleoside phosphate binding	54	2.081652e-1	1.000000e+0	1.000000e+0	4.803877e+0	2.081652e-1	1	2.081652e-1	1.000000e+0	53	1.283743e-1	1.000000e+0	1.000000e+0	7.789724e+0	1.283743e-1	1	2316	1.000000e+0	4.317789e-4	unnamed	MSH2
GO Molecular Function	GO:0003677	DNA binding	55	2.170876e-1	1.000000e+0	1.000000e+0	4.606435e+0	2.170876e-1	1	2.170876e-1	1.000000e+0	54	1.319772e-1	1.000000e+0	1.000000e+0	7.577068e+0	1.319772e-1	1	2381	1.000000e+0	4.199916e-4	unnamed	MSH2
GO Molecular Function	GO:0036094	small molecule binding	56	2.286651e-1	1.000000e+0	1.000000e+0	4.373209e+0	2.286651e-1	1	2.286651e-1	1.000000e+0	56	1.422870e-1	1.000000e+0	1.000000e+0	7.028048e+0	1.422870e-1	1	2567	1.000000e+0	3.895598e-4	unnamed	MSH2
GO Molecular Function	GO:0043168	anion binding	57	2.579088e-1	1.000000e+0	1.000000e+0	3.877340e+0	2.579088e-1	1	2.579088e-1	1.000000e+0	57	1.510448e-1	1.000000e+0	1.000000e+0	6.620550e+0	1.510448e-1	1	2725	1.000000e+0	3.669725e-4	unnamed	MSH2
GO Molecular Function	GO:0003676	nucleic acid binding	58	2.841930e-1	1.000000e+0	1.000000e+0	3.518736e+0	2.841930e-1	1	2.841930e-1	1.000000e+0	58	1.882933e-1	1.000000e+0	1.000000e+0	5.310863e+0	1.882933e-1	1	3397	1.000000e+0	2.943774e-4	unnamed	MSH2
GO Molecular Function	GO:0046872	metal ion binding	59	3.527991e-1	1.000000e+0	1.000000e+0	2.834474e+0	3.527991e-1	1	3.527991e-1	1.000000e+0	59	2.197217e-1	1.000000e+0	1.000000e+0	4.551211e+0	2.197217e-1	1	3964	1.000000e+0	2.522704e-4	unnamed	MSH2
GO Molecular Function	GO:0043169	cation binding	60	3.606111e-1	1.000000e+0	1.000000e+0	2.773071e+0	3.606111e-1	1	3.606111e-1	1.000000e+0	60	2.233801e-1	1.000000e+0	1.000000e+0	4.476675e+0	2.233801e-1	1	4030	1.000000e+0	2.481390e-4	unnamed	MSH2
GO Molecular Function	GO:1901363	heterocyclic compound binding	61	4.273925e-1	1.000000e+0	1.000000e+0	2.339769e+0	4.273925e-1	1	4.273925e-1	1.000000e+0	61	2.937753e-1	1.000000e+0	1.000000e+0	3.403962e+0	2.937753e-1	1	5300	1.000000e+0	1.886792e-4	unnamed	MSH2
GO Molecular Function	GO:0097159	organic cyclic compound binding	62	4.323803e-1	1.000000e+0	1.000000e+0	2.312779e+0	4.323803e-1	1	4.323803e-1	1.000000e+0	62	2.978216e-1	1.000000e+0	1.000000e+0	3.357714e+0	2.978216e-1	1	5373	1.000000e+0	1.861158e-4	unnamed	MSH2
GO Molecular Function	GO:0003824	catalytic activity	63	4.361959e-1	1.000000e+0	1.000000e+0	2.292548e+0	4.361959e-1	1	4.361959e-1	1.000000e+0	63	3.045286e-1	1.000000e+0	1.000000e+0	3.283764e+0	3.045286e-1	1	5494	1.000000e+0	1.820167e-4	unnamed	MSH2
GO Molecular Function	GO:0043167	ion binding	64	5.095070e-1	1.000000e+0	1.000000e+0	1.962682e+0	5.095070e-1	1	5.095070e-1	1.000000e+0	64	3.344604e-1	1.000000e+0	1.000000e+0	2.989891e+0	3.344604e-1	1	6034	1.000000e+0	1.657275e-4	unnamed	MSH2
GO Molecular Function	GO:0005515	protein binding	65	6.181781e-1	1.000000e+0	1.000000e+0	1.617657e+0	6.181781e-1	1	6.181781e-1	1.000000e+0	65	4.432681e-1	1.000000e+0	1.000000e+0	2.255971e+0	4.432681e-1	1	7997	1.000000e+0	1.250469e-4	unnamed	MSH2
GO Molecular Function	GO:0005488	binding	66	8.171102e-1	1.000000e+0	1.000000e+0	1.223825e+0	8.171102e-1	1	8.171102e-1	1.000000e+0	66	6.747963e-1	1.000000e+0	1.000000e+0	1.481929e+0	6.747963e-1	1	12174	1.000000e+0	8.214227e-5	unnamed	MSH2
GO Biological Process	GO:0045128	negative regulation of reciprocal meiotic recombination	1	6.982440e-5	7.289667e-1	7.289667e-1	1.432164e+4	6.982440e-5	1	6.982440e-5	1.000000e+0	1	5.542930e-5	5.786819e-1	5.786819e-1	1.804100e+4	5.542930e-5	1	1	1.000000e+0	1.000000e+0	unnamed	MSH2
GO Biological Process	GO:0031573	intra-S DNA damage checkpoint	2	3.926745e-4	1.000000e+0	1.000000e+0	2.546638e+3	3.926745e-4	1	3.926745e-4	1.000000e+0	7	3.880051e-4	1.000000e+0	5.786819e-1	2.577286e+3	3.880051e-4	1	7	1.000000e+0	1.428571e-1	unnamed	MSH2
GO Biological Process	GO:0016446	somatic hypermutation of immunoglobulin genes	3	5.538052e-4	1.000000e+0	1.000000e+0	1.805689e+3	5.538052e-4	1	5.538052e-4	1.000000e+0	9	4.988637e-4	1.000000e+0	5.786819e-1	2.004556e+3	4.988637e-4	1	9	1.000000e+0	1.111111e-1	unnamed	MSH2
GO Biological Process	GO:0000710	meiotic mismatch repair	4	5.902030e-4	1.000000e+0	1.000000e+0	1.694332e+3	5.902030e-4	1	5.902030e-4	1.000000e+0	3	2.217172e-4	1.000000e+0	7.715759e-1	4.510250e+3	2.217172e-4	1	4	1.000000e+0	2.500000e-1	unnamed	MSH2
GO Biological Process	GO:0051096	positive regulation of helicase activity	5	6.115101e-4	1.000000e+0	1.000000e+0	1.635296e+3	6.115101e-4	1	6.115101e-4	1.000000e+0	6	3.325758e-4	1.000000e+0	5.786819e-1	3.006833e+3	3.325758e-4	1	6	1.000000e+0	1.666667e-1	unnamed	MSH2
GO Biological Process	GO:0010520	regulation of reciprocal meiotic recombination	6	7.002683e-4	1.000000e+0	1.000000e+0	1.428024e+3	7.002683e-4	1	7.002683e-4	1.000000e+0	2	1.662879e-4	1.000000e+0	8.680228e-1	6.013667e+3	1.662879e-4	1	3	1.000000e+0	3.333333e-1	unnamed	MSH2
GO Biological Process	GO:0045835	negative regulation of meiosis	7	7.131409e-4	1.000000e+0	1.000000e+0	1.402248e+3	7.131409e-4	1	7.131409e-4	1.000000e+0	11	5.542930e-4	1.000000e+0	5.260744e-1	1.804100e+3	5.542930e-4	1	10	1.000000e+0	1.000000e-1	unnamed	MSH2
GO Biological Process	GO:0051095	regulation of helicase activity	8	7.573525e-4	1.000000e+0	9.883450e-1	1.320389e+3	7.573525e-4	1	7.573525e-4	1.000000e+0	9	4.988637e-4	1.000000e+0	5.786819e-1	2.004556e+3	4.988637e-4	1	9	1.000000e+0	1.111111e-1	unnamed	MSH2
GO Biological Process	GO:0043570	maintenance of DNA repeat elements	9	8.227937e-4	1.000000e+0	9.544407e-1	1.215372e+3	8.227937e-4	1	8.227937e-4	1.000000e+0	3	2.217172e-4	1.000000e+0	7.715759e-1	4.510250e+3	2.217172e-4	1	4	1.000000e+0	2.500000e-1	unnamed	MSH2
GO Biological Process	GO:0006311	meiotic gene conversion	10	8.715493e-4	1.000000e+0	9.098975e-1	1.147382e+3	8.715493e-4	1	8.715493e-4	1.000000e+0	3	2.217172e-4	1.000000e+0	7.715759e-1	4.510250e+3	2.217172e-4	1	4	1.000000e+0	2.500000e-1	unnamed	MSH2
GO Biological Process	GO:0060631	regulation of meiosis I	11	1.000185e-3	1.000000e+0	9.492665e-1	9.998152e+2	1.000185e-3	1	1.000185e-3	1.000000e+0	7	3.880051e-4	1.000000e+0	5.786819e-1	2.577286e+3	3.880051e-4	1	7	1.000000e+0	1.428571e-1	unnamed	MSH2
GO Biological Process	GO:0045910	negative regulation of DNA recombination	12	1.205328e-3	1.000000e+0	1.000000e+0	8.296495e+2	1.205328e-3	1	1.205328e-3	1.000000e+0	13	7.760102e-4	1.000000e+0	6.231959e-1	1.288643e+3	7.760102e-4	1	14	1.000000e+0	7.142857e-2	unnamed	MSH2
GO Biological Process	GO:0008340	determination of adult lifespan	13	1.285924e-3	1.000000e+0	1.000000e+0	7.776511e+2	1.285924e-3	1	1.285924e-3	1.000000e+0	12	6.651516e-4	1.000000e+0	5.786819e-1	1.503417e+3	6.651516e-4	1	12	1.000000e+0	8.333333e-2	unnamed	MSH2
GO Biological Process	GO:0006301	postreplication repair	14	1.322133e-3	1.000000e+0	9.859335e-1	7.563538e+2	1.322133e-3	1	1.322133e-3	1.000000e+0	15	9.422981e-4	1.000000e+0	6.558395e-1	1.061235e+3	9.422981e-4	1	17	1.000000e+0	5.882353e-2	unnamed	MSH2
GO Biological Process	GO:0010224	response to UV-B	15	1.339062e-3	1.000000e+0	9.319872e-1	7.467916e+2	1.339062e-3	1	1.339062e-3	1.000000e+0	14	8.868688e-4	1.000000e+0	6.613507e-1	1.127562e+3	8.868688e-4	1	16	1.000000e+0	6.250000e-2	unnamed	MSH2
GO Biological Process	GO:0045190	isotype switching	16	1.396641e-3	1.000000e+0	9.113083e-1	7.160035e+2	1.396641e-3	1	1.396641e-3	1.000000e+0	16	9.977274e-4	1.000000e+0	6.510171e-1	1.002278e+3	9.977274e-4	1	18	1.000000e+0	5.555556e-2	unnamed	MSH2
GO Biological Process	GO:0006298	mismatch repair	17	1.404574e-3	1.000000e+0	8.625737e-1	7.119598e+2	1.404574e-3	1	1.404574e-3	1.000000e+0	17	1.108586e-3	1.000000e+0	6.808022e-1	9.020500e+2	1.108586e-3	1	20	1.000000e+0	5.000000e-2	unnamed	MSH2
GO Biological Process	GO:0002381	immunoglobulin production involved in immunoglobulin mediated immune response	18	1.596204e-3	1.000000e+0	9.257983e-1	6.264863e+2	1.596204e-3	1	1.596204e-3	1.000000e+0	18	1.219445e-3	1.000000e+0	7.072781e-1	8.200455e+2	1.219445e-3	1	22	1.000000e+0	4.545455e-2	unnamed	MSH2
GO Biological Process	GO:0042771	intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator	19	1.804697e-3	1.000000e+0	9.916335e-1	5.541098e+2	1.804697e-3	1	1.804697e-3	1.000000e+0	20	1.385732e-3	1.000000e+0	7.233521e-1	7.216400e+2	1.385732e-3	1	25	1.000000e+0	4.000000e-2	unnamed	MSH2
GO Biological Process	GO:0016447	somatic recombination of immunoglobulin gene segments	20	2.138386e-3	1.000000e+0	1.000000e+0	4.676423e+2	2.138386e-3	1	2.138386e-3	1.000000e+0	20	1.385732e-3	1.000000e+0	7.233521e-1	7.216400e+2	1.385732e-3	1	25	1.000000e+0	4.000000e-2	unnamed	MSH2
GO Biological Process	GO:0016445	somatic diversification of immunoglobulins	21	2.719009e-3	1.000000e+0	1.000000e+0	3.677810e+2	2.719009e-3	1	2.719009e-3	1.000000e+0	24	1.607450e-3	1.000000e+0	6.992407e-1	6.221034e+2	1.607450e-3	1	29	1.000000e+0	3.448276e-2	unnamed	MSH2
GO Biological Process	GO:0010165	response to X-ray	22	2.893547e-3	1.000000e+0	1.000000e+0	3.455967e+2	2.893547e-3	1	2.893547e-3	1.000000e+0	19	1.274874e-3	1.000000e+0	7.005097e-1	7.843913e+2	1.274874e-3	1	23	1.000000e+0	4.347826e-2	unnamed	MSH2
GO Biological Process	GO:0002312	B cell activation involved in immune response	23	2.973792e-3	1.000000e+0	1.000000e+0	3.362710e+2	2.973792e-3	1	2.973792e-3	1.000000e+0	23	1.552020e-3	1.000000e+0	7.044821e-1	6.443214e+2	1.552020e-3	1	28	1.000000e+0	3.571429e-2	unnamed	MSH2
GO Biological Process	GO:0006119	oxidative phosphorylation	24	3.050287e-3	1.000000e+0	1.000000e+0	3.278380e+2	3.050287e-3	1	3.050287e-3	1.000000e+0	39	3.935480e-3	1.000000e+0	1.000000e+0	2.540986e+2	3.935480e-3	1	71	1.000000e+0	1.408451e-2	unnamed	MSH2
GO Biological Process	GO:0010259	multicellular organismal aging	25	3.257234e-3	1.000000e+0	1.000000e+0	3.070090e+2	3.257234e-3	1	3.257234e-3	1.000000e+0	24	1.607450e-3	1.000000e+0	6.992407e-1	6.221034e+2	1.607450e-3	1	29	1.000000e+0	3.448276e-2	unnamed	MSH2
GO Biological Process	GO:0040020	regulation of meiosis	26	3.388088e-3	1.000000e+0	1.000000e+0	2.951517e+2	3.388088e-3	1	3.388088e-3	1.000000e+0	22	1.441162e-3	1.000000e+0	6.838969e-1	6.938846e+2	1.441162e-3	1	26	1.000000e+0	3.846154e-2	unnamed	MSH2
GO Biological Process	GO:0002562	somatic diversification of immune receptors via germline recombination within a single locus	27	3.415576e-3	1.000000e+0	1.000000e+0	2.927763e+2	3.415576e-3	1	3.415576e-3	1.000000e+0	27	1.829167e-3	1.000000e+0	7.072779e-1	5.466970e+2	1.829167e-3	1	33	1.000000e+0	3.030303e-2	unnamed	MSH2
GO Biological Process	GO:0072332	intrinsic apoptotic signaling pathway by p53 class mediator	28	3.493815e-3	1.000000e+0	1.000000e+0	2.862201e+2	3.493815e-3	1	3.493815e-3	1.000000e+0	29	2.050884e-3	1.000000e+0	7.383182e-1	4.875946e+2	2.050884e-3	1	37	1.000000e+0	2.702703e-2	unnamed	MSH2
GO Biological Process	GO:0002200	somatic diversification of immune receptors	29	3.636505e-3	1.000000e+0	1.000000e+0	2.749893e+2	3.636505e-3	1	3.636505e-3	1.000000e+0	28	1.995455e-3	1.000000e+0	7.440197e-1	5.011389e+2	1.995455e-3	1	36	1.000000e+0	2.777778e-2	unnamed	MSH2
GO Biological Process	GO:0008630	intrinsic apoptotic signaling pathway in response to DNA damage	30	3.654312e-3	1.000000e+0	1.000000e+0	2.736493e+2	3.654312e-3	1	3.654312e-3	1.000000e+0	32	2.826894e-3	1.000000e+0	9.222742e-1	3.537451e+2	2.826894e-3	1	51	1.000000e+0	1.960784e-2	unnamed	MSH2
GO Biological Process	GO:0051445	regulation of meiotic cell cycle	31	3.735738e-3	1.000000e+0	1.000000e+0	2.676847e+2	3.735738e-3	1	3.735738e-3	1.000000e+0	26	1.718308e-3	1.000000e+0	6.899668e-1	5.819677e+2	1.718308e-3	1	31	1.000000e+0	3.225806e-2	unnamed	MSH2
GO Biological Process	GO:0016064	immunoglobulin mediated immune response	32	3.909104e-3	1.000000e+0	1.000000e+0	2.558131e+2	3.909104e-3	1	3.909104e-3	1.000000e+0	35	3.658334e-3	1.000000e+0	1.000000e+0	2.733485e+2	3.658334e-3	1	66	1.000000e+0	1.515152e-2	unnamed	MSH2
GO Biological Process	GO:0002377	immunoglobulin production	33	4.032525e-3	1.000000e+0	1.000000e+0	2.479836e+2	4.032525e-3	1	4.032525e-3	1.000000e+0	30	2.217172e-3	1.000000e+0	7.715759e-1	4.510250e+2	2.217172e-3	1	40	1.000000e+0	2.500000e-2	unnamed	MSH2
GO Biological Process	GO:0019724	B cell mediated immunity	34	4.060937e-3	1.000000e+0	1.000000e+0	2.462486e+2	4.060937e-3	1	4.060937e-3	1.000000e+0	37	3.824622e-3	1.000000e+0	1.000000e+0	2.614638e+2	3.824622e-3	1	69	1.000000e+0	1.449275e-2	unnamed	MSH2
GO Biological Process	GO:0002440	production of molecular mediator of immune response	35	4.922324e-3	1.000000e+0	1.000000e+0	2.031561e+2	4.922324e-3	1	4.922324e-3	1.000000e+0	31	2.605177e-3	1.000000e+0	8.773564e-1	3.838511e+2	2.605177e-3	1	47	1.000000e+0	2.127660e-2	unnamed	MSH2
GO Biological Process	GO:0000018	regulation of DNA recombination	36	5.026024e-3	1.000000e+0	1.000000e+0	1.989644e+2	5.026024e-3	1	5.026024e-3	1.000000e+0	32	2.826894e-3	1.000000e+0	9.222742e-1	3.537451e+2	2.826894e-3	1	51	1.000000e+0	1.960784e-2	unnamed	MSH2
GO Biological Process	GO:0007127	meiosis I	37	5.621554e-3	1.000000e+0	1.000000e+0	1.778868e+2	5.621554e-3	1	5.621554e-3	1.000000e+0	40	4.212627e-3	1.000000e+0	1.000000e+0	2.373816e+2	4.212627e-3	1	76	1.000000e+0	1.315789e-2	unnamed	MSH2
GO Biological Process	GO:0002449	lymphocyte mediated immunity	38	5.745465e-3	1.000000e+0	1.000000e+0	1.740503e+2	5.745465e-3	1	5.745465e-3	1.000000e+0	42	5.542930e-3	1.000000e+0	1.000000e+0	1.804100e+2	5.542930e-3	1	100	1.000000e+0	1.000000e-2	unnamed	MSH2
GO Biological Process	GO:0002285	lymphocyte activation involved in immune response	39	5.796329e-3	1.000000e+0	1.000000e+0	1.725230e+2	5.796329e-3	1	5.796329e-3	1.000000e+0	34	3.159470e-3	1.000000e+0	9.701431e-1	3.165088e+2	3.159470e-3	1	57	1.000000e+0	1.754386e-2	unnamed	MSH2
GO Biological Process	GO:0051053	negative regulation of DNA metabolic process	40	6.116346e-3	1.000000e+0	1.000000e+0	1.634963e+2	6.116346e-3	1	6.116346e-3	1.000000e+0	36	3.713763e-3	1.000000e+0	1.000000e+0	2.692687e+2	3.713763e-3	1	67	1.000000e+0	1.492537e-2	unnamed	MSH2
GO Biological Process	GO:0002460	adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains	41	8.424293e-3	1.000000e+0	1.000000e+0	1.187043e+2	8.424293e-3	1	8.424293e-3	1.000000e+0	48	6.152652e-3	1.000000e+0	1.000000e+0	1.625315e+2	6.152652e-3	1	111	1.000000e+0	9.009009e-3	unnamed	MSH2
GO Biological Process	GO:0002443	leukocyte mediated immunity	42	8.643079e-3	1.000000e+0	1.000000e+0	1.156995e+2	8.643079e-3	1	8.643079e-3	1.000000e+0	52	7.039521e-3	1.000000e+0	1.000000e+0	1.420551e+2	7.039521e-3	1	127	1.000000e+0	7.874016e-3	unnamed	MSH2
GO Biological Process	GO:0072331	signal transduction by p53 class mediator	43	8.850259e-3	1.000000e+0	1.000000e+0	1.129910e+2	8.850259e-3	1	8.850259e-3	1.000000e+0	51	6.651516e-3	1.000000e+0	1.000000e+0	1.503417e+2	6.651516e-3	1	120	1.000000e+0	8.333333e-3	unnamed	MSH2
GO Biological Process	GO:0006302	double-strand break repair	44	8.931580e-3	1.000000e+0	1.000000e+0	1.119623e+2	8.931580e-3	1	8.931580e-3	1.000000e+0	44	5.820076e-3	1.000000e+0	1.000000e+0	1.718190e+2	5.820076e-3	1	105	1.000000e+0	9.523810e-3	unnamed	MSH2
GO Biological Process	GO:0002366	leukocyte activation involved in immune response	45	8.959278e-3	1.000000e+0	1.000000e+0	1.116161e+2	8.959278e-3	1	8.959278e-3	1.000000e+0	41	4.877778e-3	1.000000e+0	1.000000e+0	2.050114e+2	4.877778e-3	1	88	1.000000e+0	1.136364e-2	unnamed	MSH2
GO Biological Process	GO:0030183	B cell differentiation	46	9.220034e-3	1.000000e+0	1.000000e+0	1.084595e+2	9.220034e-3	1	9.220034e-3	1.000000e+0	37	3.824622e-3	1.000000e+0	1.000000e+0	2.614638e+2	3.824622e-3	1	69	1.000000e+0	1.449275e-2	unnamed	MSH2
GO Biological Process	GO:0000077	DNA damage checkpoint	47	9.331232e-3	1.000000e+0	1.000000e+0	1.071670e+2	9.331232e-3	1	9.331232e-3	1.000000e+0	58	7.593814e-3	1.000000e+0	1.000000e+0	1.316861e+2	7.593814e-3	1	137	1.000000e+0	7.299270e-3	unnamed	MSH2
GO Biological Process	GO:0031570	DNA integrity checkpoint	48	9.607175e-3	1.000000e+0	1.000000e+0	1.040889e+2	9.607175e-3	1	9.607175e-3	1.000000e+0	60	7.981819e-3	1.000000e+0	1.000000e+0	1.252847e+2	7.981819e-3	1	144	1.000000e+0	6.944444e-3	unnamed	MSH2
GO Biological Process	GO:0009411	response to UV	49	9.876412e-3	1.000000e+0	1.000000e+0	1.012513e+2	9.876412e-3	1	9.876412e-3	1.000000e+0	46	5.986364e-3	1.000000e+0	1.000000e+0	1.670463e+2	5.986364e-3	1	108	1.000000e+0	9.259259e-3	unnamed	MSH2
GO Biological Process	GO:0002250	adaptive immune response	50	1.044836e-2	1.000000e+0	1.000000e+0	9.570883e+1	1.044836e-2	1	1.044836e-2	1.000000e+0	52	7.039521e-3	1.000000e+0	1.000000e+0	1.420551e+2	7.039521e-3	1	127	1.000000e+0	7.874016e-3	unnamed	MSH2
GO Biological Process	GO:0097193	intrinsic apoptotic signaling pathway	51	1.120250e-2	1.000000e+0	1.000000e+0	8.926576e+1	1.120250e-2	1	1.120250e-2	1.000000e+0	55	7.482955e-3	1.000000e+0	1.000000e+0	1.336370e+2	7.482955e-3	1	135	1.000000e+0	7.407407e-3	unnamed	MSH2
GO Biological Process	GO:0007126	meiosis	52	1.161777e-2	1.000000e+0	1.000000e+0	8.607507e+1	1.161777e-2	1	1.161777e-2	1.000000e+0	61	8.148107e-3	1.000000e+0	1.000000e+0	1.227279e+2	8.148107e-3	1	147	1.000000e+0	6.802721e-3	unnamed	MSH2
GO Biological Process	GO:0010212	response to ionizing radiation	53	1.181953e-2	1.000000e+0	1.000000e+0	8.460574e+1	1.181953e-2	1	1.181953e-2	1.000000e+0	50	6.596087e-3	1.000000e+0	1.000000e+0	1.516050e+2	6.596087e-3	1	119	1.000000e+0	8.403361e-3	unnamed	MSH2
GO Biological Process	GO:0043524	negative regulation of neuron apoptotic process	54	1.203392e-2	1.000000e+0	1.000000e+0	8.309845e+1	1.203392e-2	1	1.203392e-2	1.000000e+0	43	5.598359e-3	1.000000e+0	1.000000e+0	1.786238e+2	5.598359e-3	1	101	1.000000e+0	9.900990e-3	unnamed	MSH2
GO Biological Process	GO:0006200	ATP catabolic process	55	1.222124e-2	1.000000e+0	1.000000e+0	8.182474e+1	1.222124e-2	1	1.222124e-2	1.000000e+0	62	8.425254e-3	1.000000e+0	1.000000e+0	1.186908e+2	8.425254e-3	1	152	1.000000e+0	6.578947e-3	unnamed	MSH2
GO Biological Process	GO:0051321	meiotic cell cycle	56	1.229757e-2	1.000000e+0	1.000000e+0	8.131686e+1	1.229757e-2	1	1.229757e-2	1.000000e+0	62	8.425254e-3	1.000000e+0	1.000000e+0	1.186908e+2	8.425254e-3	1	152	1.000000e+0	6.578947e-3	unnamed	MSH2
GO Biological Process	GO:1901215	negative regulation of neuron death	57	1.271045e-2	1.000000e+0	1.000000e+0	7.867544e+1	1.271045e-2	1	1.271045e-2	1.000000e+0	45	5.930935e-3	1.000000e+0	1.000000e+0	1.686075e+2	5.930935e-3	1	107	1.000000e+0	9.345794e-3	unnamed	MSH2
GO Biological Process	GO:0009169	purine ribonucleoside monophosphate catabolic process	58	1.272477e-2	1.000000e+0	1.000000e+0	7.858690e+1	1.272477e-2	1	1.272477e-2	1.000000e+0	65	8.646971e-3	1.000000e+0	1.000000e+0	1.156474e+2	8.646971e-3	1	156	1.000000e+0	6.410256e-3	unnamed	MSH2
GO Biological Process	GO:0009128	purine nucleoside monophosphate catabolic process	59	1.274075e-2	1.000000e+0	1.000000e+0	7.848829e+1	1.274075e-2	1	1.274075e-2	1.000000e+0	66	8.702400e-3	1.000000e+0	1.000000e+0	1.149108e+2	8.702400e-3	1	157	1.000000e+0	6.369427e-3	unnamed	MSH2
GO Biological Process	GO:0009125	nucleoside monophosphate catabolic process	60	1.282505e-2	1.000000e+0	1.000000e+0	7.797241e+1	1.282505e-2	1	1.282505e-2	1.000000e+0	67	8.813259e-3	1.000000e+0	1.000000e+0	1.134654e+2	8.813259e-3	1	159	1.000000e+0	6.289308e-3	unnamed	MSH2
GO Biological Process	GO:0042113	B cell activation	61	1.396950e-2	1.000000e+0	1.000000e+0	7.158450e+1	1.396950e-2	1	1.396950e-2	1.000000e+0	49	6.374369e-3	1.000000e+0	1.000000e+0	1.568783e+2	6.374369e-3	1	115	1.000000e+0	8.695652e-3	unnamed	MSH2
GO Biological Process	GO:0046034	ATP metabolic process	62	1.473510e-2	1.000000e+0	1.000000e+0	6.786516e+1	1.473510e-2	1	1.473510e-2	1.000000e+0	73	1.058700e-2	1.000000e+0	1.000000e+0	9.445550e+1	1.058700e-2	1	191	1.000000e+0	5.235602e-3	unnamed	MSH2
GO Biological Process	GO:0007281	germ cell development	63	1.493390e-2	1.000000e+0	1.000000e+0	6.696173e+1	1.493390e-2	1	1.493390e-2	1.000000e+0	59	7.870961e-3	1.000000e+0	1.000000e+0	1.270493e+2	7.870961e-3	1	142	1.000000e+0	7.042254e-3	unnamed	MSH2
GO Biological Process	GO:0007050	cell cycle arrest	64	1.528140e-2	1.000000e+0	1.000000e+0	6.543905e+1	1.528140e-2	1	1.528140e-2	1.000000e+0	55	7.482955e-3	1.000000e+0	1.000000e+0	1.336370e+2	7.482955e-3	1	135	1.000000e+0	7.407407e-3	unnamed	MSH2
GO Biological Process	GO:0000075	cell cycle checkpoint	65	1.587902e-2	1.000000e+0	1.000000e+0	6.297617e+1	1.587902e-2	1	1.587902e-2	1.000000e+0	75	1.175101e-2	1.000000e+0	1.000000e+0	8.509906e+1	1.175101e-2	1	212	1.000000e+0	4.716981e-3	unnamed	MSH2
GO Biological Process	GO:0006310	DNA recombination	66	1.603875e-2	1.000000e+0	1.000000e+0	6.234901e+1	1.603875e-2	1	1.603875e-2	1.000000e+0	72	1.042071e-2	1.000000e+0	1.000000e+0	9.596277e+1	1.042071e-2	1	188	1.000000e+0	5.319149e-3	unnamed	MSH2
GO Biological Process	GO:0009167	purine ribonucleoside monophosphate metabolic process	67	1.657477e-2	1.000000e+0	1.000000e+0	6.033265e+1	1.657477e-2	1	1.657477e-2	1.000000e+0	77	1.202816e-2	1.000000e+0	1.000000e+0	8.313825e+1	1.202816e-2	1	217	1.000000e+0	4.608295e-3	unnamed	MSH2
GO Biological Process	GO:0009126	purine nucleoside monophosphate metabolic process	68	1.659076e-2	1.000000e+0	1.000000e+0	6.027451e+1	1.659076e-2	1	1.659076e-2	1.000000e+0	78	1.208359e-2	1.000000e+0	1.000000e+0	8.275688e+1	1.208359e-2	1	218	1.000000e+0	4.587156e-3	unnamed	MSH2
GO Biological Process	GO:0008584	male gonad development	69	1.665469e-2	1.000000e+0	1.000000e+0	6.004315e+1	1.665469e-2	1	1.665469e-2	1.000000e+0	47	6.041794e-3	1.000000e+0	1.000000e+0	1.655138e+2	6.041794e-3	1	109	1.000000e+0	9.174312e-3	unnamed	MSH2
GO Biological Process	GO:0009161	ribonucleoside monophosphate metabolic process	70	1.887845e-2	1.000000e+0	1.000000e+0	5.297046e+1	1.887845e-2	1	1.887845e-2	1.000000e+0	81	1.285960e-2	1.000000e+0	1.000000e+0	7.776293e+1	1.285960e-2	1	232	1.000000e+0	4.310345e-3	unnamed	MSH2
GO Biological Process	GO:0009123	nucleoside monophosphate metabolic process	71	1.920092e-2	1.000000e+0	1.000000e+0	5.208085e+1	1.920092e-2	1	1.920092e-2	1.000000e+0	82	1.324760e-2	1.000000e+0	1.000000e+0	7.548536e+1	1.324760e-2	1	239	1.000000e+0	4.184100e-3	unnamed	MSH2
GO Biological Process	GO:0010948	negative regulation of cell cycle process	72	1.920177e-2	1.000000e+0	1.000000e+0	5.207854e+1	1.920177e-2	1	1.920177e-2	1.000000e+0	76	1.197273e-2	1.000000e+0	1.000000e+0	8.352315e+1	1.197273e-2	1	216	1.000000e+0	4.629630e-3	unnamed	MSH2
GO Biological Process	GO:0043523	regulation of neuron apoptotic process	73	1.964683e-2	1.000000e+0	1.000000e+0	5.089881e+1	1.964683e-2	1	1.964683e-2	1.000000e+0	64	8.591541e-3	1.000000e+0	1.000000e+0	1.163935e+2	8.591541e-3	1	155	1.000000e+0	6.451613e-3	unnamed	MSH2
GO Biological Process	GO:0046546	development of primary male sexual characteristics	74	2.033334e-2	1.000000e+0	1.000000e+0	4.918031e+1	2.033334e-2	1	2.033334e-2	1.000000e+0	52	7.039521e-3	1.000000e+0	1.000000e+0	1.420551e+2	7.039521e-3	1	127	1.000000e+0	7.874016e-3	unnamed	MSH2
GO Biological Process	GO:1901214	regulation of neuron death	75	2.049695e-2	1.000000e+0	1.000000e+0	4.878776e+1	2.049695e-2	1	2.049695e-2	1.000000e+0	68	9.145834e-3	1.000000e+0	1.000000e+0	1.093394e+2	9.145834e-3	1	165	1.000000e+0	6.060606e-3	unnamed	MSH2
GO Biological Process	GO:0046661	male sex differentiation	76	2.097294e-2	1.000000e+0	1.000000e+0	4.768048e+1	2.097294e-2	1	2.097294e-2	1.000000e+0	55	7.482955e-3	1.000000e+0	1.000000e+0	1.336370e+2	7.482955e-3	1	135	1.000000e+0	7.407407e-3	unnamed	MSH2
GO Biological Process	GO:0022412	cellular process involved in reproduction in multicellular organism	77	2.143467e-2	1.000000e+0	1.000000e+0	4.665338e+1	2.143467e-2	1	2.143467e-2	1.000000e+0	70	1.014356e-2	1.000000e+0	1.000000e+0	9.858470e+1	1.014356e-2	1	183	1.000000e+0	5.464481e-3	unnamed	MSH2
GO Biological Process	GO:0007568	aging	78	2.160529e-2	1.000000e+0	1.000000e+0	4.628496e+1	2.160529e-2	1	2.160529e-2	1.000000e+0	71	1.036528e-2	1.000000e+0	1.000000e+0	9.647594e+1	1.036528e-2	1	187	1.000000e+0	5.347594e-3	unnamed	MSH2
GO Biological Process	GO:0030098	lymphocyte differentiation	79	2.247216e-2	1.000000e+0	1.000000e+0	4.449951e+1	2.247216e-2	1	2.247216e-2	1.000000e+0	69	9.367552e-3	1.000000e+0	1.000000e+0	1.067515e+2	9.367552e-3	1	169	1.000000e+0	5.917160e-3	unnamed	MSH2
GO Biological Process	GO:0097190	apoptotic signaling pathway	80	2.329449e-2	1.000000e+0	1.000000e+0	4.292861e+1	2.329449e-2	1	2.329449e-2	1.000000e+0	88	1.568649e-2	1.000000e+0	1.000000e+0	6.374912e+1	1.568649e-2	1	283	1.000000e+0	3.533569e-3	unnamed	MSH2
GO Biological Process	GO:0051052	regulation of DNA metabolic process	81	2.344366e-2	1.000000e+0	1.000000e+0	4.265546e+1	2.344366e-2	1	2.344366e-2	1.000000e+0	80	1.274874e-2	1.000000e+0	1.000000e+0	7.843913e+1	1.274874e-2	1	230	1.000000e+0	4.347826e-3	unnamed	MSH2
GO Biological Process	GO:0009416	response to light stimulus	82	2.717639e-2	1.000000e+0	1.000000e+0	3.679665e+1	2.717639e-2	1	2.717639e-2	1.000000e+0	90	1.640707e-2	1.000000e+0	1.000000e+0	6.094932e+1	1.640707e-2	1	296	1.000000e+0	3.378378e-3	unnamed	MSH2
GO Biological Process	GO:0002252	immune effector process	83	2.795289e-2	1.000000e+0	1.000000e+0	3.577448e+1	2.795289e-2	1	2.795289e-2	1.000000e+0	95	2.150657e-2	1.000000e+0	1.000000e+0	4.649742e+1	2.150657e-2	1	388	1.000000e+0	2.577320e-3	unnamed	MSH2
GO Biological Process	GO:0045786	negative regulation of cell cycle	84	2.832384e-2	1.000000e+0	1.000000e+0	3.530595e+1	2.832384e-2	1	2.832384e-2	1.000000e+0	84	1.374647e-2	1.000000e+0	1.000000e+0	7.274597e+1	1.374647e-2	1	248	1.000000e+0	4.032258e-3	unnamed	MSH2
GO Biological Process	GO:0008406	gonad development	85	2.959912e-2	1.000000e+0	1.000000e+0	3.378479e+1	2.959912e-2	1	2.959912e-2	1.000000e+0	74	1.086414e-2	1.000000e+0	1.000000e+0	9.204592e+1	1.086414e-2	1	196	1.000000e+0	5.102041e-3	unnamed	MSH2
GO Biological Process	GO:0002521	leukocyte differentiation	86	2.987590e-2	1.000000e+0	1.000000e+0	3.347179e+1	2.987590e-2	1	2.987590e-2	1.000000e+0	83	1.335846e-2	1.000000e+0	1.000000e+0	7.485892e+1	1.335846e-2	1	241	1.000000e+0	4.149378e-3	unnamed	MSH2
GO Biological Process	GO:0006281	DNA repair	87	3.018395e-2	1.000000e+0	1.000000e+0	3.313019e+1	3.018395e-2	1	3.018395e-2	1.000000e+0	99	2.206086e-2	1.000000e+0	1.000000e+0	4.532915e+1	2.206086e-2	1	398	1.000000e+0	2.512563e-3	unnamed	MSH2
GO Biological Process	GO:0009207	purine ribonucleoside triphosphate catabolic process	88	3.033200e-2	1.000000e+0	1.000000e+0	3.296848e+1	3.033200e-2	1	3.033200e-2	1.000000e+0	94	2.139571e-2	1.000000e+0	1.000000e+0	4.673834e+1	2.139571e-2	1	386	1.000000e+0	2.590674e-3	unnamed	MSH2
GO Biological Process	GO:0009146	purine nucleoside triphosphate catabolic process	89	3.055815e-2	1.000000e+0	1.000000e+0	3.272449e+1	3.055815e-2	1	3.055815e-2	1.000000e+0	95	2.150657e-2	1.000000e+0	1.000000e+0	4.649742e+1	2.150657e-2	1	388	1.000000e+0	2.577320e-3	unnamed	MSH2
GO Biological Process	GO:0009143	nucleoside triphosphate catabolic process	90	3.072920e-2	1.000000e+0	1.000000e+0	3.254234e+1	3.072920e-2	1	3.072920e-2	1.000000e+0	97	2.172829e-2	1.000000e+0	1.000000e+0	4.602296e+1	2.172829e-2	1	392	1.000000e+0	2.551020e-3	unnamed	MSH2
GO Biological Process	GO:0046130	purine ribonucleoside catabolic process	91	3.121346e-2	1.000000e+0	1.000000e+0	3.203746e+1	3.121346e-2	1	3.121346e-2	1.000000e+0	98	2.195000e-2	1.000000e+0	1.000000e+0	4.555808e+1	2.195000e-2	1	396	1.000000e+0	2.525253e-3	unnamed	MSH2
GO Biological Process	GO:0042454	ribonucleoside catabolic process	92	3.149923e-2	1.000000e+0	1.000000e+0	3.174681e+1	3.149923e-2	1	3.149923e-2	1.000000e+0	102	2.250430e-2	1.000000e+0	1.000000e+0	4.443596e+1	2.250430e-2	1	406	1.000000e+0	2.463054e-3	unnamed	MSH2
GO Biological Process	GO:0006091	generation of precursor metabolites and energy	93	3.205061e-2	1.000000e+0	1.000000e+0	3.120066e+1	3.205061e-2	1	3.205061e-2	1.000000e+0	93	2.100770e-2	1.000000e+0	1.000000e+0	4.760158e+1	2.100770e-2	1	379	1.000000e+0	2.638522e-3	unnamed	MSH2
GO Biological Process	GO:0046649	lymphocyte activation	94	3.238380e-2	1.000000e+0	1.000000e+0	3.087964e+1	3.238380e-2	1	3.238380e-2	1.000000e+0	89	1.596364e-2	1.000000e+0	1.000000e+0	6.264236e+1	1.596364e-2	1	288	1.000000e+0	3.472222e-3	unnamed	MSH2
GO Biological Process	GO:0009164	nucleoside catabolic process	95	3.286610e-2	1.000000e+0	1.000000e+0	3.042648e+1	3.286610e-2	1	3.286610e-2	1.000000e+0	106	2.316945e-2	1.000000e+0	1.000000e+0	4.316029e+1	2.316945e-2	1	418	1.000000e+0	2.392344e-3	unnamed	MSH2
GO Biological Process	GO:1901658	glycosyl compound catabolic process	96	3.298459e-2	1.000000e+0	1.000000e+0	3.031719e+1	3.298459e-2	1	3.298459e-2	1.000000e+0	107	2.344659e-2	1.000000e+0	1.000000e+0	4.265012e+1	2.344659e-2	1	423	1.000000e+0	2.364066e-3	unnamed	MSH2
GO Biological Process	GO:0009205	purine ribonucleoside triphosphate metabolic process	97	3.313572e-2	1.000000e+0	1.000000e+0	3.017892e+1	3.313572e-2	1	3.313572e-2	1.000000e+0	112	2.422260e-2	1.000000e+0	1.000000e+0	4.128375e+1	2.422260e-2	1	437	1.000000e+0	2.288330e-3	unnamed	MSH2
GO Biological Process	GO:0009144	purine nucleoside triphosphate metabolic process	98	3.366832e-2	1.000000e+0	1.000000e+0	2.970151e+1	3.366832e-2	1	3.366832e-2	1.000000e+0	114	2.449975e-2	1.000000e+0	1.000000e+0	4.081674e+1	2.449975e-2	1	442	1.000000e+0	2.262443e-3	unnamed	MSH2
GO Biological Process	GO:0009199	ribonucleoside triphosphate metabolic process	99	3.369805e-2	1.000000e+0	1.000000e+0	2.967530e+1	3.369805e-2	1	3.369805e-2	1.000000e+0	115	2.455518e-2	1.000000e+0	1.000000e+0	4.072460e+1	2.455518e-2	1	443	1.000000e+0	2.257336e-3	unnamed	MSH2
GO Biological Process	GO:0009154	purine ribonucleotide catabolic process	100	3.482519e-2	1.000000e+0	1.000000e+0	2.871484e+1	3.482519e-2	1	3.482519e-2	1.000000e+0	104	2.272601e-2	1.000000e+0	1.000000e+0	4.400244e+1	2.272601e-2	1	410	1.000000e+0	2.439024e-3	unnamed	MSH2
GO Biological Process	GO:0009261	ribonucleotide catabolic process	101	3.486523e-2	1.000000e+0	1.000000e+0	2.868187e+1	3.486523e-2	1	3.486523e-2	1.000000e+0	105	2.278144e-2	1.000000e+0	1.000000e+0	4.389538e+1	2.278144e-2	1	411	1.000000e+0	2.433090e-3	unnamed	MSH2
GO Biological Process	GO:0009141	nucleoside triphosphate metabolic process	102	3.527014e-2	1.000000e+0	1.000000e+0	2.835259e+1	3.527014e-2	1	3.527014e-2	1.000000e+0	118	2.555291e-2	1.000000e+0	1.000000e+0	3.913449e+1	2.555291e-2	1	461	1.000000e+0	2.169197e-3	unnamed	MSH2
GO Biological Process	GO:0045137	development of primary sexual characteristics	103	3.551401e-2	1.000000e+0	1.000000e+0	2.815790e+1	3.551401e-2	1	3.551401e-2	1.000000e+0	79	1.258245e-2	1.000000e+0	1.000000e+0	7.947577e+1	1.258245e-2	1	227	1.000000e+0	4.405286e-3	unnamed	MSH2
GO Biological Process	GO:0006195	purine nucleotide catabolic process	104	3.553241e-2	1.000000e+0	1.000000e+0	2.814332e+1	3.553241e-2	1	3.553241e-2	1.000000e+0	107	2.344659e-2	1.000000e+0	1.000000e+0	4.265012e+1	2.344659e-2	1	423	1.000000e+0	2.364066e-3	unnamed	MSH2
GO Biological Process	GO:0072523	purine-containing compound catabolic process	105	3.630339e-2	1.000000e+0	1.000000e+0	2.754563e+1	3.630339e-2	1	3.630339e-2	1.000000e+0	110	2.366831e-2	1.000000e+0	1.000000e+0	4.225059e+1	2.366831e-2	1	427	1.000000e+0	2.341920e-3	unnamed	MSH2
GO Biological Process	GO:0009166	nucleotide catabolic process	106	3.673696e-2	1.000000e+0	1.000000e+0	2.722054e+1	3.673696e-2	1	3.673696e-2	1.000000e+0	113	2.438889e-2	1.000000e+0	1.000000e+0	4.100227e+1	2.438889e-2	1	440	1.000000e+0	2.272727e-3	unnamed	MSH2
GO Biological Process	GO:1901292	nucleoside phosphate catabolic process	107	3.698603e-2	1.000000e+0	1.000000e+0	2.703723e+1	3.698603e-2	1	3.698603e-2	1.000000e+0	116	2.477690e-2	1.000000e+0	1.000000e+0	4.036018e+1	2.477690e-2	1	447	1.000000e+0	2.237136e-3	unnamed	MSH2
GO Biological Process	GO:0009314	response to radiation	108	3.804926e-2	1.000000e+0	1.000000e+0	2.628172e+1	3.804926e-2	1	3.804926e-2	1.000000e+0	103	2.267058e-2	1.000000e+0	1.000000e+0	4.411002e+1	2.267058e-2	1	409	1.000000e+0	2.444988e-3	unnamed	MSH2
GO Biological Process	GO:0007548	sex differentiation	109	3.860403e-2	1.000000e+0	1.000000e+0	2.590403e+1	3.860403e-2	1	3.860403e-2	1.000000e+0	85	1.424533e-2	1.000000e+0	1.000000e+0	7.019844e+1	1.424533e-2	1	257	1.000000e+0	3.891051e-3	unnamed	MSH2
GO Biological Process	GO:0046128	purine ribonucleoside metabolic process	110	3.860801e-2	1.000000e+0	1.000000e+0	2.590136e+1	3.860801e-2	1	3.860801e-2	1.000000e+0	121	2.793637e-2	1.000000e+0	1.000000e+0	3.579563e+1	2.793637e-2	1	504	1.000000e+0	1.984127e-3	unnamed	MSH2
GO Biological Process	GO:0045321	leukocyte activation	111	3.863898e-2	1.000000e+0	1.000000e+0	2.588060e+1	3.863898e-2	1	3.863898e-2	1.000000e+0	91	1.951111e-2	1.000000e+0	1.000000e+0	5.125284e+1	1.951111e-2	1	352	1.000000e+0	2.840909e-3	unnamed	MSH2
GO Biological Process	GO:0042278	purine nucleoside metabolic process	112	3.876404e-2	1.000000e+0	1.000000e+0	2.579711e+1	3.876404e-2	1	3.876404e-2	1.000000e+0	122	2.810266e-2	1.000000e+0	1.000000e+0	3.558383e+1	2.810266e-2	1	507	1.000000e+0	1.972387e-3	unnamed	MSH2
GO Biological Process	GO:0046434	organophosphate catabolic process	113	3.976893e-2	1.000000e+0	1.000000e+0	2.514526e+1	3.976893e-2	1	3.976893e-2	1.000000e+0	120	2.677235e-2	1.000000e+0	1.000000e+0	3.735197e+1	2.677235e-2	1	483	1.000000e+0	2.070393e-3	unnamed	MSH2
GO Biological Process	GO:0010564	regulation of cell cycle process	114	3.998440e-2	1.000000e+0	1.000000e+0	2.500975e+1	3.998440e-2	1	3.998440e-2	1.000000e+0	99	2.206086e-2	1.000000e+0	1.000000e+0	4.532915e+1	2.206086e-2	1	398	1.000000e+0	2.512563e-3	unnamed	MSH2
GO Biological Process	GO:0009119	ribonucleoside metabolic process	115	4.090218e-2	1.000000e+0	1.000000e+0	2.444858e+1	4.090218e-2	1	4.090218e-2	1.000000e+0	124	2.937753e-2	1.000000e+0	1.000000e+0	3.403962e+1	2.937753e-2	1	530	1.000000e+0	1.886792e-3	unnamed	MSH2
GO Biological Process	GO:0048608	reproductive structure development	116	4.100915e-2	1.000000e+0	1.000000e+0	2.438480e+1	4.100915e-2	1	4.100915e-2	1.000000e+0	86	1.468876e-2	1.000000e+0	1.000000e+0	6.807925e+1	1.468876e-2	1	265	1.000000e+0	3.773585e-3	unnamed	MSH2
GO Biological Process	GO:0061458	reproductive system development	117	4.105393e-2	1.000000e+0	1.000000e+0	2.435821e+1	4.105393e-2	1	4.105393e-2	1.000000e+0	87	1.479962e-2	1.000000e+0	1.000000e+0	6.756929e+1	1.479962e-2	1	267	1.000000e+0	3.745318e-3	unnamed	MSH2
GO Biological Process	GO:0009116	nucleoside metabolic process	118	4.293017e-2	1.000000e+0	1.000000e+0	2.329364e+1	4.293017e-2	1	4.293017e-2	1.000000e+0	127	3.070783e-2	1.000000e+0	1.000000e+0	3.256498e+1	3.070783e-2	1	554	1.000000e+0	1.805054e-3	unnamed	MSH2
GO Biological Process	GO:1901657	glycosyl compound metabolic process	119	4.374541e-2	1.000000e+0	1.000000e+0	2.285954e+1	4.374541e-2	1	4.374541e-2	1.000000e+0	132	3.153927e-2	1.000000e+0	1.000000e+0	3.170650e+1	3.153927e-2	1	569	1.000000e+0	1.757469e-3	unnamed	MSH2
GO Biological Process	GO:0048610	cellular process involved in reproduction	120	4.383088e-2	1.000000e+0	1.000000e+0	2.281497e+1	4.383088e-2	1	4.383088e-2	1.000000e+0	107	2.344659e-2	1.000000e+0	1.000000e+0	4.265012e+1	2.344659e-2	1	423	1.000000e+0	2.364066e-3	unnamed	MSH2
GO Biological Process	GO:0001701	in utero embryonic development	121	4.511140e-2	1.000000e+0	1.000000e+0	2.216735e+1	4.511140e-2	1	4.511140e-2	1.000000e+0	91	1.951111e-2	1.000000e+0	1.000000e+0	5.125284e+1	1.951111e-2	1	352	1.000000e+0	2.840909e-3	unnamed	MSH2
GO Biological Process	GO:1901136	carbohydrate derivative catabolic process	122	4.540843e-2	1.000000e+0	1.000000e+0	2.202234e+1	4.540843e-2	1	4.540843e-2	1.000000e+0	125	2.982096e-2	1.000000e+0	1.000000e+0	3.353346e+1	2.982096e-2	1	538	1.000000e+0	1.858736e-3	unnamed	MSH2
GO Biological Process	GO:0009150	purine ribonucleotide metabolic process	123	4.562864e-2	1.000000e+0	1.000000e+0	2.191606e+1	4.562864e-2	1	4.562864e-2	1.000000e+0	126	3.020897e-2	1.000000e+0	1.000000e+0	3.310275e+1	3.020897e-2	1	545	1.000000e+0	1.834862e-3	unnamed	MSH2
GO Biological Process	GO:0006163	purine nucleotide metabolic process	124	4.717629e-2	1.000000e+0	1.000000e+0	2.119709e+1	4.717629e-2	1	4.717629e-2	1.000000e+0	131	3.142841e-2	1.000000e+0	1.000000e+0	3.181834e+1	3.142841e-2	1	567	1.000000e+0	1.763668e-3	unnamed	MSH2
GO Biological Process	GO:0009259	ribonucleotide metabolic process	125	4.777098e-2	1.000000e+0	1.000000e+0	2.093321e+1	4.777098e-2	1	4.777098e-2	1.000000e+0	128	3.109584e-2	1.000000e+0	1.000000e+0	3.215865e+1	3.109584e-2	1	561	1.000000e+0	1.782531e-3	unnamed	MSH2
GO Biological Process	GO:0006974	cellular response to DNA damage stimulus	126	4.790195e-2	1.000000e+0	1.000000e+0	2.087598e+1	4.790195e-2	1	4.790195e-2	1.000000e+0	136	3.392273e-2	1.000000e+0	1.000000e+0	2.947876e+1	3.392273e-2	1	612	1.000000e+0	1.633987e-3	unnamed	MSH2
GO Biological Process	GO:0019693	ribose phosphate metabolic process	127	4.844027e-2	1.000000e+0	1.000000e+0	2.064398e+1	4.844027e-2	1	4.844027e-2	1.000000e+0	129	3.137298e-2	1.000000e+0	1.000000e+0	3.187456e+1	3.137298e-2	1	566	1.000000e+0	1.766784e-3	unnamed	MSH2
GO Biological Process	GO:0030097	hemopoiesis	128	4.927889e-2	1.000000e+0	1.000000e+0	2.029267e+1	4.927889e-2	1	4.927889e-2	1.000000e+0	101	2.244887e-2	1.000000e+0	1.000000e+0	4.454568e+1	2.244887e-2	1	405	1.000000e+0	2.469136e-3	unnamed	MSH2
GO Biological Process	GO:0072521	purine-containing compound metabolic process	129	5.075963e-2	1.000000e+0	1.000000e+0	1.970070e+1	5.075963e-2	1	5.075963e-2	1.000000e+0	135	3.325758e-2	1.000000e+0	1.000000e+0	3.006833e+1	3.325758e-2	1	600	1.000000e+0	1.666667e-3	unnamed	MSH2
GO Biological Process	GO:0048534	hematopoietic or lymphoid organ development	130	5.503899e-2	1.000000e+0	1.000000e+0	1.816894e+1	5.503899e-2	1	5.503899e-2	1.000000e+0	116	2.477690e-2	1.000000e+0	1.000000e+0	4.036018e+1	2.477690e-2	1	447	1.000000e+0	2.237136e-3	unnamed	MSH2
GO Biological Process	GO:0034655	nucleobase-containing compound catabolic process	131	5.526871e-2	1.000000e+0	1.000000e+0	1.809342e+1	5.526871e-2	1	5.526871e-2	1.000000e+0	149	4.046339e-2	1.000000e+0	1.000000e+0	2.471370e+1	4.046339e-2	1	730	1.000000e+0	1.369863e-3	unnamed	MSH2
GO Biological Process	GO:0007276	gamete generation	132	5.686474e-2	1.000000e+0	1.000000e+0	1.758559e+1	5.686474e-2	1	5.686474e-2	1.000000e+0	123	2.910038e-2	1.000000e+0	1.000000e+0	3.436381e+1	2.910038e-2	1	525	1.000000e+0	1.904762e-3	unnamed	MSH2
GO Biological Process	GO:0003006	developmental process involved in reproduction	133	5.715290e-2	1.000000e+0	1.000000e+0	1.749692e+1	5.715290e-2	1	5.715290e-2	1.000000e+0	111	2.389003e-2	1.000000e+0	1.000000e+0	4.185847e+1	2.389003e-2	1	431	1.000000e+0	2.320186e-3	unnamed	MSH2
GO Biological Process	GO:0002520	immune system development	134	5.732186e-2	1.000000e+0	1.000000e+0	1.744535e+1	5.732186e-2	1	5.732186e-2	1.000000e+0	119	2.621806e-2	1.000000e+0	1.000000e+0	3.814165e+1	2.621806e-2	1	473	1.000000e+0	2.114165e-3	unnamed	MSH2
GO Biological Process	GO:0044270	cellular nitrogen compound catabolic process	135	5.795872e-2	1.000000e+0	1.000000e+0	1.725366e+1	5.795872e-2	1	5.795872e-2	1.000000e+0	152	4.279142e-2	1.000000e+0	1.000000e+0	2.336917e+1	4.279142e-2	1	772	1.000000e+0	1.295337e-3	unnamed	MSH2
GO Biological Process	GO:0046700	heterocycle catabolic process	136	5.822606e-2	1.000000e+0	1.000000e+0	1.717444e+1	5.822606e-2	1	5.822606e-2	1.000000e+0	152	4.279142e-2	1.000000e+0	1.000000e+0	2.336917e+1	4.279142e-2	1	772	1.000000e+0	1.295337e-3	unnamed	MSH2
GO Biological Process	GO:1901565	organonitrogen compound catabolic process	137	5.824058e-2	1.000000e+0	1.000000e+0	1.717016e+1	5.824058e-2	1	5.824058e-2	1.000000e+0	142	3.813536e-2	1.000000e+0	1.000000e+0	2.622238e+1	3.813536e-2	1	688	1.000000e+0	1.453488e-3	unnamed	MSH2
GO Biological Process	GO:0001775	cell activation	138	5.914753e-2	1.000000e+0	1.000000e+0	1.690688e+1	5.914753e-2	1	5.914753e-2	1.000000e+0	129	3.137298e-2	1.000000e+0	1.000000e+0	3.187456e+1	3.137298e-2	1	566	1.000000e+0	1.766784e-3	unnamed	MSH2
GO Biological Process	GO:0019439	aromatic compound catabolic process	139	5.918614e-2	1.000000e+0	1.000000e+0	1.689585e+1	5.918614e-2	1	5.918614e-2	1.000000e+0	154	4.301314e-2	1.000000e+0	1.000000e+0	2.324871e+1	4.301314e-2	1	776	1.000000e+0	1.288660e-3	unnamed	MSH2
GO Biological Process	GO:0009117	nucleotide metabolic process	140	5.965229e-2	1.000000e+0	1.000000e+0	1.676382e+1	5.965229e-2	1	5.965229e-2	1.000000e+0	145	3.913309e-2	1.000000e+0	1.000000e+0	2.555382e+1	3.913309e-2	1	706	1.000000e+0	1.416431e-3	unnamed	MSH2
GO Biological Process	GO:0006753	nucleoside phosphate metabolic process	141	5.986549e-2	1.000000e+0	1.000000e+0	1.670411e+1	5.986549e-2	1	5.986549e-2	1.000000e+0	147	3.946566e-2	1.000000e+0	1.000000e+0	2.533848e+1	3.946566e-2	1	712	1.000000e+0	1.404494e-3	unnamed	MSH2
GO Biological Process	GO:1901361	organic cyclic compound catabolic process	142	6.156179e-2	1.000000e+0	1.000000e+0	1.624384e+1	6.156179e-2	1	6.156179e-2	1.000000e+0	155	4.484230e-2	1.000000e+0	1.000000e+0	2.230037e+1	4.484230e-2	1	809	1.000000e+0	1.236094e-3	unnamed	MSH2
GO Biological Process	GO:0006259	DNA metabolic process	143	6.242337e-2	1.000000e+0	1.000000e+0	1.601964e+1	6.242337e-2	1	6.242337e-2	1.000000e+0	156	4.611718e-2	1.000000e+0	1.000000e+0	2.168389e+1	4.611718e-2	1	832	1.000000e+0	1.201923e-3	unnamed	MSH2
GO Biological Process	GO:0055086	nucleobase-containing small molecule metabolic process	144	6.296632e-2	1.000000e+0	1.000000e+0	1.588151e+1	6.296632e-2	1	6.296632e-2	1.000000e+0	151	4.195998e-2	1.000000e+0	1.000000e+0	2.383223e+1	4.195998e-2	1	757	1.000000e+0	1.321004e-3	unnamed	MSH2
GO Biological Process	GO:0019953	sexual reproduction	145	6.533147e-2	1.000000e+0	1.000000e+0	1.530656e+1	6.533147e-2	1	6.533147e-2	1.000000e+0	137	3.403359e-2	1.000000e+0	1.000000e+0	2.938274e+1	3.403359e-2	1	614	1.000000e+0	1.628664e-3	unnamed	MSH2
GO Biological Process	GO:0051276	chromosome organization	146	6.817619e-2	1.000000e+0	1.000000e+0	1.466788e+1	6.817619e-2	1	6.817619e-2	1.000000e+0	150	4.184912e-2	1.000000e+0	1.000000e+0	2.389536e+1	4.184912e-2	1	755	1.000000e+0	1.324503e-3	unnamed	MSH2
GO Biological Process	GO:0051345	positive regulation of hydrolase activity	147	6.945880e-2	1.000000e+0	1.000000e+0	1.439702e+1	6.945880e-2	1	6.945880e-2	1.000000e+0	138	3.536389e-2	1.000000e+0	1.000000e+0	2.827743e+1	3.536389e-2	1	638	1.000000e+0	1.567398e-3	unnamed	MSH2
GO Biological Process	GO:0043066	negative regulation of apoptotic process	148	7.076490e-2	1.000000e+0	1.000000e+0	1.413130e+1	7.076490e-2	1	7.076490e-2	1.000000e+0	139	3.641705e-2	1.000000e+0	1.000000e+0	2.745967e+1	3.641705e-2	1	657	1.000000e+0	1.522070e-3	unnamed	MSH2
GO Biological Process	GO:0043069	negative regulation of programmed cell death	149	7.183207e-2	1.000000e+0	1.000000e+0	1.392136e+1	7.183207e-2	1	7.183207e-2	1.000000e+0	140	3.680506e-2	1.000000e+0	1.000000e+0	2.717018e+1	3.680506e-2	1	664	1.000000e+0	1.506024e-3	unnamed	MSH2
GO Biological Process	GO:0051726	regulation of cell cycle	150	7.419191e-2	1.000000e+0	1.000000e+0	1.347856e+1	7.419191e-2	1	7.419191e-2	1.000000e+0	146	3.929937e-2	1.000000e+0	1.000000e+0	2.544570e+1	3.929937e-2	1	709	1.000000e+0	1.410437e-3	unnamed	MSH2
GO Biological Process	GO:0048609	multicellular organismal reproductive process	151	7.483828e-2	1.000000e+0	1.000000e+0	1.336215e+1	7.483828e-2	1	7.483828e-2	1.000000e+0	141	3.713763e-2	1.000000e+0	1.000000e+0	2.692687e+1	3.713763e-2	1	670	1.000000e+0	1.492537e-3	unnamed	MSH2
GO Biological Process	GO:0060548	negative regulation of cell death	152	7.699389e-2	1.000000e+0	1.000000e+0	1.298804e+1	7.699389e-2	1	7.699389e-2	1.000000e+0	144	3.841250e-2	1.000000e+0	1.000000e+0	2.603319e+1	3.841250e-2	1	693	1.000000e+0	1.443001e-3	unnamed	MSH2
GO Biological Process	GO:0043009	chordate embryonic development	153	7.717062e-2	1.000000e+0	1.000000e+0	1.295830e+1	7.717062e-2	1	7.717062e-2	1.000000e+0	133	3.165013e-2	1.000000e+0	1.000000e+0	3.159545e+1	3.165013e-2	1	571	1.000000e+0	1.751313e-3	unnamed	MSH2
GO Biological Process	GO:0032504	multicellular organism reproduction	154	7.740256e-2	1.000000e+0	1.000000e+0	1.291947e+1	7.740256e-2	1	7.740256e-2	1.000000e+0	143	3.824622e-2	1.000000e+0	1.000000e+0	2.614638e+1	3.824622e-2	1	690	1.000000e+0	1.449275e-3	unnamed	MSH2
GO Biological Process	GO:0009792	embryo development ending in birth or egg hatching	155	7.766421e-2	1.000000e+0	1.000000e+0	1.287594e+1	7.766421e-2	1	7.766421e-2	1.000000e+0	134	3.203814e-2	1.000000e+0	1.000000e+0	3.121280e+1	3.203814e-2	1	578	1.000000e+0	1.730104e-3	unnamed	MSH2
GO Biological Process	GO:0044702	single organism reproductive process	156	7.805445e-2	1.000000e+0	1.000000e+0	1.281157e+1	7.805445e-2	1	7.805445e-2	1.000000e+0	148	3.985367e-2	1.000000e+0	1.000000e+0	2.509179e+1	3.985367e-2	1	719	1.000000e+0	1.390821e-3	unnamed	MSH2
GO Biological Process	GO:0019637	organophosphate metabolic process	157	8.707730e-2	1.000000e+0	1.000000e+0	1.148405e+1	8.707730e-2	1	8.707730e-2	1.000000e+0	165	5.759104e-2	1.000000e+0	1.000000e+0	1.736381e+1	5.759104e-2	1	1039	1.000000e+0	9.624639e-4	unnamed	MSH2
GO Biological Process	GO:0009628	response to abiotic stimulus	158	8.711487e-2	1.000000e+0	1.000000e+0	1.147910e+1	8.711487e-2	1	8.711487e-2	1.000000e+0	157	4.800177e-2	1.000000e+0	1.000000e+0	2.083256e+1	4.800177e-2	1	866	1.000000e+0	1.154734e-3	unnamed	MSH2
GO Biological Process	GO:0006955	immune response	159	8.762627e-2	1.000000e+0	1.000000e+0	1.141210e+1	8.762627e-2	1	8.762627e-2	1.000000e+0	169	6.152652e-2	1.000000e+0	1.000000e+0	1.625315e+1	6.152652e-2	1	1110	1.000000e+0	9.009009e-4	unnamed	MSH2
GO Biological Process	GO:0022402	cell cycle process	160	8.847677e-2	1.000000e+0	1.000000e+0	1.130240e+1	8.847677e-2	1	8.847677e-2	1.000000e+0	162	5.542930e-2	1.000000e+0	1.000000e+0	1.804100e+1	5.542930e-2	1	1000	1.000000e+0	1.000000e-3	unnamed	MSH2
GO Biological Process	GO:0006915	apoptotic process	161	9.852721e-2	1.000000e+0	1.000000e+0	1.014948e+1	9.852721e-2	1	9.852721e-2	1.000000e+0	166	5.764647e-2	1.000000e+0	1.000000e+0	1.734712e+1	5.764647e-2	1	1040	1.000000e+0	9.615385e-4	unnamed	MSH2
GO Biological Process	GO:0016310	phosphorylation	162	9.897799e-2	1.000000e+0	1.000000e+0	1.010326e+1	9.897799e-2	1	9.897799e-2	1.000000e+0	159	5.365556e-2	1.000000e+0	1.000000e+0	1.863740e+1	5.365556e-2	1	968	1.000000e+0	1.033058e-3	unnamed	MSH2
GO Biological Process	GO:0012501	programmed cell death	163	1.001273e-1	1.000000e+0	1.000000e+0	9.987290e+0	1.001273e-1	1	1.001273e-1	1.000000e+0	167	5.842248e-2	1.000000e+0	1.000000e+0	1.711670e+1	5.842248e-2	1	1054	1.000000e+0	9.487666e-4	unnamed	MSH2
GO Biological Process	GO:0033554	cellular response to stress	164	1.003642e-1	1.000000e+0	1.000000e+0	9.963713e+0	1.003642e-1	1	1.003642e-1	1.000000e+0	171	6.346655e-2	1.000000e+0	1.000000e+0	1.575633e+1	6.346655e-2	1	1145	1.000000e+0	8.733624e-4	unnamed	MSH2
GO Biological Process	GO:0051336	regulation of hydrolase activity	165	1.030572e-1	1.000000e+0	1.000000e+0	9.703349e+0	1.030572e-1	1	1.030572e-1	1.000000e+0	161	5.520758e-2	1.000000e+0	1.000000e+0	1.811345e+1	5.520758e-2	1	996	1.000000e+0	1.004016e-3	unnamed	MSH2
GO Biological Process	GO:0007049	cell cycle	166	1.078728e-1	1.000000e+0	1.000000e+0	9.270177e+0	1.078728e-1	1	1.078728e-1	1.000000e+0	176	6.845519e-2	1.000000e+0	1.000000e+0	1.460810e+1	6.845519e-2	1	1235	1.000000e+0	8.097166e-4	unnamed	MSH2
GO Biological Process	GO:0022414	reproductive process	167	1.132946e-1	1.000000e+0	1.000000e+0	8.826548e+0	1.132946e-1	1	1.132946e-1	1.000000e+0	160	5.504129e-2	1.000000e+0	1.000000e+0	1.816818e+1	5.504129e-2	1	993	1.000000e+0	1.007049e-3	unnamed	MSH2
GO Biological Process	GO:1901135	carbohydrate derivative metabolic process	168	1.134958e-1	1.000000e+0	1.000000e+0	8.810897e+0	1.134958e-1	1	1.134958e-1	1.000000e+0	174	6.662602e-2	1.000000e+0	1.000000e+0	1.500915e+1	6.662602e-2	1	1202	1.000000e+0	8.319468e-4	unnamed	MSH2
GO Biological Process	GO:0008219	cell death	169	1.161348e-1	1.000000e+0	1.000000e+0	8.610686e+0	1.161348e-1	1	1.161348e-1	1.000000e+0	177	6.851061e-2	1.000000e+0	1.000000e+0	1.459628e+1	6.851061e-2	1	1236	1.000000e+0	8.090615e-4	unnamed	MSH2
GO Biological Process	GO:0016265	death	170	1.165949e-1	1.000000e+0	1.000000e+0	8.576703e+0	1.165949e-1	1	1.165949e-1	1.000000e+0	178	6.867690e-2	1.000000e+0	1.000000e+0	1.456094e+1	6.867690e-2	1	1239	1.000000e+0	8.071025e-4	unnamed	MSH2
GO Biological Process	GO:0043085	positive regulation of catalytic activity	171	1.192177e-1	1.000000e+0	1.000000e+0	8.388019e+0	1.192177e-1	1	1.192177e-1	1.000000e+0	170	6.185910e-2	1.000000e+0	1.000000e+0	1.616577e+1	6.185910e-2	1	1116	1.000000e+0	8.960573e-4	unnamed	MSH2
GO Biological Process	GO:0042981	regulation of apoptotic process	172	1.200175e-1	1.000000e+0	1.000000e+0	8.332116e+0	1.200175e-1	1	1.200175e-1	1.000000e+0	172	6.424256e-2	1.000000e+0	1.000000e+0	1.556601e+1	6.424256e-2	1	1159	1.000000e+0	8.628128e-4	unnamed	MSH2
GO Biological Process	GO:0000003	reproduction	173	1.207341e-1	1.000000e+0	1.000000e+0	8.282661e+0	1.207341e-1	1	1.207341e-1	1.000000e+0	168	6.058422e-2	1.000000e+0	1.000000e+0	1.650595e+1	6.058422e-2	1	1093	1.000000e+0	9.149131e-4	unnamed	MSH2
GO Biological Process	GO:0043067	regulation of programmed cell death	174	1.213630e-1	1.000000e+0	1.000000e+0	8.239741e+0	1.213630e-1	1	1.213630e-1	1.000000e+0	173	6.490771e-2	1.000000e+0	1.000000e+0	1.540649e+1	6.490771e-2	1	1171	1.000000e+0	8.539710e-4	unnamed	MSH2
GO Biological Process	GO:0045934	negative regulation of nucleobase-containing compound metabolic process	175	1.236988e-1	1.000000e+0	1.000000e+0	8.084155e+0	1.236988e-1	1	1.236988e-1	1.000000e+0	163	5.592816e-2	1.000000e+0	1.000000e+0	1.788008e+1	5.592816e-2	1	1009	1.000000e+0	9.910803e-4	unnamed	MSH2
GO Biological Process	GO:0044248	cellular catabolic process	176	1.236997e-1	1.000000e+0	1.000000e+0	8.084094e+0	1.236997e-1	1	1.236997e-1	1.000000e+0	186	8.840973e-2	1.000000e+0	1.000000e+0	1.131097e+1	8.840973e-2	1	1595	1.000000e+0	6.269592e-4	unnamed	MSH2
GO Biological Process	GO:0051172	negative regulation of nitrogen compound metabolic process	177	1.247094e-1	1.000000e+0	1.000000e+0	8.018640e+0	1.247094e-1	1	1.247094e-1	1.000000e+0	164	5.670417e-2	1.000000e+0	1.000000e+0	1.763539e+1	5.670417e-2	1	1023	1.000000e+0	9.775171e-4	unnamed	MSH2
GO Biological Process	GO:0009790	embryo development	178	1.260409e-1	1.000000e+0	1.000000e+0	7.933935e+0	1.260409e-1	1	1.260409e-1	1.000000e+0	158	5.243612e-2	1.000000e+0	1.000000e+0	1.907082e+1	5.243612e-2	1	946	1.000000e+0	1.057082e-3	unnamed	MSH2
GO Biological Process	GO:0010941	regulation of cell death	179	1.261875e-1	1.000000e+0	1.000000e+0	7.924714e+0	1.261875e-1	1	1.261875e-1	1.000000e+0	175	6.706945e-2	1.000000e+0	1.000000e+0	1.490992e+1	6.706945e-2	1	1210	1.000000e+0	8.264463e-4	unnamed	MSH2
GO Biological Process	GO:1901575	organic substance catabolic process	180	1.333602e-1	1.000000e+0	1.000000e+0	7.498488e+0	1.333602e-1	1	1.333602e-1	1.000000e+0	187	9.605898e-2	1.000000e+0	1.000000e+0	1.041027e+1	9.605898e-2	1	1733	1.000000e+0	5.770340e-4	unnamed	MSH2
GO Biological Process	GO:1901564	organonitrogen compound metabolic process	181	1.379740e-1	1.000000e+0	1.000000e+0	7.247740e+0	1.379740e-1	1	1.379740e-1	1.000000e+0	184	8.552741e-2	1.000000e+0	1.000000e+0	1.169216e+1	8.552741e-2	1	1543	1.000000e+0	6.480881e-4	unnamed	MSH2
GO Biological Process	GO:0044093	positive regulation of molecular function	182	1.422599e-1	1.000000e+0	1.000000e+0	7.029386e+0	1.422599e-1	1	1.422599e-1	1.000000e+0	179	7.272324e-2	1.000000e+0	1.000000e+0	1.375076e+1	7.272324e-2	1	1312	1.000000e+0	7.621951e-4	unnamed	MSH2
GO Biological Process	GO:0009056	catabolic process	183	1.498546e-1	1.000000e+0	1.000000e+0	6.673137e+0	1.498546e-1	1	1.498546e-1	1.000000e+0	190	1.075328e-1	1.000000e+0	1.000000e+0	9.299485e+0	1.075328e-1	1	1940	1.000000e+0	5.154639e-4	unnamed	MSH2
GO Biological Process	GO:0035556	intracellular signal transduction	184	1.533855e-1	1.000000e+0	1.000000e+0	6.519521e+0	1.533855e-1	1	1.533855e-1	1.000000e+0	181	8.015077e-2	1.000000e+0	1.000000e+0	1.247649e+1	8.015077e-2	1	1446	1.000000e+0	6.915629e-4	unnamed	MSH2
GO Biological Process	GO:0002376	immune system process	185	1.536349e-1	1.000000e+0	1.000000e+0	6.508938e+0	1.536349e-1	1	1.536349e-1	1.000000e+0	189	9.916302e-2	1.000000e+0	1.000000e+0	1.008440e+1	9.916302e-2	1	1789	1.000000e+0	5.589715e-4	unnamed	MSH2
GO Biological Process	GO:0010605	negative regulation of macromolecule metabolic process	186	1.635114e-1	1.000000e+0	1.000000e+0	6.115780e+0	1.635114e-1	1	1.635114e-1	1.000000e+0	183	8.203536e-2	1.000000e+0	1.000000e+0	1.218986e+1	8.203536e-2	1	1480	1.000000e+0	6.756757e-4	unnamed	MSH2
GO Biological Process	GO:0031324	negative regulation of cellular metabolic process	187	1.637788e-1	1.000000e+0	1.000000e+0	6.105797e+0	1.637788e-1	1	1.637788e-1	1.000000e+0	182	8.170279e-2	1.000000e+0	1.000000e+0	1.223948e+1	8.170279e-2	1	1474	1.000000e+0	6.784261e-4	unnamed	MSH2
GO Biological Process	GO:0009892	negative regulation of metabolic process	188	1.743568e-1	1.000000e+0	1.000000e+0	5.735367e+0	1.743568e-1	1	1.743568e-1	1.000000e+0	185	8.818802e-2	1.000000e+0	1.000000e+0	1.133941e+1	8.818802e-2	1	1591	1.000000e+0	6.285355e-4	unnamed	MSH2
GO Biological Process	GO:0050790	regulation of catalytic activity	189	1.756788e-1	1.000000e+0	1.000000e+0	5.692208e+0	1.756788e-1	1	1.756788e-1	1.000000e+0	188	9.616984e-2	1.000000e+0	1.000000e+0	1.039827e+1	9.616984e-2	1	1735	1.000000e+0	5.763689e-4	unnamed	MSH2
GO Biological Process	GO:0048468	cell development	190	1.837839e-1	1.000000e+0	1.000000e+0	5.441172e+0	1.837839e-1	1	1.837839e-1	1.000000e+0	180	7.283410e-2	1.000000e+0	1.000000e+0	1.372983e+1	7.283410e-2	1	1314	1.000000e+0	7.610350e-4	unnamed	MSH2
GO Biological Process	GO:0006796	phosphate-containing compound metabolic process	191	1.861159e-1	1.000000e+0	1.000000e+0	5.372996e+0	1.861159e-1	1	1.861159e-1	1.000000e+0	191	1.120780e-1	1.000000e+0	1.000000e+0	8.922354e+0	1.120780e-1	1	2022	1.000000e+0	4.945598e-4	unnamed	MSH2
GO Biological Process	GO:0006793	phosphorus metabolic process	192	1.905359e-1	1.000000e+0	1.000000e+0	5.248354e+0	1.905359e-1	1	1.905359e-1	1.000000e+0	192	1.145169e-1	1.000000e+0	1.000000e+0	8.732333e+0	1.145169e-1	1	2066	1.000000e+0	4.840271e-4	unnamed	MSH2
GO Biological Process	GO:0006996	organelle organization	193	1.979117e-1	1.000000e+0	1.000000e+0	5.052758e+0	1.979117e-1	1	1.979117e-1	1.000000e+0	194	1.237182e-1	1.000000e+0	1.000000e+0	8.082885e+0	1.237182e-1	1	2232	1.000000e+0	4.480287e-4	unnamed	MSH2
GO Biological Process	GO:0044281	small molecule metabolic process	194	2.001784e-1	1.000000e+0	1.000000e+0	4.995545e+0	2.001784e-1	1	2.001784e-1	1.000000e+0	196	1.345269e-1	1.000000e+0	1.000000e+0	7.433457e+0	1.345269e-1	1	2427	1.000000e+0	4.120313e-4	unnamed	MSH2
GO Biological Process	GO:0065009	regulation of molecular function	195	2.156945e-1	1.000000e+0	1.000000e+0	4.636187e+0	2.156945e-1	1	2.156945e-1	1.000000e+0	193	1.166787e-1	1.000000e+0	1.000000e+0	8.570546e+0	1.166787e-1	1	2105	1.000000e+0	4.750594e-4	unnamed	MSH2
GO Biological Process	GO:0006950	response to stress	196	2.428193e-1	1.000000e+0	1.000000e+0	4.118289e+0	2.428193e-1	1	2.428193e-1	1.000000e+0	199	1.641816e-1	1.000000e+0	1.000000e+0	6.090817e+0	1.641816e-1	1	2962	1.000000e+0	3.376097e-4	unnamed	MSH2
GO Biological Process	GO:0044710	single-organism metabolic process	197	2.517961e-1	1.000000e+0	1.000000e+0	3.971468e+0	2.517961e-1	1	2.517961e-1	1.000000e+0	201	1.696691e-1	1.000000e+0	1.000000e+0	5.893826e+0	1.696691e-1	1	3061	1.000000e+0	3.266906e-4	unnamed	MSH2
GO Biological Process	GO:0048513	organ development	198	2.824258e-1	1.000000e+0	1.000000e+0	3.540753e+0	2.824258e-1	1	2.824258e-1	1.000000e+0	195	1.308686e-1	1.000000e+0	1.000000e+0	7.641254e+0	1.308686e-1	1	2361	1.000000e+0	4.235493e-4	unnamed	MSH2
GO Biological Process	GO:0090304	nucleic acid metabolic process	199	3.065231e-1	1.000000e+0	1.000000e+0	3.262397e+0	3.065231e-1	1	3.065231e-1	1.000000e+0	205	2.105759e-1	1.000000e+0	1.000000e+0	4.748881e+0	2.105759e-1	1	3799	1.000000e+0	2.632272e-4	unnamed	MSH2
GO Biological Process	GO:0048523	negative regulation of cellular process	200	3.146568e-1	1.000000e+0	1.000000e+0	3.178065e+0	3.146568e-1	1	3.146568e-1	1.000000e+0	200	1.686714e-1	1.000000e+0	1.000000e+0	5.928689e+0	1.686714e-1	1	3043	1.000000e+0	3.286231e-4	unnamed	MSH2
GO Biological Process	GO:0030154	cell differentiation	201	3.160741e-1	1.000000e+0	1.000000e+0	3.163815e+0	3.160741e-1	1	3.160741e-1	1.000000e+0	197	1.450585e-1	1.000000e+0	1.000000e+0	6.893771e+0	1.450585e-1	1	2617	1.000000e+0	3.821169e-4	unnamed	MSH2
GO Biological Process	GO:0048869	cellular developmental process	202	3.225257e-1	1.000000e+0	1.000000e+0	3.100528e+0	3.225257e-1	1	3.225257e-1	1.000000e+0	198	1.515991e-1	1.000000e+0	1.000000e+0	6.596344e+0	1.515991e-1	1	2735	1.000000e+0	3.656307e-4	unnamed	MSH2
GO Biological Process	GO:0048519	negative regulation of biological process	203	3.368683e-1	1.000000e+0	1.000000e+0	2.968519e+0	3.368683e-1	1	3.368683e-1	1.000000e+0	203	1.840253e-1	1.000000e+0	1.000000e+0	5.434036e+0	1.840253e-1	1	3320	1.000000e+0	3.012048e-4	unnamed	MSH2
GO Biological Process	GO:0006139	nucleobase-containing compound metabolic process	204	3.530780e-1	1.000000e+0	1.000000e+0	2.832235e+0	3.530780e-1	1	3.530780e-1	1.000000e+0	214	2.484341e-1	1.000000e+0	1.000000e+0	4.025212e+0	2.484341e-1	1	4482	1.000000e+0	2.231147e-4	unnamed	MSH2
GO Biological Process	GO:0019219	regulation of nucleobase-containing compound metabolic process	205	3.657269e-1	1.000000e+0	1.000000e+0	2.734281e+0	3.657269e-1	1	3.657269e-1	1.000000e+0	207	2.176709e-1	1.000000e+0	1.000000e+0	4.594092e+0	2.176709e-1	1	3927	1.000000e+0	2.546473e-4	unnamed	MSH2
GO Biological Process	GO:0046483	heterocycle metabolic process	206	3.657512e-1	1.000000e+0	1.000000e+0	2.734099e+0	3.657512e-1	1	3.657512e-1	1.000000e+0	216	2.580788e-1	1.000000e+0	1.000000e+0	3.874785e+0	2.580788e-1	1	4656	1.000000e+0	2.147766e-4	unnamed	MSH2
GO Biological Process	GO:0006725	cellular aromatic compound metabolic process	207	3.683046e-1	1.000000e+0	1.000000e+0	2.715144e+0	3.683046e-1	1	3.683046e-1	1.000000e+0	217	2.587994e-1	1.000000e+0	1.000000e+0	3.863997e+0	2.587994e-1	1	4669	1.000000e+0	2.141786e-4	unnamed	MSH2
GO Biological Process	GO:0051171	regulation of nitrogen compound metabolic process	208	3.708892e-1	1.000000e+0	1.000000e+0	2.696223e+0	3.708892e-1	1	3.708892e-1	1.000000e+0	209	2.225486e-1	1.000000e+0	1.000000e+0	4.493400e+0	2.225486e-1	1	4015	1.000000e+0	2.490660e-4	unnamed	MSH2
GO Biological Process	GO:0044767	single-organism developmental process	209	3.730678e-1	1.000000e+0	1.000000e+0	2.680478e+0	3.730678e-1	1	3.730678e-1	1.000000e+0	202	1.833601e-1	1.000000e+0	1.000000e+0	5.453748e+0	1.833601e-1	1	3308	1.000000e+0	3.022975e-4	unnamed	MSH2
GO Biological Process	GO:0034641	cellular nitrogen compound metabolic process	210	3.768107e-1	1.000000e+0	1.000000e+0	2.653853e+0	3.768107e-1	1	3.768107e-1	1.000000e+0	219	2.694973e-1	1.000000e+0	1.000000e+0	3.710613e+0	2.694973e-1	1	4862	1.000000e+0	2.056767e-4	unnamed	MSH2
GO Biological Process	GO:1901360	organic cyclic compound metabolic process	211	3.827617e-1	1.000000e+0	1.000000e+0	2.612592e+0	3.827617e-1	1	3.827617e-1	1.000000e+0	221	2.708830e-1	1.000000e+0	1.000000e+0	3.691631e+0	2.708830e-1	1	4887	1.000000e+0	2.046245e-4	unnamed	MSH2
GO Biological Process	GO:0016043	cellular component organization	212	3.831577e-1	1.000000e+0	1.000000e+0	2.609891e+0	3.831577e-1	1	3.831577e-1	1.000000e+0	210	2.231584e-1	1.000000e+0	1.000000e+0	4.481123e+0	2.231584e-1	1	4026	1.000000e+0	2.483855e-4	unnamed	MSH2
GO Biological Process	GO:0071840	cellular component organization or biogenesis	213	3.897194e-1	1.000000e+0	1.000000e+0	2.565949e+0	3.897194e-1	1	3.897194e-1	1.000000e+0	211	2.299762e-1	1.000000e+0	1.000000e+0	4.348277e+0	2.299762e-1	1	4149	1.000000e+0	2.410219e-4	unnamed	MSH2
GO Biological Process	GO:0048731	system development	214	3.900631e-1	1.000000e+0	1.000000e+0	2.563688e+0	3.900631e-1	1	3.900631e-1	1.000000e+0	204	1.879053e-1	1.000000e+0	1.000000e+0	5.321829e+0	1.879053e-1	1	3390	1.000000e+0	2.949853e-4	unnamed	MSH2
GO Biological Process	GO:0007165	signal transduction	215	3.912589e-1	1.000000e+0	1.000000e+0	2.555852e+0	3.912589e-1	1	3.912589e-1	1.000000e+0	212	2.385123e-1	1.000000e+0	1.000000e+0	4.192656e+0	2.385123e-1	1	4303	1.000000e+0	2.323960e-4	unnamed	MSH2
GO Biological Process	GO:0060255	regulation of macromolecule metabolic process	216	4.100897e-1	1.000000e+0	1.000000e+0	2.438491e+0	4.100897e-1	1	4.100897e-1	1.000000e+0	215	2.568594e-1	1.000000e+0	1.000000e+0	3.893181e+0	2.568594e-1	1	4634	1.000000e+0	2.157963e-4	unnamed	MSH2
GO Biological Process	GO:0006807	nitrogen compound metabolic process	217	4.138051e-1	1.000000e+0	1.000000e+0	2.416597e+0	4.138051e-1	1	4.138051e-1	1.000000e+0	224	2.925004e-1	1.000000e+0	1.000000e+0	3.418799e+0	2.925004e-1	1	5277	1.000000e+0	1.895016e-4	unnamed	MSH2
GO Biological Process	GO:0048856	anatomical structure development	218	4.234725e-1	1.000000e+0	1.000000e+0	2.361429e+0	4.234725e-1	1	4.234725e-1	1.000000e+0	206	2.155091e-1	1.000000e+0	1.000000e+0	4.640175e+0	2.155091e-1	1	3888	1.000000e+0	2.572016e-4	unnamed	MSH2
GO Biological Process	GO:0007275	multicellular organismal development	219	4.357034e-1	1.000000e+0	1.000000e+0	2.295139e+0	4.357034e-1	1	4.357034e-1	1.000000e+0	208	2.202206e-1	1.000000e+0	1.000000e+0	4.540901e+0	2.202206e-1	1	3973	1.000000e+0	2.516990e-4	unnamed	MSH2
GO Biological Process	GO:0080090	regulation of primary metabolic process	220	4.363900e-1	1.000000e+0	1.000000e+0	2.291528e+0	4.363900e-1	1	4.363900e-1	1.000000e+0	222	2.729893e-1	1.000000e+0	1.000000e+0	3.663147e+0	2.729893e-1	1	4925	1.000000e+0	2.030457e-4	unnamed	MSH2
GO Biological Process	GO:0044700	single organism signaling	221	4.371810e-1	1.000000e+0	1.000000e+0	2.287382e+0	4.371810e-1	1	4.371810e-1	1.000000e+0	218	2.635663e-1	1.000000e+0	1.000000e+0	3.794111e+0	2.635663e-1	1	4755	1.000000e+0	2.103049e-4	unnamed	MSH2
GO Biological Process	GO:0031323	regulation of cellular metabolic process	222	4.406599e-1	1.000000e+0	1.000000e+0	2.269324e+0	4.406599e-1	1	4.406599e-1	1.000000e+0	223	2.761488e-1	1.000000e+0	1.000000e+0	3.621236e+0	2.761488e-1	1	4982	1.000000e+0	2.007226e-4	unnamed	MSH2
GO Biological Process	GO:0007154	cell communication	223	4.446638e-1	1.000000e+0	1.000000e+0	2.248890e+0	4.446638e-1	1	4.446638e-1	1.000000e+0	220	2.703841e-1	1.000000e+0	1.000000e+0	3.698442e+0	2.703841e-1	1	4878	1.000000e+0	2.050021e-4	unnamed	MSH2
GO Biological Process	GO:0051716	cellular response to stimulus	224	4.562761e-1	1.000000e+0	1.000000e+0	2.191655e+0	4.562761e-1	1	4.562761e-1	1.000000e+0	225	2.957153e-1	1.000000e+0	1.000000e+0	3.381631e+0	2.957153e-1	1	5335	1.000000e+0	1.874414e-4	unnamed	MSH2
GO Biological Process	GO:0032502	developmental process	225	4.657420e-1	1.000000e+0	1.000000e+0	2.147111e+0	4.657420e-1	1	4.657420e-1	1.000000e+0	213	2.454409e-1	1.000000e+0	1.000000e+0	4.074300e+0	2.454409e-1	1	4428	1.000000e+0	2.258356e-4	unnamed	MSH2
GO Biological Process	GO:0019222	regulation of metabolic process	226	4.728179e-1	1.000000e+0	1.000000e+0	2.114979e+0	4.728179e-1	1	4.728179e-1	1.000000e+0	226	3.055263e-1	1.000000e+0	1.000000e+0	3.273041e+0	3.055263e-1	1	5512	1.000000e+0	1.814224e-4	unnamed	MSH2
GO Biological Process	GO:0044260	cellular macromolecule metabolic process	227	4.901841e-1	1.000000e+0	1.000000e+0	2.040050e+0	4.901841e-1	1	4.901841e-1	1.000000e+0	229	3.421651e-1	1.000000e+0	1.000000e+0	2.922566e+0	3.421651e-1	1	6173	1.000000e+0	1.619958e-4	unnamed	MSH2
GO Biological Process	GO:0043170	macromolecule metabolic process	228	5.266956e-1	1.000000e+0	1.000000e+0	1.898630e+0	5.266956e-1	1	5.266956e-1	1.000000e+0	230	3.758661e-1	1.000000e+0	1.000000e+0	2.660522e+0	3.758661e-1	1	6781	1.000000e+0	1.474709e-4	unnamed	MSH2
GO Biological Process	GO:0044707	single-multicellular organism process	229	5.372858e-1	1.000000e+0	1.000000e+0	1.861207e+0	5.372858e-1	1	5.372858e-1	1.000000e+0	227	3.138407e-1	1.000000e+0	1.000000e+0	3.186330e+0	3.138407e-1	1	5662	1.000000e+0	1.766160e-4	unnamed	MSH2
GO Biological Process	GO:0050896	response to stimulus	230	5.533212e-1	1.000000e+0	1.000000e+0	1.807268e+0	5.533212e-1	1	5.533212e-1	1.000000e+0	231	3.817416e-1	1.000000e+0	1.000000e+0	2.619573e+0	3.817416e-1	1	6887	1.000000e+0	1.452011e-4	unnamed	MSH2
GO Biological Process	GO:0032501	multicellular organismal process	231	5.539872e-1	1.000000e+0	1.000000e+0	1.805096e+0	5.539872e-1	1	5.539872e-1	1.000000e+0	228	3.263123e-1	1.000000e+0	1.000000e+0	3.064549e+0	3.263123e-1	1	5887	1.000000e+0	1.698658e-4	unnamed	MSH2
GO Biological Process	GO:0044237	cellular metabolic process	232	6.001923e-1	1.000000e+0	1.000000e+0	1.666133e+0	6.001923e-1	1	6.001923e-1	1.000000e+0	232	4.564049e-1	1.000000e+0	1.000000e+0	2.191037e+0	4.564049e-1	1	8234	1.000000e+0	1.214477e-4	unnamed	MSH2
GO Biological Process	GO:0044238	primary metabolic process	233	6.053666e-1	1.000000e+0	1.000000e+0	1.651892e+0	6.053666e-1	1	6.053666e-1	1.000000e+0	233	4.608946e-1	1.000000e+0	1.000000e+0	2.169693e+0	4.608946e-1	1	8315	1.000000e+0	1.202646e-4	unnamed	MSH2
GO Biological Process	GO:0071704	organic substance metabolic process	234	6.199145e-1	1.000000e+0	1.000000e+0	1.613126e+0	6.199145e-1	1	6.199145e-1	1.000000e+0	234	4.745857e-1	1.000000e+0	1.000000e+0	2.107101e+0	4.745857e-1	1	8562	1.000000e+0	1.167951e-4	unnamed	MSH2
GO Biological Process	GO:0008152	metabolic process	235	6.507895e-1	1.000000e+0	1.000000e+0	1.536595e+0	6.507895e-1	1	6.507895e-1	1.000000e+0	236	5.097278e-1	1.000000e+0	1.000000e+0	1.961831e+0	5.097278e-1	1	9196	1.000000e+0	1.087429e-4	unnamed	MSH2
GO Biological Process	GO:0050794	regulation of cellular process	236	6.759845e-1	1.000000e+0	1.000000e+0	1.479324e+0	6.759845e-1	1	6.759845e-1	1.000000e+0	235	4.907710e-1	1.000000e+0	1.000000e+0	2.037610e+0	4.907710e-1	1	8854	1.000000e+0	1.129433e-4	unnamed	MSH2
GO Biological Process	GO:0050789	regulation of biological process	237	6.921477e-1	1.000000e+0	1.000000e+0	1.444778e+0	6.921477e-1	1	6.921477e-1	1.000000e+0	237	5.170999e-1	1.000000e+0	1.000000e+0	1.933862e+0	5.170999e-1	1	9329	1.000000e+0	1.071926e-4	unnamed	MSH2
GO Biological Process	GO:0065007	biological regulation	238	7.151977e-1	1.000000e+0	1.000000e+0	1.398215e+0	7.151977e-1	1	7.151977e-1	1.000000e+0	238	5.461449e-1	1.000000e+0	1.000000e+0	1.831016e+0	5.461449e-1	1	9853	1.000000e+0	1.014919e-4	unnamed	MSH2
GO Biological Process	GO:0044763	single-organism cellular process	239	7.497126e-1	1.000000e+0	1.000000e+0	1.333844e+0	7.497126e-1	1	7.497126e-1	1.000000e+0	239	5.605011e-1	1.000000e+0	1.000000e+0	1.784118e+0	5.605011e-1	1	10112	1.000000e+0	9.889241e-5	unnamed	MSH2
GO Biological Process	GO:0044699	single-organism process	240	7.935590e-1	1.000000e+0	1.000000e+0	1.260146e+0	7.935590e-1	1	7.935590e-1	1.000000e+0	240	6.164847e-1	1.000000e+0	1.000000e+0	1.622100e+0	6.164847e-1	1	11122	1.000000e+0	8.991189e-5	unnamed	MSH2
GO Biological Process	GO:0009987	cellular process	241	8.656787e-1	1.000000e+0	1.000000e+0	1.155163e+0	8.656787e-1	1	8.656787e-1	1.000000e+0	241	7.487944e-1	1.000000e+0	1.000000e+0	1.335480e+0	7.487944e-1	1	13509	1.000000e+0	7.402472e-5	unnamed	MSH2
GO Cellular Component	GO:0032302	MutSbeta complex	1	7.192132e-5	9.098047e-2	9.098047e-2	1.390408e+4	7.192132e-5	1	7.192132e-5	1.000000e+0	1	1.108586e-4	1.402361e-1	1.402361e-1	9.020500e+3	1.108586e-4	1	2	1.000000e+0	5.000000e-1	unnamed	MSH2
GO Cellular Component	GO:0032301	MutSalpha complex	2	1.847541e-4	2.337139e-1	1.168570e-1	5.412600e+3	1.847541e-4	1	1.847541e-4	1.000000e+0	1	1.108586e-4	1.402361e-1	1.402361e-1	9.020500e+3	1.108586e-4	1	2	1.000000e+0	5.000000e-1	unnamed	MSH2
GO Cellular Component	GO:0032300	mismatch repair complex	3	7.627713e-4	9.649057e-1	3.216352e-1	1.311009e+3	7.627713e-4	1	7.627713e-4	1.000000e+0	3	4.434344e-4	5.609445e-1	1.869815e-1	2.255125e+3	4.434344e-4	1	8	1.000000e+0	1.250000e-1	unnamed	MSH2
GO Cellular Component	GO:0000228	nuclear chromosome	4	2.961235e-2	1.000000e+0	1.000000e+0	3.376969e+1	2.961235e-2	1	2.961235e-2	1.000000e+0	4	1.701680e-2	1.000000e+0	1.000000e+0	5.876547e+1	1.701680e-2	1	307	1.000000e+0	3.257329e-3	unnamed	MSH2
GO Cellular Component	GO:0005694	chromosome	5	5.644203e-2	1.000000e+0	1.000000e+0	1.771729e+1	5.644203e-2	1	5.644203e-2	1.000000e+0	5	3.841250e-2	1.000000e+0	1.000000e+0	2.603319e+1	3.841250e-2	1	693	1.000000e+0	1.443001e-3	unnamed	MSH2
GO Cellular Component	GO:0031981	nuclear lumen	6	1.748307e-1	1.000000e+0	1.000000e+0	5.719819e+0	1.748307e-1	1	1.748307e-1	1.000000e+0	6	1.154038e-1	1.000000e+0	1.000000e+0	8.665226e+0	1.154038e-1	1	2082	1.000000e+0	4.803074e-4	unnamed	MSH2
GO Cellular Component	GO:0044428	nuclear part	7	2.070089e-1	1.000000e+0	1.000000e+0	4.830709e+0	2.070089e-1	1	2.070089e-1	1.000000e+0	7	1.370212e-1	1.000000e+0	1.000000e+0	7.298139e+0	1.370212e-1	1	2472	1.000000e+0	4.045307e-4	unnamed	MSH2
GO Cellular Component	GO:0070013	intracellular organelle lumen	8	2.178720e-1	1.000000e+0	1.000000e+0	4.589852e+0	2.178720e-1	1	2.178720e-1	1.000000e+0	8	1.491048e-1	1.000000e+0	1.000000e+0	6.706691e+0	1.491048e-1	1	2690	1.000000e+0	3.717472e-4	unnamed	MSH2
GO Cellular Component	GO:0043233	organelle lumen	9	2.231770e-1	1.000000e+0	1.000000e+0	4.480748e+0	2.231770e-1	1	2.231770e-1	1.000000e+0	9	1.524306e-1	1.000000e+0	1.000000e+0	6.560364e+0	1.524306e-1	1	2750	1.000000e+0	3.636364e-4	unnamed	MSH2
GO Cellular Component	GO:0031974	membrane-enclosed lumen	10	2.255118e-1	1.000000e+0	1.000000e+0	4.434357e+0	2.255118e-1	1	2.255118e-1	1.000000e+0	10	1.552020e-1	1.000000e+0	1.000000e+0	6.443214e+0	1.552020e-1	1	2800	1.000000e+0	3.571429e-4	unnamed	MSH2
GO Cellular Component	GO:0043232	intracellular non-membrane-bounded organelle	11	2.709879e-1	1.000000e+0	1.000000e+0	3.690202e+0	2.709879e-1	1	2.709879e-1	1.000000e+0	11	1.844133e-1	1.000000e+0	1.000000e+0	5.422603e+0	1.844133e-1	1	3327	1.000000e+0	3.005711e-4	unnamed	MSH2
GO Cellular Component	GO:0043234	protein complex	12	3.027166e-1	1.000000e+0	1.000000e+0	3.303419e+0	3.027166e-1	1	3.027166e-1	1.000000e+0	12	2.018735e-1	1.000000e+0	1.000000e+0	4.953597e+0	2.018735e-1	1	3642	1.000000e+0	2.745744e-4	unnamed	MSH2
GO Cellular Component	GO:0032991	macromolecular complex	13	3.347910e-1	1.000000e+0	1.000000e+0	2.986938e+0	3.347910e-1	1	3.347910e-1	1.000000e+0	13	2.340225e-1	1.000000e+0	1.000000e+0	4.273093e+0	2.340225e-1	1	4222	1.000000e+0	2.368546e-4	unnamed	MSH2
GO Cellular Component	GO:0044446	intracellular organelle part	14	4.732075e-1	1.000000e+0	1.000000e+0	2.113238e+0	4.732075e-1	1	4.732075e-1	1.000000e+0	15	3.595144e-1	1.000000e+0	1.000000e+0	2.781529e+0	3.595144e-1	1	6486	1.000000e+0	1.541782e-4	unnamed	MSH2
GO Cellular Component	GO:0005634	nucleus	15	4.766312e-1	1.000000e+0	1.000000e+0	2.098058e+0	4.766312e-1	1	4.766312e-1	1.000000e+0	14	3.366776e-1	1.000000e+0	1.000000e+0	2.970201e+0	3.366776e-1	1	6074	1.000000e+0	1.646362e-4	unnamed	MSH2
GO Cellular Component	GO:0044422	organelle part	16	4.814989e-1	1.000000e+0	1.000000e+0	2.076848e+0	4.814989e-1	1	4.814989e-1	1.000000e+0	16	3.657225e-1	1.000000e+0	1.000000e+0	2.734313e+0	3.657225e-1	1	6598	1.000000e+0	1.515611e-4	unnamed	MSH2
GO Cellular Component	GO:0043231	intracellular membrane-bounded organelle	17	6.973299e-1	1.000000e+0	1.000000e+0	1.434041e+0	6.973299e-1	1	6.973299e-1	1.000000e+0	17	5.549582e-1	1.000000e+0	1.000000e+0	1.801938e+0	5.549582e-1	1	10012	1.000000e+0	9.988014e-5	unnamed	MSH2
GO Cellular Component	GO:0043227	membrane-bounded organelle	18	6.992039e-1	1.000000e+0	1.000000e+0	1.430198e+0	6.992039e-1	1	6.992039e-1	1.000000e+0	18	5.568427e-1	1.000000e+0	1.000000e+0	1.795839e+0	5.568427e-1	1	10046	1.000000e+0	9.954211e-5	unnamed	MSH2
GO Cellular Component	GO:0043229	intracellular organelle	19	7.399473e-1	1.000000e+0	1.000000e+0	1.351448e+0	7.399473e-1	1	7.399473e-1	1.000000e+0	19	6.092789e-1	1.000000e+0	1.000000e+0	1.641285e+0	6.092789e-1	1	10992	1.000000e+0	9.097525e-5	unnamed	MSH2
GO Cellular Component	GO:0043226	organelle	20	7.415866e-1	1.000000e+0	1.000000e+0	1.348460e+0	7.415866e-1	1	7.415866e-1	1.000000e+0	20	6.110526e-1	1.000000e+0	1.000000e+0	1.636520e+0	6.110526e-1	1	11024	1.000000e+0	9.071118e-5	unnamed	MSH2
GO Cellular Component	GO:0044424	intracellular part	21	8.017695e-1	1.000000e+0	1.000000e+0	1.247241e+0	8.017695e-1	1	8.017695e-1	1.000000e+0	21	6.971897e-1	1.000000e+0	1.000000e+0	1.434330e+0	6.971897e-1	1	12578	1.000000e+0	7.950390e-5	unnamed	MSH2
GO Cellular Component	GO:0005622	intracellular	22	8.064789e-1	1.000000e+0	1.000000e+0	1.239958e+0	8.064789e-1	1	8.064789e-1	1.000000e+0	22	7.066127e-1	1.000000e+0	1.000000e+0	1.415202e+0	7.066127e-1	1	12748	1.000000e+0	7.844368e-5	unnamed	MSH2
GO Cellular Component	GO:0044464	cell part	23	8.908971e-1	1.000000e+0	1.000000e+0	1.122464e+0	8.908971e-1	1	8.908971e-1	1.000000e+0	23	8.202982e-1	1.000000e+0	1.000000e+0	1.219069e+0	8.202982e-1	1	14799	1.000000e+0	6.757213e-5	unnamed	MSH2
GO Cellular Component	GO:0005623	cell	24	8.910977e-1	1.000000e+0	1.000000e+0	1.122211e+0	8.910977e-1	1	8.910977e-1	1.000000e+0	24	8.203536e-1	1.000000e+0	1.000000e+0	1.218986e+0	8.203536e-1	1	14800	1.000000e+0	6.756757e-5	unnamed	MSH2
Mouse Phenotype	MP:0010345	increased thyroid C-cell carcinoma incidence	1	1.554047e-4	1.000000e+0	1.000000e+0	6.434813e+3	1.554047e-4	1	1.554047e-4	1.000000e+0	1	1.662879e-4	1.000000e+0	1.000000e+0	6.013667e+3	1.662879e-4	1	3	1.000000e+0	3.333333e-1	unnamed	MSH2
Mouse Phenotype	MP:0010351	increased pituitary melanotroph tumor incidence	2	1.601797e-4	1.000000e+0	6.341514e-1	6.242989e+3	1.601797e-4	1	1.601797e-4	1.000000e+0	3	2.217172e-4	1.000000e+0	5.851856e-1	4.510250e+3	2.217172e-4	1	4	1.000000e+0	2.500000e-1	unnamed	MSH2
Mouse Phenotype	MP:0009320	lymphoblastic lymphoma	3	2.733260e-4	1.000000e+0	7.213984e-1	3.658635e+3	2.733260e-4	1	2.733260e-4	1.000000e+0	1	1.662879e-4	1.000000e+0	1.000000e+0	6.013667e+3	1.662879e-4	1	3	1.000000e+0	3.333333e-1	unnamed	MSH2
Mouse Phenotype	MP:0010350	increased pituitary adenohypophysis tumor incidence	4	4.435191e-4	1.000000e+0	8.779461e-1	2.254694e+3	4.435191e-4	1	4.435191e-4	1.000000e+0	4	2.771465e-4	1.000000e+0	5.486115e-1	3.608200e+3	2.771465e-4	1	5	1.000000e+0	2.000000e-1	unnamed	MSH2
Mouse Phenotype	MP:0009797	abnormal mismatch repair	5	4.648098e-4	1.000000e+0	7.360728e-1	2.151418e+3	4.648098e-4	1	4.648098e-4	1.000000e+0	5	4.434344e-4	1.000000e+0	7.022227e-1	2.255125e+3	4.434344e-4	1	8	1.000000e+0	1.250000e-1	unnamed	MSH2
Mouse Phenotype	MP:0004501	increased incidence of tumors by UV-induction	6	4.805611e-4	1.000000e+0	6.341805e-1	2.080901e+3	4.805611e-4	1	4.805611e-4	1.000000e+0	7	5.542930e-4	1.000000e+0	6.269846e-1	1.804100e+3	5.542930e-4	1	10	1.000000e+0	1.000000e-1	unnamed	MSH2
Mouse Phenotype	MP:0002050	pheochromocytoma	7	6.022774e-4	1.000000e+0	6.812618e-1	1.660364e+3	6.022774e-4	1	6.022774e-4	1.000000e+0	7	5.542930e-4	1.000000e+0	6.269846e-1	1.804100e+3	5.542930e-4	1	10	1.000000e+0	1.000000e-1	unnamed	MSH2
Mouse Phenotype	MP:0003269	colon polyps	8	8.835779e-4	1.000000e+0	8.745212e-1	1.131762e+3	8.835779e-4	1	8.835779e-4	1.000000e+0	10	7.760102e-4	1.000000e+0	6.144449e-1	1.288643e+3	7.760102e-4	1	14	1.000000e+0	7.142857e-2	unnamed	MSH2
Mouse Phenotype	MP:0009704	skin squamous cell carcinoma	9	9.643653e-4	1.000000e+0	8.484272e-1	1.036951e+3	9.643653e-4	1	9.643653e-4	1.000000e+0	14	9.422981e-4	1.000000e+0	5.329369e-1	1.061235e+3	9.422981e-4	1	17	1.000000e+0	5.882353e-2	unnamed	MSH2
Mouse Phenotype	MP:0002031	increased adrenal gland tumor incidence	10	1.044589e-3	1.000000e+0	8.271056e-1	9.573146e+2	1.044589e-3	1	1.044589e-3	1.000000e+0	12	8.868688e-4	1.000000e+0	5.851856e-1	1.127562e+3	8.868688e-4	1	16	1.000000e+0	6.250000e-2	unnamed	MSH2
Mouse Phenotype	MP:0010346	increased thyroid carcinoma incidence	11	1.057458e-3	1.000000e+0	7.611775e-1	9.456636e+2	1.057458e-3	1	1.057458e-3	1.000000e+0	6	4.988637e-4	1.000000e+0	6.583338e-1	2.004556e+3	4.988637e-4	1	9	1.000000e+0	1.111111e-1	unnamed	MSH2
Mouse Phenotype	MP:0004815	abnormal somatic hypermutation frequency	12	1.337091e-3	1.000000e+0	8.822572e-1	7.478925e+2	1.337091e-3	1	1.337091e-3	1.000000e+0	12	8.868688e-4	1.000000e+0	5.851856e-1	1.127562e+3	8.868688e-4	1	16	1.000000e+0	6.250000e-2	unnamed	MSH2
Mouse Phenotype	MP:0009309	small intestine adenocarcinoma	13	1.388853e-3	1.000000e+0	8.459183e-1	7.200187e+2	1.388853e-3	1	1.388853e-3	1.000000e+0	9	6.097223e-4	1.000000e+0	5.364201e-1	1.640091e+3	6.097223e-4	1	11	1.000000e+0	9.090909e-2	unnamed	MSH2
Mouse Phenotype	MP:0003324	increased liver adenoma incidence	14	1.542576e-3	1.000000e+0	8.724369e-1	6.482664e+2	1.542576e-3	1	1.542576e-3	1.000000e+0	16	1.108586e-3	1.000000e+0	5.486115e-1	9.020500e+2	1.108586e-3	1	20	1.000000e+0	5.000000e-2	unnamed	MSH2
Mouse Phenotype	MP:0010316	increased thyroid tumor incidence	15	1.574984e-3	1.000000e+0	8.313816e-1	6.349273e+2	1.574984e-3	1	1.574984e-3	1.000000e+0	15	9.977274e-4	1.000000e+0	5.266670e-1	1.002278e+3	9.977274e-4	1	18	1.000000e+0	5.555556e-2	unnamed	MSH2
Mouse Phenotype	MP:0008410	increased cellular sensitivity to ultraviolet irradiation	16	1.784512e-3	1.000000e+0	8.831104e-1	5.603772e+2	1.784512e-3	1	1.784512e-3	1.000000e+0	24	1.607450e-3	1.000000e+0	5.303245e-1	6.221034e+2	1.607450e-3	1	29	1.000000e+0	3.448276e-2	unnamed	MSH2
Mouse Phenotype	MP:0009222	uterus tumor	17	2.090356e-3	1.000000e+0	9.736140e-1	4.783874e+2	2.090356e-3	1	2.090356e-3	1.000000e+0	16	1.108586e-3	1.000000e+0	5.486115e-1	9.020500e+2	1.108586e-3	1	20	1.000000e+0	5.000000e-2	unnamed	MSH2
Mouse Phenotype	MP:0004191	neuronal intranuclear inclusions	18	2.203622e-3	1.000000e+0	9.693488e-1	4.537983e+2	2.203622e-3	1	2.203622e-3	1.000000e+0	11	8.314395e-4	1.000000e+0	5.984853e-1	1.202733e+3	8.314395e-4	1	15	1.000000e+0	6.666667e-2	unnamed	MSH2
Mouse Phenotype	MP:0008884	abnormal enterocyte apoptosis	19	2.395246e-3	1.000000e+0	9.981873e-1	4.174937e+2	2.395246e-3	1	2.395246e-3	1.000000e+0	20	1.385732e-3	1.000000e+0	5.486113e-1	7.216400e+2	1.385732e-3	1	25	1.000000e+0	4.000000e-2	unnamed	MSH2
Mouse Phenotype	MP:0009828	increased tumor latency	20	2.504078e-3	1.000000e+0	9.913645e-1	3.993486e+2	2.504078e-3	1	2.504078e-3	1.000000e+0	18	1.164015e-3	1.000000e+0	5.120373e-1	8.590952e+2	1.164015e-3	1	21	1.000000e+0	4.761905e-2	unnamed	MSH2
Mouse Phenotype	MP:0009277	brain tumor	21	2.574915e-3	1.000000e+0	9.708656e-1	3.883623e+2	2.574915e-3	1	2.574915e-3	1.000000e+0	22	1.552020e-3	1.000000e+0	5.585861e-1	6.443214e+2	1.552020e-3	1	28	1.000000e+0	3.571429e-2	unnamed	MSH2
Mouse Phenotype	MP:0003789	osteosarcoma	22	2.766283e-3	1.000000e+0	9.956104e-1	3.614958e+2	2.766283e-3	1	2.766283e-3	1.000000e+0	19	1.219445e-3	1.000000e+0	5.081877e-1	8.200455e+2	1.219445e-3	1	22	1.000000e+0	4.545455e-2	unnamed	MSH2
Mouse Phenotype	MP:0008011	intestine polyps	23	3.308763e-3	1.000000e+0	1.000000e+0	3.022277e+2	3.308763e-3	1	3.308763e-3	1.000000e+0	22	1.552020e-3	1.000000e+0	5.585861e-1	6.443214e+2	1.552020e-3	1	28	1.000000e+0	3.571429e-2	unnamed	MSH2
Mouse Phenotype	MP:0002051	skin papilloma	24	3.627202e-3	1.000000e+0	1.000000e+0	2.756946e+2	3.627202e-3	1	3.627202e-3	1.000000e+0	28	2.217172e-3	1.000000e+0	6.269846e-1	4.510250e+2	2.217172e-3	1	40	1.000000e+0	2.500000e-2	unnamed	MSH2
Mouse Phenotype	MP:0003667	hemangiosarcoma	25	3.677923e-3	1.000000e+0	1.000000e+0	2.718926e+2	3.677923e-3	1	3.677923e-3	1.000000e+0	26	1.829167e-3	1.000000e+0	5.570517e-1	5.466970e+2	1.829167e-3	1	33	1.000000e+0	3.030303e-2	unnamed	MSH2
Mouse Phenotype	MP:0010280	increased skeletal tumor incidence	26	3.963581e-3	1.000000e+0	1.000000e+0	2.522971e+2	3.963581e-3	1	3.963581e-3	1.000000e+0	21	1.441162e-3	1.000000e+0	5.433867e-1	6.938846e+2	1.441162e-3	1	26	1.000000e+0	3.846154e-2	unnamed	MSH2
Mouse Phenotype	MP:0003992	increased mortality induced by ionizing radiation	27	3.999546e-3	1.000000e+0	1.000000e+0	2.500283e+2	3.999546e-3	1	3.999546e-3	1.000000e+0	31	2.494318e-3	1.000000e+0	6.370971e-1	4.009111e+2	2.494318e-3	1	45	1.000000e+0	2.222222e-2	unnamed	MSH2
Mouse Phenotype	MP:0010352	gastrointestinal tract polyps	28	4.161266e-3	1.000000e+0	1.000000e+0	2.403115e+2	4.161266e-3	1	4.161266e-3	1.000000e+0	25	1.718308e-3	1.000000e+0	5.442225e-1	5.819677e+2	1.718308e-3	1	31	1.000000e+0	3.225806e-2	unnamed	MSH2
Mouse Phenotype	MP:0002957	intestinal adenocarcinoma	29	4.323254e-3	1.000000e+0	1.000000e+0	2.313073e+2	4.323254e-3	1	4.323254e-3	1.000000e+0	30	2.383460e-3	1.000000e+0	6.290745e-1	4.195581e+2	2.383460e-3	1	43	1.000000e+0	2.325581e-2	unnamed	MSH2
Mouse Phenotype	MP:0008000	increased ovary tumor incidence	30	4.330277e-3	1.000000e+0	1.000000e+0	2.309321e+2	4.330277e-3	1	4.330277e-3	1.000000e+0	28	2.217172e-3	1.000000e+0	6.269846e-1	4.510250e+2	2.217172e-3	1	40	1.000000e+0	2.500000e-2	unnamed	MSH2
Mouse Phenotype	MP:0002048	increased lung adenoma incidence	31	4.364080e-3	1.000000e+0	1.000000e+0	2.291433e+2	4.364080e-3	1	4.364080e-3	1.000000e+0	34	2.826894e-3	1.000000e+0	6.583337e-1	3.537451e+2	2.826894e-3	1	51	1.000000e+0	1.960784e-2	unnamed	MSH2
Mouse Phenotype	MP:0004207	squamous cell carcinoma	32	4.467479e-3	1.000000e+0	1.000000e+0	2.238399e+2	4.467479e-3	1	4.467479e-3	1.000000e+0	33	2.771465e-3	1.000000e+0	6.649836e-1	3.608200e+2	2.771465e-3	1	50	1.000000e+0	2.000000e-2	unnamed	MSH2
Mouse Phenotype	MP:0010320	increased pituitary gland tumor incidence	33	4.560929e-3	1.000000e+0	1.000000e+0	2.192536e+2	4.560929e-3	1	4.560929e-3	1.000000e+0	27	1.884596e-3	1.000000e+0	5.526752e-1	5.306176e+2	1.884596e-3	1	34	1.000000e+0	2.941176e-2	unnamed	MSH2
Mouse Phenotype	MP:0008058	abnormal DNA repair	34	5.036031e-3	1.000000e+0	1.000000e+0	1.985691e+2	5.036031e-3	1	5.036031e-3	1.000000e+0	49	4.988637e-3	1.000000e+0	8.061230e-1	2.004556e+2	4.988637e-3	1	90	1.000000e+0	1.111111e-2	unnamed	MSH2
Mouse Phenotype	MP:0008882	abnormal enterocyte physiology	35	5.183444e-3	1.000000e+0	1.000000e+0	1.929219e+2	5.183444e-3	1	5.183444e-3	1.000000e+0	38	3.104041e-3	1.000000e+0	6.467841e-1	3.221607e+2	3.104041e-3	1	56	1.000000e+0	1.785714e-2	unnamed	MSH2
Mouse Phenotype	MP:0002404	increased intestinal adenoma incidence	36	5.229360e-3	1.000000e+0	1.000000e+0	1.912280e+2	5.229360e-3	1	5.229360e-3	1.000000e+0	32	2.660606e-3	1.000000e+0	6.583337e-1	3.758542e+2	2.660606e-3	1	48	1.000000e+0	2.083333e-2	unnamed	MSH2
Mouse Phenotype	MP:0010291	increased cardiovascular system tumor incidence	37	5.232946e-3	1.000000e+0	1.000000e+0	1.910969e+2	5.232946e-3	1	5.232946e-3	1.000000e+0	36	2.937753e-3	1.000000e+0	6.461425e-1	3.403962e+2	2.937753e-3	1	53	1.000000e+0	1.886792e-2	unnamed	MSH2
Mouse Phenotype	MP:0010307	abnormal tumor latency	38	6.284847e-3	1.000000e+0	1.000000e+0	1.591129e+2	6.284847e-3	1	6.284847e-3	1.000000e+0	34	2.826894e-3	1.000000e+0	6.583337e-1	3.537451e+2	2.826894e-3	1	51	1.000000e+0	1.960784e-2	unnamed	MSH2
Mouse Phenotype	MP:0010300	increased skin tumor incidence	39	6.449714e-3	1.000000e+0	1.000000e+0	1.550456e+2	6.449714e-3	1	6.449714e-3	1.000000e+0	43	4.489773e-3	1.000000e+0	8.267447e-1	2.227284e+2	4.489773e-3	1	81	1.000000e+0	1.234568e-2	unnamed	MSH2
Mouse Phenotype	MP:0002014	increased papilloma incidence	40	6.453089e-3	1.000000e+0	1.000000e+0	1.549646e+2	6.453089e-3	1	6.453089e-3	1.000000e+0	38	3.104041e-3	1.000000e+0	6.467841e-1	3.221607e+2	3.104041e-3	1	56	1.000000e+0	1.785714e-2	unnamed	MSH2
Mouse Phenotype	MP:0002027	lung adenocarcinoma	41	6.674635e-3	1.000000e+0	1.000000e+0	1.498209e+2	6.674635e-3	1	6.674635e-3	1.000000e+0	41	3.769192e-3	1.000000e+0	7.279137e-1	2.653088e+2	3.769192e-3	1	68	1.000000e+0	1.470588e-2	unnamed	MSH2
Mouse Phenotype	MP:0009590	gonad tumor	42	6.682982e-3	1.000000e+0	1.000000e+0	1.496338e+2	6.682982e-3	1	6.682982e-3	1.000000e+0	37	3.048611e-3	1.000000e+0	6.524028e-1	3.280182e+2	3.048611e-3	1	55	1.000000e+0	1.818182e-2	unnamed	MSH2
Mouse Phenotype	MP:0010281	increased nervous system tumor incidence	43	7.002789e-3	1.000000e+0	1.000000e+0	1.428003e+2	7.002789e-3	1	7.002789e-3	1.000000e+0	40	3.436617e-3	1.000000e+0	6.802783e-1	2.909839e+2	3.436617e-3	1	62	1.000000e+0	1.612903e-2	unnamed	MSH2
Mouse Phenotype	MP:0008716	lung non-small cell carcinoma	44	7.123287e-3	1.000000e+0	1.000000e+0	1.403846e+2	7.123287e-3	1	7.123287e-3	1.000000e+0	42	4.157197e-3	1.000000e+0	7.837306e-1	2.405467e+2	4.157197e-3	1	75	1.000000e+0	1.333333e-2	unnamed	MSH2
Mouse Phenotype	MP:0004816	abnormal class switch recombination	45	7.358171e-3	1.000000e+0	1.000000e+0	1.359033e+2	7.358171e-3	1	7.358171e-3	1.000000e+0	45	4.822349e-3	1.000000e+0	8.485191e-1	2.073678e+2	4.822349e-3	1	87	1.000000e+0	1.149425e-2	unnamed	MSH2
Mouse Phenotype	MP:0008714	lung carcinoma	46	8.130735e-3	1.000000e+0	1.000000e+0	1.229901e+2	8.130735e-3	1	8.130735e-3	1.000000e+0	48	4.933208e-3	1.000000e+0	8.137738e-1	2.027079e+2	4.933208e-3	1	89	1.000000e+0	1.123596e-2	unnamed	MSH2
Mouse Phenotype	MP:0008498	decreased IgG3 level	47	9.220685e-3	1.000000e+0	1.000000e+0	1.084518e+2	9.220685e-3	1	9.220685e-3	1.000000e+0	46	4.877778e-3	1.000000e+0	8.396140e-1	2.050114e+2	4.877778e-3	1	88	1.000000e+0	1.136364e-2	unnamed	MSH2
Mouse Phenotype	MP:0010299	increased mammary gland tumor incidence	48	9.402370e-3	1.000000e+0	1.000000e+0	1.063562e+2	9.402370e-3	1	9.402370e-3	1.000000e+0	46	4.877778e-3	1.000000e+0	8.396140e-1	2.050114e+2	4.877778e-3	1	88	1.000000e+0	1.136364e-2	unnamed	MSH2
Mouse Phenotype	MP:0010279	increased gastrointestinal tumor incidence	49	9.719407e-3	1.000000e+0	1.000000e+0	1.028869e+2	9.719407e-3	1	9.719407e-3	1.000000e+0	53	5.598359e-3	1.000000e+0	8.363737e-1	1.786238e+2	5.598359e-3	1	101	1.000000e+0	9.900990e-3	unnamed	MSH2
Mouse Phenotype	MP:0010292	increased alimentary system tumor incidence	50	1.051172e-2	1.000000e+0	1.000000e+0	9.513187e+1	1.051172e-2	1	1.051172e-2	1.000000e+0	56	6.318940e-3	1.000000e+0	8.934530e-1	1.582544e+2	6.318940e-3	1	114	1.000000e+0	8.771930e-3	unnamed	MSH2
Mouse Phenotype	MP:0008943	increased sensitivity to induced cell death	51	1.087050e-2	1.000000e+0	1.000000e+0	9.199209e+1	1.087050e-2	1	1.087050e-2	1.000000e+0	62	8.369824e-3	1.000000e+0	1.000000e+0	1.194768e+2	8.369824e-3	1	151	1.000000e+0	6.622517e-3	unnamed	MSH2
Mouse Phenotype	MP:0010287	increased reproductive system tumor incidence	52	1.089120e-2	1.000000e+0	1.000000e+0	9.181723e+1	1.089120e-2	1	1.089120e-2	1.000000e+0	44	4.766920e-3	1.000000e+0	8.578289e-1	2.097791e+2	4.766920e-3	1	86	1.000000e+0	1.162791e-2	unnamed	MSH2
Mouse Phenotype	MP:0002024	T cell derived lymphoma	53	1.137483e-2	1.000000e+0	1.000000e+0	8.791344e+1	1.137483e-2	1	1.137483e-2	1.000000e+0	51	5.376642e-3	1.000000e+0	8.347500e-1	1.859897e+2	5.376642e-3	1	97	1.000000e+0	1.030928e-2	unnamed	MSH2
Mouse Phenotype	MP:0010365	increased thymus tumor incidence	54	1.140170e-2	1.000000e+0	1.000000e+0	8.770624e+1	1.140170e-2	1	1.140170e-2	1.000000e+0	52	5.432071e-3	1.000000e+0	8.271373e-1	1.840918e+2	5.432071e-3	1	98	1.000000e+0	1.020408e-2	unnamed	MSH2
Mouse Phenotype	MP:0008019	increased liver tumor incidence	55	1.160410e-2	1.000000e+0	1.000000e+0	8.617647e+1	1.160410e-2	1	1.160410e-2	1.000000e+0	55	6.208082e-3	1.000000e+0	8.937381e-1	1.610804e+2	6.208082e-3	1	112	1.000000e+0	8.928571e-3	unnamed	MSH2
Mouse Phenotype	MP:0010297	increased hepatobiliary system tumor incidence	56	1.173767e-2	1.000000e+0	1.000000e+0	8.519581e+1	1.173767e-2	1	1.173767e-2	1.000000e+0	56	6.318940e-3	1.000000e+0	8.934530e-1	1.582544e+2	6.318940e-3	1	114	1.000000e+0	8.771930e-3	unnamed	MSH2
Mouse Phenotype	MP:0002032	sarcoma	57	1.184575e-2	1.000000e+0	1.000000e+0	8.441844e+1	1.184575e-2	1	1.184575e-2	1.000000e+0	58	6.540657e-3	1.000000e+0	8.929125e-1	1.528898e+2	6.540657e-3	1	118	1.000000e+0	8.474576e-3	unnamed	MSH2
Mouse Phenotype	MP:0008014	increased lung tumor incidence	58	1.298326e-2	1.000000e+0	1.000000e+0	7.702228e+1	1.298326e-2	1	1.298326e-2	1.000000e+0	59	6.984092e-3	1.000000e+0	9.372888e-1	1.431825e+2	6.984092e-3	1	126	1.000000e+0	7.936508e-3	unnamed	MSH2
Mouse Phenotype	MP:0000495	abnormal colon morphology	59	1.299585e-2	1.000000e+0	1.000000e+0	7.694764e+1	1.299585e-2	1	1.299585e-2	1.000000e+0	50	5.321213e-3	1.000000e+0	8.426673e-1	1.879271e+2	5.321213e-3	1	96	1.000000e+0	1.041667e-2	unnamed	MSH2
Mouse Phenotype	MP:0008495	decreased IgG1 level	60	1.309759e-2	1.000000e+0	1.000000e+0	7.634992e+1	1.309759e-2	1	1.309759e-2	1.000000e+0	61	7.649243e-3	1.000000e+0	9.928968e-1	1.307319e+2	7.649243e-3	1	138	1.000000e+0	7.246377e-3	unnamed	MSH2
Mouse Phenotype	MP:0004499	increased incidence of tumors by chemical induction	61	1.311595e-2	1.000000e+0	1.000000e+0	7.624306e+1	1.311595e-2	1	1.311595e-2	1.000000e+0	54	5.875506e-3	1.000000e+0	8.615233e-1	1.701981e+2	5.875506e-3	1	106	1.000000e+0	9.433962e-3	unnamed	MSH2
Mouse Phenotype	MP:0009308	adenocarcinoma	62	1.492238e-2	1.000000e+0	1.000000e+0	6.701344e+1	1.492238e-2	1	1.492238e-2	1.000000e+0	64	8.425254e-3	1.000000e+0	1.000000e+0	1.186908e+2	8.425254e-3	1	152	1.000000e+0	6.578947e-3	unnamed	MSH2
Mouse Phenotype	MP:0010293	increased integument system tumor incidence	63	1.498579e-2	1.000000e+0	1.000000e+0	6.672990e+1	1.498579e-2	1	1.498579e-2	1.000000e+0	62	8.369824e-3	1.000000e+0	1.000000e+0	1.194768e+2	8.369824e-3	1	151	1.000000e+0	6.622517e-3	unnamed	MSH2
Mouse Phenotype	MP:0002021	increased incidence of induced tumors	64	1.567887e-2	1.000000e+0	1.000000e+0	6.378010e+1	1.567887e-2	1	1.567887e-2	1.000000e+0	60	7.593814e-3	1.000000e+0	1.000000e+0	1.316861e+2	7.593814e-3	1	137	1.000000e+0	7.299270e-3	unnamed	MSH2
Mouse Phenotype	MP:0010383	increased adenoma incidence	65	1.689252e-2	1.000000e+0	1.000000e+0	5.919779e+1	1.689252e-2	1	1.689252e-2	1.000000e+0	65	8.536112e-3	1.000000e+0	1.000000e+0	1.171494e+2	8.536112e-3	1	154	1.000000e+0	6.493506e-3	unnamed	MSH2
Mouse Phenotype	MP:0008942	abnormal induced cell death	66	1.726637e-2	1.000000e+0	1.000000e+0	5.791607e+1	1.726637e-2	1	1.726637e-2	1.000000e+0	69	1.164015e-2	1.000000e+0	1.000000e+0	8.590952e+1	1.164015e-2	1	210	1.000000e+0	4.761905e-3	unnamed	MSH2
Mouse Phenotype	MP:0003448	altered tumor morphology	67	1.851112e-2	1.000000e+0	1.000000e+0	5.402157e+1	1.851112e-2	1	1.851112e-2	1.000000e+0	68	9.367552e-3	1.000000e+0	1.000000e+0	1.067515e+2	9.367552e-3	1	169	1.000000e+0	5.917160e-3	unnamed	MSH2
Mouse Phenotype	MP:0011110	partial preweaning lethality	68	2.208760e-2	1.000000e+0	1.000000e+0	4.527427e+1	2.208760e-2	1	2.208760e-2	1.000000e+0	66	8.646971e-3	1.000000e+0	1.000000e+0	1.156474e+2	8.646971e-3	1	156	1.000000e+0	6.410256e-3	unnamed	MSH2
Mouse Phenotype	MP:0000489	abnormal large intestine morphology	69	2.211060e-2	1.000000e+0	1.000000e+0	4.522718e+1	2.211060e-2	1	2.211060e-2	1.000000e+0	67	9.034976e-3	1.000000e+0	1.000000e+0	1.106810e+2	9.034976e-3	1	163	1.000000e+0	6.134969e-3	unnamed	MSH2
Mouse Phenotype	MP:0002022	increased lymphoma incidence	70	2.227473e-2	1.000000e+0	1.000000e+0	4.489392e+1	2.227473e-2	1	2.227473e-2	1.000000e+0	71	1.213902e-2	1.000000e+0	1.000000e+0	8.237900e+1	1.213902e-2	1	219	1.000000e+0	4.566210e-3	unnamed	MSH2
Mouse Phenotype	MP:0010155	abnormal intestine physiology	71	2.326312e-2	1.000000e+0	1.000000e+0	4.298649e+1	2.326312e-2	1	2.326312e-2	1.000000e+0	80	1.457791e-2	1.000000e+0	1.000000e+0	6.859696e+1	1.457791e-2	1	263	1.000000e+0	3.802281e-3	unnamed	MSH2
Mouse Phenotype	MP:0001805	decreased IgG level	72	2.347358e-2	1.000000e+0	1.000000e+0	4.260109e+1	2.347358e-2	1	2.347358e-2	1.000000e+0	76	1.358018e-2	1.000000e+0	1.000000e+0	7.363673e+1	1.358018e-2	1	245	1.000000e+0	4.081633e-3	unnamed	MSH2
Mouse Phenotype	MP:0003077	abnormal cell cycle	73	2.376361e-2	1.000000e+0	1.000000e+0	4.208115e+1	2.376361e-2	1	2.376361e-2	1.000000e+0	78	1.435619e-2	1.000000e+0	1.000000e+0	6.965637e+1	1.435619e-2	1	259	1.000000e+0	3.861004e-3	unnamed	MSH2
Mouse Phenotype	MP:0008211	decreased mature B cell number	74	2.473708e-2	1.000000e+0	1.000000e+0	4.042514e+1	2.473708e-2	1	2.473708e-2	1.000000e+0	72	1.285960e-2	1.000000e+0	1.000000e+0	7.776293e+1	1.285960e-2	1	232	1.000000e+0	4.310345e-3	unnamed	MSH2
Mouse Phenotype	MP:0010639	altered tumor pathology	75	2.612052e-2	1.000000e+0	1.000000e+0	3.828408e+1	2.612052e-2	1	2.612052e-2	1.000000e+0	73	1.341389e-2	1.000000e+0	1.000000e+0	7.454959e+1	1.341389e-2	1	242	1.000000e+0	4.132231e-3	unnamed	MSH2
Mouse Phenotype	MP:0010296	increased hemolymphoid system tumor incidence	76	2.613114e-2	1.000000e+0	1.000000e+0	3.826852e+1	2.613114e-2	1	2.613114e-2	1.000000e+0	78	1.435619e-2	1.000000e+0	1.000000e+0	6.965637e+1	1.435619e-2	1	259	1.000000e+0	3.861004e-3	unnamed	MSH2
Mouse Phenotype	MP:0002038	carcinoma	77	2.714825e-2	1.000000e+0	1.000000e+0	3.683478e+1	2.714825e-2	1	2.714825e-2	1.000000e+0	81	1.496591e-2	1.000000e+0	1.000000e+0	6.681852e+1	1.496591e-2	1	270	1.000000e+0	3.703704e-3	unnamed	MSH2
Mouse Phenotype	MP:0008873	increased physiological sensitivity to xenobiotic	78	2.832153e-2	1.000000e+0	1.000000e+0	3.530883e+1	2.832153e-2	1	2.832153e-2	1.000000e+0	73	1.341389e-2	1.000000e+0	1.000000e+0	7.454959e+1	1.341389e-2	1	242	1.000000e+0	4.132231e-3	unnamed	MSH2
Mouse Phenotype	MP:0002460	decreased immunoglobulin level	79	2.899527e-2	1.000000e+0	1.000000e+0	3.448838e+1	2.899527e-2	1	2.899527e-2	1.000000e+0	84	1.696137e-2	1.000000e+0	1.000000e+0	5.895752e+1	1.696137e-2	1	306	1.000000e+0	3.267974e-3	unnamed	MSH2
Mouse Phenotype	MP:0001191	abnormal skin condition	80	3.067339e-2	1.000000e+0	1.000000e+0	3.260155e+1	3.067339e-2	1	3.067339e-2	1.000000e+0	82	1.612993e-2	1.000000e+0	1.000000e+0	6.199656e+1	1.612993e-2	1	291	1.000000e+0	3.436426e-3	unnamed	MSH2
Mouse Phenotype	MP:0010288	increased gland tumor incidence	81	3.105825e-2	1.000000e+0	1.000000e+0	3.219757e+1	3.105825e-2	1	3.105825e-2	1.000000e+0	75	1.346932e-2	1.000000e+0	1.000000e+0	7.424280e+1	1.346932e-2	1	243	1.000000e+0	4.115226e-3	unnamed	MSH2
Mouse Phenotype	MP:0008770	decreased survivor rate	82	3.107263e-2	1.000000e+0	1.000000e+0	3.218266e+1	3.107263e-2	1	3.107263e-2	1.000000e+0	70	1.186187e-2	1.000000e+0	1.000000e+0	8.430374e+1	1.186187e-2	1	214	1.000000e+0	4.672897e-3	unnamed	MSH2
Mouse Phenotype	MP:0008171	abnormal mature B cell morphology	83	3.123786e-2	1.000000e+0	1.000000e+0	3.201244e+1	3.123786e-2	1	3.123786e-2	1.000000e+0	83	1.690594e-2	1.000000e+0	1.000000e+0	5.915082e+1	1.690594e-2	1	305	1.000000e+0	3.278689e-3	unnamed	MSH2
Mouse Phenotype	MP:0002018	malignant tumors	84	3.474739e-2	1.000000e+0	1.000000e+0	2.877914e+1	3.474739e-2	1	3.474739e-2	1.000000e+0	85	1.840253e-2	1.000000e+0	1.000000e+0	5.434036e+1	1.840253e-2	1	332	1.000000e+0	3.012048e-3	unnamed	MSH2
Mouse Phenotype	MP:0010831	partial lethality	85	3.509983e-2	1.000000e+0	1.000000e+0	2.849017e+1	3.509983e-2	1	3.509983e-2	1.000000e+0	77	1.391275e-2	1.000000e+0	1.000000e+0	7.187649e+1	1.391275e-2	1	251	1.000000e+0	3.984064e-3	unnamed	MSH2
Mouse Phenotype	MP:0009763	increased sensitivity to induced morbidity/mortality	86	3.731243e-2	1.000000e+0	1.000000e+0	2.680072e+1	3.731243e-2	1	3.731243e-2	1.000000e+0	86	2.078599e-2	1.000000e+0	1.000000e+0	4.810933e+1	2.078599e-2	1	375	1.000000e+0	2.666667e-3	unnamed	MSH2
Mouse Phenotype	MP:0002144	abnormal B cell differentiation	87	4.316951e-2	1.000000e+0	1.000000e+0	2.316450e+1	4.316951e-2	1	4.316951e-2	1.000000e+0	89	2.255973e-2	1.000000e+0	1.000000e+0	4.432678e+1	2.255973e-2	1	407	1.000000e+0	2.457002e-3	unnamed	MSH2
Mouse Phenotype	MP:0005017	decreased B cell number	88	4.371459e-2	1.000000e+0	1.000000e+0	2.287566e+1	4.371459e-2	1	4.371459e-2	1.000000e+0	87	2.183914e-2	1.000000e+0	1.000000e+0	4.578934e+1	2.183914e-2	1	394	1.000000e+0	2.538071e-3	unnamed	MSH2
Mouse Phenotype	MP:0002490	abnormal immunoglobulin level	89	4.625320e-2	1.000000e+0	1.000000e+0	2.162013e+1	4.625320e-2	1	4.625320e-2	1.000000e+0	90	2.643978e-2	1.000000e+0	1.000000e+0	3.782180e+1	2.643978e-2	1	477	1.000000e+0	2.096436e-3	unnamed	MSH2
Mouse Phenotype	MP:0000477	abnormal intestine morphology	90	4.889648e-2	1.000000e+0	1.000000e+0	2.045137e+1	4.889648e-2	1	4.889648e-2	1.000000e+0	88	2.233801e-2	1.000000e+0	1.000000e+0	4.476675e+1	2.233801e-2	1	403	1.000000e+0	2.481390e-3	unnamed	MSH2
Mouse Phenotype	MP:0001800	abnormal humoral immune response	91	5.047245e-2	1.000000e+0	1.000000e+0	1.981279e+1	5.047245e-2	1	5.047245e-2	1.000000e+0	93	2.887867e-2	1.000000e+0	1.000000e+0	3.462764e+1	2.887867e-2	1	521	1.000000e+0	1.919386e-3	unnamed	MSH2
Mouse Phenotype	MP:0001657	abnormal induced morbidity/mortality	92	5.088453e-2	1.000000e+0	1.000000e+0	1.965234e+1	5.088453e-2	1	5.088453e-2	1.000000e+0	95	3.065240e-2	1.000000e+0	1.000000e+0	3.262387e+1	3.065240e-2	1	553	1.000000e+0	1.808318e-3	unnamed	MSH2
Mouse Phenotype	MP:0002458	abnormal B cell number	93	5.356917e-2	1.000000e+0	1.000000e+0	1.866745e+1	5.356917e-2	1	5.356917e-2	1.000000e+0	92	2.865695e-2	1.000000e+0	1.000000e+0	3.489555e+1	2.865695e-2	1	517	1.000000e+0	1.934236e-3	unnamed	MSH2
Mouse Phenotype	MP:0005266	abnormal metabolism	94	5.387393e-2	1.000000e+0	1.000000e+0	1.856186e+1	5.387393e-2	1	5.387393e-2	1.000000e+0	95	3.065240e-2	1.000000e+0	1.000000e+0	3.262387e+1	3.065240e-2	1	553	1.000000e+0	1.808318e-3	unnamed	MSH2
Mouse Phenotype	MP:0010273	increased classified tumor incidence	95	5.452900e-2	1.000000e+0	1.000000e+0	1.833887e+1	5.452900e-2	1	5.452900e-2	1.000000e+0	91	2.821351e-2	1.000000e+0	1.000000e+0	3.544401e+1	2.821351e-2	1	509	1.000000e+0	1.964637e-3	unnamed	MSH2
Mouse Phenotype	MP:0002459	abnormal B cell physiology	96	5.585276e-2	1.000000e+0	1.000000e+0	1.790422e+1	5.585276e-2	1	5.585276e-2	1.000000e+0	99	3.220442e-2	1.000000e+0	1.000000e+0	3.105164e+1	3.220442e-2	1	581	1.000000e+0	1.721170e-3	unnamed	MSH2
Mouse Phenotype	MP:0001663	abnormal digestive system physiology	97	5.827484e-2	1.000000e+0	1.000000e+0	1.716006e+1	5.827484e-2	1	5.827484e-2	1.000000e+0	98	3.170556e-2	1.000000e+0	1.000000e+0	3.154021e+1	3.170556e-2	1	572	1.000000e+0	1.748252e-3	unnamed	MSH2
Mouse Phenotype	MP:0010274	increased organ/body region tumor incidence	98	5.980108e-2	1.000000e+0	1.000000e+0	1.672211e+1	5.980108e-2	1	5.980108e-2	1.000000e+0	94	2.998725e-2	1.000000e+0	1.000000e+0	3.334750e+1	2.998725e-2	1	541	1.000000e+0	1.848429e-3	unnamed	MSH2
Mouse Phenotype	MP:0004939	abnormal B cell morphology	99	6.254515e-2	1.000000e+0	1.000000e+0	1.598845e+1	6.254515e-2	1	6.254515e-2	1.000000e+0	101	3.431074e-2	1.000000e+0	1.000000e+0	2.914540e+1	3.431074e-2	1	619	1.000000e+0	1.615509e-3	unnamed	MSH2
Mouse Phenotype	MP:0008872	abnormal physiological response to xenobiotic	100	6.542380e-2	1.000000e+0	1.000000e+0	1.528496e+1	6.542380e-2	1	6.542380e-2	1.000000e+0	97	3.142841e-2	1.000000e+0	1.000000e+0	3.181834e+1	3.142841e-2	1	567	1.000000e+0	1.763668e-3	unnamed	MSH2
Mouse Phenotype	MP:0008195	abnormal professional antigen presenting cell morphology	101	6.835128e-2	1.000000e+0	1.000000e+0	1.463030e+1	6.835128e-2	1	6.835128e-2	1.000000e+0	103	3.735935e-2	1.000000e+0	1.000000e+0	2.676706e+1	3.735935e-2	1	674	1.000000e+0	1.483680e-3	unnamed	MSH2
Mouse Phenotype	MP:0002020	increased tumor incidence	102	7.037685e-2	1.000000e+0	1.000000e+0	1.420922e+1	7.037685e-2	1	7.037685e-2	1.000000e+0	102	3.497589e-2	1.000000e+0	1.000000e+0	2.859113e+1	3.497589e-2	1	631	1.000000e+0	1.584786e-3	unnamed	MSH2
Mouse Phenotype	MP:0002019	abnormal tumor incidence	103	7.769090e-2	1.000000e+0	1.000000e+0	1.287152e+1	7.769090e-2	1	7.769090e-2	1.000000e+0	104	3.929937e-2	1.000000e+0	1.000000e+0	2.544570e+1	3.929937e-2	1	709	1.000000e+0	1.410437e-3	unnamed	MSH2
Mouse Phenotype	MP:0002166	altered tumor susceptibility	104	7.903444e-2	1.000000e+0	1.000000e+0	1.265271e+1	7.903444e-2	1	7.903444e-2	1.000000e+0	105	4.007538e-2	1.000000e+0	1.000000e+0	2.495297e+1	4.007538e-2	1	723	1.000000e+0	1.383126e-3	unnamed	MSH2
Mouse Phenotype	MP:0002401	abnormal lymphopoiesis	105	7.968565e-2	1.000000e+0	1.000000e+0	1.254931e+1	7.968565e-2	1	7.968565e-2	1.000000e+0	107	4.356743e-2	1.000000e+0	1.000000e+0	2.295293e+1	4.356743e-2	1	786	1.000000e+0	1.272265e-3	unnamed	MSH2
Mouse Phenotype	MP:0005016	decreased lymphocyte cell number	106	8.004882e-2	1.000000e+0	1.000000e+0	1.249238e+1	8.004882e-2	1	8.004882e-2	1.000000e+0	110	4.506402e-2	1.000000e+0	1.000000e+0	2.219065e+1	4.506402e-2	1	813	1.000000e+0	1.230012e-3	unnamed	MSH2
Mouse Phenotype	MP:0002445	abnormal mononuclear cell differentiation	107	8.007402e-2	1.000000e+0	1.000000e+0	1.248844e+1	8.007402e-2	1	8.007402e-2	1.000000e+0	109	4.390001e-2	1.000000e+0	1.000000e+0	2.277904e+1	4.390001e-2	1	792	1.000000e+0	1.262626e-3	unnamed	MSH2
Mouse Phenotype	MP:0002452	abnormal professional antigen presenting cell physiology	108	8.156256e-2	1.000000e+0	1.000000e+0	1.226053e+1	8.156256e-2	1	8.156256e-2	1.000000e+0	113	4.833435e-2	1.000000e+0	1.000000e+0	2.068922e+1	4.833435e-2	1	872	1.000000e+0	1.146789e-3	unnamed	MSH2
Mouse Phenotype	MP:0011085	complete postnatal lethality	109	8.232293e-2	1.000000e+0	1.000000e+0	1.214728e+1	8.232293e-2	1	8.232293e-2	1.000000e+0	100	3.281415e-2	1.000000e+0	1.000000e+0	3.047466e+1	3.281415e-2	1	592	1.000000e+0	1.689189e-3	unnamed	MSH2
Mouse Phenotype	MP:0002060	abnormal skin morphology	110	8.538698e-2	1.000000e+0	1.000000e+0	1.171139e+1	8.538698e-2	1	8.538698e-2	1.000000e+0	106	4.306857e-2	1.000000e+0	1.000000e+0	2.321879e+1	4.306857e-2	1	777	1.000000e+0	1.287001e-3	unnamed	MSH2
Mouse Phenotype	MP:0002414	abnormal myeloblast morphology/development	111	8.539083e-2	1.000000e+0	1.000000e+0	1.171086e+1	8.539083e-2	1	8.539083e-2	1.000000e+0	111	4.744748e-2	1.000000e+0	1.000000e+0	2.107593e+1	4.744748e-2	1	856	1.000000e+0	1.168224e-3	unnamed	MSH2
Mouse Phenotype	MP:0002006	tumorigenesis	112	8.579997e-2	1.000000e+0	1.000000e+0	1.165502e+1	8.579997e-2	1	8.579997e-2	1.000000e+0	108	4.384458e-2	1.000000e+0	1.000000e+0	2.280784e+1	4.384458e-2	1	791	1.000000e+0	1.264223e-3	unnamed	MSH2
Mouse Phenotype	MP:0005460	abnormal leukopoiesis	113	8.694600e-2	1.000000e+0	1.000000e+0	1.150139e+1	8.694600e-2	1	8.694600e-2	1.000000e+0	112	4.766920e-2	1.000000e+0	1.000000e+0	2.097791e+1	4.766920e-2	1	860	1.000000e+0	1.162791e-3	unnamed	MSH2
Mouse Phenotype	MP:0003945	abnormal lymphocyte physiology	114	9.054147e-2	1.000000e+0	1.000000e+0	1.104466e+1	9.054147e-2	1	9.054147e-2	1.000000e+0	115	5.215897e-2	1.000000e+0	1.000000e+0	1.917216e+1	5.215897e-2	1	941	1.000000e+0	1.062699e-3	unnamed	MSH2
Mouse Phenotype	MP:0002723	abnormal immune serum protein physiology	115	9.094959e-2	1.000000e+0	1.000000e+0	1.099510e+1	9.094959e-2	1	9.094959e-2	1.000000e+0	116	5.443157e-2	1.000000e+0	1.000000e+0	1.837169e+1	5.443157e-2	1	982	1.000000e+0	1.018330e-3	unnamed	MSH2
Mouse Phenotype	MP:0000221	decreased leukocyte cell number	116	9.549676e-2	1.000000e+0	1.000000e+0	1.047156e+1	9.549676e-2	1	9.549676e-2	1.000000e+0	117	5.448700e-2	1.000000e+0	1.000000e+0	1.835300e+1	5.448700e-2	1	983	1.000000e+0	1.017294e-3	unnamed	MSH2
Mouse Phenotype	MP:0000717	abnormal lymphocyte cell number	117	9.986740e-2	1.000000e+0	1.000000e+0	1.001328e+1	9.986740e-2	1	9.986740e-2	1.000000e+0	118	5.709218e-2	1.000000e+0	1.000000e+0	1.751553e+1	5.709218e-2	1	1030	1.000000e+0	9.708738e-4	unnamed	MSH2
Mouse Phenotype	MP:0001845	abnormal inflammatory response	118	1.012612e-1	1.000000e+0	1.000000e+0	9.875447e+0	1.012612e-1	1	1.012612e-1	1.000000e+0	119	6.014079e-2	1.000000e+0	1.000000e+0	1.662765e+1	6.014079e-2	1	1085	1.000000e+0	9.216590e-4	unnamed	MSH2
Mouse Phenotype	MP:0002398	abnormal bone marrow cell morphology/development	119	1.085064e-1	1.000000e+0	1.000000e+0	9.216047e+0	1.085064e-1	1	1.085064e-1	1.000000e+0	121	6.252425e-2	1.000000e+0	1.000000e+0	1.599379e+1	6.252425e-2	1	1128	1.000000e+0	8.865248e-4	unnamed	MSH2
Mouse Phenotype	MP:0011182	decreased hematopoietic cell number	120	1.093948e-1	1.000000e+0	1.000000e+0	9.141200e+0	1.093948e-1	1	1.093948e-1	1.000000e+0	123	6.385455e-2	1.000000e+0	1.000000e+0	1.566059e+1	6.385455e-2	1	1152	1.000000e+0	8.680556e-4	unnamed	MSH2
Mouse Phenotype	MP:0002619	abnormal lymphocyte morphology	121	1.142540e-1	1.000000e+0	1.000000e+0	8.752430e+0	1.142540e-1	1	1.142540e-1	1.000000e+0	124	6.673688e-2	1.000000e+0	1.000000e+0	1.498422e+1	6.673688e-2	1	1204	1.000000e+0	8.305648e-4	unnamed	MSH2
Mouse Phenotype	MP:0000462	abnormal digestive system morphology	122	1.165265e-1	1.000000e+0	1.000000e+0	8.581738e+0	1.165265e-1	1	1.165265e-1	1.000000e+0	114	4.844521e-2	1.000000e+0	1.000000e+0	2.064188e+1	4.844521e-2	1	874	1.000000e+0	1.144165e-3	unnamed	MSH2
Mouse Phenotype	MP:0002442	abnormal leukocyte physiology	123	1.192967e-1	1.000000e+0	1.000000e+0	8.382459e+0	1.192967e-1	1	1.192967e-1	1.000000e+0	126	7.028435e-2	1.000000e+0	1.000000e+0	1.422792e+1	7.028435e-2	1	1268	1.000000e+0	7.886435e-4	unnamed	MSH2
Mouse Phenotype	MP:0001819	abnormal immune cell physiology	124	1.203217e-1	1.000000e+0	1.000000e+0	8.311053e+0	1.203217e-1	1	1.203217e-1	1.000000e+0	130	7.155923e-2	1.000000e+0	1.000000e+0	1.397444e+1	7.155923e-2	1	1291	1.000000e+0	7.745933e-4	unnamed	MSH2
Mouse Phenotype	MP:0002421	abnormal cell-mediated immunity	125	1.209554e-1	1.000000e+0	1.000000e+0	8.267508e+0	1.209554e-1	1	1.209554e-1	1.000000e+0	131	7.216895e-2	1.000000e+0	1.000000e+0	1.385637e+1	7.216895e-2	1	1302	1.000000e+0	7.680492e-4	unnamed	MSH2
Mouse Phenotype	MP:0001648	abnormal apoptosis	126	1.225891e-1	1.000000e+0	1.000000e+0	8.157331e+0	1.225891e-1	1	1.225891e-1	1.000000e+0	120	6.219167e-2	1.000000e+0	1.000000e+0	1.607932e+1	6.219167e-2	1	1122	1.000000e+0	8.912656e-4	unnamed	MSH2
Mouse Phenotype	MP:0002420	abnormal adaptive immunity	127	1.226687e-1	1.000000e+0	1.000000e+0	8.152037e+0	1.226687e-1	1	1.226687e-1	1.000000e+0	133	7.311125e-2	1.000000e+0	1.000000e+0	1.367779e+1	7.311125e-2	1	1319	1.000000e+0	7.581501e-4	unnamed	MSH2
Mouse Phenotype	MP:0000217	abnormal leukocyte cell number	128	1.272684e-1	1.000000e+0	1.000000e+0	7.857411e+0	1.272684e-1	1	1.272684e-1	1.000000e+0	132	7.283410e-2	1.000000e+0	1.000000e+0	1.372983e+1	7.283410e-2	1	1314	1.000000e+0	7.610350e-4	unnamed	MSH2
Mouse Phenotype	MP:0008247	abnormal mononuclear cell morphology	129	1.350005e-1	1.000000e+0	1.000000e+0	7.407378e+0	1.350005e-1	1	1.350005e-1	1.000000e+0	135	8.026163e-2	1.000000e+0	1.000000e+0	1.245925e+1	8.026163e-2	1	1448	1.000000e+0	6.906077e-4	unnamed	MSH2
Mouse Phenotype	MP:0000313	abnormal cell death	130	1.373532e-1	1.000000e+0	1.000000e+0	7.280503e+0	1.373532e-1	1	1.373532e-1	1.000000e+0	129	7.144837e-2	1.000000e+0	1.000000e+0	1.399612e+1	7.144837e-2	1	1289	1.000000e+0	7.757952e-4	unnamed	MSH2
Mouse Phenotype	MP:0005381	digestive/alimentary phenotype	131	1.385091e-1	1.000000e+0	1.000000e+0	7.219740e+0	1.385091e-1	1	1.385091e-1	1.000000e+0	122	6.318940e-2	1.000000e+0	1.000000e+0	1.582544e+1	6.318940e-2	1	1140	1.000000e+0	8.771930e-4	unnamed	MSH2
Mouse Phenotype	MP:0011180	abnormal hematopoietic cell number	132	1.429801e-1	1.000000e+0	1.000000e+0	6.993980e+0	1.429801e-1	1	1.429801e-1	1.000000e+0	137	8.325481e-2	1.000000e+0	1.000000e+0	1.201132e+1	8.325481e-2	1	1502	1.000000e+0	6.657790e-4	unnamed	MSH2
Mouse Phenotype	MP:0002083	premature death	133	1.449089e-1	1.000000e+0	1.000000e+0	6.900889e+0	1.449089e-1	1	1.449089e-1	1.000000e+0	127	7.100493e-2	1.000000e+0	1.000000e+0	1.408353e+1	7.100493e-2	1	1281	1.000000e+0	7.806401e-4	unnamed	MSH2
Mouse Phenotype	MP:0008246	abnormal leukocyte morphology	134	1.497188e-1	1.000000e+0	1.000000e+0	6.679189e+0	1.497188e-1	1	1.497188e-1	1.000000e+0	138	8.885317e-2	1.000000e+0	1.000000e+0	1.125452e+1	8.885317e-2	1	1603	1.000000e+0	6.238303e-4	unnamed	MSH2
Mouse Phenotype	MP:0000716	abnormal immune system cell morphology	135	1.505458e-1	1.000000e+0	1.000000e+0	6.642496e+0	1.505458e-1	1	1.505458e-1	1.000000e+0	139	8.951832e-2	1.000000e+0	1.000000e+0	1.117090e+1	8.951832e-2	1	1615	1.000000e+0	6.191950e-4	unnamed	MSH2
Mouse Phenotype	MP:0005076	abnormal cell differentiation	136	1.541850e-1	1.000000e+0	1.000000e+0	6.485715e+0	1.541850e-1	1	1.541850e-1	1.000000e+0	128	7.111579e-2	1.000000e+0	1.000000e+0	1.406157e+1	7.111579e-2	1	1283	1.000000e+0	7.794232e-4	unnamed	MSH2
Mouse Phenotype	MP:0002082	postnatal lethality	137	1.637535e-1	1.000000e+0	1.000000e+0	6.106739e+0	1.637535e-1	1	1.637535e-1	1.000000e+0	125	6.884319e-2	1.000000e+0	1.000000e+0	1.452576e+1	6.884319e-2	1	1242	1.000000e+0	8.051530e-4	unnamed	MSH2
Mouse Phenotype	MP:0010771	integument phenotype	138	1.731215e-1	1.000000e+0	1.000000e+0	5.776291e+0	1.731215e-1	1	1.731215e-1	1.000000e+0	136	8.186908e-2	1.000000e+0	1.000000e+0	1.221462e+1	8.186908e-2	1	1477	1.000000e+0	6.770481e-4	unnamed	MSH2
Mouse Phenotype	MP:0002123	abnormal hematopoiesis	139	1.777183e-1	1.000000e+0	1.000000e+0	5.626882e+0	1.777183e-1	1	1.777183e-1	1.000000e+0	141	1.086969e-1	1.000000e+0	1.000000e+0	9.199898e+0	1.086969e-1	1	1961	1.000000e+0	5.099439e-4	unnamed	MSH2
Mouse Phenotype	MP:0002429	abnormal blood cell morphology/development	140	1.793335e-1	1.000000e+0	1.000000e+0	5.576203e+0	1.793335e-1	1	1.793335e-1	1.000000e+0	142	1.097500e-1	1.000000e+0	1.000000e+0	9.111616e+0	1.097500e-1	1	1980	1.000000e+0	5.050505e-4	unnamed	MSH2
Mouse Phenotype	MP:0000685	abnormal immune system morphology	141	1.819041e-1	1.000000e+0	1.000000e+0	5.497404e+0	1.819041e-1	1	1.819041e-1	1.000000e+0	140	1.067014e-1	1.000000e+0	1.000000e+0	9.371948e+0	1.067014e-1	1	1925	1.000000e+0	5.194805e-4	unnamed	MSH2
Mouse Phenotype	MP:0002882	abnormal neuron morphology	142	1.824896e-1	1.000000e+0	1.000000e+0	5.479764e+0	1.824896e-1	1	1.824896e-1	1.000000e+0	134	7.477413e-2	1.000000e+0	1.000000e+0	1.337361e+1	7.477413e-2	1	1349	1.000000e+0	7.412898e-4	unnamed	MSH2
Mouse Phenotype	MP:0001790	abnormal immune system physiology	143	1.911135e-1	1.000000e+0	1.000000e+0	5.232494e+0	1.911135e-1	1	1.911135e-1	1.000000e+0	143	1.141844e-1	1.000000e+0	1.000000e+0	8.757767e+0	1.141844e-1	1	2060	1.000000e+0	4.854369e-4	unnamed	MSH2
Mouse Phenotype	MP:0002396	abnormal hematopoietic system morphology/development	144	2.022701e-1	1.000000e+0	1.000000e+0	4.943885e+0	2.022701e-1	1	2.022701e-1	1.000000e+0	145	1.210576e-1	1.000000e+0	1.000000e+0	8.260531e+0	1.210576e-1	1	2184	1.000000e+0	4.578755e-4	unnamed	MSH2
Mouse Phenotype	MP:0005397	hematopoietic system phenotype	145	2.068614e-1	1.000000e+0	1.000000e+0	4.834154e+0	2.068614e-1	1	2.068614e-1	1.000000e+0	146	1.244388e-1	1.000000e+0	1.000000e+0	8.036080e+0	1.244388e-1	1	2245	1.000000e+0	4.454343e-4	unnamed	MSH2
Mouse Phenotype	MP:0005387	immune system phenotype	146	2.446842e-1	1.000000e+0	1.000000e+0	4.086901e+0	2.446842e-1	1	2.446842e-1	1.000000e+0	148	1.487722e-1	1.000000e+0	1.000000e+0	6.721684e+0	1.487722e-1	1	2684	1.000000e+0	3.725782e-4	unnamed	MSH2
Mouse Phenotype	MP:0010832	lethality during fetal growth through weaning	147	2.758093e-1	1.000000e+0	1.000000e+0	3.625694e+0	2.758093e-1	1	2.758093e-1	1.000000e+0	144	1.161798e-1	1.000000e+0	1.000000e+0	8.607347e+0	1.161798e-1	1	2096	1.000000e+0	4.770992e-4	unnamed	MSH2
Mouse Phenotype	MP:0003632	abnormal nervous system morphology	148	2.827167e-1	1.000000e+0	1.000000e+0	3.537110e+0	2.827167e-1	1	2.827167e-1	1.000000e+0	147	1.253811e-1	1.000000e+0	1.000000e+0	7.975685e+0	1.253811e-1	1	2262	1.000000e+0	4.420866e-4	unnamed	MSH2
Mouse Phenotype	MP:0005621	abnormal cell physiology	149	3.078333e-1	1.000000e+0	1.000000e+0	3.248512e+0	3.078333e-1	1	3.078333e-1	1.000000e+0	150	1.661216e-1	1.000000e+0	1.000000e+0	6.019686e+0	1.661216e-1	1	2997	1.000000e+0	3.336670e-4	unnamed	MSH2
Mouse Phenotype	MP:0005384	cellular phenotype	150	3.121556e-1	1.000000e+0	1.000000e+0	3.203530e+0	3.121556e-1	1	3.121556e-1	1.000000e+0	151	1.707777e-1	1.000000e+0	1.000000e+0	5.855566e+0	1.707777e-1	1	3081	1.000000e+0	3.245699e-4	unnamed	MSH2
Mouse Phenotype	MP:0005376	homeostasis/metabolism phenotype	151	3.389663e-1	1.000000e+0	1.000000e+0	2.950146e+0	3.389663e-1	1	3.389663e-1	1.000000e+0	153	1.917854e-1	1.000000e+0	1.000000e+0	5.214162e+0	1.917854e-1	1	3460	1.000000e+0	2.890173e-4	unnamed	MSH2
Mouse Phenotype	MP:0003631	nervous system phenotype	152	3.410385e-1	1.000000e+0	1.000000e+0	2.932220e+0	3.410385e-1	1	3.410385e-1	1.000000e+0	149	1.540935e-1	1.000000e+0	1.000000e+0	6.489568e+0	1.540935e-1	1	2780	1.000000e+0	3.597122e-4	unnamed	MSH2
Mouse Phenotype	MP:0010770	preweaning lethality	153	3.585301e-1	1.000000e+0	1.000000e+0	2.789166e+0	3.585301e-1	1	3.585301e-1	1.000000e+0	152	1.806441e-1	1.000000e+0	1.000000e+0	5.535747e+0	1.806441e-1	1	3259	1.000000e+0	3.068426e-4	unnamed	MSH2
Mouse Phenotype	MP:0010769	abnormal survival	154	3.982821e-1	1.000000e+0	1.000000e+0	2.510783e+0	3.982821e-1	1	3.982821e-1	1.000000e+0	154	2.093565e-1	1.000000e+0	1.000000e+0	4.776542e+0	2.093565e-1	1	3777	1.000000e+0	2.647604e-4	unnamed	MSH2
Mouse Phenotype	MP:0010768	mortality/aging	155	4.155501e-1	1.000000e+0	1.000000e+0	2.406449e+0	4.155501e-1	1	4.155501e-1	1.000000e+0	155	2.242669e-1	1.000000e+0	1.000000e+0	4.458972e+0	2.242669e-1	1	4046	1.000000e+0	2.471577e-4	unnamed	MSH2
Mouse Phenotype	MP:0000001	mammalian phenotype	156	6.422596e-1	1.000000e+0	1.000000e+0	1.557003e+0	6.422596e-1	1	6.422596e-1	1.000000e+0	156	4.170501e-1	1.000000e+0	1.000000e+0	2.397794e+0	4.170501e-1	1	7524	1.000000e+0	1.329080e-4	unnamed	MSH2
Human Phenotype	HP:0006758	Malignant genitourinary tract tumor	1	1.351883e-4	8.308673e-1	8.308673e-1	7.397089e+3	1.351883e-4	1	1.351883e-4	1.000000e+0	1	1.108586e-4	6.813370e-1	6.813370e-1	9.020500e+3	1.108586e-4	1	2	1.000000e+0	5.000000e-1	unnamed	MSH2
Human Phenotype	HP:0012118	Laryngeal carcinoma	1	1.351883e-4	8.308673e-1	8.308673e-1	7.397089e+3	1.351883e-4	1	1.351883e-4	1.000000e+0	1	1.108586e-4	6.813370e-1	6.813370e-1	9.020500e+3	1.108586e-4	1	2	1.000000e+0	5.000000e-1	unnamed	MSH2
Human Phenotype	HP:0006778	Benign genitourinary tract neoplasm	1	1.351883e-4	8.308673e-1	8.308673e-1	7.397089e+3	1.351883e-4	1	1.351883e-4	1.000000e+0	1	1.108586e-4	6.813370e-1	6.813370e-1	9.020500e+3	1.108586e-4	1	2	1.000000e+0	5.000000e-1	unnamed	MSH2
Human Phenotype	HP:0006719	Benign gastrointestinal tract tumors	1	1.351883e-4	8.308673e-1	8.308673e-1	7.397089e+3	1.351883e-4	1	1.351883e-4	1.000000e+0	1	1.108586e-4	6.813370e-1	6.813370e-1	9.020500e+3	1.108586e-4	1	2	1.000000e+0	5.000000e-1	unnamed	MSH2
Human Phenotype	HP:0100684	Salivary gland neoplasm	5	1.920080e-4	1.000000e+0	2.360162e-1	5.208116e+3	1.920080e-4	1	1.920080e-4	1.000000e+0	5	2.217172e-4	1.000000e+0	2.725348e-1	4.510250e+3	2.217172e-4	1	4	1.000000e+0	2.500000e-1	unnamed	MSH2
Human Phenotype	HP:0100843	Glioblastoma	6	3.029155e-4	1.000000e+0	3.102864e-1	3.301251e+3	3.029155e-4	1	3.029155e-4	1.000000e+0	6	2.771465e-4	1.000000e+0	2.838904e-1	3.608200e+3	2.771465e-4	1	5	1.000000e+0	2.000000e-1	unnamed	MSH2
Human Phenotype	HP:0010524	Agnosia	7	3.735612e-4	1.000000e+0	3.279867e-1	2.676938e+3	3.735612e-4	1	3.735612e-4	1.000000e+0	9	3.880051e-4	1.000000e+0	2.649644e-1	2.577286e+3	3.880051e-4	1	7	1.000000e+0	1.428571e-1	unnamed	MSH2
Human Phenotype	HP:0002888	Ependymoma	8	3.781202e-4	1.000000e+0	2.904908e-1	2.644661e+3	3.781202e-4	1	3.781202e-4	1.000000e+0	11	4.434344e-4	1.000000e+0	2.477589e-1	2.255125e+3	4.434344e-4	1	8	1.000000e+0	1.250000e-1	unnamed	MSH2
Human Phenotype	HP:0002253	Colonic diverticulosis	9	4.377250e-4	1.000000e+0	2.989175e-1	2.284540e+3	4.377250e-4	1	4.377250e-4	1.000000e+0	9	3.880051e-4	1.000000e+0	2.649644e-1	2.577286e+3	3.880051e-4	1	7	1.000000e+0	1.428571e-1	unnamed	MSH2
Human Phenotype	HP:0006771	Duodenal carcinoma	10	4.648978e-4	1.000000e+0	2.857262e-1	2.151010e+3	4.648978e-4	1	4.648978e-4	1.000000e+0	6	2.771465e-4	1.000000e+0	2.838904e-1	3.608200e+3	2.771465e-4	1	5	1.000000e+0	2.000000e-1	unnamed	MSH2
Human Phenotype	HP:0003003	Colon cancer	11	5.302146e-4	1.000000e+0	2.962454e-1	1.886029e+3	5.302146e-4	1	5.302146e-4	1.000000e+0	11	4.434344e-4	1.000000e+0	2.477589e-1	2.255125e+3	4.434344e-4	1	8	1.000000e+0	1.250000e-1	unnamed	MSH2
Human Phenotype	HP:0000997	Axillary freckling	12	5.829935e-4	1.000000e+0	2.985898e-1	1.715285e+3	5.829935e-4	1	5.829935e-4	1.000000e+0	8	3.325758e-4	1.000000e+0	2.555014e-1	3.006833e+3	3.325758e-4	1	6	1.000000e+0	1.666667e-1	unnamed	MSH2
Human Phenotype	HP:0009592	Astrocytoma	13	7.142707e-4	1.000000e+0	3.376852e-1	1.400029e+3	7.142707e-4	1	7.142707e-4	1.000000e+0	16	6.097223e-4	1.000000e+0	2.342096e-1	1.640091e+3	6.097223e-4	1	11	1.000000e+0	9.090909e-2	unnamed	MSH2
Human Phenotype	HP:0100743	Neoplasm of the rectum	14	7.501573e-4	1.000000e+0	3.293191e-1	1.333054e+3	7.501573e-4	1	7.501573e-4	1.000000e+0	11	4.434344e-4	1.000000e+0	2.477589e-1	2.255125e+3	4.434344e-4	1	8	1.000000e+0	1.250000e-1	unnamed	MSH2
Human Phenotype	HP:0009733	Glioma	15	7.683865e-4	1.000000e+0	3.148336e-1	1.301428e+3	7.683865e-4	1	7.683865e-4	1.000000e+0	19	7.205809e-4	1.000000e+0	2.330890e-1	1.387769e+3	7.205809e-4	1	13	1.000000e+0	7.692308e-2	unnamed	MSH2
Human Phenotype	HP:0009720	Adenoma sebaceum	16	8.217284e-4	1.000000e+0	3.156464e-1	1.216947e+3	8.217284e-4	1	8.217284e-4	1.000000e+0	23	8.868688e-4	1.000000e+0	2.369868e-1	1.127562e+3	8.868688e-4	1	16	1.000000e+0	6.250000e-2	unnamed	MSH2
Human Phenotype	HP:0100576	Amaurosis fugax	17	9.136417e-4	1.000000e+0	3.303083e-1	1.094521e+3	9.136417e-4	1	9.136417e-4	1.000000e+0	14	5.542930e-4	1.000000e+0	2.433346e-1	1.804100e+3	5.542930e-4	1	10	1.000000e+0	1.000000e-1	unnamed	MSH2
Human Phenotype	HP:0005222	Bowel diverticulosis	18	9.638921e-4	1.000000e+0	3.291156e-1	1.037460e+3	9.638921e-4	1	9.638921e-4	1.000000e+0	19	7.205809e-4	1.000000e+0	2.330890e-1	1.387769e+3	7.205809e-4	1	13	1.000000e+0	7.692308e-2	unnamed	MSH2
Human Phenotype	HP:0002885	Medulloblastoma	19	1.002871e-3	1.000000e+0	3.244024e-1	9.971376e+2	1.002871e-3	1	1.002871e-3	1.000000e+0	18	6.651516e-4	1.000000e+0	2.271123e-1	1.503417e+3	6.651516e-4	1	12	1.000000e+0	8.333333e-2	unnamed	MSH2
Human Phenotype	HP:0100833	Neoplasm of the small intestine	20	1.276192e-3	1.000000e+0	3.921738e-1	7.835814e+2	1.276192e-3	1	1.276192e-3	1.000000e+0	14	5.542930e-4	1.000000e+0	2.433346e-1	1.804100e+3	5.542930e-4	1	10	1.000000e+0	1.000000e-1	unnamed	MSH2
Human Phenotype	HP:0100649	Neoplasm of the oral cavity	21	1.330340e-3	1.000000e+0	3.893462e-1	7.516878e+2	1.330340e-3	1	1.330340e-3	1.000000e+0	16	6.097223e-4	1.000000e+0	2.342096e-1	1.640091e+3	6.097223e-4	1	11	1.000000e+0	9.090909e-2	unnamed	MSH2
Human Phenotype	HP:0002671	Basal cell carcinoma	22	1.379836e-3	1.000000e+0	3.854760e-1	7.247239e+2	1.379836e-3	1	1.379836e-3	1.000000e+0	25	9.977274e-4	1.000000e+0	2.452813e-1	1.002278e+3	9.977274e-4	1	18	1.000000e+0	5.555556e-2	unnamed	MSH2
Human Phenotype	HP:0002859	Rhabdomyosarcoma	23	1.501022e-3	1.000000e+0	4.010992e-1	6.662129e+2	1.501022e-3	1	1.501022e-3	1.000000e+0	19	7.205809e-4	1.000000e+0	2.330890e-1	1.387769e+3	7.205809e-4	1	13	1.000000e+0	7.692308e-2	unnamed	MSH2
Human Phenotype	HP:0010286	Abnormality of the salivary glands	24	1.591235e-3	1.000000e+0	4.074888e-1	6.284425e+2	1.591235e-3	1	1.591235e-3	1.000000e+0	19	7.205809e-4	1.000000e+0	2.330890e-1	1.387769e+3	7.205809e-4	1	13	1.000000e+0	7.692308e-2	unnamed	MSH2
Human Phenotype	HP:0002894	Neoplasm of the pancreas	25	1.664764e-3	1.000000e+0	4.092656e-1	6.006859e+2	1.664764e-3	1	1.664764e-3	1.000000e+0	42	1.773738e-3	1.000000e+0	2.595570e-1	5.637812e+2	1.773738e-3	1	32	1.000000e+0	3.125000e-2	unnamed	MSH2
Human Phenotype	HP:0009728	Neoplasm of striated muscle	26	1.722749e-3	1.000000e+0	4.072314e-1	5.804677e+2	1.722749e-3	1	1.722749e-3	1.000000e+0	23	8.868688e-4	1.000000e+0	2.369868e-1	1.127562e+3	8.868688e-4	1	16	1.000000e+0	6.250000e-2	unnamed	MSH2
Human Phenotype	HP:0100273	Neoplasm of the colon	27	2.057616e-3	1.000000e+0	4.683744e-1	4.859994e+2	2.057616e-3	1	2.057616e-3	1.000000e+0	27	1.164015e-3	1.000000e+0	2.649643e-1	8.590952e+2	1.164015e-3	1	21	1.000000e+0	4.761905e-2	unnamed	MSH2
Human Phenotype	HP:0003002	Breast carcinoma	28	2.270887e-3	1.000000e+0	4.984597e-1	4.403565e+2	2.270887e-3	1	2.270887e-3	1.000000e+0	29	1.219445e-3	1.000000e+0	2.584382e-1	8.200455e+2	1.219445e-3	1	22	1.000000e+0	4.545455e-2	unnamed	MSH2
Human Phenotype	HP:0010614	Fibroma	29	2.334917e-3	1.000000e+0	4.948414e-1	4.282807e+2	2.334917e-3	1	2.334917e-3	1.000000e+0	33	1.552020e-3	1.000000e+0	2.890520e-1	6.443214e+2	1.552020e-3	1	28	1.000000e+0	3.571429e-2	unnamed	MSH2
Human Phenotype	HP:0002516	Increased intracranial pressure	30	2.391495e-3	1.000000e+0	4.899376e-1	4.181486e+2	2.391495e-3	1	2.391495e-3	1.000000e+0	37	1.662879e-3	1.000000e+0	2.762177e-1	6.013667e+2	1.662879e-3	1	30	1.000000e+0	3.333333e-2	unnamed	MSH2
Human Phenotype	HP:0012316	Fibrous tissue neoplasm	31	2.493340e-3	1.000000e+0	4.943248e-1	4.010684e+2	2.493340e-3	1	2.493340e-3	1.000000e+0	34	1.607450e-3	1.000000e+0	2.905702e-1	6.221034e+2	1.607450e-3	1	29	1.000000e+0	3.448276e-2	unnamed	MSH2
Human Phenotype	HP:0100606	Neoplasm of the respiratory system	32	2.762823e-3	1.000000e+0	5.306347e-1	3.619487e+2	2.762823e-3	1	2.762823e-3	1.000000e+0	34	1.607450e-3	1.000000e+0	2.905702e-1	6.221034e+2	1.607450e-3	1	29	1.000000e+0	3.448276e-2	unnamed	MSH2
Human Phenotype	HP:0200008	Intestinal polyposis	33	2.824620e-3	1.000000e+0	5.260641e-1	3.540300e+2	2.824620e-3	1	2.824620e-3	1.000000e+0	34	1.607450e-3	1.000000e+0	2.905702e-1	6.221034e+2	1.607450e-3	1	29	1.000000e+0	3.448276e-2	unnamed	MSH2
Human Phenotype	HP:0003006	Neuroblastoma	34	2.913958e-3	1.000000e+0	5.267408e-1	3.431758e+2	2.913958e-3	1	2.913958e-3	1.000000e+0	26	1.108586e-3	1.000000e+0	2.620527e-1	9.020500e+2	1.108586e-3	1	20	1.000000e+0	5.000000e-2	unnamed	MSH2
Human Phenotype	HP:0004376	Neuroblastic tumors	35	2.928270e-3	1.000000e+0	5.142042e-1	3.414985e+2	2.928270e-3	1	2.928270e-3	1.000000e+0	27	1.164015e-3	1.000000e+0	2.649643e-1	8.590952e+2	1.164015e-3	1	21	1.000000e+0	4.761905e-2	unnamed	MSH2
Human Phenotype	HP:0010622	Neoplasm of the skeletal system	36	3.018936e-3	1.000000e+0	5.153995e-1	3.312425e+2	3.018936e-3	1	3.018936e-3	1.000000e+0	43	1.884596e-3	1.000000e+0	2.693657e-1	5.306176e+2	1.884596e-3	1	34	1.000000e+0	2.941176e-2	unnamed	MSH2
Human Phenotype	HP:0005266	Intestinal polyps	37	3.036220e-3	1.000000e+0	5.043408e-1	3.293568e+2	3.036220e-3	1	3.036220e-3	1.000000e+0	39	1.718308e-3	1.000000e+0	2.707877e-1	5.819677e+2	1.718308e-3	1	31	1.000000e+0	3.225806e-2	unnamed	MSH2
Human Phenotype	HP:0002354	Memory impairment	38	3.088943e-3	1.000000e+0	4.995959e-1	3.237353e+2	3.088943e-3	1	3.088943e-3	1.000000e+0	51	2.272601e-3	1.000000e+0	2.738707e-1	4.400244e+2	2.272601e-3	1	41	1.000000e+0	2.439024e-2	unnamed	MSH2
Human Phenotype	HP:0002034	Abnormality of the rectum	39	3.236423e-3	1.000000e+0	5.100271e-1	3.089831e+2	3.236423e-3	1	3.236423e-3	1.000000e+0	37	1.662879e-3	1.000000e+0	2.762177e-1	6.013667e+2	1.662879e-3	1	30	1.000000e+0	3.333333e-2	unnamed	MSH2
Human Phenotype	HP:0100835	Benign neoplasm of the central nervous system	40	3.247238e-3	1.000000e+0	4.989381e-1	3.079540e+2	3.247238e-3	1	3.247238e-3	1.000000e+0	39	1.718308e-3	1.000000e+0	2.707877e-1	5.819677e+2	1.718308e-3	1	31	1.000000e+0	3.225806e-2	unnamed	MSH2
Human Phenotype	HP:0002672	Gastrointestinal carcinoma	41	3.256809e-3	1.000000e+0	4.882036e-1	3.070490e+2	3.256809e-3	1	3.256809e-3	1.000000e+0	30	1.330303e-3	1.000000e+0	2.725347e-1	7.517083e+2	1.330303e-3	1	24	1.000000e+0	4.166667e-2	unnamed	MSH2
Human Phenotype	HP:0010784	Uterine neoplasm	42	3.367151e-3	1.000000e+0	4.927264e-1	2.969870e+2	3.367151e-3	1	3.367151e-3	1.000000e+0	32	1.496591e-3	1.000000e+0	2.874390e-1	6.681852e+2	1.496591e-3	1	27	1.000000e+0	3.703704e-2	unnamed	MSH2
Human Phenotype	HP:0001480	Freckling	43	3.374996e-3	1.000000e+0	4.823890e-1	2.962966e+2	3.374996e-3	1	3.374996e-3	1.000000e+0	39	1.718308e-3	1.000000e+0	2.707877e-1	5.819677e+2	1.718308e-3	1	31	1.000000e+0	3.225806e-2	unnamed	MSH2
Human Phenotype	HP:0100013	Neoplasm of the breast	44	3.912223e-3	1.000000e+0	5.464664e-1	2.556091e+2	3.912223e-3	1	3.912223e-3	1.000000e+0	47	2.050884e-3	1.000000e+0	2.681858e-1	4.875946e+2	2.050884e-3	1	37	1.000000e+0	2.702703e-2	unnamed	MSH2
Human Phenotype	HP:0100836	Malignant neoplasm of the central nervous system	45	3.920200e-3	1.000000e+0	5.354122e-1	2.550890e+2	3.920200e-3	1	3.920200e-3	1.000000e+0	46	1.940025e-3	1.000000e+0	2.592042e-1	5.154571e+2	1.940025e-3	1	35	1.000000e+0	2.857143e-2	unnamed	MSH2
Human Phenotype	HP:0100615	Ovarian neoplasm	46	4.221632e-3	1.000000e+0	5.640467e-1	2.368752e+2	4.221632e-3	1	4.221632e-3	1.000000e+0	31	1.441162e-3	1.000000e+0	2.857220e-1	6.938846e+2	1.441162e-3	1	26	1.000000e+0	3.846154e-2	unnamed	MSH2
Human Phenotype	HP:0100031	Neoplasm of the thyroid gland	47	4.257060e-3	1.000000e+0	5.566785e-1	2.349039e+2	4.257060e-3	1	4.257060e-3	1.000000e+0	47	2.050884e-3	1.000000e+0	2.681858e-1	4.875946e+2	2.050884e-3	1	37	1.000000e+0	2.702703e-2	unnamed	MSH2
Human Phenotype	HP:0100834	Neoplasm of the large intestine	48	4.259835e-3	1.000000e+0	5.454364e-1	2.347509e+2	4.259835e-3	1	4.259835e-3	1.000000e+0	43	1.884596e-3	1.000000e+0	2.693657e-1	5.306176e+2	1.884596e-3	1	34	1.000000e+0	2.941176e-2	unnamed	MSH2
Human Phenotype	HP:0002896	Neoplasm of the liver	49	4.543233e-3	1.000000e+0	5.698512e-1	2.201076e+2	4.543233e-3	1	4.543233e-3	1.000000e+0	43	1.884596e-3	1.000000e+0	2.693657e-1	5.306176e+2	1.884596e-3	1	34	1.000000e+0	2.941176e-2	unnamed	MSH2
Human Phenotype	HP:0002239	Gastrointestinal hemorrhage	50	4.659658e-3	1.000000e+0	5.727652e-1	2.146080e+2	4.659658e-3	1	4.659658e-3	1.000000e+0	66	3.658334e-3	1.000000e+0	3.406685e-1	2.733485e+2	3.658334e-3	1	66	1.000000e+0	1.515152e-2	unnamed	MSH2
Human Phenotype	HP:0003401	Paresthesia	51	4.820666e-3	1.000000e+0	5.809375e-1	2.074402e+2	4.820666e-3	1	4.820666e-3	1.000000e+0	50	2.217172e-3	1.000000e+0	2.725348e-1	4.510250e+2	2.217172e-3	1	40	1.000000e+0	2.500000e-2	unnamed	MSH2
Human Phenotype	HP:0000957	Cafe-au-lait spot	52	5.182813e-3	1.000000e+0	6.125686e-1	1.929454e+2	5.182813e-3	1	5.182813e-3	1.000000e+0	63	3.492046e-3	1.000000e+0	3.406685e-1	2.863651e+2	3.492046e-3	1	63	1.000000e+0	1.587302e-2	unnamed	MSH2
Human Phenotype	HP:0000738	Hallucinations	53	5.217956e-3	1.000000e+0	6.050860e-1	1.916459e+2	5.217956e-3	1	5.217956e-3	1.000000e+0	58	3.270329e-3	1.000000e+0	3.465421e-1	3.057797e+2	3.270329e-3	1	59	1.000000e+0	1.694915e-2	unnamed	MSH2
Human Phenotype	HP:0100568	Neoplasm of the endocrine system	54	5.285851e-3	1.000000e+0	6.016082e-1	1.891843e+2	5.285851e-3	1	5.285851e-3	1.000000e+0	52	2.826894e-3	1.000000e+0	3.341171e-1	3.537451e+2	2.826894e-3	1	51	1.000000e+0	1.960784e-2	unnamed	MSH2
Human Phenotype	HP:0006753	Neoplasm of the stomach	55	5.467798e-3	1.000000e+0	6.110016e-1	1.828890e+2	5.467798e-3	1	5.467798e-3	1.000000e+0	52	2.826894e-3	1.000000e+0	3.341171e-1	3.537451e+2	2.826894e-3	1	51	1.000000e+0	1.960784e-2	unnamed	MSH2
Human Phenotype	HP:0002665	Lymphoma	56	5.521516e-3	1.000000e+0	6.059864e-1	1.811097e+2	5.521516e-3	1	5.521516e-3	1.000000e+0	63	3.492046e-3	1.000000e+0	3.406685e-1	2.863651e+2	3.492046e-3	1	63	1.000000e+0	1.587302e-2	unnamed	MSH2
Human Phenotype	HP:0100705	Abnormality of the glial cells	57	5.741252e-3	1.000000e+0	6.190480e-1	1.741780e+2	5.741252e-3	1	5.741252e-3	1.000000e+0	68	3.769192e-3	1.000000e+0	3.406684e-1	2.653088e+2	3.769192e-3	1	68	1.000000e+0	1.470588e-2	unnamed	MSH2
Human Phenotype	HP:0001123	Visual field defect	58	5.930192e-3	1.000000e+0	6.283959e-1	1.686286e+2	5.930192e-3	1	5.930192e-3	1.000000e+0	70	3.990910e-3	1.000000e+0	3.504019e-1	2.505694e+2	3.990910e-3	1	72	1.000000e+0	1.388889e-2	unnamed	MSH2
Human Phenotype	HP:0002027	Abdominal pain	59	6.319062e-3	1.000000e+0	6.582535e-1	1.582513e+2	6.319062e-3	1	6.319062e-3	1.000000e+0	72	4.268056e-3	1.000000e+0	3.643260e-1	2.342987e+2	4.268056e-3	1	77	1.000000e+0	1.298701e-2	unnamed	MSH2
Human Phenotype	HP:0002076	Migraine	60	6.522538e-3	1.000000e+0	6.681253e-1	1.533146e+2	6.522538e-3	1	6.522538e-3	1.000000e+0	67	3.713763e-3	1.000000e+0	3.406685e-1	2.692687e+2	3.713763e-3	1	67	1.000000e+0	1.492537e-2	unnamed	MSH2
Human Phenotype	HP:0010785	Gonadal neoplasm	61	6.590097e-3	1.000000e+0	6.639793e-1	1.517428e+2	6.590097e-3	1	6.590097e-3	1.000000e+0	49	2.106313e-3	1.000000e+0	2.641918e-1	4.747632e+2	2.106313e-3	1	38	1.000000e+0	2.631579e-2	unnamed	MSH2
Human Phenotype	HP:0009726	Renal neoplasm	62	6.642061e-3	1.000000e+0	6.584211e-1	1.505557e+2	6.642061e-3	1	6.642061e-3	1.000000e+0	54	2.882324e-3	1.000000e+0	3.280512e-1	3.469423e+2	2.882324e-3	1	52	1.000000e+0	1.923077e-2	unnamed	MSH2
Human Phenotype	HP:0100006	Neoplasm of the central nervous system	63	6.795571e-3	1.000000e+0	6.629457e-1	1.471547e+2	6.795571e-3	1	6.795571e-3	1.000000e+0	57	3.159470e-3	1.000000e+0	3.406685e-1	3.165088e+2	3.159470e-3	1	57	1.000000e+0	1.754386e-2	unnamed	MSH2
Human Phenotype	HP:0007018	Attention deficit hyperactivity disorder	64	7.014625e-3	1.000000e+0	6.736232e-1	1.425593e+2	7.014625e-3	1	7.014625e-3	1.000000e+0	55	2.993182e-3	1.000000e+0	3.344745e-1	3.340926e+2	2.993182e-3	1	54	1.000000e+0	1.851852e-2	unnamed	MSH2
Human Phenotype	HP:0100242	Sarcoma	65	7.244055e-3	1.000000e+0	6.849533e-1	1.380442e+2	7.244055e-3	1	7.244055e-3	1.000000e+0	62	3.436617e-3	1.000000e+0	3.406685e-1	2.909839e+2	3.436617e-3	1	62	1.000000e+0	1.612903e-2	unnamed	MSH2
Human Phenotype	HP:0010786	Urinary tract neoplasm	66	7.320958e-3	1.000000e+0	6.817365e-1	1.365941e+2	7.320958e-3	1	7.320958e-3	1.000000e+0	60	3.325758e-3	1.000000e+0	3.406685e-1	3.006833e+2	3.325758e-3	1	60	1.000000e+0	1.666667e-2	unnamed	MSH2
Human Phenotype	HP:0011772	Abnormality of thyroid morphology	67	7.490933e-3	1.000000e+0	6.871533e-1	1.334947e+2	7.490933e-3	1	7.490933e-3	1.000000e+0	58	3.270329e-3	1.000000e+0	3.465421e-1	3.057797e+2	3.270329e-3	1	59	1.000000e+0	1.694915e-2	unnamed	MSH2
Human Phenotype	HP:0000763	Sensory neuropathy	68	7.521179e-3	1.000000e+0	6.797819e-1	1.329579e+2	7.521179e-3	1	7.521179e-3	1.000000e+0	60	3.325758e-3	1.000000e+0	3.406685e-1	3.006833e+2	3.325758e-3	1	60	1.000000e+0	1.666667e-2	unnamed	MSH2
Human Phenotype	HP:0002315	Headache	69	7.837242e-3	1.000000e+0	6.980825e-1	1.275959e+2	7.837242e-3	1	7.837242e-3	1.000000e+0	77	4.988637e-3	1.000000e+0	3.981839e-1	2.004556e+2	4.988637e-3	1	90	1.000000e+0	1.111111e-2	unnamed	MSH2
Human Phenotype	HP:0011029	Internal hemorrhage	70	8.015556e-3	1.000000e+0	7.037658e-1	1.247574e+2	8.015556e-3	1	8.015556e-3	1.000000e+0	83	5.820076e-3	1.000000e+0	4.309661e-1	1.718190e+2	5.820076e-3	1	105	1.000000e+0	9.523810e-3	unnamed	MSH2
Human Phenotype	HP:0001034	Hypermelanotic macule	71	8.294523e-3	1.000000e+0	7.180019e-1	1.205615e+2	8.294523e-3	1	8.294523e-3	1.000000e+0	82	5.598359e-3	1.000000e+0	4.196038e-1	1.786238e+2	5.598359e-3	1	101	1.000000e+0	9.900990e-3	unnamed	MSH2
Human Phenotype	HP:0000736	Short attention span	72	8.714628e-3	1.000000e+0	7.438903e-1	1.147496e+2	8.714628e-3	1	8.714628e-3	1.000000e+0	63	3.492046e-3	1.000000e+0	3.406685e-1	2.863651e+2	3.492046e-3	1	63	1.000000e+0	1.587302e-2	unnamed	MSH2
Human Phenotype	HP:0010787	Genital neoplasm	73	8.920269e-3	1.000000e+0	7.510133e-1	1.121042e+2	8.920269e-3	1	8.920269e-3	1.000000e+0	55	2.993182e-3	1.000000e+0	3.344745e-1	3.340926e+2	2.993182e-3	1	54	1.000000e+0	1.851852e-2	unnamed	MSH2
Human Phenotype	HP:0004375	Neoplasm of the nervous system	74	9.050370e-3	1.000000e+0	7.516699e-1	1.104927e+2	9.050370e-3	1	9.050370e-3	1.000000e+0	71	4.101768e-3	1.000000e+0	3.550629e-1	2.437973e+2	4.101768e-3	1	74	1.000000e+0	1.351351e-2	unnamed	MSH2
Human Phenotype	HP:0001909	Leukemia	75	9.306101e-3	1.000000e+0	7.626040e-1	1.074564e+2	9.306101e-3	1	9.306101e-3	1.000000e+0	79	5.210354e-3	1.000000e+0	4.053524e-1	1.919255e+2	5.210354e-3	1	94	1.000000e+0	1.063830e-2	unnamed	MSH2
Human Phenotype	HP:0002376	Developmental regression	76	9.522267e-3	1.000000e+0	7.700507e-1	1.050170e+2	9.522267e-3	1	9.522267e-3	1.000000e+0	86	6.485228e-3	1.000000e+0	4.634676e-1	1.541966e+2	6.485228e-3	1	117	1.000000e+0	8.547009e-3	unnamed	MSH2
Human Phenotype	HP:0001274	Agenesis of corpus callosum	77	9.567259e-3	1.000000e+0	7.636412e-1	1.045231e+2	9.567259e-3	1	9.567259e-3	1.000000e+0	73	4.489773e-3	1.000000e+0	3.780020e-1	2.227284e+2	4.489773e-3	1	81	1.000000e+0	1.234568e-2	unnamed	MSH2
Human Phenotype	HP:0006989	Dysplastic corpus callosum	78	9.599562e-3	1.000000e+0	7.563963e-1	1.041714e+2	9.599562e-3	1	9.599562e-3	1.000000e+0	74	4.600632e-3	1.000000e+0	3.821011e-1	2.173614e+2	4.600632e-3	1	83	1.000000e+0	1.204819e-2	unnamed	MSH2
Human Phenotype	HP:0002250	Abnormality of the large intestine	79	9.660118e-3	1.000000e+0	7.515327e-1	1.035184e+2	9.660118e-3	1	9.660118e-3	1.000000e+0	78	5.044066e-3	1.000000e+0	3.974465e-1	1.982527e+2	5.044066e-3	1	91	1.000000e+0	1.098901e-2	unnamed	MSH2
Human Phenotype	HP:0000130	Abnormality of the uterus	80	9.892803e-3	1.000000e+0	7.600146e-1	1.010836e+2	9.892803e-3	1	9.892803e-3	1.000000e+0	68	3.769192e-3	1.000000e+0	3.406684e-1	2.653088e+2	3.769192e-3	1	68	1.000000e+0	1.470588e-2	unnamed	MSH2
Human Phenotype	HP:0001824	Weight loss	81	1.028226e-2	1.000000e+0	7.801823e-1	9.725486e+1	1.028226e-2	1	1.028226e-2	1.000000e+0	76	4.711490e-3	1.000000e+0	3.810108e-1	2.122471e+2	4.711490e-3	1	85	1.000000e+0	1.176471e-2	unnamed	MSH2
Human Phenotype	HP:0007400	Irregular hyperpigmentation	82	1.068274e-2	1.000000e+0	8.006844e-1	9.360890e+1	1.068274e-2	1	1.068274e-2	1.000000e+0	90	7.205809e-3	1.000000e+0	4.920767e-1	1.387769e+2	7.205809e-3	1	130	1.000000e+0	7.692308e-3	unnamed	MSH2
Human Phenotype	HP:0001732	Abnormality of the pancreas	83	1.082484e-2	1.000000e+0	8.015598e-1	9.238008e+1	1.082484e-2	1	1.082484e-2	1.000000e+0	87	6.596087e-3	1.000000e+0	4.659718e-1	1.516050e+2	6.596087e-3	1	119	1.000000e+0	8.403361e-3	unnamed	MSH2
Human Phenotype	HP:0002024	Malabsorption	84	1.118208e-2	1.000000e+0	8.181555e-1	8.942881e+1	1.118208e-2	1	1.118208e-2	1.000000e+0	90	7.205809e-3	1.000000e+0	4.920767e-1	1.387769e+2	7.205809e-3	1	130	1.000000e+0	7.692308e-3	unnamed	MSH2
Human Phenotype	HP:0000137	Abnormality of the ovary	85	1.185914e-2	1.000000e+0	8.574856e-1	8.432312e+1	1.185914e-2	1	1.185914e-2	1.000000e+0	79	5.210354e-3	1.000000e+0	4.053524e-1	1.919255e+2	5.210354e-3	1	94	1.000000e+0	1.063830e-2	unnamed	MSH2
Human Phenotype	HP:0007379	Neoplasm of the genitourinary tract	86	1.245121e-2	1.000000e+0	8.898272e-1	8.031346e+1	1.245121e-2	1	1.245121e-2	1.000000e+0	75	4.656061e-3	1.000000e+0	3.815487e-1	2.147738e+2	4.656061e-3	1	84	1.000000e+0	1.190476e-2	unnamed	MSH2
Human Phenotype	HP:0008069	Neoplasm of the skin	87	1.249858e-2	1.000000e+0	8.829457e-1	8.000907e+1	1.249858e-2	1	1.249858e-2	1.000000e+0	87	6.596087e-3	1.000000e+0	4.659718e-1	1.516050e+2	6.596087e-3	1	119	1.000000e+0	8.403361e-3	unnamed	MSH2
Human Phenotype	HP:0000953	Hyperpigmentation of the skin	88	1.310828e-2	1.000000e+0	9.154942e-1	7.628765e+1	1.310828e-2	1	1.310828e-2	1.000000e+0	94	8.536112e-3	1.000000e+0	5.581164e-1	1.171494e+2	8.536112e-3	1	154	1.000000e+0	6.493506e-3	unnamed	MSH2
Human Phenotype	HP:0000752	Hyperactivity	89	1.367399e-2	1.000000e+0	9.442735e-1	7.313156e+1	1.367399e-2	1	1.367399e-2	1.000000e+0	81	5.321213e-3	1.000000e+0	4.037552e-1	1.879271e+2	5.321213e-3	1	96	1.000000e+0	1.041667e-2	unnamed	MSH2
Human Phenotype	HP:0002019	Constipation	90	1.380603e-2	1.000000e+0	9.427984e-1	7.243213e+1	1.380603e-2	1	1.380603e-2	1.000000e+0	89	6.817804e-3	1.000000e+0	4.708115e-1	1.466748e+2	6.817804e-3	1	123	1.000000e+0	8.130081e-3	unnamed	MSH2
Human Phenotype	HP:0007378	Neoplasm of the gastrointestinal tract	91	1.388019e-2	1.000000e+0	9.374467e-1	7.204511e+1	1.388019e-2	1	1.388019e-2	1.000000e+0	84	6.208082e-3	1.000000e+0	4.542247e-1	1.610804e+2	6.208082e-3	1	112	1.000000e+0	8.928571e-3	unnamed	MSH2
Human Phenotype	HP:0011792	Neoplasm by histology	92	1.405119e-2	1.000000e+0	9.386806e-1	7.116836e+1	1.405119e-2	1	1.405119e-2	1.000000e+0	85	6.263511e-3	1.000000e+0	4.528887e-1	1.596549e+2	6.263511e-3	1	113	1.000000e+0	8.849558e-3	unnamed	MSH2
Human Phenotype	HP:0004377	Hematological neoplasm	93	1.500982e-2	1.000000e+0	9.919393e-1	6.662306e+1	1.500982e-2	1	1.500982e-2	1.000000e+0	95	8.868688e-3	1.000000e+0	5.737574e-1	1.127562e+2	8.868688e-3	1	160	1.000000e+0	6.250000e-3	unnamed	MSH2
Human Phenotype	HP:0011799	Abnormality of facial soft tissue	94	1.583064e-2	1.000000e+0	1.000000e+0	6.316864e+1	1.583064e-2	1	1.583064e-2	1.000000e+0	97	8.979547e-3	1.000000e+0	5.689515e-1	1.113642e+2	8.979547e-3	1	162	1.000000e+0	6.172840e-3	unnamed	MSH2
Human Phenotype	HP:0002017	Nausea and vomiting	95	1.584584e-2	1.000000e+0	1.000000e+0	6.310803e+1	1.584584e-2	1	1.584584e-2	1.000000e+0	99	9.090405e-3	1.000000e+0	5.643397e-1	1.100061e+2	9.090405e-3	1	164	1.000000e+0	6.097561e-3	unnamed	MSH2
Human Phenotype	HP:0000820	Abnormality of the thyroid gland	96	1.638059e-2	1.000000e+0	1.000000e+0	6.104788e+1	1.638059e-2	1	1.638059e-2	1.000000e+0	92	7.316668e-3	1.000000e+0	4.887852e-1	1.366742e+2	7.316668e-3	1	132	1.000000e+0	7.575758e-3	unnamed	MSH2
Human Phenotype	HP:0001892	Abnormal bleeding	97	1.685969e-2	1.000000e+0	1.000000e+0	5.931306e+1	1.685969e-2	1	1.685969e-2	1.000000e+0	101	1.141844e-2	1.000000e+0	6.948290e-1	8.757767e+1	1.141844e-2	1	206	1.000000e+0	4.854369e-3	unnamed	MSH2
Human Phenotype	HP:0004374	Hemiplegia/hemiparesis	98	1.698524e-2	1.000000e+0	1.000000e+0	5.887465e+1	1.698524e-2	1	1.698524e-2	1.000000e+0	93	7.870961e-3	1.000000e+0	5.201605e-1	1.270493e+2	7.870961e-3	1	142	1.000000e+0	7.042254e-3	unnamed	MSH2
Human Phenotype	HP:0002577	Abnormality of the stomach	99	1.809177e-2	1.000000e+0	1.000000e+0	5.527375e+1	1.809177e-2	1	1.809177e-2	1.000000e+0	96	8.924117e-3	1.000000e+0	5.713294e-1	1.120559e+2	8.924117e-3	1	161	1.000000e+0	6.211180e-3	unnamed	MSH2
Human Phenotype	HP:0000769	Abnormality of the breast	100	2.042074e-2	1.000000e+0	1.000000e+0	4.896981e+1	2.042074e-2	1	2.042074e-2	1.000000e+0	97	8.979547e-3	1.000000e+0	5.689515e-1	1.113642e+2	8.979547e-3	1	162	1.000000e+0	6.172840e-3	unnamed	MSH2
Human Phenotype	HP:0010549	Paralysis due to lesions of the principle motor tracts	101	2.184856e-2	1.000000e+0	1.000000e+0	4.576962e+1	2.184856e-2	1	2.184856e-2	1.000000e+0	100	1.069785e-2	1.000000e+0	6.574899e-1	9.347668e+1	1.069785e-2	1	193	1.000000e+0	5.181347e-3	unnamed	MSH2
Human Phenotype	HP:0009830	Peripheral neuropathy	102	2.399642e-2	1.000000e+0	1.000000e+0	4.167288e+1	2.399642e-2	1	2.399642e-2	1.000000e+0	106	1.385732e-2	1.000000e+0	8.034631e-1	7.216400e+1	1.385732e-2	1	250	1.000000e+0	4.000000e-3	unnamed	MSH2
Human Phenotype	HP:0007370	Aplasia/Hypoplasia of the corpus callosum	103	2.446174e-2	1.000000e+0	1.000000e+0	4.088017e+1	2.446174e-2	1	2.446174e-2	1.000000e+0	102	1.180644e-2	1.000000e+0	7.113959e-1	8.469953e+1	1.180644e-2	1	213	1.000000e+0	4.694836e-3	unnamed	MSH2
Human Phenotype	HP:0001000	Abnormality of skin pigmentation	104	2.462739e-2	1.000000e+0	1.000000e+0	4.060519e+1	2.462739e-2	1	2.462739e-2	1.000000e+0	107	1.446705e-2	1.000000e+0	8.309765e-1	6.912261e+1	1.446705e-2	1	261	1.000000e+0	3.831418e-3	unnamed	MSH2
Human Phenotype	HP:0001273	Abnormality of the corpus callosum	105	2.536115e-2	1.000000e+0	1.000000e+0	3.943039e+1	2.536115e-2	1	2.536115e-2	1.000000e+0	104	1.219445e-2	1.000000e+0	7.206451e-1	8.200455e+1	1.219445e-2	1	220	1.000000e+0	4.545455e-3	unnamed	MSH2
Human Phenotype	HP:0002500	Abnormality of the cerebral white matter	106	2.765141e-2	1.000000e+0	1.000000e+0	3.616452e+1	2.765141e-2	1	2.765141e-2	1.000000e+0	105	1.352475e-2	1.000000e+0	7.916487e-1	7.393852e+1	1.352475e-2	1	244	1.000000e+0	4.098361e-3	unnamed	MSH2
Human Phenotype	HP:0001881	Abnormality of leukocytes	107	2.780174e-2	1.000000e+0	1.000000e+0	3.596897e+1	2.780174e-2	1	2.780174e-2	1.000000e+0	114	1.773738e-2	1.000000e+0	9.562626e-1	5.637812e+1	1.773738e-2	1	320	1.000000e+0	3.125000e-3	unnamed	MSH2
Human Phenotype	HP:0001600	Abnormality of the larynx	108	2.804911e-2	1.000000e+0	1.000000e+0	3.565176e+1	2.804911e-2	1	2.804911e-2	1.000000e+0	103	1.208359e-2	1.000000e+0	7.210266e-1	8.275688e+1	1.208359e-2	1	218	1.000000e+0	4.587156e-3	unnamed	MSH2
Human Phenotype	HP:0010993	Abnormality of the cerebral subcortex	109	3.078375e-2	1.000000e+0	1.000000e+0	3.248468e+1	3.078375e-2	1	3.078375e-2	1.000000e+0	108	1.491048e-2	1.000000e+0	8.485168e-1	6.706691e+1	1.491048e-2	1	269	1.000000e+0	3.717472e-3	unnamed	MSH2
Human Phenotype	HP:0001371	Flexion contracture	110	3.355127e-2	1.000000e+0	1.000000e+0	2.980513e+1	3.355127e-2	1	3.355127e-2	1.000000e+0	110	1.651793e-2	1.000000e+0	9.229018e-1	6.054027e+1	1.651793e-2	1	298	1.000000e+0	3.355705e-3	unnamed	MSH2
Human Phenotype	HP:0000008	Abnormality of female internal genitalia	111	3.365925e-2	1.000000e+0	1.000000e+0	2.970951e+1	3.365925e-2	1	3.365925e-2	1.000000e+0	109	1.502134e-2	1.000000e+0	8.469831e-1	6.657196e+1	1.502134e-2	1	271	1.000000e+0	3.690037e-3	unnamed	MSH2
Human Phenotype	HP:0002118	Abnormality of the cerebral ventricles	112	3.540846e-2	1.000000e+0	1.000000e+0	2.824184e+1	3.540846e-2	1	3.540846e-2	1.000000e+0	111	1.707222e-2	1.000000e+0	9.452781e-1	5.857468e+1	1.707222e-2	1	308	1.000000e+0	3.246753e-3	unnamed	MSH2
Human Phenotype	HP:0002087	Abnormality of the upper respiratory tract	113	3.607184e-2	1.000000e+0	1.000000e+0	2.772246e+1	3.607184e-2	1	3.607184e-2	1.000000e+0	113	1.740480e-2	1.000000e+0	9.466363e-1	5.745541e+1	1.740480e-2	1	314	1.000000e+0	3.184713e-3	unnamed	MSH2
Human Phenotype	HP:0011355	Localized skin lesion	114	3.611249e-2	1.000000e+0	1.000000e+0	2.769125e+1	3.611249e-2	1	3.611249e-2	1.000000e+0	116	1.901225e-2	1.000000e+0	1.000000e+0	5.259767e+1	1.901225e-2	1	343	1.000000e+0	2.915452e-3	unnamed	MSH2
Human Phenotype	HP:0001276	Hypertonia	115	3.644032e-2	1.000000e+0	1.000000e+0	2.744213e+1	3.644032e-2	1	3.644032e-2	1.000000e+0	118	2.089685e-2	1.000000e+0	1.000000e+0	4.785411e+1	2.089685e-2	1	377	1.000000e+0	2.652520e-3	unnamed	MSH2
Human Phenotype	HP:0001288	Gait disturbance	116	3.682158e-2	1.000000e+0	1.000000e+0	2.715798e+1	3.682158e-2	1	3.682158e-2	1.000000e+0	115	1.818081e-2	1.000000e+0	9.716457e-1	5.500305e+1	1.818081e-2	1	328	1.000000e+0	3.048780e-3	unnamed	MSH2
Human Phenotype	HP:0010460	Abnormality of the female genitalia	117	3.799718e-2	1.000000e+0	1.000000e+0	2.631774e+1	3.799718e-2	1	3.799718e-2	1.000000e+0	112	1.723851e-2	1.000000e+0	9.459632e-1	5.800965e+1	1.723851e-2	1	311	1.000000e+0	3.215434e-3	unnamed	MSH2
Human Phenotype	HP:0002242	Abnormality of the intestine	118	3.988204e-2	1.000000e+0	1.000000e+0	2.507394e+1	3.988204e-2	1	3.988204e-2	1.000000e+0	117	2.034255e-2	1.000000e+0	1.000000e+0	4.915804e+1	2.034255e-2	1	367	1.000000e+0	2.724796e-3	unnamed	MSH2
Human Phenotype	HP:0002167	Neurological speech impairment	119	4.456011e-2	1.000000e+0	1.000000e+0	2.244160e+1	4.456011e-2	1	4.456011e-2	1.000000e+0	119	2.161743e-2	1.000000e+0	1.000000e+0	4.625897e+1	2.161743e-2	1	390	1.000000e+0	2.564103e-3	unnamed	MSH2
Human Phenotype	HP:0001392	Abnormality of the liver	120	4.545608e-2	1.000000e+0	1.000000e+0	2.199926e+1	4.545608e-2	1	4.545608e-2	1.000000e+0	133	3.126213e-2	1.000000e+0	1.000000e+0	3.198759e+1	3.126213e-2	1	564	1.000000e+0	1.773050e-3	unnamed	MSH2
Human Phenotype	HP:0000505	Visual impairment	121	4.619257e-2	1.000000e+0	1.000000e+0	2.164850e+1	4.619257e-2	1	4.619257e-2	1.000000e+0	121	2.466604e-2	1.000000e+0	1.000000e+0	4.054157e+1	2.466604e-2	1	445	1.000000e+0	2.247191e-3	unnamed	MSH2
Human Phenotype	HP:0011025	Abnormality of cardiovascular system physiology	122	4.649297e-2	1.000000e+0	1.000000e+0	2.150863e+1	4.649297e-2	1	4.649297e-2	1.000000e+0	123	2.510947e-2	1.000000e+0	1.000000e+0	3.982561e+1	2.510947e-2	1	453	1.000000e+0	2.207506e-3	unnamed	MSH2
Human Phenotype	HP:0004325	Decreased body weight	123	4.649404e-2	1.000000e+0	1.000000e+0	2.150813e+1	4.649404e-2	1	4.649404e-2	1.000000e+0	121	2.466604e-2	1.000000e+0	1.000000e+0	4.054157e+1	2.466604e-2	1	445	1.000000e+0	2.247191e-3	unnamed	MSH2
Human Phenotype	HP:0011793	Neoplasm by anatomical site	124	4.811988e-2	1.000000e+0	1.000000e+0	2.078143e+1	4.811988e-2	1	4.811988e-2	1.000000e+0	120	2.355745e-2	1.000000e+0	1.000000e+0	4.244941e+1	2.355745e-2	1	425	1.000000e+0	2.352941e-3	unnamed	MSH2
Human Phenotype	HP:0000759	Abnormality of the peripheral nervous system	125	4.946470e-2	1.000000e+0	1.000000e+0	2.021644e+1	4.946470e-2	1	4.946470e-2	1.000000e+0	125	2.632892e-2	1.000000e+0	1.000000e+0	3.798105e+1	2.632892e-2	1	475	1.000000e+0	2.105263e-3	unnamed	MSH2
Human Phenotype	HP:0000504	Abnormality of vision	126	4.984025e-2	1.000000e+0	1.000000e+0	2.006411e+1	4.984025e-2	1	4.984025e-2	1.000000e+0	126	2.743750e-2	1.000000e+0	1.000000e+0	3.644646e+1	2.743750e-2	1	495	1.000000e+0	2.020202e-3	unnamed	MSH2
Human Phenotype	HP:0002664	Neoplasm	127	5.084040e-2	1.000000e+0	1.000000e+0	1.966940e+1	5.084040e-2	1	5.084040e-2	1.000000e+0	124	2.527576e-2	1.000000e+0	1.000000e+0	3.956360e+1	2.527576e-2	1	456	1.000000e+0	2.192982e-3	unnamed	MSH2
Human Phenotype	HP:0011121	Abnormality of skin morphology	128	5.311577e-2	1.000000e+0	1.000000e+0	1.882680e+1	5.311577e-2	1	5.311577e-2	1.000000e+0	134	3.142841e-2	1.000000e+0	1.000000e+0	3.181834e+1	3.142841e-2	1	567	1.000000e+0	1.763668e-3	unnamed	MSH2
Human Phenotype	HP:0007364	Aplasia/Hypoplasia of the cerebrum	129	5.539730e-2	1.000000e+0	1.000000e+0	1.805142e+1	5.539730e-2	1	5.539730e-2	1.000000e+0	129	2.882324e-2	1.000000e+0	1.000000e+0	3.469423e+1	2.882324e-2	1	520	1.000000e+0	1.923077e-3	unnamed	MSH2
Human Phenotype	HP:0011458	Abdominal symptom	130	5.682180e-2	1.000000e+0	1.000000e+0	1.759888e+1	5.682180e-2	1	5.682180e-2	1.000000e+0	131	3.048611e-2	1.000000e+0	1.000000e+0	3.280182e+1	3.048611e-2	1	550	1.000000e+0	1.818182e-3	unnamed	MSH2
Human Phenotype	HP:0000818	Abnormality of the endocrine system	131	5.830630e-2	1.000000e+0	1.000000e+0	1.715081e+1	5.830630e-2	1	5.830630e-2	1.000000e+0	136	3.198271e-2	1.000000e+0	1.000000e+0	3.126690e+1	3.198271e-2	1	577	1.000000e+0	1.733102e-3	unnamed	MSH2
Human Phenotype	HP:0001871	Abnormality of  blood and blood-forming tissues	132	5.831227e-2	1.000000e+0	1.000000e+0	1.714905e+1	5.831227e-2	1	5.831227e-2	1.000000e+0	150	3.863422e-2	1.000000e+0	1.000000e+0	2.588379e+1	3.863422e-2	1	697	1.000000e+0	1.434720e-3	unnamed	MSH2
Human Phenotype	HP:0007256	Abnormality of pyramidal motor function	133	5.852599e-2	1.000000e+0	1.000000e+0	1.708643e+1	5.852599e-2	1	5.852599e-2	1.000000e+0	137	3.286957e-2	1.000000e+0	1.000000e+0	3.042327e+1	3.286957e-2	1	593	1.000000e+0	1.686341e-3	unnamed	MSH2
Human Phenotype	HP:0002062	Abnormality of the pyramidal tracts	134	5.873395e-2	1.000000e+0	1.000000e+0	1.702593e+1	5.873395e-2	1	5.873395e-2	1.000000e+0	138	3.303586e-2	1.000000e+0	1.000000e+0	3.027013e+1	3.303586e-2	1	596	1.000000e+0	1.677852e-3	unnamed	MSH2
Human Phenotype	HP:0000077	Abnormality of the kidney	135	5.877112e-2	1.000000e+0	1.000000e+0	1.701516e+1	5.877112e-2	1	5.877112e-2	1.000000e+0	127	2.810266e-2	1.000000e+0	1.000000e+0	3.558383e+1	2.810266e-2	1	507	1.000000e+0	1.972387e-3	unnamed	MSH2
Human Phenotype	HP:0011729	Abnormality of joint mobility	136	6.014038e-2	1.000000e+0	1.000000e+0	1.662776e+1	6.014038e-2	1	6.014038e-2	1.000000e+0	128	2.876781e-2	1.000000e+0	1.000000e+0	3.476108e+1	2.876781e-2	1	519	1.000000e+0	1.926782e-3	unnamed	MSH2
Human Phenotype	HP:0000708	Behavioural/Psychiatric Abnormality	137	6.042589e-2	1.000000e+0	1.000000e+0	1.654920e+1	6.042589e-2	1	6.042589e-2	1.000000e+0	134	3.142841e-2	1.000000e+0	1.000000e+0	3.181834e+1	3.142841e-2	1	567	1.000000e+0	1.763668e-3	unnamed	MSH2
Human Phenotype	HP:0010935	Abnormality of the upper urinary tract	138	6.180045e-2	1.000000e+0	1.000000e+0	1.618111e+1	6.180045e-2	1	6.180045e-2	1.000000e+0	130	3.026440e-2	1.000000e+0	1.000000e+0	3.304212e+1	3.026440e-2	1	546	1.000000e+0	1.831502e-3	unnamed	MSH2
Human Phenotype	HP:0011805	Abnormality of muscle morphology	139	6.379056e-2	1.000000e+0	1.000000e+0	1.567630e+1	6.379056e-2	1	6.379056e-2	1.000000e+0	145	3.530846e-2	1.000000e+0	1.000000e+0	2.832182e+1	3.530846e-2	1	637	1.000000e+0	1.569859e-3	unnamed	MSH2
Human Phenotype	HP:0004323	Abnormality of body weight	140	6.465988e-2	1.000000e+0	1.000000e+0	1.546554e+1	6.465988e-2	1	6.465988e-2	1.000000e+0	139	3.325758e-2	1.000000e+0	1.000000e+0	3.006833e+1	3.325758e-2	1	600	1.000000e+0	1.666667e-3	unnamed	MSH2
Human Phenotype	HP:0000812	Abnormal internal genitalia	141	6.482038e-2	1.000000e+0	1.000000e+0	1.542725e+1	6.482038e-2	1	6.482038e-2	1.000000e+0	132	3.081869e-2	1.000000e+0	1.000000e+0	3.244784e+1	3.081869e-2	1	556	1.000000e+0	1.798561e-3	unnamed	MSH2
Human Phenotype	HP:0001252	Muscular hypotonia	142	6.484906e-2	1.000000e+0	1.000000e+0	1.542042e+1	6.484906e-2	1	6.484906e-2	1.000000e+0	140	3.370101e-2	1.000000e+0	1.000000e+0	2.967270e+1	3.370101e-2	1	608	1.000000e+0	1.644737e-3	unnamed	MSH2
Human Phenotype	HP:0003808	Abnormal muscle tone	143	6.512600e-2	1.000000e+0	1.000000e+0	1.535485e+1	6.512600e-2	1	6.512600e-2	1.000000e+0	142	3.375644e-2	1.000000e+0	1.000000e+0	2.962397e+1	3.375644e-2	1	609	1.000000e+0	1.642036e-3	unnamed	MSH2
Human Phenotype	HP:0011024	Abnormality of the gastrointestinal tract	144	6.745114e-2	1.000000e+0	1.000000e+0	1.482555e+1	6.745114e-2	1	6.745114e-2	1.000000e+0	140	3.370101e-2	1.000000e+0	1.000000e+0	2.967270e+1	3.370101e-2	1	608	1.000000e+0	1.644737e-3	unnamed	MSH2
Human Phenotype	HP:0002977	Aplasia/Hypoplasia involving the central nervous system	145	6.843249e-2	1.000000e+0	1.000000e+0	1.461294e+1	6.843249e-2	1	6.843249e-2	1.000000e+0	146	3.641705e-2	1.000000e+0	1.000000e+0	2.745967e+1	3.641705e-2	1	657	1.000000e+0	1.522070e-3	unnamed	MSH2
Human Phenotype	HP:0003549	Abnormality of connective tissue	146	6.968666e-2	1.000000e+0	1.000000e+0	1.434995e+1	6.968666e-2	1	6.968666e-2	1.000000e+0	144	3.458788e-2	1.000000e+0	1.000000e+0	2.891186e+1	3.458788e-2	1	624	1.000000e+0	1.602564e-3	unnamed	MSH2
Human Phenotype	HP:0100022	Abnormality of movement	147	7.002976e-2	1.000000e+0	1.000000e+0	1.427964e+1	7.002976e-2	1	7.002976e-2	1.000000e+0	147	3.652791e-2	1.000000e+0	1.000000e+0	2.737633e+1	3.652791e-2	1	659	1.000000e+0	1.517451e-3	unnamed	MSH2
Human Phenotype	HP:0002715	Abnormality of the immune system	148	7.036261e-2	1.000000e+0	1.000000e+0	1.421209e+1	7.036261e-2	1	7.036261e-2	1.000000e+0	154	4.373372e-2	1.000000e+0	1.000000e+0	2.286565e+1	4.373372e-2	1	789	1.000000e+0	1.267427e-3	unnamed	MSH2
Human Phenotype	HP:0012243	Abnormal genital system morphology	149	7.339808e-2	1.000000e+0	1.000000e+0	1.362434e+1	7.339808e-2	1	7.339808e-2	1.000000e+0	143	3.414445e-2	1.000000e+0	1.000000e+0	2.928734e+1	3.414445e-2	1	616	1.000000e+0	1.623377e-3	unnamed	MSH2
Human Phenotype	HP:0002060	Abnormality of the cerebrum	150	7.579775e-2	1.000000e+0	1.000000e+0	1.319300e+1	7.579775e-2	1	7.579775e-2	1.000000e+0	151	4.018624e-2	1.000000e+0	1.000000e+0	2.488414e+1	4.018624e-2	1	725	1.000000e+0	1.379310e-3	unnamed	MSH2
Human Phenotype	HP:0100547	Abnormality of the forebrain	151	7.625082e-2	1.000000e+0	1.000000e+0	1.311461e+1	7.625082e-2	1	7.625082e-2	1.000000e+0	152	4.040796e-2	1.000000e+0	1.000000e+0	2.474760e+1	4.040796e-2	1	729	1.000000e+0	1.371742e-3	unnamed	MSH2
Human Phenotype	HP:0001367	Abnormal joint morphology	152	7.644753e-2	1.000000e+0	1.000000e+0	1.308087e+1	7.644753e-2	1	7.644753e-2	1.000000e+0	149	3.846793e-2	1.000000e+0	1.000000e+0	2.599568e+1	3.846793e-2	1	694	1.000000e+0	1.440922e-3	unnamed	MSH2
Human Phenotype	HP:0000078	Abnormality of the genital system	153	7.832480e-2	1.000000e+0	1.000000e+0	1.276735e+1	7.832480e-2	1	7.832480e-2	1.000000e+0	148	3.830165e-2	1.000000e+0	1.000000e+0	2.610854e+1	3.830165e-2	1	691	1.000000e+0	1.447178e-3	unnamed	MSH2
Human Phenotype	HP:0011354	Generalized abnormality of skin	154	7.852036e-2	1.000000e+0	1.000000e+0	1.273555e+1	7.852036e-2	1	7.852036e-2	1.000000e+0	159	4.789092e-2	1.000000e+0	1.000000e+0	2.088079e+1	4.789092e-2	1	864	1.000000e+0	1.157407e-3	unnamed	MSH2
Human Phenotype	HP:0001250	Seizures	155	7.857598e-2	1.000000e+0	1.000000e+0	1.272654e+1	7.857598e-2	1	7.857598e-2	1.000000e+0	153	4.195998e-2	1.000000e+0	1.000000e+0	2.383223e+1	4.195998e-2	1	757	1.000000e+0	1.321004e-3	unnamed	MSH2
Human Phenotype	HP:0011442	Abnormality of central motor function	156	7.946206e-2	1.000000e+0	1.000000e+0	1.258462e+1	7.946206e-2	1	7.946206e-2	1.000000e+0	157	4.484230e-2	1.000000e+0	1.000000e+0	2.230037e+1	4.484230e-2	1	809	1.000000e+0	1.236094e-3	unnamed	MSH2
Human Phenotype	HP:0012252	Abnormal respiratory system morphology	157	8.040224e-2	1.000000e+0	1.000000e+0	1.243746e+1	8.040224e-2	1	8.040224e-2	1.000000e+0	156	4.428801e-2	1.000000e+0	1.000000e+0	2.257947e+1	4.428801e-2	1	799	1.000000e+0	1.251564e-3	unnamed	MSH2
Human Phenotype	HP:0002086	Abnormality of the respiratory system	158	8.717457e-2	1.000000e+0	1.000000e+0	1.147124e+1	8.717457e-2	1	8.717457e-2	1.000000e+0	160	4.794634e-2	1.000000e+0	1.000000e+0	2.085665e+1	4.794634e-2	1	865	1.000000e+0	1.156069e-3	unnamed	MSH2
Human Phenotype	HP:0000079	Abnormality of the urinary system	159	8.807497e-2	1.000000e+0	1.000000e+0	1.135396e+1	8.807497e-2	1	8.807497e-2	1.000000e+0	158	4.633889e-2	1.000000e+0	1.000000e+0	2.158014e+1	4.633889e-2	1	836	1.000000e+0	1.196172e-3	unnamed	MSH2
Human Phenotype	HP:0000163	Abnormality of the oral cavity	160	8.862539e-2	1.000000e+0	1.000000e+0	1.128345e+1	8.862539e-2	1	8.862539e-2	1.000000e+0	155	4.384458e-2	1.000000e+0	1.000000e+0	2.280784e+1	4.384458e-2	1	791	1.000000e+0	1.264223e-3	unnamed	MSH2
Human Phenotype	HP:0012443	Abnormality of the brain	161	9.259756e-2	1.000000e+0	1.000000e+0	1.079942e+1	9.259756e-2	1	9.259756e-2	1.000000e+0	162	5.044066e-2	1.000000e+0	1.000000e+0	1.982527e+1	5.044066e-2	1	910	1.000000e+0	1.098901e-3	unnamed	MSH2
Human Phenotype	HP:0002012	Abnormality of the abdominal organs	162	9.395144e-2	1.000000e+0	1.000000e+0	1.064380e+1	9.395144e-2	1	9.395144e-2	1.000000e+0	164	5.448700e-2	1.000000e+0	1.000000e+0	1.835300e+1	5.448700e-2	1	983	1.000000e+0	1.017294e-3	unnamed	MSH2
Human Phenotype	HP:0011804	Abnormality of muscle physiology	163	9.636400e-2	1.000000e+0	1.000000e+0	1.037732e+1	9.636400e-2	1	9.636400e-2	1.000000e+0	163	5.398814e-2	1.000000e+0	1.000000e+0	1.852259e+1	5.398814e-2	1	974	1.000000e+0	1.026694e-3	unnamed	MSH2
Human Phenotype	HP:0000951	Abnormality of the skin	164	9.900756e-2	1.000000e+0	1.000000e+0	1.010024e+1	9.900756e-2	1	9.900756e-2	1.000000e+0	165	5.664874e-2	1.000000e+0	1.000000e+0	1.765264e+1	5.664874e-2	1	1022	1.000000e+0	9.784736e-4	unnamed	MSH2
Human Phenotype	HP:0000153	Abnormality of the mouth	165	1.037371e-1	1.000000e+0	1.000000e+0	9.639755e+0	1.037371e-1	1	1.037371e-1	1.000000e+0	161	5.038523e-2	1.000000e+0	1.000000e+0	1.984708e+1	5.038523e-2	1	909	1.000000e+0	1.100110e-3	unnamed	MSH2
Human Phenotype	HP:0012373	Abnormal eye physiology	166	1.069560e-1	1.000000e+0	1.000000e+0	9.349641e+0	1.069560e-1	1	1.069560e-1	1.000000e+0	167	5.858877e-2	1.000000e+0	1.000000e+0	1.706812e+1	5.858877e-2	1	1057	1.000000e+0	9.460738e-4	unnamed	MSH2
Human Phenotype	HP:0001626	Abnormality of the cardiovascular system	167	1.079230e-1	1.000000e+0	1.000000e+0	9.265867e+0	1.079230e-1	1	1.079230e-1	1.000000e+0	166	5.831162e-2	1.000000e+0	1.000000e+0	1.714924e+1	5.831162e-2	1	1052	1.000000e+0	9.505703e-4	unnamed	MSH2
Human Phenotype	HP:0001507	Growth abnormality	168	1.155115e-1	1.000000e+0	1.000000e+0	8.657146e+0	1.155115e-1	1	1.155115e-1	1.000000e+0	168	5.980821e-2	1.000000e+0	1.000000e+0	1.672011e+1	5.980821e-2	1	1079	1.000000e+0	9.267841e-4	unnamed	MSH2
Human Phenotype	HP:0000119	Abnormality of the genitourinary system	169	1.156102e-1	1.000000e+0	1.000000e+0	8.649757e+0	1.156102e-1	1	1.156102e-1	1.000000e+0	170	6.241339e-2	1.000000e+0	1.000000e+0	1.602220e+1	6.241339e-2	1	1126	1.000000e+0	8.880995e-4	unnamed	MSH2
Human Phenotype	HP:0003011	Abnormality of the musculature	170	1.167900e-1	1.000000e+0	1.000000e+0	8.562375e+0	1.167900e-1	1	1.167900e-1	1.000000e+0	171	6.446428e-2	1.000000e+0	1.000000e+0	1.551247e+1	6.446428e-2	1	1163	1.000000e+0	8.598452e-4	unnamed	MSH2
Human Phenotype	HP:0001438	Abnormality of the abdomen	171	1.198484e-1	1.000000e+0	1.000000e+0	8.343876e+0	1.198484e-1	1	1.198484e-1	1.000000e+0	173	6.806718e-2	1.000000e+0	1.000000e+0	1.469137e+1	6.806718e-2	1	1228	1.000000e+0	8.143322e-4	unnamed	MSH2
Human Phenotype	HP:0000006	Autosomal dominant inheritance	172	1.208130e-1	1.000000e+0	1.000000e+0	8.277255e+0	1.208130e-1	1	1.208130e-1	1.000000e+0	169	6.147109e-2	1.000000e+0	1.000000e+0	1.626781e+1	6.147109e-2	1	1109	1.000000e+0	9.017133e-4	unnamed	MSH2
Human Phenotype	HP:0001574	Abnormality of the integument	173	1.221743e-1	1.000000e+0	1.000000e+0	8.185030e+0	1.221743e-1	1	1.221743e-1	1.000000e+0	172	6.784546e-2	1.000000e+0	1.000000e+0	1.473938e+1	6.784546e-2	1	1224	1.000000e+0	8.169935e-4	unnamed	MSH2
Human Phenotype	HP:0007319	Morphological abnormality of the central nervous system	174	1.231213e-1	1.000000e+0	1.000000e+0	8.122074e+0	1.231213e-1	1	1.231213e-1	1.000000e+0	174	6.839976e-2	1.000000e+0	1.000000e+0	1.461994e+1	6.839976e-2	1	1234	1.000000e+0	8.103728e-4	unnamed	MSH2
Human Phenotype	HP:0100543	Cognitive impairment	175	1.275944e-1	1.000000e+0	1.000000e+0	7.837337e+0	1.275944e-1	1	1.275944e-1	1.000000e+0	175	6.878776e-2	1.000000e+0	1.000000e+0	1.453747e+1	6.878776e-2	1	1241	1.000000e+0	8.058018e-4	unnamed	MSH2
Human Phenotype	HP:0000271	Abnormality of the face	176	1.330333e-1	1.000000e+0	1.000000e+0	7.516916e+0	1.330333e-1	1	1.330333e-1	1.000000e+0	176	7.039521e-2	1.000000e+0	1.000000e+0	1.420551e+1	7.039521e-2	1	1270	1.000000e+0	7.874016e-4	unnamed	MSH2
Human Phenotype	HP:0000007	Autosomal recessive inheritance	177	1.382544e-1	1.000000e+0	1.000000e+0	7.233043e+0	1.382544e-1	1	1.382544e-1	1.000000e+0	183	8.924117e-2	1.000000e+0	1.000000e+0	1.120559e+1	8.924117e-2	1	1610	1.000000e+0	6.211180e-4	unnamed	MSH2
Human Phenotype	HP:0000478	Abnormality of the eye	178	1.387497e-1	1.000000e+0	1.000000e+0	7.207222e+0	1.387497e-1	1	1.387497e-1	1.000000e+0	177	7.715759e-2	1.000000e+0	1.000000e+0	1.296049e+1	7.715759e-2	1	1392	1.000000e+0	7.183908e-4	unnamed	MSH2
Human Phenotype	HP:0011446	Abnormality of higher mental function	179	1.446140e-1	1.000000e+0	1.000000e+0	6.914961e+0	1.446140e-1	1	1.446140e-1	1.000000e+0	178	7.843246e-2	1.000000e+0	1.000000e+0	1.274982e+1	7.843246e-2	1	1415	1.000000e+0	7.067138e-4	unnamed	MSH2
Human Phenotype	HP:0000234	Abnormality of the head	180	1.454011e-1	1.000000e+0	1.000000e+0	6.877527e+0	1.454011e-1	1	1.454011e-1	1.000000e+0	180	7.893132e-2	1.000000e+0	1.000000e+0	1.266924e+1	7.893132e-2	1	1424	1.000000e+0	7.022472e-4	unnamed	MSH2
Human Phenotype	HP:0000152	Abnormality of head and neck	181	1.484435e-1	1.000000e+0	1.000000e+0	6.736568e+0	1.484435e-1	1	1.484435e-1	1.000000e+0	181	8.031706e-2	1.000000e+0	1.000000e+0	1.245066e+1	8.031706e-2	1	1449	1.000000e+0	6.901311e-4	unnamed	MSH2
Human Phenotype	HP:0011842	Abnormality of skeletal morphology	182	1.489554e-1	1.000000e+0	1.000000e+0	6.713421e+0	1.489554e-1	1	1.489554e-1	1.000000e+0	179	7.882046e-2	1.000000e+0	1.000000e+0	1.268706e+1	7.882046e-2	1	1422	1.000000e+0	7.032349e-4	unnamed	MSH2
Human Phenotype	HP:0000924	Abnormality of the skeletal system	183	1.521487e-1	1.000000e+0	1.000000e+0	6.572520e+0	1.521487e-1	1	1.521487e-1	1.000000e+0	182	8.103764e-2	1.000000e+0	1.000000e+0	1.233995e+1	8.103764e-2	1	1462	1.000000e+0	6.839945e-4	unnamed	MSH2
Human Phenotype	HP:0002011	Abnormality of the central nervous system	184	1.748665e-1	1.000000e+0	1.000000e+0	5.718647e+0	1.748665e-1	1	1.748665e-1	1.000000e+0	184	9.567097e-2	1.000000e+0	1.000000e+0	1.045249e+1	9.567097e-2	1	1726	1.000000e+0	5.793743e-4	unnamed	MSH2
Human Phenotype	HP:0000707	Abnormality of the nervous system	185	1.846645e-1	1.000000e+0	1.000000e+0	5.415226e+0	1.846645e-1	1	1.846645e-1	1.000000e+0	185	1.001607e-1	1.000000e+0	1.000000e+0	9.983951e+0	1.001607e-1	1	1807	1.000000e+0	5.534034e-4	unnamed	MSH2
Human Phenotype	HP:0000005	Mode of inheritance	186	2.495240e-1	1.000000e+0	1.000000e+0	4.007630e+0	2.495240e-1	1	2.495240e-1	1.000000e+0	186	1.452248e-1	1.000000e+0	1.000000e+0	6.885878e+0	1.452248e-1	1	2620	1.000000e+0	3.816794e-4	unnamed	MSH2
Human Phenotype	HP:0000118	Phenotypic abnormality	187	2.682332e-1	1.000000e+0	1.000000e+0	3.728099e+0	2.682332e-1	1	2.682332e-1	1.000000e+0	187	1.548140e-1	1.000000e+0	1.000000e+0	6.459363e+0	1.548140e-1	1	2793	1.000000e+0	3.580380e-4	unnamed	MSH2
Human Phenotype	HP:0000001	All	188	2.696410e-1	1.000000e+0	1.000000e+0	3.708635e+0	2.696410e-1	1	2.696410e-1	1.000000e+0	188	1.564215e-1	1.000000e+0	1.000000e+0	6.392984e+0	1.564215e-1	1	2822	1.000000e+0	3.543586e-4	unnamed	MSH2
Disease Ontology	DOID:7398	cerebral primitive neuroectodermal tumor	1	6.982440e-5	1.560575e-1	1.560575e-1	1.432164e+4	6.982440e-5	1	6.982440e-5	1.000000e+0	1	5.542930e-5	1.238845e-1	1.238845e-1	1.804100e+4	5.542930e-5	1	1	1.000000e+0	1.000000e+0	unnamed	MSH2
Disease Ontology	DOID:0050465	Muir-Torre syndrome	2	1.351883e-4	3.021459e-1	1.510729e-1	7.397089e+3	1.351883e-4	1	1.351883e-4	1.000000e+0	2	1.108586e-4	2.477690e-1	1.238845e-1	9.020500e+3	1.108586e-4	1	2	1.000000e+0	5.000000e-1	unnamed	MSH2
Disease Ontology	DOID:4102	secondary carcinoma	2	1.351883e-4	3.021459e-1	1.510729e-1	7.397089e+3	1.351883e-4	1	1.351883e-4	1.000000e+0	2	1.108586e-4	2.477690e-1	1.238845e-1	9.020500e+3	1.108586e-4	1	2	1.000000e+0	5.000000e-1	unnamed	MSH2
Disease Ontology	DOID:4239	alveolar soft part sarcoma	4	2.927193e-4	6.542276e-1	1.635569e-1	3.416243e+3	2.927193e-4	1	2.927193e-4	1.000000e+0	6	2.771465e-4	6.194224e-1	1.032371e-1	3.608200e+3	2.771465e-4	1	5	1.000000e+0	2.000000e-1	unnamed	MSH2
Disease Ontology	DOID:4791	supratentorial primitive neuroectodermal tumor	5	3.189233e-4	7.127936e-1	1.425587e-1	3.135550e+3	3.189233e-4	1	3.189233e-4	1.000000e+0	4	2.217172e-4	4.955379e-1	1.238845e-1	4.510250e+3	2.217172e-4	1	4	1.000000e+0	2.500000e-1	unnamed	MSH2
Disease Ontology	DOID:4840	malignant sebaceous neoplasm	6	3.900090e-4	8.716701e-1	1.452784e-1	2.564043e+3	3.900090e-4	1	3.900090e-4	1.000000e+0	6	2.771465e-4	6.194224e-1	1.032371e-1	3.608200e+3	2.771465e-4	1	5	1.000000e+0	2.000000e-1	unnamed	MSH2
Disease Ontology	DOID:1294	vulva carcinoma	7	4.709107e-4	1.000000e+0	1.503551e-1	2.123545e+3	4.709107e-4	1	4.709107e-4	1.000000e+0	4	2.217172e-4	4.955379e-1	1.238845e-1	4.510250e+3	2.217172e-4	1	4	1.000000e+0	2.500000e-1	unnamed	MSH2
Disease Ontology	DOID:4240	malignant miscellaneous mesenchymal tumor	8	5.324450e-4	1.000000e+0	1.487518e-1	1.878128e+3	5.324450e-4	1	5.324450e-4	1.000000e+0	11	3.880051e-4	8.671914e-1	7.883558e-2	2.577286e+3	3.880051e-4	1	7	1.000000e+0	1.428571e-1	unnamed	MSH2
Disease Ontology	DOID:1282	vulvar neoplasm	9	5.959671e-4	1.000000e+0	1.479985e-1	1.677945e+3	5.959671e-4	1	5.959671e-4	1.000000e+0	6	2.771465e-4	6.194224e-1	1.032371e-1	3.608200e+3	2.771465e-4	1	5	1.000000e+0	2.000000e-1	unnamed	MSH2
Disease Ontology	DOID:2059	vulvar disease	10	6.663531e-4	1.000000e+0	1.489299e-1	1.500706e+3	6.663531e-4	1	6.663531e-4	1.000000e+0	10	3.325758e-4	7.433069e-1	7.433069e-2	3.006833e+3	3.325758e-4	1	6	1.000000e+0	1.666667e-1	unnamed	MSH2
Disease Ontology	DOID:4036	Helicobacter pylori gastritis	11	6.936270e-4	1.000000e+0	1.409324e-1	1.441697e+3	6.936270e-4	1	6.936270e-4	1.000000e+0	6	2.771465e-4	6.194224e-1	1.032371e-1	3.608200e+3	2.771465e-4	1	5	1.000000e+0	2.000000e-1	unnamed	MSH2
Disease Ontology	DOID:9297	lip disease	12	1.046509e-3	1.000000e+0	1.949123e-1	9.555582e+2	1.046509e-3	1	1.046509e-3	1.000000e+0	12	4.434344e-4	9.910759e-1	8.258966e-2	2.255125e+3	4.434344e-4	1	8	1.000000e+0	1.250000e-1	unnamed	MSH2
Disease Ontology	DOID:2433	tumor of epidermal appendage	13	1.204109e-3	1.000000e+0	2.070141e-1	8.304897e+2	1.204109e-3	1	1.204109e-3	1.000000e+0	13	4.988637e-4	1.000000e+0	8.576618e-2	2.004556e+3	4.988637e-4	1	9	1.000000e+0	1.111111e-1	unnamed	MSH2
Disease Ontology	DOID:8711	neurofibromatosis type 1	14	2.261135e-3	1.000000e+0	3.609741e-1	4.422557e+2	2.261135e-3	1	2.261135e-3	1.000000e+0	14	8.314395e-4	1.000000e+0	1.327334e-1	1.202733e+3	8.314395e-4	1	15	1.000000e+0	6.666667e-2	unnamed	MSH2
Disease Ontology	DOID:9098	sebaceous gland disease	15	2.678860e-3	1.000000e+0	3.991501e-1	3.732932e+2	2.678860e-3	1	2.678860e-3	1.000000e+0	17	1.552020e-3	1.000000e+0	2.040450e-1	6.443214e+2	1.552020e-3	1	28	1.000000e+0	3.571429e-2	unnamed	MSH2
Disease Ontology	DOID:8712	neurofibromatosis	16	3.113317e-3	1.000000e+0	4.348915e-1	3.212008e+2	3.113317e-3	1	3.113317e-3	1.000000e+0	15	1.164015e-3	1.000000e+0	1.734382e-1	8.590952e+2	1.164015e-3	1	21	1.000000e+0	4.761905e-2	unnamed	MSH2
Disease Ontology	DOID:4928	intrahepatic cholangiocarcinoma	17	3.825003e-3	1.000000e+0	5.028754e-1	2.614377e+2	3.825003e-3	1	3.825003e-3	1.000000e+0	19	1.940025e-3	1.000000e+0	2.282082e-1	5.154571e+2	1.940025e-3	1	35	1.000000e+0	2.857143e-2	unnamed	MSH2
Disease Ontology	DOID:3463	breast disease	18	4.191570e-3	1.000000e+0	5.204533e-1	2.385741e+2	4.191570e-3	1	4.191570e-3	1.000000e+0	16	1.330303e-3	1.000000e+0	1.858267e-1	7.517083e+2	1.330303e-3	1	24	1.000000e+0	4.166667e-2	unnamed	MSH2
Disease Ontology	DOID:2870	endometrial adenocarcinoma	19	4.506054e-3	1.000000e+0	5.300542e-1	2.219237e+2	4.506054e-3	1	4.506054e-3	1.000000e+0	18	1.718308e-3	1.000000e+0	2.133566e-1	5.819677e+2	1.718308e-3	1	31	1.000000e+0	3.225806e-2	unnamed	MSH2
Disease Ontology	DOID:4029	gastritis	20	5.221363e-3	1.000000e+0	5.834873e-1	1.915209e+2	5.221363e-3	1	5.221363e-3	1.000000e+0	22	3.769192e-3	1.000000e+0	3.829156e-1	2.653088e+2	3.769192e-3	1	68	1.000000e+0	1.470588e-2	unnamed	MSH2
Disease Ontology	DOID:4948	gallbladder carcinoma	21	5.973413e-3	1.000000e+0	6.357418e-1	1.674085e+2	5.973413e-3	1	5.973413e-3	1.000000e+0	20	2.716036e-3	1.000000e+0	3.035170e-1	3.681837e+2	2.716036e-3	1	49	1.000000e+0	2.040816e-2	unnamed	MSH2
Disease Ontology	DOID:2876	laryngeal squamous cell carcinoma	22	6.126726e-3	1.000000e+0	6.224197e-1	1.632193e+2	6.126726e-3	1	6.126726e-3	1.000000e+0	23	4.268056e-3	1.000000e+0	4.147437e-1	2.342987e+2	4.268056e-3	1	77	1.000000e+0	1.298701e-2	unnamed	MSH2
Disease Ontology	DOID:76	stomach disease	23	6.326538e-3	1.000000e+0	6.147745e-1	1.580643e+2	6.326538e-3	1	6.326538e-3	1.000000e+0	25	4.489773e-3	1.000000e+0	4.013857e-1	2.227284e+2	4.489773e-3	1	81	1.000000e+0	1.234568e-2	unnamed	MSH2
Disease Ontology	DOID:2600	carcinoma of larynx	24	6.580420e-3	1.000000e+0	6.128016e-1	1.519660e+2	6.580420e-3	1	6.580420e-3	1.000000e+0	24	4.378915e-3	1.000000e+0	4.077865e-1	2.283671e+2	4.378915e-3	1	79	1.000000e+0	1.265823e-2	unnamed	MSH2
Disease Ontology	DOID:2598	laryngeal neoplasm	25	6.707173e-3	1.000000e+0	5.996213e-1	1.490941e+2	6.707173e-3	1	6.707173e-3	1.000000e+0	26	4.600632e-3	1.000000e+0	3.954774e-1	2.173614e+2	4.600632e-3	1	83	1.000000e+0	1.204819e-2	unnamed	MSH2
Disease Ontology	DOID:786	laryngeal disease	26	7.022191e-3	1.000000e+0	6.036383e-1	1.424057e+2	7.022191e-3	1	7.022191e-3	1.000000e+0	27	5.154925e-3	1.000000e+0	4.267132e-1	1.939892e+2	5.154925e-3	1	93	1.000000e+0	1.075269e-2	unnamed	MSH2
Disease Ontology	DOID:0050339	commensal bacterial infectious disease	27	8.669785e-3	1.000000e+0	7.176655e-1	1.153431e+2	8.669785e-3	1	8.669785e-3	1.000000e+0	29	6.152652e-3	1.000000e+0	4.741785e-1	1.625315e+2	6.152652e-3	1	111	1.000000e+0	9.009009e-3	unnamed	MSH2
Disease Ontology	DOID:2991	stromal neoplasm	28	9.226644e-3	1.000000e+0	7.364839e-1	1.083818e+2	9.226644e-3	1	9.226644e-3	1.000000e+0	21	3.713763e-3	1.000000e+0	3.952505e-1	2.692687e+2	3.713763e-3	1	67	1.000000e+0	1.492537e-2	unnamed	MSH2
Disease Ontology	DOID:10286	prostate carcinoma	29	1.155289e-2	1.000000e+0	8.903693e-1	8.655844e+1	1.155289e-2	1	1.155289e-2	1.000000e+0	28	5.542930e-3	1.000000e+0	4.424446e-1	1.804100e+2	5.542930e-3	1	100	1.000000e+0	1.000000e-2	unnamed	MSH2
Disease Ontology	DOID:4947	cholangiocarcinoma	30	1.226587e-2	1.000000e+0	9.138073e-1	8.152704e+1	1.226587e-2	1	1.226587e-2	1.000000e+0	30	6.651516e-3	1.000000e+0	4.955379e-1	1.503417e+2	6.651516e-3	1	120	1.000000e+0	8.333333e-3	unnamed	MSH2
Disease Ontology	DOID:4897	bile duct carcinoma	31	1.342514e-2	1.000000e+0	9.679093e-1	7.448712e+1	1.342514e-2	1	1.342514e-2	1.000000e+0	31	7.316668e-3	1.000000e+0	5.275082e-1	1.366742e+2	7.316668e-3	1	132	1.000000e+0	7.575758e-3	unnamed	MSH2
Disease Ontology	DOID:4606	bile duct cancer	32	1.345417e-2	1.000000e+0	9.396897e-1	7.432642e+1	1.345417e-2	1	1.345417e-2	1.000000e+0	32	7.372097e-3	1.000000e+0	5.148949e-1	1.356466e+2	7.372097e-3	1	133	1.000000e+0	7.518797e-3	unnamed	MSH2
Disease Ontology	DOID:8778	Crohn's disease	33	1.382583e-2	1.000000e+0	9.363858e-1	7.232841e+1	1.382583e-2	1	1.382583e-2	1.000000e+0	40	9.700127e-3	1.000000e+0	5.419946e-1	1.030914e+2	9.700127e-3	1	175	1.000000e+0	5.714286e-3	unnamed	MSH2
Disease Ontology	DOID:0060031	autoimmune disease of gastrointestinal tract	34	1.484353e-2	1.000000e+0	9.757438e-1	6.736941e+1	1.484353e-2	1	1.484353e-2	1.000000e+0	44	1.069785e-2	1.000000e+0	5.434022e-1	9.347668e+1	1.069785e-2	1	193	1.000000e+0	5.181347e-3	unnamed	MSH2
Disease Ontology	DOID:403	mouth disease	35	1.606891e-2	1.000000e+0	1.000000e+0	6.223199e+1	1.606891e-2	1	1.606891e-2	1.000000e+0	42	9.866415e-3	1.000000e+0	5.250342e-1	1.013539e+2	9.866415e-3	1	178	1.000000e+0	5.617978e-3	unnamed	MSH2
Disease Ontology	DOID:974	upper respiratory tract disease	36	1.623572e-2	1.000000e+0	1.000000e+0	6.159258e+1	1.623572e-2	1	1.623572e-2	1.000000e+0	47	1.169558e-2	1.000000e+0	5.561622e-1	8.550237e+1	1.169558e-2	1	211	1.000000e+0	4.739336e-3	unnamed	MSH2
Disease Ontology	DOID:2871	endometrial carcinoma	37	1.675841e-2	1.000000e+0	1.000000e+0	5.967153e+1	1.675841e-2	1	1.675841e-2	1.000000e+0	32	7.372097e-3	1.000000e+0	5.148949e-1	1.356466e+2	7.372097e-3	1	133	1.000000e+0	7.518797e-3	unnamed	MSH2
Disease Ontology	DOID:5520	head and neck squamous cell carcinoma	38	1.765121e-2	1.000000e+0	1.000000e+0	5.665335e+1	1.765121e-2	1	1.765121e-2	1.000000e+0	37	9.201264e-3	1.000000e+0	5.558061e-1	1.086807e+2	9.201264e-3	1	166	1.000000e+0	6.024096e-3	unnamed	MSH2
Disease Ontology	DOID:4607	biliary tract cancer	39	1.820947e-2	1.000000e+0	1.000000e+0	5.491648e+1	1.820947e-2	1	1.820947e-2	1.000000e+0	39	9.533840e-3	1.000000e+0	5.463624e-1	1.048895e+2	9.533840e-3	1	172	1.000000e+0	5.813953e-3	unnamed	MSH2
Disease Ontology	DOID:2692	muscle tissue neoplasm	40	1.849050e-2	1.000000e+0	1.000000e+0	5.408184e+1	1.849050e-2	1	1.849050e-2	1.000000e+0	38	9.478410e-3	1.000000e+0	5.574802e-1	1.055029e+2	9.478410e-3	1	171	1.000000e+0	5.847953e-3	unnamed	MSH2
Disease Ontology	DOID:4138	bile duct disease	41	1.956557e-2	1.000000e+0	1.000000e+0	5.111019e+1	1.956557e-2	1	1.956557e-2	1.000000e+0	46	1.125215e-2	1.000000e+0	5.467077e-1	8.887192e+1	1.125215e-2	1	203	1.000000e+0	4.926108e-3	unnamed	MSH2
Disease Ontology	DOID:10283	malignant neoplasm of prostate	42	1.968080e-2	1.000000e+0	1.000000e+0	5.081093e+1	1.968080e-2	1	1.968080e-2	1.000000e+0	34	8.536112e-3	1.000000e+0	5.611238e-1	1.171494e+2	8.536112e-3	1	154	1.000000e+0	6.493506e-3	unnamed	MSH2
Disease Ontology	DOID:10284	malignant neoplasm of male genital organ or tract	43	1.969552e-2	1.000000e+0	1.000000e+0	5.077298e+1	1.969552e-2	1	1.969552e-2	1.000000e+0	35	8.591541e-3	1.000000e+0	5.486313e-1	1.163935e+2	8.591541e-3	1	155	1.000000e+0	6.451613e-3	unnamed	MSH2
Disease Ontology	DOID:514	prostatic neoplasm	44	2.097895e-2	1.000000e+0	1.000000e+0	4.766682e+1	2.097895e-2	1	2.097895e-2	1.000000e+0	36	9.145834e-3	1.000000e+0	5.678039e-1	1.093394e+2	9.145834e-3	1	165	1.000000e+0	6.060606e-3	unnamed	MSH2
Disease Ontology	DOID:47	prostate disease	45	2.176279e-2	1.000000e+0	1.000000e+0	4.595000e+1	2.176279e-2	1	2.176279e-2	1.000000e+0	41	9.755557e-3	1.000000e+0	5.317968e-1	1.025057e+2	9.755557e-3	1	176	1.000000e+0	5.681818e-3	unnamed	MSH2
Disease Ontology	DOID:3856	male genital cancer	46	2.324048e-2	1.000000e+0	1.000000e+0	4.302837e+1	2.324048e-2	1	2.324048e-2	1.000000e+0	42	9.866415e-3	1.000000e+0	5.250342e-1	1.013539e+2	9.866415e-3	1	178	1.000000e+0	5.617978e-3	unnamed	MSH2
Disease Ontology	DOID:9741	biliary tract disease	47	2.393130e-2	1.000000e+0	1.000000e+0	4.178628e+1	2.393130e-2	1	2.393130e-2	1.000000e+0	50	1.330303e-2	1.000000e+0	5.946454e-1	7.517083e+1	1.330303e-2	1	240	1.000000e+0	4.166667e-3	unnamed	MSH2
Disease Ontology	DOID:3117	hepatobiliary neoplasm	48	2.482426e-2	1.000000e+0	1.000000e+0	4.028318e+1	2.482426e-2	1	2.482426e-2	1.000000e+0	49	1.219445e-2	1.000000e+0	5.562162e-1	8.200455e+1	1.219445e-2	1	220	1.000000e+0	4.545455e-3	unnamed	MSH2
Disease Ontology	DOID:3007	ductal carcinoma	49	2.482786e-2	1.000000e+0	1.000000e+0	4.027733e+1	2.482786e-2	1	2.482786e-2	1.000000e+0	45	1.086414e-2	1.000000e+0	5.395856e-1	9.204592e+1	1.086414e-2	1	196	1.000000e+0	5.102041e-3	unnamed	MSH2
Disease Ontology	DOID:104	bacterial infectious disease	50	2.577429e-2	1.000000e+0	1.000000e+0	3.879835e+1	2.577429e-2	1	2.577429e-2	1.000000e+0	58	1.795909e-2	1.000000e+0	6.920442e-1	5.568210e+1	1.795909e-2	1	324	1.000000e+0	3.086420e-3	unnamed	MSH2
Disease Ontology	DOID:3996	cancer of urinary tract	51	2.754903e-2	1.000000e+0	1.000000e+0	3.629892e+1	2.754903e-2	1	2.754903e-2	1.000000e+0	48	1.208359e-2	1.000000e+0	5.626422e-1	8.275688e+1	1.208359e-2	1	218	1.000000e+0	4.587156e-3	unnamed	MSH2
Disease Ontology	DOID:2620	ductal, lobular, and medullary neoplasm	52	2.916543e-2	1.000000e+0	1.000000e+0	3.428716e+1	2.916543e-2	1	2.916543e-2	1.000000e+0	50	1.330303e-2	1.000000e+0	5.946454e-1	7.517083e+1	1.330303e-2	1	240	1.000000e+0	4.166667e-3	unnamed	MSH2
Disease Ontology	DOID:5428	bladder cancer	53	2.930843e-2	1.000000e+0	1.000000e+0	3.411987e+1	2.930843e-2	1	2.930843e-2	1.000000e+0	52	1.507677e-2	1.000000e+0	6.480112e-1	6.632721e+1	1.507677e-2	1	272	1.000000e+0	3.676471e-3	unnamed	MSH2
Disease Ontology	DOID:365	bladder disease	54	3.085662e-2	1.000000e+0	1.000000e+0	3.240796e+1	3.085662e-2	1	3.085662e-2	1.000000e+0	53	1.574192e-2	1.000000e+0	6.638338e-1	6.352465e+1	1.574192e-2	1	284	1.000000e+0	3.521127e-3	unnamed	MSH2
Disease Ontology	DOID:1542	neck carcinoma	55	3.222879e-2	1.000000e+0	1.000000e+0	3.102816e+1	3.222879e-2	1	3.222879e-2	1.000000e+0	56	1.657336e-2	1.000000e+0	6.614546e-1	6.033779e+1	1.657336e-2	1	299	1.000000e+0	3.344482e-3	unnamed	MSH2
Disease Ontology	DOID:4450	renal cell carcinoma	56	3.398104e-2	1.000000e+0	1.000000e+0	2.942817e+1	3.398104e-2	1	3.398104e-2	1.000000e+0	57	1.768195e-2	1.000000e+0	6.933186e-1	5.655486e+1	1.768195e-2	1	319	1.000000e+0	3.134796e-3	unnamed	MSH2
Disease Ontology	DOID:5295	intestinal disease	57	3.418180e-2	1.000000e+0	1.000000e+0	2.925534e+1	3.418180e-2	1	3.418180e-2	1.000000e+0	67	2.139571e-2	1.000000e+0	7.137226e-1	4.673834e+1	2.139571e-2	1	386	1.000000e+0	2.590674e-3	unnamed	MSH2
Disease Ontology	DOID:48	male reproductive system disease	58	3.620361e-2	1.000000e+0	1.000000e+0	2.762155e+1	3.620361e-2	1	3.620361e-2	1.000000e+0	54	1.607450e-2	1.000000e+0	6.653057e-1	6.221034e+1	1.607450e-2	1	290	1.000000e+0	3.448276e-3	unnamed	MSH2
Disease Ontology	DOID:3068	glioblastoma	59	3.687427e-2	1.000000e+0	1.000000e+0	2.711918e+1	3.687427e-2	1	3.687427e-2	1.000000e+0	55	1.646250e-2	1.000000e+0	6.689761e-1	6.074411e+1	1.646250e-2	1	297	1.000000e+0	3.367003e-3	unnamed	MSH2
Disease Ontology	DOID:731	urologic neoplasm	60	3.752395e-2	1.000000e+0	1.000000e+0	2.664965e+1	3.752395e-2	1	3.752395e-2	1.000000e+0	59	1.845796e-2	1.000000e+0	6.992126e-1	5.417718e+1	1.845796e-2	1	333	1.000000e+0	3.003003e-3	unnamed	MSH2
Disease Ontology	DOID:4451	renal carcinoma	61	3.907764e-2	1.000000e+0	1.000000e+0	2.559008e+1	3.907764e-2	1	3.907764e-2	1.000000e+0	60	1.989912e-2	1.000000e+0	7.412422e-1	5.025348e+1	1.989912e-2	1	359	1.000000e+0	2.785515e-3	unnamed	MSH2
Disease Ontology	DOID:1112	neck cancer	62	4.017075e-2	1.000000e+0	1.000000e+0	2.489373e+1	4.017075e-2	1	4.017075e-2	1.000000e+0	61	2.084142e-2	1.000000e+0	7.636160e-1	4.798138e+1	2.084142e-2	1	376	1.000000e+0	2.659574e-3	unnamed	MSH2
Disease Ontology	DOID:4725	neck neoplasm	63	4.031124e-2	1.000000e+0	1.000000e+0	2.480698e+1	4.031124e-2	1	4.031124e-2	1.000000e+0	63	2.106313e-2	1.000000e+0	7.472396e-1	4.747632e+1	2.106313e-2	1	380	1.000000e+0	2.631579e-3	unnamed	MSH2
Disease Ontology	DOID:3069	astrocytoma	64	4.313016e-2	1.000000e+0	1.000000e+0	2.318563e+1	4.313016e-2	1	4.313016e-2	1.000000e+0	62	2.100770e-2	1.000000e+0	7.572937e-1	4.760158e+1	2.100770e-2	1	379	1.000000e+0	2.638522e-3	unnamed	MSH2
Disease Ontology	DOID:2126	primary brain tumor	65	4.334785e-2	1.000000e+0	1.000000e+0	2.306920e+1	4.334785e-2	1	4.334785e-2	1.000000e+0	63	2.106313e-2	1.000000e+0	7.472396e-1	4.747632e+1	2.106313e-2	1	380	1.000000e+0	2.631579e-3	unnamed	MSH2
Disease Ontology	DOID:911	malignant neoplasm of brain	66	4.364353e-2	1.000000e+0	1.000000e+0	2.291290e+1	4.364353e-2	1	4.364353e-2	1.000000e+0	66	2.134028e-2	1.000000e+0	7.226595e-1	4.685974e+1	2.134028e-2	1	385	1.000000e+0	2.597403e-3	unnamed	MSH2
Disease Ontology	DOID:3119	gastrointestinal neoplasm	67	4.370194e-2	1.000000e+0	1.000000e+0	2.288228e+1	4.370194e-2	1	4.370194e-2	1.000000e+0	65	2.128485e-2	1.000000e+0	7.318714e-1	4.698177e+1	2.128485e-2	1	384	1.000000e+0	2.604167e-3	unnamed	MSH2
Disease Ontology	DOID:8377	digestive system cancer	68	4.455231e-2	1.000000e+0	1.000000e+0	2.244552e+1	4.455231e-2	1	4.455231e-2	1.000000e+0	68	2.150657e-2	1.000000e+0	7.068704e-1	4.649742e+1	2.150657e-2	1	388	1.000000e+0	2.577320e-3	unnamed	MSH2
Disease Ontology	DOID:3459	breast carcinoma	69	4.496474e-2	1.000000e+0	1.000000e+0	2.223965e+1	4.496474e-2	1	4.496474e-2	1.000000e+0	69	2.167286e-2	1.000000e+0	7.020122e-1	4.614066e+1	2.167286e-2	1	391	1.000000e+0	2.557545e-3	unnamed	MSH2
Disease Ontology	DOID:368	neoplasm of cerebrum	70	4.511970e-2	1.000000e+0	1.000000e+0	2.216327e+1	4.511970e-2	1	4.511970e-2	1.000000e+0	70	2.172829e-2	1.000000e+0	6.937533e-1	4.602296e+1	2.172829e-2	1	392	1.000000e+0	2.551020e-3	unnamed	MSH2
Disease Ontology	DOID:1659	supratentorial neoplasm	71	4.529725e-2	1.000000e+0	1.000000e+0	2.207640e+1	4.529725e-2	1	4.529725e-2	1.000000e+0	71	2.183914e-2	1.000000e+0	6.874715e-1	4.578934e+1	2.183914e-2	1	394	1.000000e+0	2.538071e-3	unnamed	MSH2
Disease Ontology	DOID:3908	non-small cell lung carcinoma	72	4.635042e-2	1.000000e+0	1.000000e+0	2.157478e+1	4.635042e-2	1	4.635042e-2	1.000000e+0	72	2.278144e-2	1.000000e+0	7.071739e-1	4.389538e+1	2.278144e-2	1	411	1.000000e+0	2.433090e-3	unnamed	MSH2
Disease Ontology	DOID:657	adenoma	73	4.777118e-2	1.000000e+0	1.000000e+0	2.093312e+1	4.777118e-2	1	4.777118e-2	1.000000e+0	73	2.355745e-2	1.000000e+0	7.212452e-1	4.244941e+1	2.355745e-2	1	425	1.000000e+0	2.352941e-3	unnamed	MSH2
Disease Ontology	DOID:449	head neoplasm	74	5.090150e-2	1.000000e+0	1.000000e+0	1.964579e+1	5.090150e-2	1	5.090150e-2	1.000000e+0	74	2.555291e-2	1.000000e+0	7.717669e-1	3.913449e+1	2.555291e-2	1	461	1.000000e+0	2.169197e-3	unnamed	MSH2
Disease Ontology	DOID:37	skin disease	75	5.172018e-2	1.000000e+0	1.000000e+0	1.933481e+1	5.172018e-2	1	5.172018e-2	1.000000e+0	80	3.425531e-2	1.000000e+0	9.570077e-1	2.919256e+1	3.425531e-2	1	618	1.000000e+0	1.618123e-3	unnamed	MSH2
Disease Ontology	DOID:229	female reproductive system disease	76	5.249388e-2	1.000000e+0	1.000000e+0	1.904984e+1	5.249388e-2	1	5.249388e-2	1.000000e+0	76	2.627349e-2	1.000000e+0	7.726480e-1	3.806118e+1	2.627349e-2	1	474	1.000000e+0	2.109705e-3	unnamed	MSH2
Disease Ontology	DOID:3905	lung carcinoma	77	5.322895e-2	1.000000e+0	1.000000e+0	1.878677e+1	5.322895e-2	1	5.322895e-2	1.000000e+0	75	2.605177e-2	1.000000e+0	7.763427e-1	3.838511e+1	2.605177e-2	1	470	1.000000e+0	2.127660e-3	unnamed	MSH2
Disease Ontology	DOID:16	integumentary system disease	78	5.565040e-2	1.000000e+0	1.000000e+0	1.796932e+1	5.565040e-2	1	5.565040e-2	1.000000e+0	82	3.553018e-2	1.000000e+0	9.684141e-1	2.814509e+1	3.553018e-2	1	641	1.000000e+0	1.560062e-3	unnamed	MSH2
Disease Ontology	DOID:0050177	simple genetic disease	79	5.697693e-2	1.000000e+0	1.000000e+0	1.755096e+1	5.697693e-2	1	5.697693e-2	1.000000e+0	79	3.220442e-2	1.000000e+0	9.110997e-1	3.105164e+1	3.220442e-2	1	581	1.000000e+0	1.721170e-3	unnamed	MSH2
Disease Ontology	DOID:630	genetic disease	80	6.499915e-2	1.000000e+0	1.000000e+0	1.538482e+1	6.499915e-2	1	6.499915e-2	1.000000e+0	81	3.525303e-2	1.000000e+0	9.727225e-1	2.836635e+1	3.525303e-2	1	636	1.000000e+0	1.572327e-3	unnamed	MSH2
Disease Ontology	DOID:3118	hepatobiliary disease	81	6.824507e-2	1.000000e+0	1.000000e+0	1.465307e+1	6.824507e-2	1	6.824507e-2	1.000000e+0	93	4.140569e-2	1.000000e+0	9.950722e-1	2.415127e+1	4.140569e-2	1	747	1.000000e+0	1.338688e-3	unnamed	MSH2
Disease Ontology	DOID:168	primitive neuroectodermal tumor	82	6.935969e-2	1.000000e+0	1.000000e+0	1.441760e+1	6.935969e-2	1	6.935969e-2	1.000000e+0	77	2.937753e-2	1.000000e+0	8.527114e-1	3.403962e+1	2.937753e-2	1	530	1.000000e+0	1.886792e-3	unnamed	MSH2
Disease Ontology	DOID:688	embryonal cancer	83	7.040036e-2	1.000000e+0	1.000000e+0	1.420447e+1	7.040036e-2	1	7.040036e-2	1.000000e+0	78	3.026440e-2	1.000000e+0	8.671915e-1	3.304212e+1	3.026440e-2	1	546	1.000000e+0	1.831502e-3	unnamed	MSH2
Disease Ontology	DOID:1749	squamous cell carcinoma	84	7.192071e-2	1.000000e+0	1.000000e+0	1.390420e+1	7.192071e-2	1	7.192071e-2	1.000000e+0	85	3.902223e-2	1.000000e+0	1.000000e+0	2.562642e+1	3.902223e-2	1	704	1.000000e+0	1.420455e-3	unnamed	MSH2
Disease Ontology	DOID:2428	epithelioma	85	7.206581e-2	1.000000e+0	1.000000e+0	1.387621e+1	7.206581e-2	1	7.206581e-2	1.000000e+0	86	3.913309e-2	1.000000e+0	1.000000e+0	2.555382e+1	3.913309e-2	1	706	1.000000e+0	1.416431e-3	unnamed	MSH2
Disease Ontology	DOID:353	lymphoma	86	7.370780e-2	1.000000e+0	1.000000e+0	1.356708e+1	7.370780e-2	1	7.370780e-2	1.000000e+0	87	3.924394e-2	1.000000e+0	1.000000e+0	2.548164e+1	3.924394e-2	1	708	1.000000e+0	1.412429e-3	unnamed	MSH2
Disease Ontology	DOID:2144	malignant neoplasm of ovary	87	7.395274e-2	1.000000e+0	1.000000e+0	1.352215e+1	7.395274e-2	1	7.395274e-2	1.000000e+0	88	3.946566e-2	1.000000e+0	1.000000e+0	2.533848e+1	3.946566e-2	1	712	1.000000e+0	1.404494e-3	unnamed	MSH2
Disease Ontology	DOID:417	autoimmune disease	88	7.426329e-2	1.000000e+0	1.000000e+0	1.346560e+1	7.426329e-2	1	7.426329e-2	1.000000e+0	101	4.511945e-2	1.000000e+0	9.984354e-1	2.216339e+1	4.511945e-2	1	814	1.000000e+0	1.228501e-3	unnamed	MSH2
Disease Ontology	DOID:1244	malignant neoplasm of female genital organ	89	7.450734e-2	1.000000e+0	1.000000e+0	1.342150e+1	7.450734e-2	1	7.450734e-2	1.000000e+0	89	3.985367e-2	1.000000e+0	1.000000e+0	2.509179e+1	3.985367e-2	1	719	1.000000e+0	1.390821e-3	unnamed	MSH2
Disease Ontology	DOID:1281	female reproductive cancer	90	7.531950e-2	1.000000e+0	1.000000e+0	1.327677e+1	7.531950e-2	1	7.531950e-2	1.000000e+0	92	4.024167e-2	1.000000e+0	9.776101e-1	2.484986e+1	4.024167e-2	1	726	1.000000e+0	1.377410e-3	unnamed	MSH2
Disease Ontology	DOID:2394	ovarian neoplasm	91	7.564403e-2	1.000000e+0	1.000000e+0	1.321981e+1	7.564403e-2	1	7.564403e-2	1.000000e+0	91	4.018624e-2	1.000000e+0	9.869917e-1	2.488414e+1	4.018624e-2	1	725	1.000000e+0	1.379310e-3	unnamed	MSH2
Disease Ontology	DOID:1909	melanoma	92	8.029886e-2	1.000000e+0	1.000000e+0	1.245348e+1	8.029886e-2	1	8.029886e-2	1.000000e+0	83	3.874508e-2	1.000000e+0	1.000000e+0	2.580973e+1	3.874508e-2	1	699	1.000000e+0	1.430615e-3	unnamed	MSH2
Disease Ontology	DOID:191	melanocytic neoplasm	93	8.062511e-2	1.000000e+0	1.000000e+0	1.240308e+1	8.062511e-2	1	8.062511e-2	1.000000e+0	84	3.891137e-2	1.000000e+0	1.000000e+0	2.569943e+1	3.891137e-2	1	702	1.000000e+0	1.424501e-3	unnamed	MSH2
Disease Ontology	DOID:9256	colorectal cancer	94	8.071500e-2	1.000000e+0	1.000000e+0	1.238927e+1	8.071500e-2	1	8.071500e-2	1.000000e+0	90	3.996453e-2	1.000000e+0	9.924525e-1	2.502219e+1	3.996453e-2	1	721	1.000000e+0	1.386963e-3	unnamed	MSH2
Disease Ontology	DOID:3168	squamous cell neoplasm	95	8.073938e-2	1.000000e+0	1.000000e+0	1.238553e+1	8.073938e-2	1	8.073938e-2	1.000000e+0	97	4.340114e-2	1.000000e+0	1.000000e+0	2.304087e+1	4.340114e-2	1	783	1.000000e+0	1.277139e-3	unnamed	MSH2
Disease Ontology	DOID:120	female genital cancer	96	8.268050e-2	1.000000e+0	1.000000e+0	1.209475e+1	8.268050e-2	1	8.268050e-2	1.000000e+0	98	4.367829e-2	1.000000e+0	9.961324e-1	2.289467e+1	4.367829e-2	1	788	1.000000e+0	1.269036e-3	unnamed	MSH2
Disease Ontology	DOID:1579	respiratory system disease	97	8.437815e-2	1.000000e+0	1.000000e+0	1.185141e+1	8.437815e-2	1	8.437815e-2	1.000000e+0	107	4.977551e-2	1.000000e+0	1.000000e+0	2.009020e+1	4.977551e-2	1	898	1.000000e+0	1.113586e-3	unnamed	MSH2
Disease Ontology	DOID:1994	large Intestine carcinoma	98	8.851868e-2	1.000000e+0	1.000000e+0	1.129705e+1	8.851868e-2	1	8.851868e-2	1.000000e+0	99	4.390001e-2	1.000000e+0	9.910760e-1	2.277904e+1	4.390001e-2	1	792	1.000000e+0	1.262626e-3	unnamed	MSH2
Disease Ontology	DOID:15	reproductive system disease	99	8.872162e-2	1.000000e+0	1.000000e+0	1.127121e+1	8.872162e-2	1	8.872162e-2	1.000000e+0	94	4.234799e-2	1.000000e+0	1.000000e+0	2.361387e+1	4.234799e-2	1	764	1.000000e+0	1.308901e-3	unnamed	MSH2
Disease Ontology	DOID:684	hepatocellular carcinoma	100	9.124792e-2	1.000000e+0	1.000000e+0	1.095915e+1	9.124792e-2	1	9.124792e-2	1.000000e+0	104	4.717033e-2	1.000000e+0	1.000000e+0	2.119976e+1	4.717033e-2	1	851	1.000000e+0	1.175088e-3	unnamed	MSH2
Disease Ontology	DOID:284	malignant neoplasm of abdomen	101	9.133327e-2	1.000000e+0	1.000000e+0	1.094891e+1	9.133327e-2	1	9.133327e-2	1.000000e+0	103	4.639432e-2	1.000000e+0	1.000000e+0	2.155436e+1	4.639432e-2	1	837	1.000000e+0	1.194743e-3	unnamed	MSH2
Disease Ontology	DOID:686	liver and intrahepatic biliary tract carcinoma	102	9.251093e-2	1.000000e+0	1.000000e+0	1.080953e+1	9.251093e-2	1	9.251093e-2	1.000000e+0	105	4.783549e-2	1.000000e+0	1.000000e+0	2.090498e+1	4.783549e-2	1	863	1.000000e+0	1.158749e-3	unnamed	MSH2
Disease Ontology	DOID:1318	malignant neoplasm of central nervous system	103	9.457325e-2	1.000000e+0	1.000000e+0	1.057381e+1	9.457325e-2	1	9.457325e-2	1.000000e+0	95	4.290228e-2	1.000000e+0	1.000000e+0	2.330879e+1	4.290228e-2	1	774	1.000000e+0	1.291990e-3	unnamed	MSH2
Disease Ontology	DOID:4695	malignant neoplasm of nervous system	104	9.564362e-2	1.000000e+0	1.000000e+0	1.045548e+1	9.564362e-2	1	9.564362e-2	1.000000e+0	96	4.312400e-2	1.000000e+0	1.000000e+0	2.318895e+1	4.312400e-2	1	778	1.000000e+0	1.285347e-3	unnamed	MSH2
Disease Ontology	DOID:1033	lymphoid cancer	105	9.576498e-2	1.000000e+0	1.000000e+0	1.044223e+1	9.576498e-2	1	9.576498e-2	1.000000e+0	106	4.922122e-2	1.000000e+0	1.000000e+0	2.031644e+1	4.922122e-2	1	888	1.000000e+0	1.126126e-3	unnamed	MSH2
Disease Ontology	DOID:169	neuroendocrine tumor	106	9.840882e-2	1.000000e+0	1.000000e+0	1.016169e+1	9.840882e-2	1	9.840882e-2	1.000000e+0	102	4.567374e-2	1.000000e+0	1.000000e+0	2.189442e+1	4.567374e-2	1	824	1.000000e+0	1.213592e-3	unnamed	MSH2
Disease Ontology	DOID:3070	malignant glioma	107	9.870456e-2	1.000000e+0	1.000000e+0	1.013124e+1	9.870456e-2	1	9.870456e-2	1.000000e+0	100	4.456516e-2	1.000000e+0	9.960313e-1	2.243905e+1	4.456516e-2	1	804	1.000000e+0	1.243781e-3	unnamed	MSH2
Disease Ontology	DOID:619	lymphoproliferative disease	108	9.974272e-2	1.000000e+0	1.000000e+0	1.002579e+1	9.974272e-2	1	9.974272e-2	1.000000e+0	108	5.188182e-2	1.000000e+0	1.000000e+0	1.927457e+1	5.188182e-2	1	936	1.000000e+0	1.068376e-3	unnamed	MSH2
Disease Ontology	DOID:2916	immunoproliferative disease	109	9.975771e-2	1.000000e+0	1.000000e+0	1.002429e+1	9.975771e-2	1	9.975771e-2	1.000000e+0	109	5.193725e-2	1.000000e+0	1.000000e+0	1.925400e+1	5.193725e-2	1	937	1.000000e+0	1.067236e-3	unnamed	MSH2
Disease Ontology	DOID:75	lymphatic system disease	110	1.035697e-1	1.000000e+0	1.000000e+0	9.655335e+0	1.035697e-1	1	1.035697e-1	1.000000e+0	110	5.409900e-2	1.000000e+0	1.000000e+0	1.848463e+1	5.409900e-2	1	976	1.000000e+0	1.024590e-3	unnamed	MSH2
Disease Ontology	DOID:1265	genitourinary cancer	111	1.098597e-1	1.000000e+0	1.000000e+0	9.102521e+0	1.098597e-1	1	1.098597e-1	1.000000e+0	115	5.659332e-2	1.000000e+0	1.000000e+0	1.766993e+1	5.659332e-2	1	1021	1.000000e+0	9.794319e-4	unnamed	MSH2
Disease Ontology	DOID:1240	leukemia	112	1.114394e-1	1.000000e+0	1.000000e+0	8.973483e+0	1.114394e-1	1	1.114394e-1	1.000000e+0	117	5.797905e-2	1.000000e+0	1.000000e+0	1.724761e+1	5.797905e-2	1	1046	1.000000e+0	9.560229e-4	unnamed	MSH2
Disease Ontology	DOID:122	abdominal cancer	113	1.132547e-1	1.000000e+0	1.000000e+0	8.829653e+0	1.132547e-1	1	1.132547e-1	1.000000e+0	118	5.808991e-2	1.000000e+0	1.000000e+0	1.721469e+1	5.808991e-2	1	1048	1.000000e+0	9.541985e-4	unnamed	MSH2
Disease Ontology	DOID:170	endocrine gland cancer	114	1.163017e-1	1.000000e+0	1.000000e+0	8.598327e+0	1.163017e-1	1	1.163017e-1	1.000000e+0	111	5.454243e-2	1.000000e+0	1.000000e+0	1.833435e+1	5.454243e-2	1	984	1.000000e+0	1.016260e-3	unnamed	MSH2
Disease Ontology	DOID:3165	skin neoplasm	115	1.200813e-1	1.000000e+0	1.000000e+0	8.327690e+0	1.200813e-1	1	1.200813e-1	1.000000e+0	113	5.609445e-2	1.000000e+0	1.000000e+0	1.782708e+1	5.609445e-2	1	1012	1.000000e+0	9.881423e-4	unnamed	MSH2
Disease Ontology	DOID:0050117	disease by infectious agent	116	1.209421e-1	1.000000e+0	1.000000e+0	8.268418e+0	1.209421e-1	1	1.209421e-1	1.000000e+0	126	7.848789e-2	1.000000e+0	1.000000e+0	1.274082e+1	7.848789e-2	1	1416	1.000000e+0	7.062147e-4	unnamed	MSH2
Disease Ontology	DOID:2627	glioma	117	1.253026e-1	1.000000e+0	1.000000e+0	7.980682e+0	1.253026e-1	1	1.253026e-1	1.000000e+0	112	5.576188e-2	1.000000e+0	1.000000e+0	1.793340e+1	5.576188e-2	1	1006	1.000000e+0	9.940358e-4	unnamed	MSH2
Disease Ontology	DOID:1319	brain neoplasm	118	1.265868e-1	1.000000e+0	1.000000e+0	7.899721e+0	1.265868e-1	1	1.265868e-1	1.000000e+0	114	5.631617e-2	1.000000e+0	1.000000e+0	1.775689e+1	5.631617e-2	1	1016	1.000000e+0	9.842520e-4	unnamed	MSH2
Disease Ontology	DOID:3620	central nervous system neoplasm	119	1.271973e-1	1.000000e+0	1.000000e+0	7.861801e+0	1.271973e-1	1	1.271973e-1	1.000000e+0	116	5.670417e-2	1.000000e+0	1.000000e+0	1.763539e+1	5.670417e-2	1	1023	1.000000e+0	9.775171e-4	unnamed	MSH2
Disease Ontology	DOID:2227	malignant neoplasm of lymphatic and hemopoietic tissue	120	1.308045e-1	1.000000e+0	1.000000e+0	7.644994e+0	1.308045e-1	1	1.308045e-1	1.000000e+0	122	6.912034e-2	1.000000e+0	1.000000e+0	1.446752e+1	6.912034e-2	1	1247	1.000000e+0	8.019246e-4	unnamed	MSH2
Disease Ontology	DOID:171	neuroectodermal tumor	121	1.311969e-1	1.000000e+0	1.000000e+0	7.622132e+0	1.311969e-1	1	1.311969e-1	1.000000e+0	119	6.124938e-2	1.000000e+0	1.000000e+0	1.632670e+1	6.124938e-2	1	1105	1.000000e+0	9.049774e-4	unnamed	MSH2
Disease Ontology	DOID:3095	germ cell and embryonal cancer	122	1.321992e-1	1.000000e+0	1.000000e+0	7.564342e+0	1.321992e-1	1	1.321992e-1	1.000000e+0	120	6.213625e-2	1.000000e+0	1.000000e+0	1.609367e+1	6.213625e-2	1	1121	1.000000e+0	8.920607e-4	unnamed	MSH2
Disease Ontology	DOID:2994	germ cell cancer	123	1.346344e-1	1.000000e+0	1.000000e+0	7.427520e+0	1.346344e-1	1	1.346344e-1	1.000000e+0	121	6.346655e-2	1.000000e+0	1.000000e+0	1.575633e+1	6.346655e-2	1	1145	1.000000e+0	8.733624e-4	unnamed	MSH2
Disease Ontology	DOID:177	soft tissue neoplasm	124	1.450676e-1	1.000000e+0	1.000000e+0	6.893336e+0	1.450676e-1	1	1.450676e-1	1.000000e+0	123	7.072779e-2	1.000000e+0	1.000000e+0	1.413871e+1	7.072779e-2	1	1276	1.000000e+0	7.836991e-4	unnamed	MSH2
Disease Ontology	DOID:3350	mesenchymal cell neoplasm	125	1.453323e-1	1.000000e+0	1.000000e+0	6.880783e+0	1.453323e-1	1	1.453323e-1	1.000000e+0	124	7.100493e-2	1.000000e+0	1.000000e+0	1.408353e+1	7.100493e-2	1	1281	1.000000e+0	7.806401e-4	unnamed	MSH2
Disease Ontology	DOID:2531	hematologic cancer	126	1.484252e-1	1.000000e+0	1.000000e+0	6.737401e+0	1.484252e-1	1	1.484252e-1	1.000000e+0	127	7.882046e-2	1.000000e+0	1.000000e+0	1.268706e+1	7.882046e-2	1	1422	1.000000e+0	7.032349e-4	unnamed	MSH2
Disease Ontology	DOID:1115	sarcoma	127	1.495909e-1	1.000000e+0	1.000000e+0	6.684897e+0	1.495909e-1	1	1.495909e-1	1.000000e+0	125	7.349925e-2	1.000000e+0	1.000000e+0	1.360558e+1	7.349925e-2	1	1326	1.000000e+0	7.541478e-4	unnamed	MSH2
Disease Ontology	DOID:77	gastrointestinal system disease	128	1.566959e-1	1.000000e+0	1.000000e+0	6.381787e+0	1.566959e-1	1	1.566959e-1	1.000000e+0	138	9.168006e-2	1.000000e+0	1.000000e+0	1.090750e+1	9.168006e-2	1	1654	1.000000e+0	6.045949e-4	unnamed	MSH2
Disease Ontology	DOID:74	hematopoietic system disease	129	1.634383e-1	1.000000e+0	1.000000e+0	6.118517e+0	1.634383e-1	1	1.634383e-1	1.000000e+0	136	9.040519e-2	1.000000e+0	1.000000e+0	1.106131e+1	9.040519e-2	1	1631	1.000000e+0	6.131208e-4	unnamed	MSH2
Disease Ontology	DOID:3094	neuroepithelial neoplasm	130	1.687017e-1	1.000000e+0	1.000000e+0	5.927623e+0	1.687017e-1	1	1.687017e-1	1.000000e+0	128	7.992905e-2	1.000000e+0	1.000000e+0	1.251110e+1	7.992905e-2	1	1442	1.000000e+0	6.934813e-4	unnamed	MSH2
Disease Ontology	DOID:4241	malignant neoplasm of breast	131	1.689834e-1	1.000000e+0	1.000000e+0	5.917740e+0	1.689834e-1	1	1.689834e-1	1.000000e+0	131	8.480683e-2	1.000000e+0	1.000000e+0	1.179150e+1	8.480683e-2	1	1530	1.000000e+0	6.535948e-4	unnamed	MSH2
Disease Ontology	DOID:3937	malignant neoplasm of thorax	132	1.691008e-1	1.000000e+0	1.000000e+0	5.913634e+0	1.691008e-1	1	1.691008e-1	1.000000e+0	132	8.491769e-2	1.000000e+0	1.000000e+0	1.177611e+1	8.491769e-2	1	1532	1.000000e+0	6.527415e-4	unnamed	MSH2
Disease Ontology	DOID:3195	neural neoplasm	133	1.692055e-1	1.000000e+0	1.000000e+0	5.909975e+0	1.692055e-1	1	1.692055e-1	1.000000e+0	129	8.031706e-2	1.000000e+0	1.000000e+0	1.245066e+1	8.031706e-2	1	1449	1.000000e+0	6.901311e-4	unnamed	MSH2
Disease Ontology	DOID:5093	thoracic cancer	134	1.702657e-1	1.000000e+0	1.000000e+0	5.873173e+0	1.702657e-1	1	1.702657e-1	1.000000e+0	133	8.563827e-2	1.000000e+0	1.000000e+0	1.167702e+1	8.563827e-2	1	1545	1.000000e+0	6.472492e-4	unnamed	MSH2
Disease Ontology	DOID:299	adenocarcinoma	135	1.706462e-1	1.000000e+0	1.000000e+0	5.860077e+0	1.706462e-1	1	1.706462e-1	1.000000e+0	135	8.890860e-2	1.000000e+0	1.000000e+0	1.124751e+1	8.890860e-2	1	1604	1.000000e+0	6.234414e-4	unnamed	MSH2
Disease Ontology	DOID:3093	nervous system cancer	136	1.722624e-1	1.000000e+0	1.000000e+0	5.805099e+0	1.722624e-1	1	1.722624e-1	1.000000e+0	130	8.203536e-2	1.000000e+0	1.000000e+0	1.218986e+1	8.203536e-2	1	1480	1.000000e+0	6.756757e-4	unnamed	MSH2
Disease Ontology	DOID:1612	mammary cancer	137	1.772500e-1	1.000000e+0	1.000000e+0	5.641748e+0	1.772500e-1	1	1.772500e-1	1.000000e+0	134	8.774458e-2	1.000000e+0	1.000000e+0	1.139672e+1	8.774458e-2	1	1583	1.000000e+0	6.317119e-4	unnamed	MSH2
Disease Ontology	DOID:197	glandular cell epithelial neoplasm	138	1.860840e-1	1.000000e+0	1.000000e+0	5.373918e+0	1.860840e-1	1	1.860840e-1	1.000000e+0	139	9.727842e-2	1.000000e+0	1.000000e+0	1.027977e+1	9.727842e-2	1	1755	1.000000e+0	5.698006e-4	unnamed	MSH2
Disease Ontology	DOID:936	brain disease	139	1.872681e-1	1.000000e+0	1.000000e+0	5.339937e+0	1.872681e-1	1	1.872681e-1	1.000000e+0	137	9.162463e-2	1.000000e+0	1.000000e+0	1.091410e+1	9.162463e-2	1	1653	1.000000e+0	6.049607e-4	unnamed	MSH2
Disease Ontology	DOID:225	syndrome	140	2.011593e-1	1.000000e+0	1.000000e+0	4.971185e+0	2.011593e-1	1	2.011593e-1	1.000000e+0	140	1.052048e-1	1.000000e+0	1.000000e+0	9.505269e+0	1.052048e-1	1	1898	1.000000e+0	5.268704e-4	unnamed	MSH2
Disease Ontology	DOID:193	reproductive system cancer	141	2.095200e-1	1.000000e+0	1.000000e+0	4.772814e+0	2.095200e-1	1	2.095200e-1	1.000000e+0	141	1.074220e-1	1.000000e+0	1.000000e+0	9.309082e+0	1.074220e-1	1	1938	1.000000e+0	5.159959e-4	unnamed	MSH2
Disease Ontology	DOID:157	epithelial carcinoma	142	2.158701e-1	1.000000e+0	1.000000e+0	4.632416e+0	2.158701e-1	1	2.158701e-1	1.000000e+0	143	1.150712e-1	1.000000e+0	1.000000e+0	8.690270e+0	1.150712e-1	1	2076	1.000000e+0	4.816956e-4	unnamed	MSH2
Disease Ontology	DOID:155	glandular and epithelial neoplasm	143	2.196335e-1	1.000000e+0	1.000000e+0	4.553039e+0	2.196335e-1	1	2.196335e-1	1.000000e+0	142	1.115792e-1	1.000000e+0	1.000000e+0	8.962245e+0	1.115792e-1	1	2013	1.000000e+0	4.967710e-4	unnamed	MSH2
Disease Ontology	DOID:331	central nervous system disease	144	2.247960e-1	1.000000e+0	1.000000e+0	4.448477e+0	2.247960e-1	1	2.247960e-1	1.000000e+0	144	1.169004e-1	1.000000e+0	1.000000e+0	8.554291e+0	1.169004e-1	1	2109	1.000000e+0	4.741584e-4	unnamed	MSH2
Disease Ontology	DOID:1287	cardiovascular system disease	145	2.464292e-1	1.000000e+0	1.000000e+0	4.057961e+0	2.464292e-1	1	2.464292e-1	1.000000e+0	145	1.389613e-1	1.000000e+0	1.000000e+0	7.196250e+0	1.389613e-1	1	2507	1.000000e+0	3.988831e-4	unnamed	MSH2
Disease Ontology	DOID:863	nervous system disease	146	2.662634e-1	1.000000e+0	1.000000e+0	3.755680e+0	2.662634e-1	1	2.662634e-1	1.000000e+0	146	1.428413e-1	1.000000e+0	1.000000e+0	7.000776e+0	1.428413e-1	1	2577	1.000000e+0	3.880481e-4	unnamed	MSH2
Disease Ontology	DOID:2985	chronic rejection of renal transplant	147	2.674662e-1	1.000000e+0	1.000000e+0	3.738791e+0	2.674662e-1	1	2.674662e-1	1.000000e+0	147	1.553683e-1	1.000000e+0	1.000000e+0	6.436318e+0	1.553683e-1	1	2803	1.000000e+0	3.567606e-4	unnamed	MSH2
Disease Ontology	DOID:2108	transplant-related disease	148	2.674780e-1	1.000000e+0	1.000000e+0	3.738626e+0	2.674780e-1	1	2.674780e-1	1.000000e+0	148	1.554238e-1	1.000000e+0	1.000000e+0	6.434023e+0	1.554238e-1	1	2804	1.000000e+0	3.566334e-4	unnamed	MSH2
Disease Ontology	DOID:557	kidney disease	149	2.854845e-1	1.000000e+0	1.000000e+0	3.502817e+0	2.854845e-1	1	2.854845e-1	1.000000e+0	149	1.670639e-1	1.000000e+0	1.000000e+0	5.985733e+0	1.670639e-1	1	3014	1.000000e+0	3.317850e-4	unnamed	MSH2
Disease Ontology	DOID:18	urinary system disease	150	2.923209e-1	1.000000e+0	1.000000e+0	3.420898e+0	2.923209e-1	1	2.923209e-1	1.000000e+0	150	1.706668e-1	1.000000e+0	1.000000e+0	5.859370e+0	1.706668e-1	1	3079	1.000000e+0	3.247808e-4	unnamed	MSH2
Disease Ontology	DOID:2914	immune system disease	151	3.205063e-1	1.000000e+0	1.000000e+0	3.120063e+0	3.205063e-1	1	3.205063e-1	1.000000e+0	152	1.897345e-1	1.000000e+0	1.000000e+0	5.270523e+0	1.897345e-1	1	3423	1.000000e+0	2.921414e-4	unnamed	MSH2
Disease Ontology	DOID:305	carcinoma	152	3.218892e-1	1.000000e+0	1.000000e+0	3.106659e+0	3.218892e-1	1	3.218892e-1	1.000000e+0	151	1.786486e-1	1.000000e+0	1.000000e+0	5.597580e+0	1.786486e-1	1	3223	1.000000e+0	3.102699e-4	unnamed	MSH2
Disease Ontology	DOID:462	cancer by anatomical entity	153	3.485076e-1	1.000000e+0	1.000000e+0	2.869378e+0	3.485076e-1	1	3.485076e-1	1.000000e+0	153	1.917299e-1	1.000000e+0	1.000000e+0	5.215669e+0	1.917299e-1	1	3459	1.000000e+0	2.891009e-4	unnamed	MSH2
Disease Ontology	DOID:162	cancer	154	4.681931e-1	1.000000e+0	1.000000e+0	2.135871e+0	4.681931e-1	1	4.681931e-1	1.000000e+0	154	2.826894e-1	1.000000e+0	1.000000e+0	3.537451e+0	2.826894e-1	1	5100	1.000000e+0	1.960784e-4	unnamed	MSH2
Disease Ontology	DOID:7	disease of anatomical entity	155	5.144599e-1	1.000000e+0	1.000000e+0	1.943786e+0	5.144599e-1	1	5.144599e-1	1.000000e+0	155	3.268666e-1	1.000000e+0	1.000000e+0	3.059352e+0	3.268666e-1	1	5897	1.000000e+0	1.695778e-4	unnamed	MSH2
Disease Ontology	DOID:4	disease	156	6.581397e-1	1.000000e+0	1.000000e+0	1.519434e+0	6.581397e-1	1	6.581397e-1	1.000000e+0	156	4.371155e-1	1.000000e+0	1.000000e+0	2.287725e+0	4.371155e-1	1	7886	1.000000e+0	1.268070e-4	unnamed	MSH2
MSigDB Cancer Neighborhood	GNF2_MSH2	Neighborhood of MSH2	1	1.492318e-3	6.372198e-1	6.372198e-1	6.700983e+2	1.492318e-3	1	1.492318e-3	1.000000e+0	1	1.552020e-3	6.627125e-1	6.627125e-1	6.443214e+2	1.552020e-3	1	28	1.000000e+0	3.571429e-2	unnamed	MSH2
MSigDB Cancer Neighborhood	GNF2_MLH1	Neighborhood of MLH1	2	2.398387e-3	1.000000e+0	5.120556e-1	4.169469e+2	2.398387e-3	1	2.398387e-3	1.000000e+0	3	2.328031e-3	9.940692e-1	3.313564e-1	4.295476e+2	2.328031e-3	1	42	1.000000e+0	2.380952e-2	unnamed	MSH2
MSigDB Cancer Neighborhood	GNF2_MSH6	Neighborhood of MSH6	3	2.513529e-3	1.000000e+0	3.577590e-1	3.978471e+2	2.513529e-3	1	2.513529e-3	1.000000e+0	2	1.718308e-3	7.337175e-1	3.668588e-1	5.819677e+2	1.718308e-3	1	31	1.000000e+0	3.225806e-2	unnamed	MSH2
MSigDB Cancer Neighborhood	MORF_MSH2	Neighborhood of MSH2	4	3.253665e-3	1.000000e+0	3.473287e-1	3.073457e+2	3.253665e-3	1	3.253665e-3	1.000000e+0	5	3.325758e-3	1.000000e+0	2.840197e-1	3.006833e+2	3.325758e-3	1	60	1.000000e+0	1.666667e-2	unnamed	MSH2
MSigDB Cancer Neighborhood	MORF_RPA1	Neighborhood of RPA1	5	3.824413e-3	1.000000e+0	3.266049e-1	2.614781e+2	3.824413e-3	1	3.824413e-3	1.000000e+0	5	3.325758e-3	1.000000e+0	2.840197e-1	3.006833e+2	3.325758e-3	1	60	1.000000e+0	1.666667e-2	unnamed	MSH2
MSigDB Cancer Neighborhood	MORF_SMC1L1	Neighborhood of SMC1L1	6	3.973058e-3	1.000000e+0	2.827493e-1	2.516953e+2	3.973058e-3	1	3.973058e-3	1.000000e+0	7	3.381187e-3	1.000000e+0	2.062524e-1	2.957541e+2	3.381187e-3	1	61	1.000000e+0	1.639344e-2	unnamed	MSH2
MSigDB Cancer Neighborhood	GNF2_FEN1	Neighborhood of FEN1	7	4.065299e-3	1.000000e+0	2.479832e-1	2.459844e+2	4.065299e-3	1	4.065299e-3	1.000000e+0	4	3.104041e-3	1.000000e+0	3.313564e-1	3.221607e+2	3.104041e-3	1	56	1.000000e+0	1.785714e-2	unnamed	MSH2
MSigDB Cancer Neighborhood	MORF_PCNA	Neighborhood of PCNA	8	4.142711e-3	1.000000e+0	2.211172e-1	2.413878e+2	4.142711e-3	1	4.142711e-3	1.000000e+0	11	4.600632e-3	1.000000e+0	1.785882e-1	2.173614e+2	4.600632e-3	1	83	1.000000e+0	1.204819e-2	unnamed	MSH2
MSigDB Cancer Neighborhood	GNF2_RFC4	Neighborhood of RFC4	9	4.321763e-3	1.000000e+0	2.050436e-1	2.313871e+2	4.321763e-3	1	4.321763e-3	1.000000e+0	7	3.381187e-3	1.000000e+0	2.062524e-1	2.957541e+2	3.381187e-3	1	61	1.000000e+0	1.639344e-2	unnamed	MSH2
MSigDB Cancer Neighborhood	MORF_UNG	Neighborhood of UNG	10	5.151025e-3	1.000000e+0	2.199488e-1	1.941361e+2	5.151025e-3	1	5.151025e-3	1.000000e+0	10	4.157197e-3	1.000000e+0	1.775123e-1	2.405467e+2	4.157197e-3	1	75	1.000000e+0	1.333333e-2	unnamed	MSH2
MSigDB Cancer Neighborhood	GNF2_PCNA	Neighborhood of PCNA	11	5.712645e-3	1.000000e+0	2.217545e-1	1.750503e+2	5.712645e-3	1	5.712645e-3	1.000000e+0	9	3.713763e-3	1.000000e+0	1.761974e-1	2.692687e+2	3.713763e-3	1	67	1.000000e+0	1.492537e-2	unnamed	MSH2
MSigDB Cancer Neighborhood	GNF2_SMC4L1	Neighborhood of SMC4L1	12	6.877679e-3	1.000000e+0	2.447307e-1	1.453979e+2	6.877679e-3	1	6.877679e-3	1.000000e+0	12	4.656061e-3	1.000000e+0	1.656782e-1	2.147738e+2	4.656061e-3	1	84	1.000000e+0	1.190476e-2	unnamed	MSH2
MSigDB Cancer Neighborhood	GNF2_RRM1	Neighborhood of RRM1	13	7.344077e-3	1.000000e+0	2.412247e-1	1.361641e+2	7.344077e-3	1	7.344077e-3	1.000000e+0	13	4.822349e-3	1.000000e+0	1.583956e-1	2.073678e+2	4.822349e-3	1	87	1.000000e+0	1.149425e-2	unnamed	MSH2
MSigDB Cancer Neighborhood	MORF_RRM1	Neighborhood of RRM1	14	8.080274e-3	1.000000e+0	2.464484e-1	1.237582e+2	8.080274e-3	1	8.080274e-3	1.000000e+0	14	5.653789e-3	1.000000e+0	1.724406e-1	1.768725e+2	5.653789e-3	1	102	1.000000e+0	9.803922e-3	unnamed	MSH2
MSigDB Cancer Neighborhood	MORF_RFC4	Neighborhood of RFC4	15	1.096595e-2	1.000000e+0	3.121640e-1	9.119140e+1	1.096595e-2	1	1.096595e-2	1.000000e+0	15	8.258966e-3	1.000000e+0	2.351052e-1	1.210805e+2	8.258966e-3	1	149	1.000000e+0	6.711409e-3	unnamed	MSH2
MSigDB Cancer Neighborhood	MORF_HAT1	Neighborhood of HAT1	16	1.209821e-2	1.000000e+0	3.228710e-1	8.265689e+1	1.209821e-2	1	1.209821e-2	1.000000e+0	16	9.700127e-3	1.000000e+0	2.588721e-1	1.030914e+2	9.700127e-3	1	175	1.000000e+0	5.714286e-3	unnamed	MSH2
MSigDB Cancer Neighborhood	MORF_RAD21	Neighborhood of RAD21	17	1.228195e-2	1.000000e+0	3.084937e-1	8.142029e+1	1.228195e-2	1	1.228195e-2	1.000000e+0	17	1.003270e-2	1.000000e+0	2.519978e-1	9.967403e+1	1.003270e-2	1	181	1.000000e+0	5.524862e-3	unnamed	MSH2
MSigDB Cancer Neighborhood	MORF_BUB3	Neighborhood of BUB3	18	1.577193e-2	1.000000e+0	3.741452e-1	6.340380e+1	1.577193e-2	1	1.577193e-2	1.000000e+0	19	1.540935e-2	1.000000e+0	3.463049e-1	6.489568e+1	1.540935e-2	1	278	1.000000e+0	3.597122e-3	unnamed	MSH2
MSigDB Cancer Neighborhood	MORF_SOD1	Neighborhood of SOD1	19	1.778344e-2	1.000000e+0	3.996594e-1	5.623208e+1	1.778344e-2	1	1.778344e-2	1.000000e+0	21	1.552020e-2	1.000000e+0	3.155774e-1	6.443214e+1	1.552020e-2	1	280	1.000000e+0	3.571429e-3	unnamed	MSH2
MSigDB Cancer Neighborhood	MORF_DEK	Neighborhood of DEK	20	1.800421e-2	1.000000e+0	3.843899e-1	5.554256e+1	1.800421e-2	1	1.800421e-2	1.000000e+0	18	1.452248e-2	1.000000e+0	3.445055e-1	6.885878e+1	1.452248e-2	1	262	1.000000e+0	3.816794e-3	unnamed	MSH2
MSigDB Cancer Neighborhood	MORF_HDAC2	Neighborhood of HDAC2	21	2.010072e-2	1.000000e+0	4.087146e-1	4.974947e+1	2.010072e-2	1	2.010072e-2	1.000000e+0	19	1.540935e-2	1.000000e+0	3.463049e-1	6.489568e+1	1.540935e-2	1	278	1.000000e+0	3.597122e-3	unnamed	MSH2
MSigDB Pathway	KEGG_MISMATCH_REPAIR	Mismatch repair	1	1.939902e-3	1.000000e+0	1.000000e+0	5.154900e+2	1.939902e-3	1	1.939902e-3	1.000000e+0	1	1.274874e-3	1.000000e+0	1.000000e+0	7.843913e+2	1.274874e-3	1	23	1.000000e+0	4.347826e-2	unnamed	MSH2
MSigDB Pathway	KEGG_COLORECTAL_CANCER	Colorectal cancer	2	8.576116e-3	1.000000e+0	1.000000e+0	1.166029e+2	8.576116e-3	1	8.576116e-3	1.000000e+0	2	3.492046e-3	1.000000e+0	1.000000e+0	2.863651e+2	3.492046e-3	1	63	1.000000e+0	1.587302e-2	unnamed	MSH2
MSigDB Pathway	PID_P53DOWNSTREAMPATHWAY	Direct p53 effectors	3	1.324006e-2	1.000000e+0	1.000000e+0	7.552838e+1	1.324006e-2	1	1.324006e-2	1.000000e+0	3	7.593814e-3	1.000000e+0	1.000000e+0	1.316861e+2	7.593814e-3	1	137	1.000000e+0	7.299270e-3	unnamed	MSH2
MSigDB Pathway	KEGG_PATHWAYS_IN_CANCER	Pathways in cancer	4	4.235254e-2	1.000000e+0	1.000000e+0	2.361133e+1	4.235254e-2	1	4.235254e-2	1.000000e+0	4	1.812538e-2	1.000000e+0	1.000000e+0	5.517125e+1	1.812538e-2	1	327	1.000000e+0	3.058104e-3	unnamed	MSH2
MGI Expression: Detected	9412	TS23_tail dorsal root ganglion	1	6.808155e-3	1.000000e+0	1.000000e+0	1.468827e+2	6.808155e-3	1	6.808155e-3	1.000000e+0	1	3.547475e-3	1.000000e+0	1.000000e+0	2.818906e+2	3.547475e-3	1	64	1.000000e+0	1.562500e-2	unnamed	MSH2
MGI Expression: Detected	7752	TS23_tail peripheral nervous system	2	7.066020e-3	1.000000e+0	1.000000e+0	1.415224e+2	7.066020e-3	1	7.066020e-3	1.000000e+0	2	3.602904e-3	1.000000e+0	1.000000e+0	2.775538e+2	3.602904e-3	1	65	1.000000e+0	1.538462e-2	unnamed	MSH2
MGI Expression: Detected	7509	TS23_tail nervous system	3	7.129084e-3	1.000000e+0	1.000000e+0	1.402705e+2	7.129084e-3	1	7.129084e-3	1.000000e+0	3	3.713763e-3	1.000000e+0	1.000000e+0	2.692687e+2	3.713763e-3	1	67	1.000000e+0	1.492537e-2	unnamed	MSH2
MGI Expression: Detected	7457	TS23_tail	4	7.206411e-2	1.000000e+0	1.000000e+0	1.387653e+1	7.206411e-2	1	7.206411e-2	1.000000e+0	4	2.871238e-2	1.000000e+0	1.000000e+0	3.482819e+1	2.871238e-2	1	518	1.000000e+0	1.930502e-3	unnamed	MSH2
MGI Expression: Detected	6963	TS28_liver	5	2.213497e-1	1.000000e+0	1.000000e+0	4.517739e+0	2.213497e-1	1	2.213497e-1	1.000000e+0	7	1.315892e-1	1.000000e+0	1.000000e+0	7.599410e+0	1.315892e-1	1	2374	1.000000e+0	4.212300e-4	unnamed	MSH2
MGI Expression: Detected	6962	TS28_liver and biliary system	6	2.293478e-1	1.000000e+0	1.000000e+0	4.360190e+0	2.293478e-1	1	2.293478e-1	1.000000e+0	10	1.358018e-1	1.000000e+0	1.000000e+0	7.363673e+0	1.358018e-1	1	2450	1.000000e+0	4.081633e-4	unnamed	MSH2
MGI Expression: Detected	6948	TS28_lung	7	2.297513e-1	1.000000e+0	1.000000e+0	4.352532e+0	2.297513e-1	1	2.297513e-1	1.000000e+0	5	1.248822e-1	1.000000e+0	1.000000e+0	8.007545e+0	1.248822e-1	1	2253	1.000000e+0	4.438526e-4	unnamed	MSH2
MGI Expression: Detected	6946	TS28_respiratory system	8	2.309063e-1	1.000000e+0	1.000000e+0	4.330761e+0	2.309063e-1	1	2.309063e-1	1.000000e+0	6	1.256028e-1	1.000000e+0	1.000000e+0	7.961606e+0	1.256028e-1	1	2266	1.000000e+0	4.413063e-4	unnamed	MSH2
MGI Expression: Detected	7103	TS28_heart	9	2.471289e-1	1.000000e+0	1.000000e+0	4.046471e+0	2.471289e-1	1	2.471289e-1	1.000000e+0	8	1.319772e-1	1.000000e+0	1.000000e+0	7.577068e+0	1.319772e-1	1	2381	1.000000e+0	4.199916e-4	unnamed	MSH2
MGI Expression: Detected	6960	TS28_kidney	10	2.525264e-1	1.000000e+0	1.000000e+0	3.959982e+0	2.525264e-1	1	2.525264e-1	1.000000e+0	11	1.401807e-1	1.000000e+0	1.000000e+0	7.133650e+0	1.401807e-1	1	2529	1.000000e+0	3.954132e-4	unnamed	MSH2
MGI Expression: Detected	7098	TS28_cardiovascular system	11	2.541249e-1	1.000000e+0	1.000000e+0	3.935073e+0	2.541249e-1	1	2.541249e-1	1.000000e+0	9	1.353584e-1	1.000000e+0	1.000000e+0	7.387797e+0	1.353584e-1	1	2442	1.000000e+0	4.095004e-4	unnamed	MSH2
MGI Expression: Detected	6959	TS28_renal-urinary system	12	2.619747e-1	1.000000e+0	1.000000e+0	3.817163e+0	2.619747e-1	1	2.619747e-1	1.000000e+0	12	1.452248e-1	1.000000e+0	1.000000e+0	6.885878e+0	1.452248e-1	1	2620	1.000000e+0	3.816794e-4	unnamed	MSH2
MGI Expression: Detected	6945	TS28_visceral organ	13	4.216843e-1	1.000000e+0	1.000000e+0	2.371443e+0	4.216843e-1	1	4.216843e-1	1.000000e+0	13	2.566377e-1	1.000000e+0	1.000000e+0	3.896544e+0	2.566377e-1	1	4630	1.000000e+0	2.159827e-4	unnamed	MSH2
MGI Expression: Detected	7005	TS28_brain	14	4.776274e-1	1.000000e+0	1.000000e+0	2.093682e+0	4.776274e-1	1	4.776274e-1	1.000000e+0	14	2.625686e-1	1.000000e+0	1.000000e+0	3.808529e+0	2.625686e-1	1	4737	1.000000e+0	2.111041e-4	unnamed	MSH2
MGI Expression: Detected	7003	TS28_central nervous system	15	4.961740e-1	1.000000e+0	1.000000e+0	2.015422e+0	4.961740e-1	1	4.961740e-1	1.000000e+0	15	2.777562e-1	1.000000e+0	1.000000e+0	3.600279e+0	2.777562e-1	1	5011	1.000000e+0	1.995610e-4	unnamed	MSH2
MGI Expression: Detected	7001	TS28_nervous system	16	4.974351e-1	1.000000e+0	1.000000e+0	2.010313e+0	4.974351e-1	1	4.974351e-1	1.000000e+0	16	2.788094e-1	1.000000e+0	1.000000e+0	3.586680e+0	2.788094e-1	1	5030	1.000000e+0	1.988072e-4	unnamed	MSH2
MGI Expression: Detected	6944	TS28_organ system	17	6.191523e-1	1.000000e+0	1.000000e+0	1.615112e+0	6.191523e-1	1	6.191523e-1	1.000000e+0	17	3.938806e-1	1.000000e+0	1.000000e+0	2.538840e+0	3.938806e-1	1	7106	1.000000e+0	1.407261e-4	unnamed	MSH2
MGI Expression: Detected	6937	TS28_postnatal mouse	18	6.225233e-1	1.000000e+0	1.000000e+0	1.606366e+0	6.225233e-1	1	6.225233e-1	1.000000e+0	18	3.978161e-1	1.000000e+0	1.000000e+0	2.513724e+0	3.978161e-1	1	7177	1.000000e+0	1.393340e-4	unnamed	MSH2
MGI Expression: Detected	6925	TS23_embryo	19	7.220129e-1	1.000000e+0	1.000000e+0	1.385017e+0	7.220129e-1	1	7.220129e-1	1.000000e+0	19	4.840086e-1	1.000000e+0	1.000000e+0	2.066079e+0	4.840086e-1	1	8732	1.000000e+0	1.145213e-4	unnamed	MSH2
MGI Expression: Detected	6924	Theiler_stage_23	20	7.220179e-1	1.000000e+0	1.000000e+0	1.385007e+0	7.220179e-1	1	7.220179e-1	1.000000e+0	20	4.841749e-1	1.000000e+0	1.000000e+0	2.065369e+0	4.841749e-1	1	8735	1.000000e+0	1.144820e-4	unnamed	MSH2
MSigDB Perturbation	ZHAN_MULTIPLE_MYELOMA_SUBGROUPS	Top genes up-regulated in MM4 vs MM1 subgroup of multiple myeloma samples.	1	1.851898e-3	1.000000e+0	1.000000e+0	5.399864e+2	1.851898e-3	1	1.851898e-3	1.000000e+0	1	1.718308e-3	1.000000e+0	1.000000e+0	5.819677e+2	1.718308e-3	1	31	1.000000e+0	3.225806e-2	unnamed	MSH2
MSigDB Perturbation	WHITFIELD_CELL_CYCLE_LITERATURE	A list of known cell cycle regulated genes that was compiled from the literature by the authors.	2	2.399525e-3	1.000000e+0	1.000000e+0	4.167492e+2	2.399525e-3	1	2.399525e-3	1.000000e+0	4	2.438889e-3	1.000000e+0	1.000000e+0	4.100227e+2	2.438889e-3	1	44	1.000000e+0	2.272727e-2	unnamed	MSH2
MSigDB Perturbation	MENSSEN_MYC_TARGETS	Genes up-regulated by adenoviral expression of c-MYC [GeneID=4609] in HUVEC cells (umbilical vein endothelium).	3	2.872563e-3	1.000000e+0	1.000000e+0	3.481211e+2	2.872563e-3	1	2.872563e-3	1.000000e+0	7	2.993182e-3	1.000000e+0	1.000000e+0	3.340926e+2	2.993182e-3	1	54	1.000000e+0	1.851852e-2	unnamed	MSH2
MSigDB Perturbation	ABRAMSON_INTERACT_WITH_AIRE	Proteins interacting with AIRE [GeneID=326], based on massspectroscopy analysis of co-immunoprecipitates in 293T cells (embryonic kidney).	4	2.930563e-3	1.000000e+0	1.000000e+0	3.412314e+2	2.930563e-3	1	2.930563e-3	1.000000e+0	5	2.494318e-3	1.000000e+0	1.000000e+0	4.009111e+2	2.494318e-3	1	45	1.000000e+0	2.222222e-2	unnamed	MSH2
MSigDB Perturbation	ZHAN_EARLY_DIFFERENTIATION_GENES_DN	B lymphocyte early differentiation genes (EDG): top genes down-regulated in tonsil B lymphocytes (TBC) compared to the tonsil plasma cells (TPC).	5	2.970181e-3	1.000000e+0	1.000000e+0	3.366798e+2	2.970181e-3	1	2.970181e-3	1.000000e+0	3	2.383460e-3	1.000000e+0	1.000000e+0	4.195581e+2	2.383460e-3	1	43	1.000000e+0	2.325581e-2	unnamed	MSH2
MSigDB Perturbation	WAKASUGI_HAVE_ZNF143_BINDING_SITES	DNA repair genes whose promoters contain putative ZNF143 [GeneID=7702] binding sites.	6	3.967709e-3	1.000000e+0	1.000000e+0	2.520346e+2	3.967709e-3	1	3.967709e-3	1.000000e+0	10	3.214899e-3	1.000000e+0	1.000000e+0	3.110517e+2	3.214899e-3	1	58	1.000000e+0	1.724138e-2	unnamed	MSH2
MSigDB Perturbation	PUJANA_BREAST_CANCER_WITH_BRCA1_MUTATED_UP	The XPRSS-Int network genes up-regulated in breast tumors from patients with germline mutations in BRCA1 [GeneID=672] compared to those with the wild type allele.	7	4.023358e-3	1.000000e+0	1.000000e+0	2.485486e+2	4.023358e-3	1	4.023358e-3	1.000000e+0	9	3.104041e-3	1.000000e+0	1.000000e+0	3.221607e+2	3.104041e-3	1	56	1.000000e+0	1.785714e-2	unnamed	MSH2
MSigDB Perturbation	WONG_IFNA2_RESISTANCE_DN	Genes down-regulated in hepatocellular carcinoma (HCC) cell lines  resistant to IFNA2 [GeneID=3440].	8	4.329262e-3	1.000000e+0	1.000000e+0	2.309863e+2	4.329262e-3	1	4.329262e-3	1.000000e+0	2	1.995455e-3	1.000000e+0	1.000000e+0	5.011389e+2	1.995455e-3	1	36	1.000000e+0	2.777778e-2	unnamed	MSH2
MSigDB Perturbation	HESS_TARGETS_OF_HOXA9_AND_MEIS1_UP	Genes up-regulated in hematopoietic precursor cells conditionally expressing HOXA9 and MEIS1 [GeneID=3205;4211].	9	4.844030e-3	1.000000e+0	1.000000e+0	2.064397e+2	4.844030e-3	1	4.844030e-3	1.000000e+0	13	3.547475e-3	1.000000e+0	9.179774e-1	2.818906e+2	3.547475e-3	1	64	1.000000e+0	1.562500e-2	unnamed	MSH2
MSigDB Perturbation	ALCALA_APOPTOSIS	Genes able to induce cell death in an expression cDNA library screen.	10	5.081512e-3	1.000000e+0	1.000000e+0	1.967918e+2	5.081512e-3	1	5.081512e-3	1.000000e+0	18	4.766920e-3	1.000000e+0	8.908844e-1	2.097791e+2	4.766920e-3	1	86	1.000000e+0	1.162791e-2	unnamed	MSH2
MSigDB Perturbation	REN_BOUND_BY_E2F	Genes whose promoters were bound by E2F1 and E2F4 [GeneID=1869;1874] in the primary fibroblasts WI-38, by ChIP on chip assay.	11	5.473169e-3	1.000000e+0	1.000000e+0	1.827095e+2	5.473169e-3	1	5.473169e-3	1.000000e+0	15	3.935480e-3	1.000000e+0	8.825970e-1	2.540986e+2	3.935480e-3	1	71	1.000000e+0	1.408451e-2	unnamed	MSH2
MSigDB Perturbation	MAYBURD_RESPONSE_TO_L663536_DN	Genes down-regulated in H720 cells (lung cancer) after treatment with L663536 (MK886) [PubChem=105049], an inhibitor of leukotriene biosynthesis.	12	5.494099e-3	1.000000e+0	1.000000e+0	1.820135e+2	5.494099e-3	1	5.494099e-3	1.000000e+0	7	2.993182e-3	1.000000e+0	1.000000e+0	3.340926e+2	2.993182e-3	1	54	1.000000e+0	1.851852e-2	unnamed	MSH2
MSigDB Perturbation	KAUFFMANN_MELANOMA_RELAPSE_UP	DNA repair and replication genes up-regulated in melanoma patients who will relapse vs patients who will not.	13	5.549016e-3	1.000000e+0	1.000000e+0	1.802121e+2	5.549016e-3	1	5.549016e-3	1.000000e+0	11	3.325758e-3	1.000000e+0	1.000000e+0	3.006833e+2	3.325758e-3	1	60	1.000000e+0	1.666667e-2	unnamed	MSH2
MSigDB Perturbation	SONG_TARGETS_OF_IE86_CMV_PROTEIN	Cellular genes up-regulated in forskin fibroblasts by expression of CMV EI86 protein off an adenovirus vector.	14	5.686757e-3	1.000000e+0	1.000000e+0	1.758472e+2	5.686757e-3	1	5.686757e-3	1.000000e+0	11	3.325758e-3	1.000000e+0	1.000000e+0	3.006833e+2	3.325758e-3	1	60	1.000000e+0	1.666667e-2	unnamed	MSH2
MSigDB Perturbation	FRASOR_TAMOXIFEN_RESPONSE_UP	Genes preferentially up-regulated in MCF-7 cells (breast cancer) by tamoxifen [PubChem=5376] but not by estradiol or fulvestrant (ICI 182780) [PubChem=5757;3478439].	15	7.278030e-3	1.000000e+0	1.000000e+0	1.373998e+2	7.278030e-3	1	7.278030e-3	1.000000e+0	6	2.716036e-3	1.000000e+0	1.000000e+0	3.681837e+2	2.716036e-3	1	49	1.000000e+0	2.040816e-2	unnamed	MSH2
MSigDB Perturbation	GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_DN	Genes down-regulated in quiescent vs dividing CD34+ [GeneID=8842] cells isolated from peripheral blood of normal donors.	16	7.721462e-3	1.000000e+0	1.000000e+0	1.295092e+2	7.721462e-3	1	7.721462e-3	1.000000e+0	19	4.877778e-3	1.000000e+0	8.636234e-1	2.050114e+2	4.877778e-3	1	88	1.000000e+0	1.136364e-2	unnamed	MSH2
MSigDB Perturbation	PUJANA_BREAST_CANCER_LIT_INT_NETWORK	Genes constituting the LIT-Int network of proteins interacting with breast cancer reference proteins BRCA1, BRCA2, ATM, and CHEK2 [GeneID=672;675;472;11200]; the interactions were manually curated from the literature.	17	8.136893e-3	1.000000e+0	1.000000e+0	1.228970e+2	8.136893e-3	1	8.136893e-3	1.000000e+0	20	5.598359e-3	1.000000e+0	9.416440e-1	1.786238e+2	5.598359e-3	1	101	1.000000e+0	9.900990e-3	unnamed	MSH2
MSigDB Perturbation	HOSHIDA_LIVER_CANCER_LATE_RECURRENCE_UP	Genes whose expression correlated with higher risk of late recurrence of hepatocellular carcinoma (HCC).	18	8.419958e-3	1.000000e+0	1.000000e+0	1.187654e+2	8.419958e-3	1	8.419958e-3	1.000000e+0	14	3.658334e-3	1.000000e+0	8.790454e-1	2.733485e+2	3.658334e-3	1	66	1.000000e+0	1.515152e-2	unnamed	MSH2
MSigDB Perturbation	LEE_CALORIE_RESTRICTION_NEOCORTEX_UP	Up-regulated in the neocortex of aged (30-month) mice subjected to caloric restriction since young adulthood.	19	8.665415e-3	1.000000e+0	1.000000e+0	1.154013e+2	8.665415e-3	1	8.665415e-3	1.000000e+0	17	4.711490e-3	1.000000e+0	9.323207e-1	2.122471e+2	4.711490e-3	1	85	1.000000e+0	1.176471e-2	unnamed	MSH2
MSigDB Perturbation	DANG_MYC_TARGETS_UP	Genes up-regulated by MYC [GeneID=4609] and whose promoters are bound by MYC, according to MYC Target Gene Database.	20	9.822124e-3	1.000000e+0	1.000000e+0	1.018110e+2	9.822124e-3	1	9.822124e-3	1.000000e+0	25	7.981819e-3	1.000000e+0	1.000000e+0	1.252847e+2	7.981819e-3	1	144	1.000000e+0	6.944444e-3	unnamed	MSH2
MSigDB Perturbation	PUJANA_BRCA_CENTERED_NETWORK	Genes constituting the BRCA-centered network (BCN).	21	1.065216e-2	1.000000e+0	1.000000e+0	9.387771e+1	1.065216e-2	1	1.065216e-2	1.000000e+0	22	6.485228e-3	1.000000e+0	9.916503e-1	1.541966e+2	6.485228e-3	1	117	1.000000e+0	8.547009e-3	unnamed	MSH2
MSigDB Perturbation	WHITFIELD_CELL_CYCLE_G1_S	Genes periodically expressed in synchronized HeLa cells (cervical carcinoma), with peak during the G1/S phase of cell cycle.	22	1.093297e-2	1.000000e+0	1.000000e+0	9.146648e+1	1.093297e-2	1	1.093297e-2	1.000000e+0	23	7.039521e-3	1.000000e+0	1.000000e+0	1.420551e+2	7.039521e-3	1	127	1.000000e+0	7.874016e-3	unnamed	MSH2
MSigDB Perturbation	BENPORATH_PROLIFERATION	Set 'Proliferation Cluster': genes defined in human breast tumor expression data.	23	1.146571e-2	1.000000e+0	1.000000e+0	8.721655e+1	1.146571e-2	1	1.146571e-2	1.000000e+0	26	8.037248e-3	1.000000e+0	1.000000e+0	1.244207e+2	8.037248e-3	1	145	1.000000e+0	6.896552e-3	unnamed	MSH2
MSigDB Perturbation	KAUFFMANN_DNA_REPLICATION_GENES	Genes involved in DNA replication, compiled manually by the authors.	24	1.201358e-2	1.000000e+0	1.000000e+0	8.323914e+1	1.201358e-2	1	1.201358e-2	1.000000e+0	27	8.092678e-3	1.000000e+0	1.000000e+0	1.235685e+2	8.092678e-3	1	146	1.000000e+0	6.849315e-3	unnamed	MSH2
MSigDB Perturbation	BROWN_MYELOID_CELL_DEVELOPMENT_DN	Genes defining proliferation and self renewal potential of the bipotential myeloid cell line FDB.	25	1.252641e-2	1.000000e+0	1.000000e+0	7.983136e+1	1.252641e-2	1	1.252641e-2	1.000000e+0	23	7.039521e-3	1.000000e+0	1.000000e+0	1.420551e+2	7.039521e-3	1	127	1.000000e+0	7.874016e-3	unnamed	MSH2
MSigDB Perturbation	MARKEY_RB1_CHRONIC_LOF_UP	Genes up-regulated in MEF cells (embryonic fibroblasts) isolated from RB1 [GeneID=5925] knockout mice: chronic loss of function (LOF) of RB1.	26	1.343301e-2	1.000000e+0	1.000000e+0	7.444348e+1	1.343301e-2	1	1.343301e-2	1.000000e+0	21	6.263511e-3	1.000000e+0	1.000000e+0	1.596549e+2	6.263511e-3	1	113	1.000000e+0	8.849558e-3	unnamed	MSH2
MSigDB Perturbation	HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_UP	Genes up-regulated in hematopoietic progenitor cells (HPC) of T lymphocyte and NK (natural killer) lineage.	27	1.459875e-2	1.000000e+0	1.000000e+0	6.849903e+1	1.459875e-2	1	1.459875e-2	1.000000e+0	16	4.378915e-3	1.000000e+0	9.206669e-1	2.283671e+2	4.378915e-3	1	79	1.000000e+0	1.265823e-2	unnamed	MSH2
MSigDB Perturbation	PENG_GLUCOSE_DEPRIVATION_DN	Genes down-regulated in BJAB cells (B-lymphoma) after glucose [PubChem=206] deprivation.	28	1.502966e-2	1.000000e+0	1.000000e+0	6.653511e+1	1.502966e-2	1	1.502966e-2	1.000000e+0	31	9.256693e-3	1.000000e+0	1.000000e+0	1.080299e+2	9.256693e-3	1	167	1.000000e+0	5.988024e-3	unnamed	MSH2
MSigDB Perturbation	JISON_SICKLE_CELL_DISEASE_DN	Genes down-regulated in peripheral blood mononuclear cells (PBMC) from sickle cell disease patients compared to those from healthy subjects.	29	1.569682e-2	1.000000e+0	1.000000e+0	6.370719e+1	1.569682e-2	1	1.569682e-2	1.000000e+0	34	9.700127e-3	1.000000e+0	9.597420e-1	1.030914e+2	9.700127e-3	1	175	1.000000e+0	5.714286e-3	unnamed	MSH2
MSigDB Perturbation	TSAI_RESPONSE_TO_IONIZING_RADIATION	Genes up-regulated in TK6, WTK1, and NH32 cell lines (lymphoblast) in response to ionizing radiation.	30	1.571399e-2	1.000000e+0	1.000000e+0	6.363755e+1	1.571399e-2	1	1.571399e-2	1.000000e+0	28	8.258966e-3	1.000000e+0	9.922558e-1	1.210805e+2	8.258966e-3	1	149	1.000000e+0	6.711409e-3	unnamed	MSH2
MSigDB Perturbation	LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_DN	Genes down-regulated in Wilm's tumor samples compared to fetal  kidney.	31	1.583386e-2	1.000000e+0	1.000000e+0	6.315578e+1	1.583386e-2	1	1.583386e-2	1.000000e+0	29	9.034976e-3	1.000000e+0	1.000000e+0	1.106810e+2	9.034976e-3	1	163	1.000000e+0	6.134969e-3	unnamed	MSH2
MSigDB Perturbation	PUJANA_XPRSS_INT_NETWORK	Genes constituting the XPRSS-Int network: intersection of genes whose expression correlates with BRCA1, BRCA2, ATM, and CHEK2 [GeneID=672;675;472;11200] in a compendium of normal tissues.	32	1.610988e-2	1.000000e+0	1.000000e+0	6.207372e+1	1.610988e-2	1	1.610988e-2	1.000000e+0	31	9.256693e-3	1.000000e+0	1.000000e+0	1.080299e+2	9.256693e-3	1	167	1.000000e+0	5.988024e-3	unnamed	MSH2
MSigDB Perturbation	CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_DN	Marker genes down-regulated in the 'unannotated' subclass of hepatocellular carcinoma (HCC) samples.	33	1.636872e-2	1.000000e+0	1.000000e+0	6.109215e+1	1.636872e-2	1	1.636872e-2	1.000000e+0	35	1.047614e-2	1.000000e+0	1.000000e+0	9.545503e+1	1.047614e-2	1	189	1.000000e+0	5.291005e-3	unnamed	MSH2
MSigDB Perturbation	HEDENFALK_BREAST_CANCER_BRCA1_VS_BRCA2	Genes differentially expressed in hereditary breast cancer tumors with mutated BRCA1 [GeneID=672] compared to those with mutated BRCA2 [GeneID=675].	34	1.653298e-2	1.000000e+0	1.000000e+0	6.048516e+1	1.653298e-2	1	1.653298e-2	1.000000e+0	29	9.034976e-3	1.000000e+0	1.000000e+0	1.106810e+2	9.034976e-3	1	163	1.000000e+0	6.134969e-3	unnamed	MSH2
MSigDB Perturbation	SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_UP	Genes up-regulated in MCF10A cells (breast cancer) grown at low (mesenchymal phenotype) compared to those grown at high (epithelial, basal-like phenotype) confluency.	35	1.771869e-2	1.000000e+0	1.000000e+0	5.643757e+1	1.771869e-2	1	1.771869e-2	1.000000e+0	36	1.053157e-2	1.000000e+0	9.841167e-1	9.495263e+1	1.053157e-2	1	190	1.000000e+0	5.263158e-3	unnamed	MSH2
MSigDB Perturbation	KAUFFMANN_DNA_REPAIR_GENES	Genes involved in DNA repair, compiled manually by the authors.	36	1.883782e-2	1.000000e+0	1.000000e+0	5.308469e+1	1.883782e-2	1	1.883782e-2	1.000000e+0	38	1.241616e-2	1.000000e+0	1.000000e+0	8.054018e+1	1.241616e-2	1	224	1.000000e+0	4.464286e-3	unnamed	MSH2
MSigDB Perturbation	BROWNE_HCMV_INFECTION_48HR_UP	Genes up-regulated in primary fibroblast cell culture after infection with HCMV (AD169 strain) at 48 h time point that were not up-regulated at the previous time point, 24 h.	37	1.990267e-2	1.000000e+0	1.000000e+0	5.024451e+1	1.990267e-2	1	1.990267e-2	1.000000e+0	33	9.533840e-3	1.000000e+0	9.718739e-1	1.048895e+2	9.533840e-3	1	172	1.000000e+0	5.813953e-3	unnamed	MSH2
MSigDB Perturbation	RAMALHO_STEMNESS_UP	Genes enriched in embryonic, neural and hematopoietic stem cells.	38	2.029016e-2	1.000000e+0	1.000000e+0	4.928497e+1	2.029016e-2	1	2.029016e-2	1.000000e+0	37	1.114129e-2	1.000000e+0	1.000000e+0	8.975622e+1	1.114129e-2	1	201	1.000000e+0	4.975124e-3	unnamed	MSH2
MSigDB Perturbation	KOBAYASHI_EGFR_SIGNALING_24HR_DN	Genes down-regulated in H1975 cells (non-small cell lung cancer, NSCLC) resistant to gefitinib [PubChem=123631] after treatment with EGFR inhibitor CL-387785 [PubChem=2776] for 24h.	39	2.179460e-2	1.000000e+0	1.000000e+0	4.588292e+1	2.179460e-2	1	2.179460e-2	1.000000e+0	42	1.457791e-2	1.000000e+0	1.000000e+0	6.859696e+1	1.457791e-2	1	263	1.000000e+0	3.802281e-3	unnamed	MSH2
MSigDB Perturbation	MUELLER_PLURINET	Genes constituting the PluriNet protein-protein network shared by the pluripotent cells (embryonic stem cells, embryonical carcinomas and induced pluripotent cells).	40	2.247319e-2	1.000000e+0	1.000000e+0	4.449746e+1	2.247319e-2	1	2.247319e-2	1.000000e+0	44	1.685051e-2	1.000000e+0	1.000000e+0	5.934539e+1	1.685051e-2	1	304	1.000000e+0	3.289474e-3	unnamed	MSH2
MSigDB Perturbation	AFFAR_YY1_TARGETS_DN	Genes down-regulated in MEF cells (embryonic fibroblast) expressing ~25% of YY1 [GeneID=7528].	41	2.386809e-2	1.000000e+0	1.000000e+0	4.189694e+1	2.386809e-2	1	2.386809e-2	1.000000e+0	40	1.330303e-2	1.000000e+0	1.000000e+0	7.517083e+1	1.330303e-2	1	240	1.000000e+0	4.166667e-3	unnamed	MSH2
MSigDB Perturbation	WONG_EMBRYONIC_STEM_CELL_CORE	The 'core ESC-like gene module': genes coordinately up-regulated in a compendium of mouse embryonic stem cells (ESC) which are shared with the human ESC-like module.	42	2.401219e-2	1.000000e+0	1.000000e+0	4.164551e+1	2.401219e-2	1	2.401219e-2	1.000000e+0	47	1.867967e-2	1.000000e+0	1.000000e+0	5.353412e+1	1.867967e-2	1	337	1.000000e+0	2.967359e-3	unnamed	MSH2
MSigDB Perturbation	MITSIADES_RESPONSE_TO_APLIDIN_DN	Genes down-regulated in the MM1S cells (multiple myeloma) after treatment with aplidin [PubChem=44152164], a marine-derived compound with potential anti-cancer properties.	43	2.562386e-2	1.000000e+0	1.000000e+0	3.902613e+1	2.562386e-2	1	2.562386e-2	1.000000e+0	41	1.369104e-2	1.000000e+0	1.000000e+0	7.304049e+1	1.369104e-2	1	247	1.000000e+0	4.048583e-3	unnamed	MSH2
MSigDB Perturbation	LINDGREN_BLADDER_CANCER_CLUSTER_3_UP	Genes whose expression profile is specific to Cluster III of urothelial cell carcinoma (UCC) tumors.	44	2.574991e-2	1.000000e+0	1.000000e+0	3.883509e+1	2.574991e-2	1	2.574991e-2	1.000000e+0	45	1.834710e-2	1.000000e+0	1.000000e+0	5.450453e+1	1.834710e-2	1	331	1.000000e+0	3.021148e-3	unnamed	MSH2
MSigDB Perturbation	WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_DN	Genes down-regulated in RS4;11 cells (MLL, mixed lineage leukemia) in response to SB216763 [PubChemID=176158], an inhibitor of GSK3B [GeneID=2932].	45	2.928641e-2	1.000000e+0	1.000000e+0	3.414553e+1	2.928641e-2	1	2.928641e-2	1.000000e+0	50	2.100770e-2	1.000000e+0	1.000000e+0	4.760158e+1	2.100770e-2	1	379	1.000000e+0	2.638522e-3	unnamed	MSH2
MSigDB Perturbation	BLUM_RESPONSE_TO_SALIRASIB_DN	Selected genes down-regulated in response to the Ras inhibitor salirasib [PubChem=5469318] in a panel of cancer cell lines with constantly active HRAS [GeneID=3265].	46	3.335018e-2	1.000000e+0	1.000000e+0	2.998484e+1	3.335018e-2	1	3.335018e-2	1.000000e+0	48	1.884596e-2	1.000000e+0	1.000000e+0	5.306176e+1	1.884596e-2	1	340	1.000000e+0	2.941176e-3	unnamed	MSH2
MSigDB Perturbation	CHICAS_RB1_TARGETS_GROWING	Genes up-regulated in growing IMR90 cells (fibroblast) after knockdown of RB1 [GeneID=5925] by RNAi.	47	3.635781e-2	1.000000e+0	1.000000e+0	2.750440e+1	3.635781e-2	1	3.635781e-2	1.000000e+0	39	1.313674e-2	1.000000e+0	1.000000e+0	7.612236e+1	1.313674e-2	1	237	1.000000e+0	4.219409e-3	unnamed	MSH2
MSigDB Perturbation	PUJANA_BRCA2_PCC_NETWORK	Genes constituting the BRCA2-PCC network of transcripts whose expression positively correlated (Pearson correlation coefficient, PCC &gt;= 0.4) with that of BRCA2 [GeneID=675] across a compendium of normal tissues.	48	3.791785e-2	1.000000e+0	1.000000e+0	2.637280e+1	3.791785e-2	1	3.791785e-2	1.000000e+0	51	2.311402e-2	1.000000e+0	1.000000e+0	4.326379e+1	2.311402e-2	1	417	1.000000e+0	2.398082e-3	unnamed	MSH2
MSigDB Perturbation	GRESHOCK_CANCER_COPY_NUMBER_UP	Genes from common genomic gains observed in a meta analyis of copy number alterations across a panel of different cancer cell lines and tumor samples.	49	3.901444e-2	1.000000e+0	1.000000e+0	2.563154e+1	3.901444e-2	1	3.901444e-2	1.000000e+0	46	1.851339e-2	1.000000e+0	1.000000e+0	5.401497e+1	1.851339e-2	1	334	1.000000e+0	2.994012e-3	unnamed	MSH2
MSigDB Perturbation	MOHANKUMAR_TLX1_TARGETS_UP	Up-regulated in MCF7 cells (breast cancer) by TLX1 (HOX11) [GeneID=3195].	50	3.940953e-2	1.000000e+0	1.000000e+0	2.537457e+1	3.940953e-2	1	3.940953e-2	1.000000e+0	52	2.344659e-2	1.000000e+0	1.000000e+0	4.265012e+1	2.344659e-2	1	423	1.000000e+0	2.364066e-3	unnamed	MSH2
MSigDB Perturbation	CAIRO_HEPATOBLASTOMA_CLASSES_UP	Genes up-regulated in robust Cluster 2 (rC2) of hepatoblastoma samples compared to those in the robust Cluster 1 (rC1).	51	3.989950e-2	1.000000e+0	1.000000e+0	2.506297e+1	3.989950e-2	1	3.989950e-2	1.000000e+0	59	3.270329e-2	1.000000e+0	1.000000e+0	3.057797e+1	3.270329e-2	1	590	1.000000e+0	1.694915e-3	unnamed	MSH2
MSigDB Perturbation	GABRIELY_MIR21_TARGETS	Genes significantly de-regulated (p &lt; 0.05) by MIR21 [GeneID=406991] in A172 cells (glioma).	52	4.148238e-2	1.000000e+0	1.000000e+0	2.410662e+1	4.148238e-2	1	4.148238e-2	1.000000e+0	43	1.518763e-2	1.000000e+0	1.000000e+0	6.584307e+1	1.518763e-2	1	274	1.000000e+0	3.649635e-3	unnamed	MSH2
MSigDB Perturbation	MARSON_BOUND_BY_E2F4_UNSTIMULATED	Genes with promoters bound by E2F4 [GeneID=1874] in unstimulated hybridoma cells.	53	4.167922e-2	1.000000e+0	1.000000e+0	2.399277e+1	4.167922e-2	1	4.167922e-2	1.000000e+0	63	3.841250e-2	1.000000e+0	1.000000e+0	2.603319e+1	3.841250e-2	1	693	1.000000e+0	1.443001e-3	unnamed	MSH2
MSigDB Perturbation	BENPORATH_ES_1	Set 'ES exp1': genes overexpressed in human embryonic stem cells according to 5 or more out of 20 profiling studies.	54	4.210765e-2	1.000000e+0	1.000000e+0	2.374865e+1	4.210765e-2	1	4.210765e-2	1.000000e+0	49	2.078599e-2	1.000000e+0	1.000000e+0	4.810933e+1	2.078599e-2	1	375	1.000000e+0	2.666667e-3	unnamed	MSH2
MSigDB Perturbation	BERENJENO_TRANSFORMED_BY_RHOA_UP	Genes up-regulated in NIH3T3 cells (fibroblasts) transformed by  expression of contitutively active (Q63L) form of RHOA [GeneID=387] off plasmid vector.	55	5.123973e-2	1.000000e+0	1.000000e+0	1.951611e+1	5.123973e-2	1	5.123973e-2	1.000000e+0	55	2.943296e-2	1.000000e+0	1.000000e+0	3.397552e+1	2.943296e-2	1	531	1.000000e+0	1.883239e-3	unnamed	MSH2
MSigDB Perturbation	BENPORATH_MYC_MAX_TARGETS	Set 'Myc targets2': targets of c-Myc [GeneID=4609] and Max [GeneID=4149] identified by ChIP on chip in a Burkitt's lymphoma cell line; overlap set.	56	5.249114e-2	1.000000e+0	1.000000e+0	1.905083e+1	5.249114e-2	1	5.249114e-2	1.000000e+0	65	4.384458e-2	1.000000e+0	1.000000e+0	2.280784e+1	4.384458e-2	1	791	1.000000e+0	1.264223e-3	unnamed	MSH2
MSigDB Perturbation	FEVR_CTNNB1_TARGETS_DN	Genes down-regulated in intestinal crypt cells upon deletion of CTNNB1 [GeneID=1499].	57	5.544406e-2	1.000000e+0	1.000000e+0	1.803620e+1	5.544406e-2	1	5.544406e-2	1.000000e+0	57	3.020897e-2	1.000000e+0	1.000000e+0	3.310275e+1	3.020897e-2	1	545	1.000000e+0	1.834862e-3	unnamed	MSH2
MSigDB Perturbation	BENPORATH_CYCLING_GENES	Genes showing cell-cycle stage-specific expression [PMID=12058064].	58	5.607900e-2	1.000000e+0	1.000000e+0	1.783199e+1	5.607900e-2	1	5.607900e-2	1.000000e+0	60	3.575190e-2	1.000000e+0	1.000000e+0	2.797054e+1	3.575190e-2	1	645	1.000000e+0	1.550388e-3	unnamed	MSH2
MSigDB Perturbation	CHICAS_RB1_TARGETS_SENESCENT	Genes up-regulated in senescent IMR90 cells (fibroblast) after knockdown of RB1 [GeneID=5925] by RNAi.	59	5.829074e-2	1.000000e+0	1.000000e+0	1.715538e+1	5.829074e-2	1	5.829074e-2	1.000000e+0	56	2.998725e-2	1.000000e+0	1.000000e+0	3.334750e+1	2.998725e-2	1	541	1.000000e+0	1.848429e-3	unnamed	MSH2
MSigDB Perturbation	BAELDE_DIABETIC_NEPHROPATHY_DN	Genes down-regulated in glomeruli of kidneys from patients with diabetic nephropathy (type 2 diabetes mellitus).	60	5.861782e-2	1.000000e+0	1.000000e+0	1.705966e+1	5.861782e-2	1	5.861782e-2	1.000000e+0	53	2.361288e-2	1.000000e+0	1.000000e+0	4.234977e+1	2.361288e-2	1	426	1.000000e+0	2.347418e-3	unnamed	MSH2
MSigDB Perturbation	PUJANA_CHEK2_PCC_NETWORK	Genes constituting the CHEK2-PCC network of transcripts whose expression positively correlates (Pearson correlation coefficient, PCC &gt;= 0.4) with that of CHEK2 [GeneID=11200].	61	5.889590e-2	1.000000e+0	1.000000e+0	1.697911e+1	5.889590e-2	1	5.889590e-2	1.000000e+0	66	4.401086e-2	1.000000e+0	1.000000e+0	2.272166e+1	4.401086e-2	1	794	1.000000e+0	1.259446e-3	unnamed	MSH2
MSigDB Perturbation	LOPEZ_MBD_TARGETS	Genes up-regulated in HeLa cells (cervical cancer) after simultaneus knockdown of all three MBD (methyl-CpG binding domain) proteins MeCP2, MBD1 and MBD2 [GeneID=4204;4152;8932] by RNAi.	62	6.397820e-2	1.000000e+0	1.000000e+0	1.563032e+1	6.397820e-2	1	6.397820e-2	1.000000e+0	69	5.210354e-2	1.000000e+0	1.000000e+0	1.919255e+1	5.210354e-2	1	940	1.000000e+0	1.063830e-3	unnamed	MSH2
MSigDB Perturbation	WEI_MYCN_TARGETS_WITH_E_BOX	Genes whose promoters contain E-box motifs and whose expression changed in MYCN-3 cells (neuroblastoma) upon induction of MYCN [GeneID=4613].	63	6.806111e-2	1.000000e+0	1.000000e+0	1.469268e+1	6.806111e-2	1	6.806111e-2	1.000000e+0	64	4.262513e-2	1.000000e+0	1.000000e+0	2.346034e+1	4.262513e-2	1	769	1.000000e+0	1.300390e-3	unnamed	MSH2
MSigDB Perturbation	IVANOVA_HEMATOPOIESIS_STEM_CELL_AND_PROGENITOR	Genes in the expression cluster 'HSC and Progenitors Shared': up-regulated in hematopoietic stem cells (HSC) and progenitors from adult bone marrow and fetal liver.	64	7.135492e-2	1.000000e+0	1.000000e+0	1.401445e+1	7.135492e-2	1	7.135492e-2	1.000000e+0	61	3.591819e-2	1.000000e+0	1.000000e+0	2.784105e+1	3.591819e-2	1	648	1.000000e+0	1.543210e-3	unnamed	MSH2
MSigDB Perturbation	SCHLOSSER_SERUM_RESPONSE_DN	Cluster 4: genes down-regulated in B493-6 cells (B lymphocytes) upon serum stimulation but not affected by MYC [GeneID=4609].	65	7.399847e-2	1.000000e+0	1.000000e+0	1.351379e+1	7.399847e-2	1	7.399847e-2	1.000000e+0	62	3.835708e-2	1.000000e+0	1.000000e+0	2.607081e+1	3.835708e-2	1	692	1.000000e+0	1.445087e-3	unnamed	MSH2
MSigDB Perturbation	HAMAI_APOPTOSIS_VIA_TRAIL_UP	Genes up-regulated in T1 cells (primary melanoma, sensitive to TRAIL [GeneID=8743]) compared to G1 cells (metastatic melanoma, resistant to TRAIL).	66	7.409110e-2	1.000000e+0	1.000000e+0	1.349690e+1	7.409110e-2	1	7.409110e-2	1.000000e+0	58	3.120670e-2	1.000000e+0	1.000000e+0	3.204440e+1	3.120670e-2	1	563	1.000000e+0	1.776199e-3	unnamed	MSH2
MSigDB Perturbation	DANG_BOUND_BY_MYC	Genes whose promoters are bound by MYC [GeneID=4609], according to MYC Target Gene Database.	67	7.799204e-2	1.000000e+0	1.000000e+0	1.282182e+1	7.799204e-2	1	7.799204e-2	1.000000e+0	72	6.130481e-2	1.000000e+0	1.000000e+0	1.631193e+1	6.130481e-2	1	1106	1.000000e+0	9.041591e-4	unnamed	MSH2
MSigDB Perturbation	DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN	Common down-regulated transcripts in fibroblasts expressing either XP/CS or TDD mutant forms of ERCC3 [GeneID=2071], after UVC irradiation.	68	8.562533e-2	1.000000e+0	1.000000e+0	1.167879e+1	8.562533e-2	1	8.562533e-2	1.000000e+0	54	2.649521e-2	1.000000e+0	1.000000e+0	3.774268e+1	2.649521e-2	1	478	1.000000e+0	2.092050e-3	unnamed	MSH2
MSigDB Perturbation	JOHNSTONE_PARVB_TARGETS_3_DN	Genes down-regulated upon overexpression of PARVB [GeneID=29780] in MDA-MB-231 cells (breast cancer) cultured in 3D Matrigel only.	69	8.753961e-2	1.000000e+0	1.000000e+0	1.142340e+1	8.753961e-2	1	8.753961e-2	1.000000e+0	68	4.772463e-2	1.000000e+0	1.000000e+0	2.095354e+1	4.772463e-2	1	861	1.000000e+0	1.161440e-3	unnamed	MSH2
MSigDB Perturbation	BENPORATH_NANOG_TARGETS	Set 'Nanog targets': genes upregulated and identified by ChIP on chip as Nanog [GeneID=79923] transcription factor targets in human embryonic stem cells.	70	1.005508e-1	1.000000e+0	1.000000e+0	9.945225e+0	1.005508e-1	1	1.005508e-1	1.000000e+0	70	5.398814e-2	1.000000e+0	1.000000e+0	1.852259e+1	5.398814e-2	1	974	1.000000e+0	1.026694e-3	unnamed	MSH2
MSigDB Perturbation	BRUINS_UVC_RESPONSE_LATE	Late response genes: differentially expressed only 12 h after UV-C irradiation of MEF cells (embryonic fibroblast).	71	1.021113e-1	1.000000e+0	1.000000e+0	9.793235e+0	1.021113e-1	1	1.021113e-1	1.000000e+0	71	6.075051e-2	1.000000e+0	1.000000e+0	1.646077e+1	6.075051e-2	1	1096	1.000000e+0	9.124088e-4	unnamed	MSH2
MSigDB Perturbation	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP	Genes up-regulated in TC71 and EWS502 cells (Ewing's sarcoma) by EWSR1-FLI1  [GeneID=2130;2314] as inferred from RNAi knockdown of this fusion protein.	72	1.219335e-1	1.000000e+0	1.000000e+0	8.201193e+0	1.219335e-1	1	1.219335e-1	1.000000e+0	73	6.801175e-2	1.000000e+0	1.000000e+0	1.470334e+1	6.801175e-2	1	1227	1.000000e+0	8.149959e-4	unnamed	MSH2
MSigDB Perturbation	DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_UP	Genes up-regulated in CD34+ [GeneID=947] cells isolated from bone marrow of CML (chronic myelogenous leukemia) patients, compared to those from normal donors.	73	1.224048e-1	1.000000e+0	1.000000e+0	8.169613e+0	1.224048e-1	1	1.224048e-1	1.000000e+0	76	7.654786e-2	1.000000e+0	1.000000e+0	1.306372e+1	7.654786e-2	1	1381	1.000000e+0	7.241130e-4	unnamed	MSH2
MSigDB Perturbation	PUJANA_ATM_PCC_NETWORK	Genes constituting the ATM-PCC network of transcripts whose expression positively correlated (Pearson correlation coefficient, PCC &gt;= 0.4) with that of ATM [GeneID=472] across a compendium of normal tissues.	74	1.248339e-1	1.000000e+0	1.000000e+0	8.010648e+0	1.248339e-1	1	1.248339e-1	1.000000e+0	77	7.848789e-2	1.000000e+0	1.000000e+0	1.274082e+1	7.848789e-2	1	1416	1.000000e+0	7.062147e-4	unnamed	MSH2
MSigDB Perturbation	DODD_NASOPHARYNGEAL_CARCINOMA_DN	Genes down-regulated in nasopharyngeal carcinoma (NPC) compared to the normal tissue.	75	1.258050e-1	1.000000e+0	1.000000e+0	7.948812e+0	1.258050e-1	1	1.258050e-1	1.000000e+0	75	7.167008e-2	1.000000e+0	1.000000e+0	1.395282e+1	7.167008e-2	1	1293	1.000000e+0	7.733952e-4	unnamed	MSH2
MSigDB Perturbation	PUJANA_BRCA1_PCC_NETWORK	Genes constituting the BRCA1-PCC network of transcripts whose expression positively correlated (Pearson correlation coefficient, PCC &gt;= 0.4) with that of BRCA1 [GeneID=672] across a compendium of normal tissues.	76	1.292550e-1	1.000000e+0	1.000000e+0	7.736644e+0	1.292550e-1	1	1.292550e-1	1.000000e+0	78	9.068233e-2	1.000000e+0	1.000000e+0	1.102751e+1	9.068233e-2	1	1636	1.000000e+0	6.112469e-4	unnamed	MSH2
MSigDB Perturbation	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	Genes down-regulated in fibroblasts expressing mutant forms of ERCC3 [GeneID=2071] after UV irradiation.	77	1.422357e-1	1.000000e+0	1.000000e+0	7.030586e+0	1.422357e-1	1	1.422357e-1	1.000000e+0	67	4.656061e-2	1.000000e+0	1.000000e+0	2.147738e+1	4.656061e-2	1	840	1.000000e+0	1.190476e-3	unnamed	MSH2
MSigDB Perturbation	BLALOCK_ALZHEIMERS_DISEASE_DN	Genes down-regulated in brain from patients with Alzheimer's disease.	78	1.457059e-1	1.000000e+0	1.000000e+0	6.863142e+0	1.457059e-1	1	1.457059e-1	1.000000e+0	74	6.817804e-2	1.000000e+0	1.000000e+0	1.466748e+1	6.817804e-2	1	1230	1.000000e+0	8.130081e-4	unnamed	MSH2
MSigDB Perturbation	PILON_KLF1_TARGETS_DN	Genes down-regulated in erythroid progenitor cells from fetal livers of E13.5 embryos with KLF1 [GeneID=10661] knockout compared to those from the wild type embryos.	79	1.766774e-1	1.000000e+0	1.000000e+0	5.660033e+0	1.766774e-1	1	1.766774e-1	1.000000e+0	79	1.057591e-1	1.000000e+0	1.000000e+0	9.455451e+0	1.057591e-1	1	1908	1.000000e+0	5.241090e-4	unnamed	MSH2
MSigDB Predicted Promoter Motifs	SGCGSSAAA_V$E2F1DP2_01	Motif SGCGSSAAA matches E2F1: E2F transcription factor 1&lt;br&gt; TFDP1: transcription factor Dp-1&lt;br&gt; RB1: retinoblastoma 1 (including osteosarcoma)	1	1.245324e-2	1.000000e+0	1.000000e+0	8.030041e+1	1.245324e-2	1	1.245324e-2	1.000000e+0	1	1.036528e-2	1.000000e+0	1.000000e+0	9.647594e+1	1.036528e-2	1	187	1.000000e+0	5.347594e-3	unnamed	MSH2
MSigDB Predicted Promoter Motifs	V$E2F1DP1RB_01	Motif TTTSGCGC matches E2F1: E2F transcription factor 1&lt;br&gt; TFDP1: transcription factor Dp-1&lt;br&gt; RB1: retinoblastoma 1 (including osteosarcoma)	2	2.030172e-2	1.000000e+0	1.000000e+0	4.925690e+1	2.030172e-2	1	2.030172e-2	1.000000e+0	3	1.269331e-2	1.000000e+0	1.000000e+0	7.878166e+1	1.269331e-2	1	229	1.000000e+0	4.366812e-3	unnamed	MSH2
MSigDB Predicted Promoter Motifs	V$E2F1_Q6_01	Motif NTTTCGCGCS matches E2F1: E2F transcription factor 1	3	2.079478e-2	1.000000e+0	1.000000e+0	4.808899e+1	2.079478e-2	1	2.079478e-2	1.000000e+0	4	1.285960e-2	1.000000e+0	1.000000e+0	7.776293e+1	1.285960e-2	1	232	1.000000e+0	4.310345e-3	unnamed	MSH2
MSigDB Predicted Promoter Motifs	V$E2F_02	Motif TTTSGCGC (no known TF)	4	2.146128e-2	1.000000e+0	1.000000e+0	4.659555e+1	2.146128e-2	1	2.146128e-2	1.000000e+0	9	1.407904e-2	1.000000e+0	9.620677e-1	7.102756e+1	1.407904e-2	1	254	1.000000e+0	3.937008e-3	unnamed	MSH2
MSigDB Predicted Promoter Motifs	V$E2F_Q6	Motif TTTSGCGS (no known TF)	5	2.155031e-2	1.000000e+0	1.000000e+0	4.640305e+1	2.155031e-2	1	2.155031e-2	1.000000e+0	8	1.402361e-2	1.000000e+0	1.000000e+0	7.130830e+1	1.402361e-2	1	253	1.000000e+0	3.952569e-3	unnamed	MSH2
MSigDB Predicted Promoter Motifs	V$E2F_Q4	Motif TTTSGCGS (no known TF)	6	2.157092e-2	1.000000e+0	1.000000e+0	4.635871e+1	2.157092e-2	1	2.157092e-2	1.000000e+0	5	1.291503e-2	1.000000e+0	1.000000e+0	7.742918e+1	1.291503e-2	1	233	1.000000e+0	4.291845e-3	unnamed	MSH2
MSigDB Predicted Promoter Motifs	V$E2F1DP2_01	Motif TTTSSCGC matches E2F1: E2F transcription factor 1&lt;br&gt; TFDP2: transcription factor Dp-2 (E2F dimerization partner 2)	7	2.172672e-2	1.000000e+0	1.000000e+0	4.602627e+1	2.172672e-2	1	2.172672e-2	1.000000e+0	9	1.407904e-2	1.000000e+0	9.620677e-1	7.102756e+1	1.407904e-2	1	254	1.000000e+0	3.937008e-3	unnamed	MSH2
MSigDB Predicted Promoter Motifs	V$E2F1DP1_01	Motif TTTCSCGC matches E2F1: E2F transcription factor 1&lt;br&gt; TFDP1: transcription factor Dp-1	7	2.172672e-2	1.000000e+0	1.000000e+0	4.602627e+1	2.172672e-2	1	2.172672e-2	1.000000e+0	9	1.407904e-2	1.000000e+0	9.620677e-1	7.102756e+1	1.407904e-2	1	254	1.000000e+0	3.937008e-3	unnamed	MSH2
MSigDB Predicted Promoter Motifs	V$E2F4DP2_01	Motif TTTCSCGC matches E2F4: E2F transcription factor 4, p107/p130-binding&lt;br&gt; TFDP2: transcription factor Dp-2 (E2F dimerization partner 2)	7	2.172672e-2	1.000000e+0	1.000000e+0	4.602627e+1	2.172672e-2	1	2.172672e-2	1.000000e+0	9	1.407904e-2	1.000000e+0	9.620677e-1	7.102756e+1	1.407904e-2	1	254	1.000000e+0	3.937008e-3	unnamed	MSH2
MSigDB Predicted Promoter Motifs	V$E2F1_Q6	Motif TTTSGCGS matches E2F1: E2F transcription factor 1	10	2.206827e-2	1.000000e+0	1.000000e+0	4.531393e+1	2.206827e-2	1	2.206827e-2	1.000000e+0	7	1.391275e-2	1.000000e+0	1.000000e+0	7.187649e+1	1.391275e-2	1	251	1.000000e+0	3.984064e-3	unnamed	MSH2
MSigDB Predicted Promoter Motifs	V$E2F4DP1_01	Motif TTTSGCGC matches E2F4: E2F transcription factor 4, p107/p130-binding&lt;br&gt; TFDP1: transcription factor Dp-1	11	2.242736e-2	1.000000e+0	1.000000e+0	4.458839e+1	2.242736e-2	1	2.242736e-2	1.000000e+0	13	1.430076e-2	1.000000e+0	6.765360e-1	6.992636e+1	1.430076e-2	1	258	1.000000e+0	3.875969e-3	unnamed	MSH2
MSigDB Predicted Promoter Motifs	V$E2F1_Q3	Motif NKTSSCGC matches E2F1: E2F transcription factor 1	12	2.249982e-2	1.000000e+0	1.000000e+0	4.444481e+1	2.249982e-2	1	2.249982e-2	1.000000e+0	6	1.335846e-2	1.000000e+0	1.000000e+0	7.485892e+1	1.335846e-2	1	241	1.000000e+0	4.149378e-3	unnamed	MSH2
MSigDB Predicted Promoter Motifs	V$NFY_Q6	Motif TRRCCAATSRN (no known TF)	13	2.815657e-2	1.000000e+0	1.000000e+0	3.551569e+1	2.815657e-2	1	2.815657e-2	1.000000e+0	14	1.463334e-2	1.000000e+0	6.428217e-1	6.833712e+1	1.463334e-2	1	264	1.000000e+0	3.787879e-3	unnamed	MSH2
MSigDB Predicted Promoter Motifs	V$GATA1_01	Motif SNNGATNNNN matches GATA1: GATA binding protein 1 (globin transcription factor 1)	14	3.085231e-2	1.000000e+0	1.000000e+0	3.241249e+1	3.085231e-2	1	3.085231e-2	1.000000e+0	2	1.247159e-2	1.000000e+0	1.000000e+0	8.018222e+1	1.247159e-2	1	225	1.000000e+0	4.444444e-3	unnamed	MSH2
MSigDB Predicted Promoter Motifs	TGCGCANK_UNKNOWN	Motif TGCGCANK (no known TF)	15	4.586364e-2	1.000000e+0	1.000000e+0	2.180377e+1	4.586364e-2	1	4.586364e-2	1.000000e+0	15	2.876781e-2	1.000000e+0	1.000000e+0	3.476108e+1	2.876781e-2	1	519	1.000000e+0	1.926782e-3	unnamed	MSH2
MSigDB Predicted Promoter Motifs	GATTGGY_V$NFY_Q6_01	Motif GATTGGY (no known TF)	16	1.117321e-1	1.000000e+0	1.000000e+0	8.949976e+0	1.117321e-1	1	1.117321e-1	1.000000e+0	16	6.280140e-2	1.000000e+0	1.000000e+0	1.592321e+1	6.280140e-2	1	1133	1.000000e+0	8.826125e-4	unnamed	MSH2
InterPro	IPR011184	DNA mismatch repair protein, MSH2	1	6.982440e-5	6.578855e-1	6.578855e-1	1.432164e+4	6.982440e-5	1	6.982440e-5	1.000000e+0	1	5.542930e-5	5.222549e-1	5.222549e-1	1.804100e+4	5.542930e-5	1	1	1.000000e+0	1.000000e+0	unnamed	MSH2
InterPro	IPR007695	DNA mismatch repair protein MutS-like, N-terminal	2	1.868510e-4	1.000000e+0	8.802551e-1	5.351857e+3	1.868510e-4	1	1.868510e-4	1.000000e+0	2	1.662879e-4	1.000000e+0	7.833823e-1	6.013667e+3	1.662879e-4	1	3	1.000000e+0	3.333333e-1	unnamed	MSH2
InterPro	IPR007860	DNA mismatch repair protein MutS, connector domain	3	2.372577e-4	1.000000e+0	7.451473e-1	4.214827e+3	2.372577e-4	1	2.372577e-4	1.000000e+0	3	2.217172e-4	1.000000e+0	6.963398e-1	4.510250e+3	2.217172e-4	1	4	1.000000e+0	2.500000e-1	unnamed	MSH2
InterPro	IPR007861	DNA mismatch repair protein MutS, clamp	4	2.516827e-4	1.000000e+0	5.928386e-1	3.973257e+3	2.516827e-4	1	2.516827e-4	1.000000e+0	4	3.325758e-4	1.000000e+0	7.833823e-1	3.006833e+3	3.325758e-4	1	6	1.000000e+0	1.666667e-1	unnamed	MSH2
InterPro	IPR000432	DNA mismatch repair protein MutS, C-terminal	4	2.516827e-4	1.000000e+0	5.928386e-1	3.973257e+3	2.516827e-4	1	2.516827e-4	1.000000e+0	4	3.325758e-4	1.000000e+0	7.833823e-1	3.006833e+3	3.325758e-4	1	6	1.000000e+0	1.666667e-1	unnamed	MSH2
InterPro	IPR007696	DNA mismatch repair protein MutS, core	4	2.516827e-4	1.000000e+0	5.928386e-1	3.973257e+3	2.516827e-4	1	2.516827e-4	1.000000e+0	4	3.325758e-4	1.000000e+0	7.833823e-1	3.006833e+3	3.325758e-4	1	6	1.000000e+0	1.666667e-1	unnamed	MSH2
InterPro	IPR027417	P-loop containing nucleoside triphosphate hydrolase	7	7.861815e-2	1.000000e+0	1.000000e+0	1.271971e+1	7.861815e-2	1	7.861815e-2	1.000000e+0	7	4.750291e-2	1.000000e+0	1.000000e+0	2.105134e+1	4.750291e-2	1	857	1.000000e+0	1.166861e-3	unnamed	MSH2
TreeFam	TF351780	MSH2	1	6.982440e-5	5.673931e-1	5.673931e-1	1.432164e+4	6.982440e-5	1	6.982440e-5	1.000000e+0	1	5.542930e-5	4.504185e-1	4.504185e-1	1.804100e+4	5.542930e-5	1	1	1.000000e+0	1.000000e+0	unnamed	MSH2
Ensembl Genes	10933	MSH2	1	6.982440e-5	1.000000e+0	1.000000e+0	1.432164e+4	6.982440e-5	1	6.982440e-5	1.000000e+0	1	5.542930e-5	1.000000e+0	1.000000e+0	1.804100e+4	5.542930e-5	1	1	1.000000e+0	1.000000e+0	unnamed	MSH2
MSigDB Oncogenic Signatures	RPS14_DN.V1_DN	Genes down-regulated in CD34+ hematopoietic progenitor cells after knockdown of RPS14 [Gene ID=6208] by RNAi.	1	1.454501e-2	1.000000e+0	1.000000e+0	6.875211e+1	1.454501e-2	1	1.454501e-2	1.000000e+0	1	1.019899e-2	1.000000e+0	1.000000e+0	9.804891e+1	1.019899e-2	1	184	1.000000e+0	5.434783e-3	unnamed	MSH2
MSigDB Oncogenic Signatures	ERB2_UP.V1_DN	Genes down-regulated in MCF-7 cells (breast cancer) positive for ESR1 [Gene ID=2099] and engineered to express ligand-activatable ERBB2 [Gene ID=2064].	2	2.349699e-2	1.000000e+0	1.000000e+0	4.255865e+1	2.349699e-2	1	2.349699e-2	1.000000e+0	2	1.064243e-2	1.000000e+0	9.950672e-1	9.396354e+1	1.064243e-2	1	192	1.000000e+0	5.208333e-3	unnamed	MSH2
MSigDB Oncogenic Signatures	TBK1.DF_DN	Genes down-regulated in epithelial lung cancer cell lines upon over-expression of an oncogenic form of KRAS [Gene ID=3845] gene and knockdown of TBK1 [Gene ID=29110] gene by RNAi.	3	3.599592e-2	1.000000e+0	1.000000e+0	2.778093e+1	3.599592e-2	1	3.599592e-2	1.000000e+0	3	1.618536e-2	1.000000e+0	1.000000e+0	6.178425e+1	1.618536e-2	1	292	1.000000e+0	3.424658e-3	unnamed	MSH2
MSigDB Immunologic Signatures	GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_6H_UP	Genes up-regulated in comparison of control conventional dendritic cells (cDC) at 0 h versus cDCs infected with Newcastle disease virus (NDV) at 6 h.	1	1.127530e-2	1.000000e+0	1.000000e+0	8.868940e+1	1.127530e-2	1	1.127530e-2	1.000000e+0	13	1.053157e-2	1.000000e+0	1.000000e+0	9.495263e+1	1.053157e-2	1	190	1.000000e+0	5.263158e-3	unnamed	MSH2
MSigDB Immunologic Signatures	GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_4H_UP	Genes up-regulated in comparison of control conventional dendritic cells (cDC) at 0 h versus cDCs infected with Newcastle disease virus (NDV) at 4 h.	2	1.296595e-2	1.000000e+0	1.000000e+0	7.712510e+1	1.296595e-2	1	1.296595e-2	1.000000e+0	2	1.014356e-2	1.000000e+0	1.000000e+0	9.858470e+1	1.014356e-2	1	183	1.000000e+0	5.464481e-3	unnamed	MSH2
MSigDB Immunologic Signatures	GSE3982_MAST_CELL_VS_TH2_DN	Genes down-regulated in comparison of mast cells versus Th2 cells.	3	1.345597e-2	1.000000e+0	1.000000e+0	7.431648e+1	1.345597e-2	1	1.345597e-2	1.000000e+0	31	1.114129e-2	1.000000e+0	6.864472e-1	8.975622e+1	1.114129e-2	1	201	1.000000e+0	4.975124e-3	unnamed	MSH2
MSigDB Immunologic Signatures	GSE14000_UNSTIM_VS_4H_LPS_DC_TRANSLATED_RNA_UP	Genes up-regulated in comparison of polysome bound (translated) mRNA before and 4 h after LPS (TLR4 agonist) stimulation.	4	1.361816e-2	1.000000e+0	1.000000e+0	7.343134e+1	1.361816e-2	1	1.361816e-2	1.000000e+0	12	1.047614e-2	1.000000e+0	1.000000e+0	9.545503e+1	1.047614e-2	1	189	1.000000e+0	5.291005e-3	unnamed	MSH2
MSigDB Immunologic Signatures	GSE1460_CD4_THYMOCYTE_VS_THYMIC_STROMAL_CELL_UP	Genes up-regulated in comparison of CD4 [GeneID=920] thymocytes versus thymic stromal cells.	5	1.377939e-2	1.000000e+0	1.000000e+0	7.257216e+1	1.377939e-2	1	1.377939e-2	1.000000e+0	4	1.025442e-2	1.000000e+0	1.000000e+0	9.751892e+1	1.025442e-2	1	185	1.000000e+0	5.405405e-3	unnamed	MSH2
MSigDB Immunologic Signatures	GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_10H_UP	Genes up-regulated in comparison of control conventional dendritic cells (cDC) at 0 h versus cDCs infected with Newcastle disease virus (NDV) at 10 h.	6	1.394933e-2	1.000000e+0	1.000000e+0	7.168801e+1	1.394933e-2	1	1.394933e-2	1.000000e+0	5	1.030985e-2	1.000000e+0	1.000000e+0	9.699462e+1	1.030985e-2	1	186	1.000000e+0	5.376344e-3	unnamed	MSH2
MSigDB Immunologic Signatures	GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_6H_UP	Genes up-regulated in comparison of control conventional dendritic cells (cDC) at 6 h versus cDCs infected with Newcastle disease virus (NDV) at 6 h.	7	1.417033e-2	1.000000e+0	1.000000e+0	7.056996e+1	1.417033e-2	1	1.417033e-2	1.000000e+0	5	1.030985e-2	1.000000e+0	1.000000e+0	9.699462e+1	1.030985e-2	1	186	1.000000e+0	5.376344e-3	unnamed	MSH2
MSigDB Immunologic Signatures	GSE360_L_MAJOR_VS_T_GONDII_MAC_DN	Genes down-regulated in comparison of macrophages exposed to L. major versus macrophages exposed to M. tuberculosis.	8	1.439255e-2	1.000000e+0	1.000000e+0	6.948041e+1	1.439255e-2	1	1.439255e-2	1.000000e+0	39	1.164015e-2	1.000000e+0	5.700689e-1	8.590952e+1	1.164015e-2	1	210	1.000000e+0	4.761905e-3	unnamed	MSH2
MSigDB Immunologic Signatures	GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_12H_UP	Genes up-regulated in comparison of control conventional dendritic cells (cDC) at 0 h versus cDCs infected with Newcastle disease virus (NDV) at 12 h.	9	1.461935e-2	1.000000e+0	1.000000e+0	6.840248e+1	1.461935e-2	1	1.461935e-2	1.000000e+0	5	1.030985e-2	1.000000e+0	1.000000e+0	9.699462e+1	1.030985e-2	1	186	1.000000e+0	5.376344e-3	unnamed	MSH2
MSigDB Immunologic Signatures	GSE360_CTRL_VS_L_MAJOR_MAC_UP	Genes up-regulated in comparison of macrophages versus macrophages exposed to L. major.	10	1.474389e-2	1.000000e+0	1.000000e+0	6.782470e+1	1.474389e-2	1	1.474389e-2	1.000000e+0	28	1.097500e-2	1.000000e+0	7.486518e-1	9.111616e+1	1.097500e-2	1	198	1.000000e+0	5.050505e-3	unnamed	MSH2
MSigDB Immunologic Signatures	GSE9650_GP33_VS_GP276_LCMV_SPECIFIC_EXHAUSTED_CD8_TCELL_DN	Genes down-regulated in comparison of virus specific (gp33) exhausted CD8 T cells versus the virus specific (gp276) cells.	11	1.475137e-2	1.000000e+0	1.000000e+0	6.779029e+1	1.475137e-2	1	1.475137e-2	1.000000e+0	24	1.080871e-2	1.000000e+0	8.601932e-1	9.251795e+1	1.080871e-2	1	195	1.000000e+0	5.128205e-3	unnamed	MSH2
MSigDB Immunologic Signatures	GSE3982_BASOPHIL_VS_TH2_DN	Genes down-regulated in comparison of basophils versus Th2 cells.	12	1.531831e-2	1.000000e+0	1.000000e+0	6.528134e+1	1.531831e-2	1	1.531831e-2	1.000000e+0	21	1.069785e-2	1.000000e+0	9.729949e-1	9.347668e+1	1.069785e-2	1	193	1.000000e+0	5.181347e-3	unnamed	MSH2
MSigDB Immunologic Signatures	GSE13485_DAY1_VS_DAY7_YF17D_VACCINE_PBMC_DN	Genes down-regulated in comparison of unstimulated peripheral blood mononuclear cells (PBMC) 1 day after stimulation with YF17D vaccine versus PBMC 7 days after the stimulation.	13	1.539378e-2	1.000000e+0	1.000000e+0	6.496130e+1	1.539378e-2	1	1.539378e-2	1.000000e+0	13	1.053157e-2	1.000000e+0	1.000000e+0	9.495263e+1	1.053157e-2	1	190	1.000000e+0	5.263158e-3	unnamed	MSH2
MSigDB Immunologic Signatures	GSE13485_CTRL_VS_DAY7_YF17D_VACCINE_PBMC_DN	Genes down-regulated in comparison of unstimulated peripheral blood mononuclear cells (PBMC) versus PBMC 7 days after stimulation with YF17D vaccine.	14	1.559108e-2	1.000000e+0	1.000000e+0	6.413926e+1	1.559108e-2	1	1.559108e-2	1.000000e+0	18	1.058700e-2	1.000000e+0	1.000000e+0	9.445550e+1	1.058700e-2	1	191	1.000000e+0	5.235602e-3	unnamed	MSH2
MSigDB Immunologic Signatures	GSE12845_IGD_NEG_BLOOD_VS_DARKZONE_GC_TONSIL_BCELL_DN	Genes down-regulated in comparison of IgD- peripheral blood B cells versus dark zone germinal center B cells.	15	1.582168e-2	1.000000e+0	1.000000e+0	6.320441e+1	1.582168e-2	1	1.582168e-2	1.000000e+0	23	1.075328e-2	1.000000e+0	8.929898e-1	9.299485e+1	1.075328e-2	1	194	1.000000e+0	5.154639e-3	unnamed	MSH2
MSigDB Immunologic Signatures	GSE3982_BASOPHIL_VS_TH1_DN	Genes down-regulated in comparison of basophils versus Th1 cells.	16	1.586461e-2	1.000000e+0	1.000000e+0	6.303338e+1	1.586461e-2	1	1.586461e-2	1.000000e+0	13	1.053157e-2	1.000000e+0	1.000000e+0	9.495263e+1	1.053157e-2	1	190	1.000000e+0	5.263158e-3	unnamed	MSH2
MSigDB Immunologic Signatures	GSE3982_MEMORY_CD4_TCELL_VS_TH2_DN	Genes down-regulated in comparison of memory CD4 [GeneID=920] T cells versus Th2 cells.	17	1.608243e-2	1.000000e+0	1.000000e+0	6.217967e+1	1.608243e-2	1	1.608243e-2	1.000000e+0	40	1.180644e-2	1.000000e+0	5.637575e-1	8.469953e+1	1.180644e-2	1	213	1.000000e+0	4.694836e-3	unnamed	MSH2
MSigDB Immunologic Signatures	GSE1460_INTRATHYMIC_T_PROGENITOR_VS_THYMIC_STROMAL_CELL_UP	Genes up-regulated in comparison of intrathymic T progenitor cells (ITTP) versus thymic stromal cells.	18	1.658251e-2	1.000000e+0	1.000000e+0	6.030451e+1	1.658251e-2	1	1.658251e-2	1.000000e+0	8	1.036528e-2	1.000000e+0	1.000000e+0	9.647594e+1	1.036528e-2	1	187	1.000000e+0	5.347594e-3	unnamed	MSH2
MSigDB Immunologic Signatures	GSE27786_NKCELL_VS_MONO_MAC_UP	Genes up-regulated in comparison of NK cells versus monocyte macrophages.	19	1.665736e-2	1.000000e+0	1.000000e+0	6.003353e+1	1.665736e-2	1	1.665736e-2	1.000000e+0	24	1.080871e-2	1.000000e+0	8.601932e-1	9.251795e+1	1.080871e-2	1	195	1.000000e+0	5.128205e-3	unnamed	MSH2
MSigDB Immunologic Signatures	GSE3982_MEMORY_CD4_TCELL_VS_TH1_DN	Genes down-regulated in comparison of memory CD4 [GeneID=920] T cells versus Th1 cells.	20	1.678214e-2	1.000000e+0	1.000000e+0	5.958715e+1	1.678214e-2	1	1.678214e-2	1.000000e+0	31	1.114129e-2	1.000000e+0	6.864472e-1	8.975622e+1	1.114129e-2	1	201	1.000000e+0	4.975124e-3	unnamed	MSH2
MSigDB Immunologic Signatures	GSE27786_CD8_TCELL_VS_NKCELL_UP	Genes up-regulated in comparison of CD8 T cells versus NK cells.	21	1.683751e-2	1.000000e+0	1.000000e+0	5.939121e+1	1.683751e-2	1	1.683751e-2	1.000000e+0	13	1.053157e-2	1.000000e+0	1.000000e+0	9.495263e+1	1.053157e-2	1	190	1.000000e+0	5.263158e-3	unnamed	MSH2
MSigDB Immunologic Signatures	GSE360_T_GONDII_VS_M_TUBERCULOSIS_MAC_UP	Genes up-regulated in comparison of macrophages exposed to T. gondii versus macrophages exposed to M. tuberculosis.	22	1.695740e-2	1.000000e+0	1.000000e+0	5.897129e+1	1.695740e-2	1	1.695740e-2	1.000000e+0	35	1.136301e-2	1.000000e+0	6.200957e-1	8.800488e+1	1.136301e-2	1	205	1.000000e+0	4.878049e-3	unnamed	MSH2
MSigDB Immunologic Signatures	GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_16H_UP	Genes up-regulated in comparison of control conventional dendritic cells (cDC) at 0 h versus cDCs infected with Newcastle disease virus (NDV) at 16 h.	23	1.718212e-2	1.000000e+0	1.000000e+0	5.820004e+1	1.718212e-2	1	1.718212e-2	1.000000e+0	18	1.058700e-2	1.000000e+0	1.000000e+0	9.445550e+1	1.058700e-2	1	191	1.000000e+0	5.235602e-3	unnamed	MSH2
MSigDB Immunologic Signatures	GSE360_CTRL_VS_T_GONDII_MAC_DN	Genes down-regulated in comparison of macrophages versus macrophages exposed to T. gondii.	24	1.718937e-2	1.000000e+0	1.000000e+0	5.817548e+1	1.718937e-2	1	1.718937e-2	1.000000e+0	30	1.108586e-2	1.000000e+0	7.057998e-1	9.020500e+1	1.108586e-2	1	200	1.000000e+0	5.000000e-3	unnamed	MSH2
MSigDB Immunologic Signatures	GSE3982_NKCELL_VS_TH2_DN	Genes down-regulated in comparison of NK cells versus Th2 cells.	25	1.720574e-2	1.000000e+0	1.000000e+0	5.812015e+1	1.720574e-2	1	1.720574e-2	1.000000e+0	37	1.147387e-2	1.000000e+0	5.922998e-1	8.715459e+1	1.147387e-2	1	207	1.000000e+0	4.830918e-3	unnamed	MSH2
MSigDB Immunologic Signatures	GSE1432_CTRL_VS_IFNG_6H_MICROGLIA_UP	Genes up-regulated in comparison of control microglia cells versus those 6 h after stimulation with IFNG [GeneID=3458].	26	1.736983e-2	1.000000e+0	1.000000e+0	5.757108e+1	1.736983e-2	1	1.736983e-2	1.000000e+0	10	1.042071e-2	1.000000e+0	1.000000e+0	9.596277e+1	1.042071e-2	1	188	1.000000e+0	5.319149e-3	unnamed	MSH2
MSigDB Immunologic Signatures	GSE3982_NKCELL_VS_TH1_DN	Genes down-regulated in comparison of NK cells versus Th1 cells.	27	1.767959e-2	1.000000e+0	1.000000e+0	5.656238e+1	1.767959e-2	1	1.767959e-2	1.000000e+0	24	1.080871e-2	1.000000e+0	8.601932e-1	9.251795e+1	1.080871e-2	1	195	1.000000e+0	5.128205e-3	unnamed	MSH2
MSigDB Immunologic Signatures	GSE360_T_GONDII_VS_B_MALAYI_HIGH_DOSE_MAC_UP	Genes up-regulated in comparison of macrophages exposed to T. gondii versus  macrophages exposed to 50 worms/well B. malayi.	28	1.809191e-2	1.000000e+0	1.000000e+0	5.527332e+1	1.809191e-2	1	1.809191e-2	1.000000e+0	35	1.136301e-2	1.000000e+0	6.200957e-1	8.800488e+1	1.136301e-2	1	205	1.000000e+0	4.878049e-3	unnamed	MSH2
MSigDB Immunologic Signatures	GSE27786_NKCELL_VS_NKTCELL_DN	Genes down-regulated in comparison of NK cells versus NKT cells.	29	1.870951e-2	1.000000e+0	1.000000e+0	5.344875e+1	1.870951e-2	1	1.870951e-2	1.000000e+0	3	1.019899e-2	1.000000e+0	1.000000e+0	9.804891e+1	1.019899e-2	1	184	1.000000e+0	5.434783e-3	unnamed	MSH2
MSigDB Immunologic Signatures	GSE3982_MAST_CELL_VS_TH1_DN	Genes down-regulated in comparison of mast cells versus Th1 cells.	30	1.880871e-2	1.000000e+0	1.000000e+0	5.316686e+1	1.880871e-2	1	1.880871e-2	1.000000e+0	21	1.069785e-2	1.000000e+0	9.729949e-1	9.347668e+1	1.069785e-2	1	193	1.000000e+0	5.181347e-3	unnamed	MSH2
MSigDB Immunologic Signatures	GSE360_L_DONOVANI_VS_L_MAJOR_MAC_UP	Genes up-regulated in comparison of macrophages exposed to L. donovani versus macrophages exposed to L. major.	31	1.884169e-2	1.000000e+0	1.000000e+0	5.307378e+1	1.884169e-2	1	1.884169e-2	1.000000e+0	29	1.103043e-2	1.000000e+0	7.264869e-1	9.065829e+1	1.103043e-2	1	199	1.000000e+0	5.025126e-3	unnamed	MSH2
MSigDB Immunologic Signatures	GSE360_L_DONOVANI_VS_T_GONDII_DC_DN	Genes down-regulated in comparison of dendritic cells (DC) exposed to L. donovani versus DCs exposed to T. gondii.	32	1.891202e-2	1.000000e+0	1.000000e+0	5.287643e+1	1.891202e-2	1	1.891202e-2	1.000000e+0	24	1.080871e-2	1.000000e+0	8.601932e-1	9.251795e+1	1.080871e-2	1	195	1.000000e+0	5.128205e-3	unnamed	MSH2
MSigDB Immunologic Signatures	GSE1460_INTRATHYMIC_T_PROGENITOR_VS_NAIVE_CD4_TCELL_CORD_BLOOD_UP	Genes up-regulated in comparison of intrathymic T progenitor cells (ITTP) versus naive CD4 [GeneID=920] T cells from cord blood.	33	1.927061e-2	1.000000e+0	1.000000e+0	5.189250e+1	1.927061e-2	1	1.927061e-2	1.000000e+0	38	1.158472e-2	1.000000e+0	5.822846e-1	8.632057e+1	1.158472e-2	1	209	1.000000e+0	4.784689e-3	unnamed	MSH2
MSigDB Immunologic Signatures	GSE3982_EFF_MEMORY_VS_CENT_MEMORY_CD4_TCELL_DN	Genes down-regulated in comparison of effective memory CD4 [GeneID=920] T cells versus central memory CD4 [GeneID=920] T cells.	34	2.011301e-2	1.000000e+0	1.000000e+0	4.971907e+1	2.011301e-2	1	2.011301e-2	1.000000e+0	13	1.053157e-2	1.000000e+0	1.000000e+0	9.495263e+1	1.053157e-2	1	190	1.000000e+0	5.263158e-3	unnamed	MSH2
MSigDB Immunologic Signatures	GSE2706_R848_VS_R848_AND_LPS_8H_STIM_DC_UP	Genes up-regulated in comparison of dendritic cells (DC) stimulated with R848 at 8 h versus DCs stimulated with LPS (TLR4 agonist) and R848 for 8 h.	35	2.047346e-2	1.000000e+0	1.000000e+0	4.884371e+1	2.047346e-2	1	2.047346e-2	1.000000e+0	1	9.478410e-3	1.000000e+0	1.000000e+0	1.055029e+2	9.478410e-3	1	171	1.000000e+0	5.847953e-3	unnamed	MSH2
MSigDB Immunologic Signatures	GSE1460_CD4_THYMOCYTE_VS_NAIVE_CD4_TCELL_CORD_BLOOD_UP	Genes up-regulated in comparison of CD4 [GeneID=920] thymocytes versus naive CD4 [GeneID=920] T cells from cord blood.	36	2.191022e-2	1.000000e+0	1.000000e+0	4.564081e+1	2.191022e-2	1	2.191022e-2	1.000000e+0	31	1.114129e-2	1.000000e+0	6.864472e-1	8.975622e+1	1.114129e-2	1	201	1.000000e+0	4.975124e-3	unnamed	MSH2
MSigDB Immunologic Signatures	GSE22886_NAIVE_TCELL_VS_MONOCYTE_UP	Genes up-regulated in comparison of naive CD4 [GeneID=920] CD8 T cells versus monocytes cultured for 0 days.	37	2.217254e-2	1.000000e+0	1.000000e+0	4.510083e+1	2.217254e-2	1	2.217254e-2	1.000000e+0	8	1.036528e-2	1.000000e+0	1.000000e+0	9.647594e+1	1.036528e-2	1	187	1.000000e+0	5.347594e-3	unnamed	MSH2
MSigDB Immunologic Signatures	GSE1460_CD4_THYMOCYTE_VS_NAIVE_CD4_TCELL_ADULT_BLOOD_UP	Genes up-regulated in comparison of CD4 [GeneID=920] thymocytes versus naive CD4 [GeneID=920] T cells from adult blood.	38	2.231274e-2	1.000000e+0	1.000000e+0	4.481744e+1	2.231274e-2	1	2.231274e-2	1.000000e+0	34	1.125215e-2	1.000000e+0	6.321061e-1	8.887192e+1	1.125215e-2	1	203	1.000000e+0	4.926108e-3	unnamed	MSH2
MSigDB Immunologic Signatures	GSE22886_NAIVE_CD8_TCELL_VS_MONOCYTE_UP	Genes up-regulated in comparison of naive CD8 T cells versus day 0 monocytes.	39	2.394608e-2	1.000000e+0	1.000000e+0	4.176049e+1	2.394608e-2	1	2.394608e-2	1.000000e+0	20	1.064243e-2	1.000000e+0	1.000000e+0	9.396354e+1	1.064243e-2	1	192	1.000000e+0	5.208333e-3	unnamed	MSH2
MSigDB Immunologic Signatures	GSE10325_CD4_TCELL_VS_MYELOID_UP	Genes up-regulated in comparison of healthy CD4 [GeneID=920] T cells versus healthy myeloid cells.	40	2.519278e-2	1.000000e+0	1.000000e+0	3.969391e+1	2.519278e-2	1	2.519278e-2	1.000000e+0	10	1.042071e-2	1.000000e+0	1.000000e+0	9.596277e+1	1.042071e-2	1	188	1.000000e+0	5.319149e-3	unnamed	MSH2
#
# Ontology	TermsTested	MinAnnotCount	MaxAnnotCount
#
# GO Molecular Function	3688	1	Inf
# GO Biological Process	10440	1	Inf
# GO Cellular Component	1265	1	Inf
# Mouse Phenotype	7918	1	Inf
# Human Phenotype	6146	1	Inf
# Disease Ontology	2235	1	Inf
# MSigDB Cancer Neighborhood	427	1	Inf
# Placenta Disorders	3	1	Inf
# PANTHER Pathway	152	1	Inf
# BioCyc Pathway	332	1	Inf
# MSigDB Pathway	1320	1	Inf
# MGI Expression: Detected	9337	1	Inf
# MSigDB Perturbation	3364	1	Inf
# MSigDB Predicted Promoter Motifs	615	1	Inf
# MSigDB miRNA Motifs	221	1	Inf
# InterPro	9422	1	Inf
# TreeFam	8126	1	Inf
# HGNC Gene Families	478	1	Inf
# Ensembl Genes	18041	1	Inf
# MSigDB Oncogenic Signatures	187	1	Inf
# MSigDB Immunologic Signatures	1910	1	Inf
